DrugA,DrugB,Interaction,Mechanism,risk_level
Apixaban,Oxycodone,The metabolism of Apixaban can be decreased when combined with Oxycodone.,decrease,no risk
Apixaban,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Apixaban.,increase,risk
Apixaban,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Quetiapine,The metabolism of Apixaban can be decreased when combined with Quetiapine.,decrease,no risk
Apixaban,Quinestrol,Quinestrol may decrease the anticoagulant activities of Apixaban.,decrease,no risk
Apixaban,Quinidine,The therapeutic efficacy of Apixaban can be increased when used in combination with Quinidine.,increase,no risk
Apixaban,Quinine,The therapeutic efficacy of Apixaban can be increased when used in combination with Quinine.,increase,no risk
Apixaban,Quizartinib,The serum concentration of Apixaban can be increased when it is combined with Quizartinib.,increase,no risk
Apixaban,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Udenafil,The metabolism of Apixaban can be decreased when combined with Udenafil.,decrease,no risk
Apixaban,Ulipristal,The therapeutic efficacy of Apixaban can be decreased when used in combination with Ulipristal.,decrease,no risk
Apixaban,Umbralisib,The serum concentration of Apixaban can be increased when it is combined with Umbralisib.,increase,no risk
Apixaban,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Urokinase,Apixaban may increase the anticoagulant activities of Urokinase.,increase,no risk
Apixaban,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Apixaban is combined with Ursodeoxycholic acid.,increase,risk
Apixaban,Vadadustat,The serum concentration of Apixaban can be increased when it is combined with Vadadustat.,increase,no risk
Apixaban,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Apixaban.,increase,risk
Apixaban,Valproic acid,The metabolism of Apixaban can be decreased when combined with Valproic acid.,decrease,no risk
Apixaban,Valsartan,The metabolism of Apixaban can be decreased when combined with Valsartan.,decrease,no risk
Apixaban,Vandetanib,Vandetanib may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Vardenafil,The serum concentration of Apixaban can be increased when it is combined with Vardenafil.,increase,no risk
Apixaban,Velpatasvir,Velpatasvir may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Vemurafenib,The serum concentration of Apixaban can be increased when it is combined with Vemurafenib.,increase,no risk
Apixaban,Venetoclax,The metabolism of Apixaban can be decreased when combined with Venetoclax.,decrease,no risk
Apixaban,Venlafaxine,The risk or severity of bleeding can be increased when Apixaban is combined with Venlafaxine.,increase,risk
Apixaban,Verapamil,The metabolism of Apixaban can be decreased when combined with Verapamil.,decrease,no risk
Apixaban,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Viloxazine,The metabolism of Apixaban can be decreased when combined with Viloxazine.,decrease,no risk
Apixaban,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Vincristine,The metabolism of Vincristine can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Vindesine,The risk or severity of bleeding can be increased when Apixaban is combined with Vindesine.,increase,risk
Apixaban,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Vinorelbine,The risk or severity of bleeding can be increased when Apixaban is combined with Vinorelbine.,increase,risk
Apixaban,Vismodegib,Vismodegib may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Vitamin E,Vitamin E may increase the anticoagulant activities of Apixaban.,increase,no risk
Apixaban,Voclosporin,The serum concentration of Apixaban can be increased when it is combined with Voclosporin.,increase,no risk
Apixaban,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Apixaban.,decrease,no risk
Apixaban,Vonoprazan,The metabolism of Apixaban can be decreased when combined with Vonoprazan.,decrease,no risk
Apixaban,Vorapaxar,Apixaban may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Apixaban,Voriconazole,The metabolism of Apixaban can be decreased when combined with Voriconazole.,decrease,no risk
Apixaban,Vorinostat,The risk or severity of bleeding can be increased when Apixaban is combined with Vorinostat.,increase,risk
Apixaban,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Warfarin,Apixaban may increase the anticoagulant activities of Warfarin.,increase,no risk
Apixaban,Ximelagatran,Apixaban may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Apixaban,Zafirlukast,The metabolism of Apixaban can be decreased when combined with Zafirlukast.,decrease,no risk
Apixaban,Zaleplon,The metabolism of Apixaban can be decreased when combined with Zaleplon.,decrease,no risk
Apixaban,Zidovudine,The metabolism of Apixaban can be decreased when combined with Zidovudine.,decrease,no risk
Apixaban,Zileuton,The metabolism of Apixaban can be decreased when combined with Zileuton.,decrease,no risk
Apixaban,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Apixaban.,increase,risk
Apixaban,Ziprasidone,The metabolism of Apixaban can be decreased when combined with Ziprasidone.,decrease,no risk
Apixaban,Zolpidem,The metabolism of Apixaban can be decreased when combined with Zolpidem.,decrease,no risk
Apixaban,Zonisamide,The serum concentration of Apixaban can be increased when it is combined with Zonisamide.,increase,no risk
Apixaban,Zopiclone,The metabolism of Apixaban can be decreased when combined with Zopiclone.,decrease,no risk
Teplizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Teplizumab.,increase,risk
Teplizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Teplizumab is combined with Obinutuzumab.,increase,risk
Teplizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Teplizumab is combined with Ocrelizumab.,increase,risk
Teplizumab,Odesivimab,The risk or severity of adverse effects can be increased when Teplizumab is combined with Odesivimab.,increase,risk
Teplizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Teplizumab is combined with Ofatumumab.,increase,risk
Teplizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Teplizumab.,increase,risk
Teplizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Teplizumab.,increase,risk
Teplizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Teplizumab.,increase,no risk
Teplizumab,Ublituximab,The risk or severity of adverse effects can be increased when Teplizumab is combined with Ublituximab.,increase,risk
Teplizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Teplizumab.,increase,risk
Teplizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Teplizumab is combined with Vedolizumab.,increase,risk
Catumaxomab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Catumaxomab.,increase,risk
Catumaxomab,Obinutuzumab,The risk or severity of adverse effects can be increased when Catumaxomab is combined with Obinutuzumab.,increase,risk
Catumaxomab,Ocrelizumab,The risk or severity of adverse effects can be increased when Catumaxomab is combined with Ocrelizumab.,increase,risk
Catumaxomab,Odesivimab,The risk or severity of adverse effects can be increased when Catumaxomab is combined with Odesivimab.,increase,risk
Catumaxomab,Ofatumumab,The risk or severity of adverse effects can be increased when Catumaxomab is combined with Ofatumumab.,increase,risk
Catumaxomab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Catumaxomab.,increase,risk
Catumaxomab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Catumaxomab.,increase,risk
Catumaxomab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Catumaxomab is combined with Oxetacaine.,increase,risk
Catumaxomab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Catumaxomab is combined with Oxybuprocaine.,increase,risk
Catumaxomab,Quinestrol,Quinestrol may increase the thrombogenic activities of Catumaxomab.,increase,no risk
Catumaxomab,Ublituximab,The risk or severity of adverse effects can be increased when Catumaxomab is combined with Ublituximab.,increase,risk
Catumaxomab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Catumaxomab.,increase,risk
Catumaxomab,Vedolizumab,The risk or severity of adverse effects can be increased when Catumaxomab is combined with Vedolizumab.,increase,risk
Tafenoquine,Galantamine,The metabolism of Tafenoquine can be decreased when combined with Galantamine.,decrease,no risk
Tafenoquine,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Gefitinib,The metabolism of Tafenoquine can be decreased when combined with Gefitinib.,decrease,no risk
Tafenoquine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Tafenoquine.,increase,no risk
Tafenoquine,Givosiran,The serum concentration of Tafenoquine can be increased when it is combined with Givosiran.,increase,no risk
Tafenoquine,Glycerol phenylbutyrate,The metabolism of Tafenoquine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Tafenoquine,Golimumab,The metabolism of Tafenoquine can be increased when combined with Golimumab.,increase,no risk
Tafenoquine,Guanidine,The excretion of Guanidine can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Halofantrine,The metabolism of Tafenoquine can be decreased when combined with Halofantrine.,decrease,no risk
Tafenoquine,Haloperidol,The serum concentration of Tafenoquine can be increased when it is combined with Haloperidol.,increase,no risk
Tafenoquine,Histamine,The serum concentration of Histamine can be increased when it is combined with Tafenoquine.,increase,no risk
Tafenoquine,Hydroxychloroquine,The metabolism of Tafenoquine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Tafenoquine,Hydroxyzine,The metabolism of Tafenoquine can be decreased when combined with Hydroxyzine.,decrease,no risk
Tafenoquine,Ketoconazole,The metabolism of Tafenoquine can be decreased when combined with Ketoconazole.,decrease,no risk
Tafenoquine,Olanzapine,The metabolism of Tafenoquine can be decreased when combined with Olanzapine.,decrease,no risk
Tafenoquine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Ondansetron,The metabolism of Tafenoquine can be decreased when combined with Ondansetron.,decrease,no risk
Tafenoquine,Opium,The metabolism of Opium can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Oritavancin,The metabolism of Tafenoquine can be decreased when combined with Oritavancin.,decrease,no risk
Tafenoquine,Orphenadrine,The metabolism of Tafenoquine can be decreased when combined with Orphenadrine.,decrease,no risk
Tafenoquine,Osilodrostat,The metabolism of Tafenoquine can be decreased when combined with Osilodrostat.,decrease,no risk
Tafenoquine,Ospemifene,The metabolism of Tafenoquine can be decreased when combined with Ospemifene.,decrease,no risk
Tafenoquine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Tafenoquine.,increase,no risk
Tafenoquine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Tafenoquine.,increase,no risk
Tafenoquine,Oxamniquine,The metabolism of Tafenoquine can be decreased when combined with Oxamniquine.,decrease,no risk
Tafenoquine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tafenoquine is combined with Oxetacaine.,increase,risk
Tafenoquine,Oxprenolol,The metabolism of Tafenoquine can be decreased when combined with Oxprenolol.,decrease,no risk
Tafenoquine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tafenoquine is combined with Oxybuprocaine.,increase,risk
Tafenoquine,Oxybutynin,The metabolism of Tafenoquine can be decreased when combined with Oxybutynin.,decrease,no risk
Tafenoquine,Oxycodone,The metabolism of Tafenoquine can be decreased when combined with Oxycodone.,decrease,no risk
Tafenoquine,Oxymorphone,The metabolism of Tafenoquine can be decreased when combined with Oxymorphone.,decrease,no risk
Tafenoquine,Quetiapine,The metabolism of Tafenoquine can be decreased when combined with Quetiapine.,decrease,no risk
Tafenoquine,Quinidine,The metabolism of Tafenoquine can be decreased when combined with Quinidine.,decrease,no risk
Tafenoquine,Quinine,The metabolism of Tafenoquine can be decreased when combined with Quinine.,decrease,no risk
Tafenoquine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Varenicline,The excretion of Varenicline can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Tafenoquine.,increase,risk
Tafenoquine,Venlafaxine,The metabolism of Tafenoquine can be decreased when combined with Venlafaxine.,decrease,no risk
Tafenoquine,Verapamil,The metabolism of Tafenoquine can be decreased when combined with Verapamil.,decrease,no risk
Tafenoquine,Vernakalant,The metabolism of Tafenoquine can be decreased when combined with Vernakalant.,decrease,no risk
Tafenoquine,Vilazodone,The metabolism of Tafenoquine can be decreased when combined with Vilazodone.,decrease,no risk
Tafenoquine,Viloxazine,The metabolism of Tafenoquine can be decreased when combined with Viloxazine.,decrease,no risk
Tafenoquine,Vinblastine,The metabolism of Tafenoquine can be decreased when combined with Vinblastine.,decrease,no risk
Tafenoquine,Vinorelbine,The metabolism of Tafenoquine can be decreased when combined with Vinorelbine.,decrease,no risk
Tafenoquine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Tafenoquine.,decrease,no risk
Tafenoquine,Yohimbine,The metabolism of Tafenoquine can be decreased when combined with Yohimbine.,decrease,no risk
Tafenoquine,Zolpidem,The metabolism of Tafenoquine can be decreased when combined with Zolpidem.,decrease,no risk
Tafenoquine,Zuclopenthixol,The metabolism of Tafenoquine can be decreased when combined with Zuclopenthixol.,decrease,no risk
Mepolizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Galcanezumab.,increase,risk
Mepolizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mepolizumab.,increase,risk
Mepolizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mepolizumab.,increase,risk
Mepolizumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Mepolizumab.,increase,risk
Mepolizumab,Glofitamab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Glofitamab.,increase,risk
Mepolizumab,Golimumab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Golimumab.,increase,risk
Mepolizumab,Guselkumab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Guselkumab.,increase,risk
Mepolizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Mepolizumab.,decrease,no risk
Mepolizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Mepolizumab.,decrease,no risk
Mepolizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Mepolizumab.,increase,risk
Mepolizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Mepolizumab.,decrease,no risk
Mepolizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Mepolizumab.,increase,risk
Mepolizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Mepolizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Mepolizumab.,increase,risk
Mepolizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Human Rho(D) immune globulin.,increase,risk
Mepolizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Mepolizumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Hydrocortisone acetate.,increase,risk
Mepolizumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Hydrocortisone butyrate.,increase,risk
Mepolizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Hydrocortisone succinate.,increase,risk
Mepolizumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Mepolizumab.,increase,risk
Mepolizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Mepolizumab.,increase,risk
Mepolizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Mepolizumab.,decrease,no risk
Mepolizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Mepolizumab.,decrease,no risk
Mepolizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Mepolizumab.,increase,risk
Mepolizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Obinutuzumab.,increase,risk
Mepolizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Ocrelizumab.,increase,risk
Mepolizumab,Odesivimab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Odesivimab.,increase,risk
Mepolizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Ofatumumab.,increase,risk
Mepolizumab,Olaparib,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Olaparib.,increase,risk
Mepolizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Mepolizumab.,increase,risk
Mepolizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Mepolizumab.,increase,risk
Mepolizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Mepolizumab.,increase,risk
Mepolizumab,Ozanimod,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Ozanimod.,increase,risk
Mepolizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Mepolizumab.,increase,no risk
Mepolizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Mepolizumab.,increase,risk
Mepolizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Upadacitinib.,increase,risk
Mepolizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Mepolizumab.,increase,risk
Mepolizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Mepolizumab.,increase,risk
Mepolizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Mepolizumab.,decrease,no risk
Mepolizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Vedolizumab.,increase,risk
Mepolizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mepolizumab.,decrease,no risk
Mepolizumab,Vilanterol,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Vilanterol.,increase,risk
Mepolizumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Mepolizumab.,increase,risk
Mepolizumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Mepolizumab.,increase,risk
Mepolizumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Mepolizumab.,increase,risk
Mepolizumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Mepolizumab.,increase,risk
Mepolizumab,Voclosporin,The risk or severity of adverse effects can be increased when Mepolizumab is combined with Voclosporin.,increase,risk
Mepolizumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Mepolizumab.,increase,risk
Mepolizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Mepolizumab.,increase,risk
Mepolizumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Mepolizumab.,increase,risk
Bosutinib,Berotralstat,The serum concentration of Bosutinib can be increased when it is combined with Berotralstat.,increase,no risk
Bosutinib,Betamethasone,The metabolism of Bosutinib can be increased when combined with Betamethasone.,increase,no risk
Bosutinib,Betamethasone phosphate,The metabolism of Bosutinib can be increased when combined with Betamethasone phosphate.,increase,no risk
Bosutinib,Betrixaban,The serum concentration of Bosutinib can be increased when it is combined with Betrixaban.,increase,no risk
Bosutinib,Bexarotene,The metabolism of Bosutinib can be increased when combined with Bexarotene.,increase,no risk
Bosutinib,Bicalutamide,The metabolism of Bosutinib can be decreased when combined with Bicalutamide.,decrease,no risk
Bosutinib,Bifonazole,The metabolism of Bosutinib can be decreased when combined with Bifonazole.,decrease,no risk
Bosutinib,Bimekizumab,The metabolism of Bosutinib can be increased when combined with Bimekizumab.,increase,no risk
Bosutinib,Binimetinib,The serum concentration of Bosutinib can be increased when it is combined with Binimetinib.,increase,no risk
Bosutinib,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bosutinib,Bisoprolol,The serum concentration of Bosutinib can be increased when it is combined with Bisoprolol.,increase,no risk
Bosutinib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Bosutinib.,increase,risk
Bosutinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Bosutinib.,increase,risk
Bosutinib,Blinatumomab,The risk or severity of adverse effects can be increased when Bosutinib is combined with Blinatumomab.,increase,risk
Bosutinib,Boceprevir,The metabolism of Bosutinib can be decreased when combined with Boceprevir.,decrease,no risk
Bosutinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Bosutinib.",decrease,no risk
Bosutinib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Bosentan,The metabolism of Bosutinib can be increased when combined with Bosentan.,increase,no risk
Bosutinib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Brodalumab,The risk or severity of adverse effects can be increased when Bosutinib is combined with Brodalumab.,increase,risk
Bosutinib,Budesonide,The metabolism of Bosutinib can be increased when combined with Budesonide.,increase,no risk
Bosutinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Bupivacaine.,increase,risk
Bosutinib,Buprenorphine,The metabolism of Bosutinib can be decreased when combined with Buprenorphine.,decrease,no risk
Bosutinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Butacaine.,increase,risk
Bosutinib,Butalbital,The metabolism of Bosutinib can be increased when combined with Butalbital.,increase,no risk
Bosutinib,Butamben,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Butamben.,increase,risk
Bosutinib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bosutinib.,increase,risk
Bosutinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bosutinib.,increase,risk
Bosutinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Bosutinib.,increase,no risk
Bosutinib,Gilteritinib,The metabolism of Bosutinib can be decreased when combined with Gilteritinib.,decrease,no risk
Bosutinib,Ginkgo biloba,The metabolism of Bosutinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Bosutinib,Glasdegib,The serum concentration of Bosutinib can be increased when it is combined with Glasdegib.,increase,no risk
Bosutinib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Bosutinib.,increase,risk
Bosutinib,Glecaprevir,The serum concentration of Bosutinib can be increased when it is combined with Glecaprevir.,increase,no risk
Bosutinib,Glofitamab,The serum concentration of Bosutinib can be increased when it is combined with Glofitamab.,increase,no risk
Bosutinib,Glyburide,The metabolism of Bosutinib can be decreased when combined with Glyburide.,decrease,no risk
Bosutinib,Glycerol phenylbutyrate,The metabolism of Bosutinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Bosutinib,Golimumab,The metabolism of Bosutinib can be increased when combined with Golimumab.,increase,no risk
Bosutinib,Grapefruit,The serum concentration of Bosutinib can be increased when it is combined with Grapefruit.,increase,no risk
Bosutinib,Grazoprevir,The serum concentration of Bosutinib can be increased when it is combined with Grazoprevir.,increase,no risk
Bosutinib,Griseofulvin,The metabolism of Bosutinib can be increased when combined with Griseofulvin.,increase,no risk
Bosutinib,Guselkumab,The risk or severity of adverse effects can be increased when Bosutinib is combined with Guselkumab.,increase,risk
Bosutinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Bosutinib.,decrease,no risk
Bosutinib,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Bosutinib.,increase,no risk
Bosutinib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Bosutinib.,increase,risk
Bosutinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Bosutinib.,decrease,no risk
Bosutinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Bosutinib.,decrease,no risk
Bosutinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Bosutinib.,increase,risk
Bosutinib,Hydralazine,The serum concentration of Bosutinib can be increased when it is combined with Hydralazine.,increase,no risk
Bosutinib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Bosutinib.,increase,risk
Bosutinib,Hydrocortamate,The metabolism of Bosutinib can be increased when combined with Hydrocortamate.,increase,no risk
Bosutinib,Hydrocortisone,The metabolism of Bosutinib can be increased when combined with Hydrocortisone.,increase,no risk
Bosutinib,Hydrocortisone acetate,The metabolism of Bosutinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Bosutinib,Hydrocortisone butyrate,The metabolism of Bosutinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Bosutinib,Hydrocortisone succinate,The metabolism of Bosutinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Bosutinib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Bosutinib.,increase,risk
Bosutinib,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bosutinib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Bosutinib.,increase,risk
Bosutinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Bosutinib.,increase,risk
Bosutinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bosutinib.,decrease,no risk
Bosutinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Bosutinib.,decrease,no risk
Bosutinib,Ketamine,The metabolism of Ketamine can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Ketazolam,The serum concentration of Bosutinib can be increased when it is combined with Ketazolam.,increase,no risk
Bosutinib,Ketoconazole,The serum concentration of Bosutinib can be increased when it is combined with Ketoconazole.,increase,no risk
Bosutinib,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Bosutinib is combined with Obinutuzumab.,increase,risk
Bosutinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Bosutinib is combined with Ocrelizumab.,increase,risk
Bosutinib,Octreotide,The serum concentration of Bosutinib can be increased when it is combined with Octreotide.,increase,no risk
Bosutinib,Ofatumumab,The risk or severity of adverse effects can be increased when Bosutinib is combined with Ofatumumab.,increase,risk
Bosutinib,Olanzapine,Olanzapine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bosutinib,Olaparib,The metabolism of Bosutinib can be decreased when combined with Olaparib.,decrease,no risk
Bosutinib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Olutasidenib,The metabolism of Bosutinib can be increased when combined with Olutasidenib.,increase,no risk
Bosutinib,Omadacycline,The serum concentration of Bosutinib can be increased when it is combined with Omadacycline.,increase,no risk
Bosutinib,Omaveloxolone,The serum concentration of Bosutinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Bosutinib,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Omeprazole,Omeprazole can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bosutinib,Oritavancin,The metabolism of Bosutinib can be increased when combined with Oritavancin.,increase,no risk
Bosutinib,Orphenadrine,The metabolism of Bosutinib can be decreased when combined with Orphenadrine.,decrease,no risk
Bosutinib,Osilodrostat,The serum concentration of Bosutinib can be increased when it is combined with Osilodrostat.,increase,no risk
Bosutinib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Bosutinib.,increase,risk
Bosutinib,Oxcarbazepine,The metabolism of Bosutinib can be increased when combined with Oxcarbazepine.,increase,no risk
Bosutinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Oxetacaine.,increase,risk
Bosutinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Oxybuprocaine.,increase,risk
Bosutinib,Oxybutynin,The serum concentration of Bosutinib can be increased when it is combined with Oxybutynin.,increase,no risk
Bosutinib,Ozanimod,The risk or severity of adverse effects can be increased when Bosutinib is combined with Ozanimod.,increase,risk
Bosutinib,Quinidine,The serum concentration of Bosutinib can be increased when it is combined with Quinidine.,increase,no risk
Bosutinib,Quinine,The serum concentration of Bosutinib can be increased when it is combined with Quinine.,increase,no risk
Bosutinib,Quinupristin,The metabolism of Bosutinib can be decreased when combined with Quinupristin.,decrease,no risk
Bosutinib,Quizartinib,The serum concentration of Bosutinib can be increased when it is combined with Quizartinib.,increase,no risk
Bosutinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Bosutinib.,increase,risk
Bosutinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Bosutinib.,increase,no risk
Bosutinib,Umbralisib,The serum concentration of Bosutinib can be increased when it is combined with Umbralisib.,increase,no risk
Bosutinib,Umeclidinium,The serum concentration of Bosutinib can be increased when it is combined with Umeclidinium.,increase,no risk
Bosutinib,Upadacitinib,The risk or severity of adverse effects can be increased when Bosutinib is combined with Upadacitinib.,increase,risk
Bosutinib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Bosutinib.,increase,risk
Bosutinib,Vadadustat,The serum concentration of Bosutinib can be increased when it is combined with Vadadustat.,increase,no risk
Bosutinib,Valproic acid,The serum concentration of Bosutinib can be increased when it is combined with Valproic acid.,increase,no risk
Bosutinib,Vandetanib,The serum concentration of Bosutinib can be increased when it is combined with Vandetanib.,increase,no risk
Bosutinib,Vardenafil,The serum concentration of Bosutinib can be increased when it is combined with Vardenafil.,increase,no risk
Bosutinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Bosutinib.,increase,risk
Bosutinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Bosutinib.,decrease,no risk
Bosutinib,Vedolizumab,The risk or severity of adverse effects can be increased when Bosutinib is combined with Vedolizumab.,increase,risk
Bosutinib,Velpatasvir,The serum concentration of Bosutinib can be increased when it is combined with Velpatasvir.,increase,no risk
Bosutinib,Vemurafenib,The serum concentration of Bosutinib can be increased when it is combined with Vemurafenib.,increase,no risk
Bosutinib,Venetoclax,The serum concentration of Bosutinib can be increased when it is combined with Venetoclax.,increase,no risk
Bosutinib,Verapamil,The serum concentration of Bosutinib can be increased when it is combined with Verapamil.,increase,no risk
Bosutinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Bosutinib.,decrease,no risk
Bosutinib,Vilanterol,The risk or severity of adverse effects can be increased when Bosutinib is combined with Vilanterol.,increase,risk
Bosutinib,Viloxazine,The serum concentration of Bosutinib can be increased when it is combined with Viloxazine.,increase,no risk
Bosutinib,Vinblastine,The metabolism of Bosutinib can be increased when combined with Vinblastine.,increase,no risk
Bosutinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Vitamin E,The metabolism of Bosutinib can be increased when combined with Vitamin E.,increase,no risk
Bosutinib,Voclosporin,The serum concentration of Bosutinib can be increased when it is combined with Voclosporin.,increase,no risk
Bosutinib,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bosutinib,Vorapaxar,The serum concentration of Bosutinib can be increased when it is combined with Vorapaxar.,increase,no risk
Bosutinib,Voriconazole,The serum concentration of Bosutinib can be increased when it is combined with Voriconazole.,increase,no risk
Bosutinib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Bosutinib.,increase,risk
Bosutinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Voxelotor,The serum concentration of Bosutinib can be increased when it is combined with Voxelotor.,increase,no risk
Bosutinib,Voxilaprevir,The serum concentration of Bosutinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Bosutinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Bosutinib.,increase,no risk
Bosutinib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Bosutinib.,increase,risk
Bosutinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Bosutinib.,increase,risk
Bosutinib,Zafirlukast,The serum concentration of Bosutinib can be increased when it is combined with Zafirlukast.,increase,no risk
Bosutinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Bosutinib.,increase,risk
Bosutinib,Zimelidine,The metabolism of Bosutinib can be decreased when combined with Zimelidine.,decrease,no risk
Bosutinib,Ziprasidone,The metabolism of Bosutinib can be decreased when combined with Ziprasidone.,decrease,no risk
Bosutinib,Zonisamide,The serum concentration of Bosutinib can be increased when it is combined with Zonisamide.,increase,no risk
Bosutinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Bosutinib.,decrease,no risk
Bosutinib,Zuclopenthixol,The metabolism of Bosutinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Flupirtine,Gabapentin enacarbil,Flupirtine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Flupirtine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Gadodiamide,Gadodiamide may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Gadofosveset trisodium,Flupirtine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Flupirtine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Gadoteric acid,Flupirtine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Flupirtine,Gadoteridol,Gadoteridol may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Ganciclovir,Ganciclovir may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Gemcitabine,Gemcitabine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Gentamicin,Flupirtine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Flupirtine,Gimeracil,Flupirtine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Flupirtine,Givosiran,Givosiran may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Glipizide,Glipizide may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Glycerol phenylbutyrate,Flupirtine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Flupirtine,Golodirsen,Flupirtine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Flupirtine,Goserelin,Goserelin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Guanethidine,Guanethidine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Guanfacine,Guanfacine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Haloperidol,Haloperidol may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Hydralazine,Hydralazine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flupirtine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flupirtine,Hydromorphone,Hydromorphone may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Hydroxyethyl Starch,Flupirtine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Flupirtine,Kanamycin,Flupirtine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Flupirtine,Ketamine,Ketamine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Ketazolam,Ketazolam may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Ketoprofen,Ketoprofen may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Ketorolac,Ketorolac may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Octinoxate,Flupirtine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Flupirtine,Olsalazine,Olsalazine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Opium,Flupirtine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Flupirtine,Oseltamivir,Oseltamivir may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Oxacillin,Oxacillin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Oxaprozin,Oxaprozin may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Oxazepam,Oxazepam may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Oxybenzone,Oxybenzone may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Oxyquinoline,Flupirtine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Flupirtine,Quetiapine,Quetiapine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Quinethazone,Quinethazone may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Flupirtine,Quinidine,Flupirtine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Flupirtine,Vaborbactam,Flupirtine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Flupirtine,Valaciclovir,Valaciclovir may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Valbenazine,Flupirtine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Flupirtine,Valdecoxib,Valdecoxib may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Valganciclovir,Valganciclovir may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Vancomycin,Flupirtine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Flupirtine,Varenicline,Varenicline may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Venlafaxine,Venlafaxine may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Verapamil,Verapamil may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Vilanterol,Flupirtine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Flupirtine,Viloxazine,Flupirtine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Flupirtine,Vortioxetine,Flupirtine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Flupirtine,Warfarin,Flupirtine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Flupirtine,Zaleplon,Zaleplon may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Zanamivir,Zanamivir may decrease the excretion rate of Flupirtine which could result in a higher serum level.,decrease,no risk
Flupirtine,Zonisamide,Zonisamide may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Taranabant,Gabapentin,The risk or severity of adverse effects can be increased when Taranabant is combined with Gabapentin.,increase,risk
Taranabant,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Taranabant is combined with Gabapentin enacarbil.,increase,risk
Taranabant,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Taranabant is combined with Gallamine triethiodide.,increase,risk
Taranabant,Ganaxolone,The risk or severity of adverse effects can be increased when Taranabant is combined with Ganaxolone.,increase,risk
Taranabant,Gepirone,The risk or severity of adverse effects can be increased when Taranabant is combined with Gepirone.,increase,risk
Taranabant,Glutethimide,The risk or severity of adverse effects can be increased when Taranabant is combined with Glutethimide.,increase,risk
Taranabant,Glycopyrronium,The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Taranabant.,increase,risk
Taranabant,Granisetron,The risk or severity of adverse effects can be increased when Taranabant is combined with Granisetron.,increase,risk
Taranabant,Guanfacine,The risk or severity of adverse effects can be increased when Taranabant is combined with Guanfacine.,increase,risk
Taranabant,Halazepam,The risk or severity of adverse effects can be increased when Taranabant is combined with Halazepam.,increase,risk
Taranabant,Haloperidol,The risk or severity of adverse effects can be increased when Taranabant is combined with Haloperidol.,increase,risk
Taranabant,Halothane,The risk or severity of adverse effects can be increased when Taranabant is combined with Halothane.,increase,risk
Taranabant,Hexafluronium,The risk or severity of adverse effects can be increased when Taranabant is combined with Hexafluronium.,increase,risk
Taranabant,Hexocyclium,The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Taranabant.,increase,risk
Taranabant,Homatropine methylbromide,The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Taranabant.,increase,risk
Taranabant,Hydrocodone,The risk or severity of adverse effects can be increased when Taranabant is combined with Hydrocodone.,increase,risk
Taranabant,Hydromorphone,The risk or severity of adverse effects can be increased when Taranabant is combined with Hydromorphone.,increase,risk
Taranabant,Hydroxyzine,The risk or severity of adverse effects can be increased when Taranabant is combined with Hydroxyzine.,increase,risk
Taranabant,Hyoscyamine,The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Taranabant.,increase,risk
Taranabant,Ketamine,The risk or severity of adverse effects can be increased when Taranabant is combined with Ketamine.,increase,risk
Taranabant,Ketazolam,The risk or severity of adverse effects can be increased when Taranabant is combined with Ketazolam.,increase,risk
Taranabant,Olanzapine,The risk or severity of adverse effects can be increased when Taranabant is combined with Olanzapine.,increase,risk
Taranabant,Oliceridine,The risk or severity of adverse effects can be increased when Taranabant is combined with Oliceridine.,increase,risk
Taranabant,Ondansetron,The risk or severity of adverse effects can be increased when Taranabant is combined with Ondansetron.,increase,risk
Taranabant,Opium,The risk or severity of adverse effects can be increased when Taranabant is combined with Opium.,increase,risk
Taranabant,Orciprenaline,The risk or severity of Tachycardia can be increased when Taranabant is combined with Orciprenaline.,increase,risk
Taranabant,Orphenadrine,The risk or severity of adverse effects can be increased when Taranabant is combined with Orphenadrine.,increase,risk
Taranabant,Oxazepam,The risk or severity of adverse effects can be increased when Taranabant is combined with Oxazepam.,increase,risk
Taranabant,Oxcarbazepine,The risk or severity of adverse effects can be increased when Taranabant is combined with Oxcarbazepine.,increase,risk
Taranabant,Oxitriptan,The risk or severity of adverse effects can be increased when Taranabant is combined with Oxitriptan.,increase,risk
Taranabant,Oxprenolol,The risk or severity of adverse effects can be increased when Taranabant is combined with Oxprenolol.,increase,risk
Taranabant,Oxybuprocaine,The risk or severity of adverse effects can be increased when Taranabant is combined with Oxybuprocaine.,increase,risk
Taranabant,Oxybutynin,The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with Taranabant.,increase,risk
Taranabant,Oxycodone,The risk or severity of adverse effects can be increased when Taranabant is combined with Oxycodone.,increase,risk
Taranabant,Oxymetazoline,The risk or severity of Tachycardia can be increased when Taranabant is combined with Oxymetazoline.,increase,risk
Taranabant,Oxymorphone,The risk or severity of adverse effects can be increased when Taranabant is combined with Oxymorphone.,increase,risk
Taranabant,Oxyphencyclimine,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Taranabant.,increase,risk
Taranabant,Oxyphenonium,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Taranabant.,increase,risk
Taranabant,Quazepam,The risk or severity of adverse effects can be increased when Taranabant is combined with Quazepam.,increase,risk
Taranabant,Quetiapine,The risk or severity of adverse effects can be increased when Taranabant is combined with Quetiapine.,increase,risk
Taranabant,Quinidine,The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Taranabant.,increase,risk
Taranabant,Quinine,The risk or severity of adverse effects can be increased when Taranabant is combined with Quinine.,increase,risk
Taranabant,Quinupramine,The risk or severity of adverse effects can be increased when Taranabant is combined with Quinupramine.,increase,risk
Taranabant,Umeclidinium,The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Taranabant.,increase,risk
Taranabant,Urethane,The risk or severity of adverse effects can be increased when Taranabant is combined with Urethane.,increase,risk
Taranabant,Valproic acid,The risk or severity of adverse effects can be increased when Taranabant is combined with Valproic acid.,increase,risk
Taranabant,Vecuronium,The risk or severity of adverse effects can be increased when Taranabant is combined with Vecuronium.,increase,risk
Taranabant,Venlafaxine,The risk or severity of adverse effects can be increased when Taranabant is combined with Venlafaxine.,increase,risk
Taranabant,Vigabatrin,The risk or severity of adverse effects can be increased when Taranabant is combined with Vigabatrin.,increase,risk
Taranabant,Vilazodone,The risk or severity of adverse effects can be increased when Taranabant is combined with Vilazodone.,increase,risk
Taranabant,Viloxazine,The risk or severity of adverse effects can be increased when Taranabant is combined with Viloxazine.,increase,risk
Taranabant,Vortioxetine,The risk or severity of adverse effects can be increased when Taranabant is combined with Vortioxetine.,increase,risk
Taranabant,Yohimbine,The risk or severity of adverse effects can be increased when Taranabant is combined with Yohimbine.,increase,risk
Taranabant,Zaleplon,The risk or severity of adverse effects can be increased when Taranabant is combined with Zaleplon.,increase,risk
Taranabant,Ziconotide,The risk or severity of adverse effects can be increased when Taranabant is combined with Ziconotide.,increase,risk
Taranabant,Zimelidine,The risk or severity of adverse effects can be increased when Taranabant is combined with Zimelidine.,increase,risk
Taranabant,Ziprasidone,The risk or severity of adverse effects can be increased when Taranabant is combined with Ziprasidone.,increase,risk
Taranabant,Zolmitriptan,The risk or severity of adverse effects can be increased when Taranabant is combined with Zolmitriptan.,increase,risk
Taranabant,Zolpidem,The risk or severity of adverse effects can be increased when Taranabant is combined with Zolpidem.,increase,risk
Taranabant,Zonisamide,The risk or severity of adverse effects can be increased when Taranabant is combined with Zonisamide.,increase,risk
Taranabant,Zopiclone,The risk or severity of adverse effects can be increased when Taranabant is combined with Zopiclone.,increase,risk
Taranabant,Zotepine,The risk or severity of adverse effects can be increased when Taranabant is combined with Zotepine.,increase,risk
Taranabant,Zuclopenthixol,The risk or severity of adverse effects can be increased when Taranabant is combined with Zuclopenthixol.,increase,risk
Taranabant,Zuranolone,The risk or severity of adverse effects can be increased when Taranabant is combined with Zuranolone.,increase,risk
Axitinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Axitinib.,decrease,no risk
Axitinib,Gatifloxacin,The metabolism of Axitinib can be decreased when combined with Gatifloxacin.,decrease,no risk
Axitinib,Gefitinib,The metabolism of Axitinib can be decreased when combined with Gefitinib.,decrease,no risk
Axitinib,Gemcitabine,The serum concentration of Axitinib can be increased when it is combined with Gemcitabine.,increase,no risk
Axitinib,Gemfibrozil,The metabolism of Axitinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Axitinib,Gemifloxacin,The metabolism of Axitinib can be decreased when combined with Gemifloxacin.,decrease,no risk
Axitinib,Gilteritinib,The metabolism of Axitinib can be decreased when combined with Gilteritinib.,decrease,no risk
Axitinib,Ginkgo biloba,The metabolism of Axitinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Axitinib,Givosiran,The serum concentration of Axitinib can be increased when it is combined with Givosiran.,increase,no risk
Axitinib,Glasdegib,The serum concentration of Axitinib can be increased when it is combined with Glasdegib.,increase,no risk
Axitinib,Glecaprevir,The serum concentration of Axitinib can be increased when it is combined with Glecaprevir.,increase,no risk
Axitinib,Gliclazide,The metabolism of Axitinib can be decreased when combined with Gliclazide.,decrease,no risk
Axitinib,Glofitamab,The serum concentration of Axitinib can be increased when it is combined with Glofitamab.,increase,no risk
Axitinib,Glyburide,The metabolism of Axitinib can be decreased when combined with Glyburide.,decrease,no risk
Axitinib,Glycerol phenylbutyrate,The metabolism of Axitinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Axitinib,Golimumab,The metabolism of Axitinib can be increased when combined with Golimumab.,increase,no risk
Axitinib,Grapefruit,The serum concentration of Axitinib can be increased when it is combined with Grapefruit.,increase,no risk
Axitinib,Grazoprevir,The serum concentration of Axitinib can be increased when it is combined with Grazoprevir.,increase,no risk
Axitinib,Grepafloxacin,The metabolism of Axitinib can be decreased when combined with Grepafloxacin.,decrease,no risk
Axitinib,Griseofulvin,The metabolism of Axitinib can be increased when combined with Griseofulvin.,increase,no risk
Axitinib,Guanabenz,The metabolism of Axitinib can be decreased when combined with Guanabenz.,decrease,no risk
Axitinib,Halofantrine,The metabolism of Axitinib can be decreased when combined with Halofantrine.,decrease,no risk
Axitinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Axitinib.,increase,no risk
Axitinib,Hydralazine,The serum concentration of Axitinib can be increased when it is combined with Hydralazine.,increase,no risk
Axitinib,Hydrocortamate,The metabolism of Axitinib can be increased when combined with Hydrocortamate.,increase,no risk
Axitinib,Hydrocortisone,The metabolism of Axitinib can be increased when combined with Hydrocortisone.,increase,no risk
Axitinib,Hydrocortisone acetate,The metabolism of Axitinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Axitinib,Hydrocortisone butyrate,The metabolism of Axitinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Axitinib,Hydrocortisone cypionate,The metabolism of Axitinib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Axitinib,Hydrocortisone phosphate,The metabolism of Axitinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Axitinib,Hydrocortisone succinate,The metabolism of Axitinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Axitinib,Hydroxyprogesterone caproate,The metabolism of Axitinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Axitinib,Hydroxyzine,The metabolism of Axitinib can be decreased when combined with Hydroxyzine.,decrease,no risk
Axitinib,Ketazolam,The serum concentration of Axitinib can be increased when it is combined with Ketazolam.,increase,no risk
Axitinib,Ketoconazole,The metabolism of Axitinib can be decreased when combined with Ketoconazole.,decrease,no risk
Axitinib,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Axitinib.,increase,risk
Axitinib,Octreotide,The serum concentration of Axitinib can be increased when it is combined with Octreotide.,increase,no risk
Axitinib,Olanzapine,The metabolism of Axitinib can be decreased when combined with Olanzapine.,decrease,no risk
Axitinib,Olaparib,The metabolism of Axitinib can be decreased when combined with Olaparib.,decrease,no risk
Axitinib,Olutasidenib,The metabolism of Axitinib can be increased when combined with Olutasidenib.,increase,no risk
Axitinib,Omadacycline,The serum concentration of Axitinib can be increased when it is combined with Omadacycline.,increase,no risk
Axitinib,Omaveloxolone,The serum concentration of Axitinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Axitinib,Ombitasvir,The metabolism of Axitinib can be decreased when combined with Ombitasvir.,decrease,no risk
Axitinib,Omeprazole,The metabolism of Axitinib can be decreased when combined with Omeprazole.,decrease,no risk
Axitinib,Ondansetron,The metabolism of Axitinib can be decreased when combined with Ondansetron.,decrease,no risk
Axitinib,Oritavancin,The metabolism of Axitinib can be increased when combined with Oritavancin.,increase,no risk
Axitinib,Orphenadrine,The metabolism of Axitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Axitinib,Osilodrostat,The serum concentration of Axitinib can be increased when it is combined with Osilodrostat.,increase,no risk
Axitinib,Osimertinib,The serum concentration of Axitinib can be decreased when it is combined with Osimertinib.,decrease,no risk
Axitinib,Ouabain,The excretion of Axitinib can be decreased when combined with Ouabain.,decrease,no risk
Axitinib,Oxcarbazepine,The metabolism of Axitinib can be increased when combined with Oxcarbazepine.,increase,no risk
Axitinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Axitinib is combined with Oxetacaine.,increase,risk
Axitinib,Oxtriphylline,The metabolism of Axitinib can be decreased when combined with Oxtriphylline.,decrease,no risk
Axitinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Axitinib is combined with Oxybuprocaine.,increase,risk
Axitinib,Oxybutynin,The serum concentration of Axitinib can be increased when it is combined with Oxybutynin.,increase,no risk
Axitinib,Oxycodone,The metabolism of Axitinib can be decreased when combined with Oxycodone.,decrease,no risk
Axitinib,Quetiapine,The metabolism of Axitinib can be decreased when combined with Quetiapine.,decrease,no risk
Axitinib,Quinidine,The serum concentration of Axitinib can be increased when it is combined with Quinidine.,increase,no risk
Axitinib,Quinine,The serum concentration of Axitinib can be increased when it is combined with Quinine.,increase,no risk
Axitinib,Quinupristin,The metabolism of Axitinib can be decreased when combined with Quinupristin.,decrease,no risk
Axitinib,Quizartinib,The serum concentration of Axitinib can be increased when it is combined with Quizartinib.,increase,no risk
Axitinib,Ubrogepant,The serum concentration of Axitinib can be increased when it is combined with Ubrogepant.,increase,no risk
Axitinib,Udenafil,The metabolism of Axitinib can be decreased when combined with Udenafil.,decrease,no risk
Axitinib,Umbralisib,The serum concentration of Axitinib can be increased when it is combined with Umbralisib.,increase,no risk
Axitinib,Umeclidinium,The serum concentration of Axitinib can be increased when it is combined with Umeclidinium.,increase,no risk
Axitinib,Vadadustat,The serum concentration of Axitinib can be increased when it is combined with Vadadustat.,increase,no risk
Axitinib,Valbenazine,The metabolism of Axitinib can be decreased when combined with Valbenazine.,decrease,no risk
Axitinib,Valproic acid,The serum concentration of Axitinib can be increased when it is combined with Valproic acid.,increase,no risk
Axitinib,Valsartan,The excretion of Axitinib can be decreased when combined with Valsartan.,decrease,no risk
Axitinib,Vandetanib,The serum concentration of Axitinib can be increased when it is combined with Vandetanib.,increase,no risk
Axitinib,Vardenafil,The serum concentration of Axitinib can be increased when it is combined with Vardenafil.,increase,no risk
Axitinib,Velpatasvir,The serum concentration of Axitinib can be increased when it is combined with Velpatasvir.,increase,no risk
Axitinib,Vemurafenib,The serum concentration of Axitinib can be increased when it is combined with Vemurafenib.,increase,no risk
Axitinib,Venetoclax,The serum concentration of Axitinib can be increased when it is combined with Venetoclax.,increase,no risk
Axitinib,Verapamil,The serum concentration of Axitinib can be increased when it is combined with Verapamil.,increase,no risk
Axitinib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Axitinib.,decrease,no risk
Axitinib,Viloxazine,The metabolism of Axitinib can be decreased when combined with Viloxazine.,decrease,no risk
Axitinib,Vinblastine,The metabolism of Axitinib can be increased when combined with Vinblastine.,increase,no risk
Axitinib,Vincristine,The metabolism of Axitinib can be decreased when combined with Vincristine.,decrease,no risk
Axitinib,Vinflunine,The serum concentration of Axitinib can be increased when it is combined with Vinflunine.,increase,no risk
Axitinib,Vitamin E,The metabolism of Axitinib can be increased when combined with Vitamin E.,increase,no risk
Axitinib,Voclosporin,The serum concentration of Axitinib can be increased when it is combined with Voclosporin.,increase,no risk
Axitinib,Vonoprazan,The metabolism of Axitinib can be decreased when combined with Vonoprazan.,decrease,no risk
Axitinib,Vorapaxar,The serum concentration of Axitinib can be increased when it is combined with Vorapaxar.,increase,no risk
Axitinib,Voriconazole,The metabolism of Axitinib can be decreased when combined with Voriconazole.,decrease,no risk
Axitinib,Vortioxetine,The metabolism of Axitinib can be decreased when combined with Vortioxetine.,decrease,no risk
Axitinib,Voxelotor,The serum concentration of Axitinib can be increased when it is combined with Voxelotor.,increase,no risk
Axitinib,Voxilaprevir,The serum concentration of Axitinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Axitinib,Warfarin,The metabolism of Axitinib can be increased when combined with Warfarin.,increase,no risk
Axitinib,Zafirlukast,The serum concentration of Axitinib can be increased when it is combined with Zafirlukast.,increase,no risk
Axitinib,Zaleplon,The metabolism of Axitinib can be decreased when combined with Zaleplon.,decrease,no risk
Axitinib,Zidovudine,The metabolism of Axitinib can be increased when combined with Zidovudine.,increase,no risk
Axitinib,Zileuton,The metabolism of Axitinib can be decreased when combined with Zileuton.,decrease,no risk
Axitinib,Zimelidine,The metabolism of Axitinib can be decreased when combined with Zimelidine.,decrease,no risk
Axitinib,Ziprasidone,The metabolism of Axitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Axitinib,Zolmitriptan,The metabolism of Axitinib can be decreased when combined with Zolmitriptan.,decrease,no risk
Axitinib,Zolpidem,The metabolism of Axitinib can be decreased when combined with Zolpidem.,decrease,no risk
Axitinib,Zonisamide,The serum concentration of Axitinib can be increased when it is combined with Zonisamide.,increase,no risk
Axitinib,Zotepine,The metabolism of Zotepine can be decreased when combined with Axitinib.,decrease,no risk
Axitinib,Zuclopenthixol,The metabolism of Axitinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Otamixaban,Gemcitabine,The risk or severity of bleeding can be increased when Otamixaban is combined with Gemcitabine.,increase,risk
Otamixaban,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Otamixaban is combined with Gemtuzumab ozogamicin.,increase,risk
Otamixaban,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Otamixaban.,increase,risk
Otamixaban,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Otamixaban.,increase,no risk
Otamixaban,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Otamixaban.,increase,risk
Otamixaban,Hemin,Hemin may increase the anticoagulant activities of Otamixaban.,increase,no risk
Otamixaban,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Otamixaban.,increase,risk
Otamixaban,Hydrochlorothiazide,The therapeutic efficacy of Otamixaban can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Otamixaban,Hydroflumethiazide,The therapeutic efficacy of Otamixaban can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Otamixaban,Hydroxyprogesterone caproate,The therapeutic efficacy of Otamixaban can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Otamixaban,Hydroxyurea,The risk or severity of bleeding can be increased when Otamixaban is combined with Hydroxyurea.,increase,risk
Otamixaban,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Otamixaban.,increase,risk
Otamixaban,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Otamixaban.,increase,risk
Otamixaban,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Otamixaban is combined with Obeticholic acid.,increase,risk
Otamixaban,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Otamixaban is combined with Obinutuzumab.,increase,risk
Otamixaban,Olaparib,The risk or severity of bleeding can be increased when Otamixaban is combined with Olaparib.,increase,risk
Otamixaban,Olive oil,The therapeutic efficacy of Otamixaban can be decreased when used in combination with Olive oil.,decrease,no risk
Otamixaban,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Otamixaban.,increase,risk
Otamixaban,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Otamixaban is combined with Omacetaxine mepesuccinate.,increase,risk
Otamixaban,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Otamixaban.,increase,no risk
Otamixaban,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Otamixaban.,increase,risk
Otamixaban,Omega-3-carboxylic acids,The therapeutic efficacy of Otamixaban can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Otamixaban,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Otamixaban.,increase,risk
Otamixaban,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Otamixaban.,increase,risk
Otamixaban,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Otamixaban.,increase,risk
Otamixaban,Quinestrol,Quinestrol may decrease the anticoagulant activities of Otamixaban.,decrease,no risk
Otamixaban,Quinidine,The therapeutic efficacy of Otamixaban can be increased when used in combination with Quinidine.,increase,no risk
Otamixaban,Quinine,The therapeutic efficacy of Otamixaban can be increased when used in combination with Quinine.,increase,no risk
Isavuconazonium,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Boceprevir,The metabolism of Isavuconazonium can be decreased when combined with Boceprevir.,decrease,no risk
Isavuconazonium,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Bosentan,The metabolism of Bosentan can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Brigatinib,The metabolism of Brigatinib can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Budesonide,The metabolism of Budesonide can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Bupropion,The serum concentration of Bupropion can be decreased when it is combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Buspirone,The metabolism of Buspirone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Busulfan,The metabolism of Busulfan can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Galantamine,Galantamine may increase the neuromuscular blocking activities of Isavuconazonium.,increase,no risk
Isavuconazonium,Gallamine triethiodide,Gallamine triethiodide may increase the neuromuscular blocking activities of Isavuconazonium.,increase,no risk
Isavuconazonium,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Isavuconazonium.,increase,no risk
Isavuconazonium,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Glipizide,The metabolism of Glipizide can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Glofitamab,The serum concentration of Isavuconazonium can be increased when it is combined with Glofitamab.,increase,no risk
Isavuconazonium,Glyburide,The metabolism of Glyburide can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Golimumab,The metabolism of Isavuconazonium can be increased when combined with Golimumab.,increase,no risk
Isavuconazonium,Granisetron,The metabolism of Granisetron can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Halothane,The metabolism of Halothane can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Isavuconazonium.,increase,no risk
Isavuconazonium,Histamine,The serum concentration of Histamine can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Isavuconazonium.,increase,no risk
Isavuconazonium,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Isavuconazonium resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Isavuconazonium,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Ketamine,Ketamine may increase the neuromuscular blocking activities of Isavuconazonium.,increase,no risk
Isavuconazonium,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Ketoconazole,The serum concentration of Isavuconazonium can be increased when it is combined with Ketoconazole.,increase,no risk
Isavuconazonium,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Olaparib,The metabolism of Olaparib can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Opium,The metabolism of Opium can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Oxcarbazepine,The metabolism of Isavuconazonium can be increased when combined with Oxcarbazepine.,increase,no risk
Isavuconazonium,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Oxybuprocaine,The serum concentration of Isavuconazonium can be increased when it is combined with Oxybuprocaine.,increase,no risk
Isavuconazonium,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Ozanimod,Isavuconazonium may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Isavuconazonium,Quazepam,The metabolism of Quazepam can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Quinine,The serum concentration of Quinine can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Udenafil,The metabolism of Udenafil can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vadadustat,The serum concentration of Isavuconazonium can be increased when it is combined with Vadadustat.,increase,no risk
Isavuconazonium,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Valsartan,The metabolism of Valsartan can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vandetanib,The metabolism of Vandetanib can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Varenicline,The excretion of Varenicline can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Viloxazine,The metabolism of Isavuconazonium can be decreased when combined with Viloxazine.,decrease,no risk
Isavuconazonium,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Vincristine,The excretion of Vincristine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vindesine,The metabolism of Vindesine can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Voriconazole,The metabolism of Isavuconazonium can be decreased when combined with Voriconazole.,decrease,no risk
Isavuconazonium,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Xylometazoline,The therapeutic efficacy of Isavuconazonium can be increased when used in combination with Xylometazoline.,increase,no risk
Isavuconazonium,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Ziconotide,The therapeutic efficacy of Isavuconazonium can be increased when used in combination with Ziconotide.,increase,no risk
Isavuconazonium,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zileuton,The metabolism of Zileuton can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zimelidine,The metabolism of Isavuconazonium can be decreased when combined with Zimelidine.,decrease,no risk
Isavuconazonium,Ziprasidone,The metabolism of Isavuconazonium can be decreased when combined with Ziprasidone.,decrease,no risk
Isavuconazonium,Zolpidem,The metabolism of Zolpidem can be increased when combined with Isavuconazonium.,increase,no risk
Isavuconazonium,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zotepine,The metabolism of Zotepine can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Isavuconazonium.,decrease,no risk
Isavuconazonium,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Isavuconazonium.,decrease,no risk
Dalfampridine,Gabapentin enacarbil,Dalfampridine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gadodiamide,Gadodiamide may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gadofosveset trisodium,Dalfampridine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gadoteric acid,Dalfampridine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gadoteridol,Gadoteridol may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gamolenic acid,The risk or severity of seizure can be increased when Gamolenic acid is combined with Dalfampridine.,increase,risk
Dalfampridine,Ganciclovir,The risk or severity of seizure can be increased when Ganciclovir is combined with Dalfampridine.,increase,risk
Dalfampridine,Gemcitabine,Gemcitabine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gentamicin,Dalfampridine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Dalfampridine,Gimeracil,Dalfampridine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Dalfampridine,Givosiran,Givosiran may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Glipizide,Glipizide may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Glycerol phenylbutyrate,Dalfampridine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Dalfampridine,Golodirsen,Dalfampridine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Dalfampridine,Goserelin,Goserelin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Grepafloxacin,The serum concentration of Dalfampridine can be increased when it is combined with Grepafloxacin.,increase,no risk
Dalfampridine,Guanethidine,Guanethidine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Guanfacine,Guanfacine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Guanidine,The serum concentration of Dalfampridine can be increased when it is combined with Guanidine.,increase,no risk
Dalfampridine,Halofantrine,The risk or severity of seizure can be increased when Halofantrine is combined with Dalfampridine.,increase,risk
Dalfampridine,Haloperidol,The risk or severity of seizure can be increased when Haloperidol is combined with Dalfampridine.,increase,risk
Dalfampridine,Histamine,The serum concentration of Dalfampridine can be increased when it is combined with Histamine.,increase,no risk
Dalfampridine,Hydralazine,Hydralazine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dalfampridine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dalfampridine,Hydromorphone,Hydromorphone may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Hydroxyethyl Starch,Dalfampridine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Dalfampridine,Kanamycin,Dalfampridine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Dalfampridine,Ketamine,Ketamine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Ketazolam,Ketazolam may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Ketoprofen,Ketoprofen may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Ketorolac,Ketorolac may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Octinoxate,Dalfampridine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Dalfampridine,Olsalazine,Olsalazine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Opium,Dalfampridine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Dalfampridine,Oseltamivir,Oseltamivir may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Oxacillin,Oxacillin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Oxaprozin,Oxaprozin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Oxazepam,Oxazepam may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Oxprenolol,The serum concentration of Dalfampridine can be increased when it is combined with Oxprenolol.,increase,no risk
Dalfampridine,Oxybenzone,Oxybenzone may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Oxyquinoline,Dalfampridine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Dalfampridine,Quetiapine,Quetiapine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Quinethazone,Quinethazone may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dalfampridine,Quinidine,The risk or severity of seizure can be increased when Quinidine is combined with Dalfampridine.,increase,risk
Dalfampridine,Quinine,The risk or severity of seizure can be increased when Quinine is combined with Dalfampridine.,increase,risk
Dalfampridine,Quinupramine,The risk or severity of seizure can be increased when Quinupramine is combined with Dalfampridine.,increase,risk
Dalfampridine,Vaborbactam,Dalfampridine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Dalfampridine,Valaciclovir,Valaciclovir may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Valbenazine,Dalfampridine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Valdecoxib,Valdecoxib may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Valganciclovir,The risk or severity of seizure can be increased when Valganciclovir is combined with Dalfampridine.,increase,risk
Dalfampridine,Vancomycin,Dalfampridine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Dalfampridine,Vandetanib,The serum concentration of Dalfampridine can be increased when it is combined with Vandetanib.,increase,no risk
Dalfampridine,Varenicline,The serum concentration of Dalfampridine can be increased when it is combined with Varenicline.,increase,no risk
Dalfampridine,Venlafaxine,The risk or severity of seizure can be increased when Venlafaxine is combined with Dalfampridine.,increase,risk
Dalfampridine,Verapamil,Verapamil may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Vilanterol,Dalfampridine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Dalfampridine,Viloxazine,Dalfampridine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Vortioxetine,Dalfampridine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Warfarin,Dalfampridine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Dalfampridine,Zaleplon,Zaleplon may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Zanamivir,Zanamivir may decrease the excretion rate of Dalfampridine which could result in a higher serum level.,decrease,no risk
Dalfampridine,Zonisamide,Zonisamide may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Denosumab,Galcanezumab,The risk or severity of adverse effects can be increased when Denosumab is combined with Galcanezumab.,increase,risk
Denosumab,Gemcitabine,The risk or severity of adverse effects can be increased when Denosumab is combined with Gemcitabine.,increase,risk
Denosumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Denosumab is combined with Gemtuzumab ozogamicin.,increase,risk
Denosumab,Glatiramer,The risk or severity of adverse effects can be increased when Denosumab is combined with Glatiramer.,increase,risk
Denosumab,Glofitamab,The risk or severity of adverse effects can be increased when Denosumab is combined with Glofitamab.,increase,risk
Denosumab,Golimumab,The risk or severity of adverse effects can be increased when Denosumab is combined with Golimumab.,increase,risk
Denosumab,Guselkumab,The risk or severity of adverse effects can be increased when Denosumab is combined with Guselkumab.,increase,risk
Denosumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Denosumab.,decrease,no risk
Denosumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Denosumab.,decrease,no risk
Denosumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Denosumab.,increase,risk
Denosumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Denosumab.,decrease,no risk
Denosumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Denosumab.,increase,risk
Denosumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Denosumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Denosumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Denosumab.,increase,risk
Denosumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Denosumab is combined with Human Rho(D) immune globulin.,increase,risk
Denosumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Denosumab is combined with Human varicella-zoster immune globulin.,increase,risk
Denosumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Denosumab is combined with Hydrocortisone acetate.,increase,risk
Denosumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Denosumab is combined with Hydrocortisone butyrate.,increase,risk
Denosumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Denosumab is combined with Hydrocortisone succinate.,increase,risk
Denosumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Denosumab is combined with Hydroxychloroquine.,increase,risk
Denosumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Denosumab is combined with Hydroxyurea.,increase,risk
Denosumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Denosumab.,decrease,no risk
Denosumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Denosumab.,decrease,no risk
Denosumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Denosumab.,increase,risk
Denosumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Denosumab is combined with Obinutuzumab.,increase,risk
Denosumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Denosumab is combined with Ocrelizumab.,increase,risk
Denosumab,Odesivimab,The risk or severity of adverse effects can be increased when Denosumab is combined with Odesivimab.,increase,risk
Denosumab,Ofatumumab,The risk or severity of adverse effects can be increased when Denosumab is combined with Ofatumumab.,increase,risk
Denosumab,Olaparib,The risk or severity of adverse effects can be increased when Denosumab is combined with Olaparib.,increase,risk
Denosumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Denosumab.,increase,risk
Denosumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Denosumab.,increase,risk
Denosumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Denosumab is combined with Oxaliplatin.,increase,risk
Denosumab,Ozanimod,The risk or severity of adverse effects can be increased when Denosumab is combined with Ozanimod.,increase,risk
Denosumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Denosumab.,increase,no risk
Denosumab,Ublituximab,The risk or severity of adverse effects can be increased when Denosumab is combined with Ublituximab.,increase,risk
Denosumab,Upadacitinib,The risk or severity of adverse effects can be increased when Denosumab is combined with Upadacitinib.,increase,risk
Denosumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Denosumab.,increase,risk
Denosumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Denosumab.,increase,risk
Denosumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Denosumab.,decrease,no risk
Denosumab,Vedolizumab,The risk or severity of adverse effects can be increased when Denosumab is combined with Vedolizumab.,increase,risk
Denosumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Denosumab.,decrease,no risk
Denosumab,Vilanterol,The risk or severity of adverse effects can be increased when Denosumab is combined with Vilanterol.,increase,risk
Denosumab,Vinblastine,The risk or severity of adverse effects can be increased when Denosumab is combined with Vinblastine.,increase,risk
Denosumab,Vincristine,The risk or severity of adverse effects can be increased when Denosumab is combined with Vincristine.,increase,risk
Denosumab,Vindesine,The risk or severity of adverse effects can be increased when Denosumab is combined with Vindesine.,increase,risk
Denosumab,Vinorelbine,The risk or severity of adverse effects can be increased when Denosumab is combined with Vinorelbine.,increase,risk
Denosumab,Voclosporin,The risk or severity of adverse effects can be increased when Denosumab is combined with Voclosporin.,increase,risk
Denosumab,Vorinostat,The risk or severity of adverse effects can be increased when Denosumab is combined with Vorinostat.,increase,risk
Denosumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Denosumab.,increase,risk
Denosumab,Zidovudine,The risk or severity of adverse effects can be increased when Denosumab is combined with Zidovudine.,increase,risk
Volociximab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Volociximab is combined with Human cytomegalovirus immune globulin.,increase,risk
Volociximab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Volociximab.,increase,risk
Volociximab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Volociximab is combined with Human Rho(D) immune globulin.,increase,risk
Volociximab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Volociximab is combined with Human varicella-zoster immune globulin.,increase,risk
Volociximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Volociximab.,increase,risk
Volociximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Volociximab is combined with Obinutuzumab.,increase,risk
Volociximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Volociximab is combined with Ocrelizumab.,increase,risk
Volociximab,Odesivimab,The risk or severity of adverse effects can be increased when Volociximab is combined with Odesivimab.,increase,risk
Volociximab,Ofatumumab,The risk or severity of adverse effects can be increased when Volociximab is combined with Ofatumumab.,increase,risk
Volociximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Volociximab.,increase,risk
Volociximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Volociximab.,increase,risk
Volociximab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Volociximab is combined with Oxetacaine.,increase,risk
Volociximab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Volociximab is combined with Oxybuprocaine.,increase,risk
Volociximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Volociximab.,increase,no risk
Volociximab,Ublituximab,The risk or severity of adverse effects can be increased when Volociximab is combined with Ublituximab.,increase,risk
Volociximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Volociximab.,increase,risk
Volociximab,Vedolizumab,The risk or severity of adverse effects can be increased when Volociximab is combined with Vedolizumab.,increase,risk
Volociximab,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Volociximab is combined with Zoledronic acid.,increase,risk
Anthrax vaccine,Ganciclovir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ganciclovir.,decrease,no risk
Anthrax vaccine,Gemcitabine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Gemcitabine.,decrease,no risk
Anthrax vaccine,Gemtuzumab ozogamicin,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
Anthrax vaccine,Glatiramer,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Glatiramer.,decrease,no risk
Anthrax vaccine,Glecaprevir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Glecaprevir.,decrease,no risk
Anthrax vaccine,Golimumab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Golimumab.,decrease,no risk
Anthrax vaccine,Grazoprevir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Grazoprevir.,decrease,no risk
Anthrax vaccine,Guselkumab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Guselkumab.,decrease,no risk
Anthrax vaccine,Halcinonide,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Halcinonide.,decrease,no risk
Anthrax vaccine,Hydrocortisone,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Anthrax vaccine,Hydrocortisone acetate,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Anthrax vaccine,Hydrocortisone butyrate,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Anthrax vaccine,Hydrocortisone probutate,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydrocortisone probutate.,decrease,no risk
Anthrax vaccine,Hydrocortisone succinate,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Anthrax vaccine,Hydrocortisone valerate,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydrocortisone valerate.,decrease,no risk
Anthrax vaccine,Hydroxychloroquine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Anthrax vaccine,Hydroxyurea,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Anthrax vaccine,Obinutuzumab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Anthrax vaccine,Ocrelizumab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ocrelizumab.,decrease,no risk
Anthrax vaccine,Odesivimab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Odesivimab.,decrease,no risk
Anthrax vaccine,Ofatumumab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ofatumumab.,decrease,no risk
Anthrax vaccine,Olaparib,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Olaparib.,decrease,no risk
Anthrax vaccine,Ombitasvir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ombitasvir.,decrease,no risk
Anthrax vaccine,Onasemnogene abeparvovec,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Onasemnogene abeparvovec.,decrease,no risk
Anthrax vaccine,Oseltamivir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Oseltamivir.,decrease,no risk
Anthrax vaccine,Oxaliplatin,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Oxaliplatin.,decrease,no risk
Anthrax vaccine,Ozanimod,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ozanimod.,decrease,no risk
Anthrax vaccine,Ublituximab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ublituximab.,decrease,no risk
Anthrax vaccine,Ulobetasol,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ulobetasol.,decrease,no risk
Anthrax vaccine,Upadacitinib,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Upadacitinib.,decrease,no risk
Anthrax vaccine,Valaciclovir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Valaciclovir.,decrease,no risk
Anthrax vaccine,Valganciclovir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Valganciclovir.,decrease,no risk
Anthrax vaccine,Vedolizumab,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Vedolizumab.,decrease,no risk
Anthrax vaccine,Velpatasvir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Velpatasvir.,decrease,no risk
Anthrax vaccine,Vilanterol,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Vilanterol.,decrease,no risk
Anthrax vaccine,Vinblastine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Vinblastine.,decrease,no risk
Anthrax vaccine,Vincristine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Vincristine.,decrease,no risk
Anthrax vaccine,Vindesine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Vindesine.,decrease,no risk
Anthrax vaccine,Vinorelbine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Vinorelbine.,decrease,no risk
Anthrax vaccine,Voclosporin,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Voclosporin.,decrease,no risk
Anthrax vaccine,Vorinostat,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Vorinostat.,decrease,no risk
Anthrax vaccine,Voxilaprevir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Voxilaprevir.,decrease,no risk
Anthrax vaccine,Zalcitabine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Zalcitabine.,decrease,no risk
Anthrax vaccine,Zanamivir,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Zanamivir.,decrease,no risk
Anthrax vaccine,Zidovudine,The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Zidovudine.,decrease,no risk
Ofatumumab,Galcanezumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Galcanezumab.,increase,risk
Ofatumumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ofatumumab.,increase,risk
Ofatumumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ofatumumab.,increase,risk
Ofatumumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ofatumumab.,increase,risk
Ofatumumab,Glofitamab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Glofitamab.,increase,risk
Ofatumumab,Golimumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Golimumab.,increase,risk
Ofatumumab,Guselkumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Guselkumab.,increase,risk
Ofatumumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Ofatumumab.,decrease,no risk
Ofatumumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Ofatumumab.,decrease,no risk
Ofatumumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Ofatumumab.,increase,risk
Ofatumumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ofatumumab.,decrease,no risk
Ofatumumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Ofatumumab.,increase,risk
Ofatumumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Ofatumumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ofatumumab.,increase,risk
Ofatumumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Human Rho(D) immune globulin.,increase,risk
Ofatumumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Human varicella-zoster immune globulin.,increase,risk
Ofatumumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Hydrocortisone acetate.,increase,risk
Ofatumumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Hydrocortisone butyrate.,increase,risk
Ofatumumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Hydrocortisone succinate.,increase,risk
Ofatumumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ofatumumab.,increase,risk
Ofatumumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ofatumumab.,increase,risk
Ofatumumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ofatumumab.,decrease,no risk
Ofatumumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Ofatumumab.,decrease,no risk
Ofatumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ofatumumab.,increase,risk
Ofatumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Obinutuzumab.,increase,risk
Ofatumumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Ofatumumab.,increase,no risk
Ofatumumab,Odesivimab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Odesivimab.,increase,risk
Ofatumumab,Olaparib,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Olaparib.,increase,risk
Ofatumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ofatumumab.,increase,risk
Ofatumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ofatumumab.,increase,risk
Ofatumumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Ofatumumab.,increase,risk
Ofatumumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Oxetacaine.,increase,risk
Ofatumumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Oxybuprocaine.,increase,risk
Ofatumumab,Ozanimod,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Ozanimod.,increase,risk
Ofatumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Ofatumumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Ofatumumab.,increase,risk
Ofatumumab,Upadacitinib,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Upadacitinib.,increase,risk
Ofatumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ofatumumab.,increase,risk
Ofatumumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Ofatumumab.,increase,risk
Ofatumumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Ofatumumab.,decrease,no risk
Ofatumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Vedolizumab.,increase,risk
Ofatumumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ofatumumab.,decrease,no risk
Ofatumumab,Vilanterol,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Vilanterol.,increase,risk
Ofatumumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Ofatumumab.,increase,risk
Ofatumumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Ofatumumab.,increase,risk
Ofatumumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Ofatumumab.,increase,risk
Ofatumumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ofatumumab.,increase,risk
Ofatumumab,Voclosporin,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Voclosporin.,increase,risk
Ofatumumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Ofatumumab.,increase,risk
Ofatumumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Ofatumumab.,increase,risk
Ofatumumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Ofatumumab.,increase,risk
Vicriviroc,Gefitinib,The metabolism of Vicriviroc can be decreased when combined with Gefitinib.,decrease,no risk
Vicriviroc,Gemfibrozil,The metabolism of Vicriviroc can be decreased when combined with Gemfibrozil.,decrease,no risk
Vicriviroc,Ginkgo biloba,The metabolism of Vicriviroc can be decreased when combined with Ginkgo biloba.,decrease,no risk
Vicriviroc,Gliclazide,The metabolism of Vicriviroc can be decreased when combined with Gliclazide.,decrease,no risk
Vicriviroc,Glimepiride,The metabolism of Vicriviroc can be decreased when combined with Glimepiride.,decrease,no risk
Vicriviroc,Glipizide,The metabolism of Vicriviroc can be decreased when combined with Glipizide.,decrease,no risk
Vicriviroc,Gliquidone,The metabolism of Vicriviroc can be decreased when combined with Gliquidone.,decrease,no risk
Vicriviroc,Glofitamab,The serum concentration of Vicriviroc can be increased when it is combined with Glofitamab.,increase,no risk
Vicriviroc,Glyburide,The metabolism of Vicriviroc can be decreased when combined with Glyburide.,decrease,no risk
Vicriviroc,Golimumab,The metabolism of Vicriviroc can be increased when combined with Golimumab.,increase,no risk
Vicriviroc,Halofantrine,The metabolism of Vicriviroc can be decreased when combined with Halofantrine.,decrease,no risk
Vicriviroc,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Vicriviroc.,increase,no risk
Vicriviroc,Halothane,The metabolism of Vicriviroc can be decreased when combined with Halothane.,decrease,no risk
Vicriviroc,Hydrocortisone,The metabolism of Vicriviroc can be decreased when combined with Hydrocortisone.,decrease,no risk
Vicriviroc,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Hydromorphone,The metabolism of Vicriviroc can be decreased when combined with Hydromorphone.,decrease,no risk
Vicriviroc,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Hydroxyzine,The metabolism of Vicriviroc can be decreased when combined with Hydroxyzine.,decrease,no risk
Vicriviroc,Ketamine,The metabolism of Vicriviroc can be decreased when combined with Ketamine.,decrease,no risk
Vicriviroc,Ketoconazole,The metabolism of Vicriviroc can be decreased when combined with Ketoconazole.,decrease,no risk
Vicriviroc,Ketorolac,The metabolism of Vicriviroc can be decreased when combined with Ketorolac.,decrease,no risk
Vicriviroc,Olanzapine,The metabolism of Vicriviroc can be decreased when combined with Olanzapine.,decrease,no risk
Vicriviroc,Olaparib,The metabolism of Olaparib can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Omaveloxolone,The serum concentration of Vicriviroc can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vicriviroc,Ondansetron,The metabolism of Vicriviroc can be decreased when combined with Ondansetron.,decrease,no risk
Vicriviroc,Oritavancin,The metabolism of Vicriviroc can be decreased when combined with Oritavancin.,decrease,no risk
Vicriviroc,Osilodrostat,The metabolism of Vicriviroc can be decreased when combined with Osilodrostat.,decrease,no risk
Vicriviroc,Ospemifene,The metabolism of Vicriviroc can be decreased when combined with Ospemifene.,decrease,no risk
Vicriviroc,Oxandrolone,The metabolism of Vicriviroc can be decreased when combined with Oxandrolone.,decrease,no risk
Vicriviroc,Oxcarbazepine,The metabolism of Vicriviroc can be increased when combined with Oxcarbazepine.,increase,no risk
Vicriviroc,Oxybutynin,The metabolism of Vicriviroc can be decreased when combined with Oxybutynin.,decrease,no risk
Vicriviroc,Oxycodone,The metabolism of Vicriviroc can be decreased when combined with Oxycodone.,decrease,no risk
Vicriviroc,Quetiapine,The metabolism of Vicriviroc can be decreased when combined with Quetiapine.,decrease,no risk
Vicriviroc,Quinidine,The metabolism of Vicriviroc can be decreased when combined with Quinidine.,decrease,no risk
Vicriviroc,Quinine,The metabolism of Vicriviroc can be decreased when combined with Quinine.,decrease,no risk
Vicriviroc,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Udenafil,The metabolism of Vicriviroc can be decreased when combined with Udenafil.,decrease,no risk
Vicriviroc,Vadadustat,The serum concentration of Vicriviroc can be increased when it is combined with Vadadustat.,increase,no risk
Vicriviroc,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Valdecoxib,The metabolism of Vicriviroc can be decreased when combined with Valdecoxib.,decrease,no risk
Vicriviroc,Valproic acid,The metabolism of Vicriviroc can be decreased when combined with Valproic acid.,decrease,no risk
Vicriviroc,Valsartan,The metabolism of Vicriviroc can be decreased when combined with Valsartan.,decrease,no risk
Vicriviroc,Vardenafil,The metabolism of Vicriviroc can be decreased when combined with Vardenafil.,decrease,no risk
Vicriviroc,Vemurafenib,The metabolism of Vicriviroc can be decreased when combined with Vemurafenib.,decrease,no risk
Vicriviroc,Venetoclax,The metabolism of Vicriviroc can be decreased when combined with Venetoclax.,decrease,no risk
Vicriviroc,Verapamil,The metabolism of Vicriviroc can be decreased when combined with Verapamil.,decrease,no risk
Vicriviroc,Viloxazine,The metabolism of Vicriviroc can be decreased when combined with Viloxazine.,decrease,no risk
Vicriviroc,Vincristine,The metabolism of Vincristine can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Voriconazole,The metabolism of Vicriviroc can be decreased when combined with Voriconazole.,decrease,no risk
Vicriviroc,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Vicriviroc.,decrease,no risk
Vicriviroc,Warfarin,The metabolism of Vicriviroc can be increased when combined with Warfarin.,increase,no risk
Vicriviroc,Ximelagatran,The metabolism of Vicriviroc can be decreased when combined with Ximelagatran.,decrease,no risk
Vicriviroc,Zafirlukast,The metabolism of Vicriviroc can be decreased when combined with Zafirlukast.,decrease,no risk
Vicriviroc,Zaleplon,The metabolism of Vicriviroc can be decreased when combined with Zaleplon.,decrease,no risk
Vicriviroc,Zidovudine,The metabolism of Vicriviroc can be decreased when combined with Zidovudine.,decrease,no risk
Vicriviroc,Zileuton,The metabolism of Vicriviroc can be decreased when combined with Zileuton.,decrease,no risk
Vicriviroc,Zimelidine,The metabolism of Vicriviroc can be decreased when combined with Zimelidine.,decrease,no risk
Vicriviroc,Ziprasidone,The metabolism of Vicriviroc can be decreased when combined with Ziprasidone.,decrease,no risk
Vicriviroc,Zolpidem,The metabolism of Vicriviroc can be decreased when combined with Zolpidem.,decrease,no risk
Vicriviroc,Zonisamide,The metabolism of Vicriviroc can be decreased when combined with Zonisamide.,decrease,no risk
Vicriviroc,Zopiclone,The metabolism of Vicriviroc can be decreased when combined with Zopiclone.,decrease,no risk
Safinamide,Binimetinib,Safinamide may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Safinamide,Bisoprolol,Safinamide may increase the hypotensive activities of Bisoprolol.,increase,no risk
Safinamide,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Bivalirudin.,increase,risk
Safinamide,Boceprevir,The metabolism of Safinamide can be decreased when combined with Boceprevir.,decrease,no risk
Safinamide,Bosentan,Safinamide may increase the hypotensive activities of Bosentan.,increase,no risk
Safinamide,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Safinamide.,increase,risk
Safinamide,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Safinamide.,increase,risk
Safinamide,Bretylium,Safinamide may increase the hypotensive activities of Bretylium.,increase,no risk
Safinamide,Brexanolone,The risk or severity of CNS depression can be increased when Safinamide is combined with Brexanolone.,increase,risk
Safinamide,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Safinamide.,decrease,no risk
Safinamide,Brigatinib,Safinamide may decrease the excretion rate of Brigatinib which could result in a higher serum level.,decrease,no risk
Safinamide,Brimonidine,The metabolism of Brimonidine can be decreased when combined with Safinamide.,decrease,no risk
Safinamide,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Safinamide.,increase,risk
Safinamide,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Safinamide.,increase,risk
Safinamide,Bromocriptine,Safinamide may increase the hypertensive activities of Bromocriptine.,increase,no risk
Safinamide,Bromperidol,The risk or severity of CNS depression can be increased when Safinamide is combined with Bromperidol.,increase,risk
Safinamide,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Safinamide.,increase,risk
Safinamide,Bumadizone,The risk or severity of hypertension can be increased when Safinamide is combined with Bumadizone.,increase,risk
Safinamide,Bumetanide,Safinamide may increase the orthostatic hypotensive activities of Bumetanide.,increase,no risk
Safinamide,Bupivacaine,Safinamide may increase the orthostatic hypotensive activities of Bupivacaine.,increase,no risk
Safinamide,Buprenorphine,Safinamide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Safinamide,Bupropion,The risk or severity of adverse effects can be increased when Safinamide is combined with Bupropion.,increase,risk
Safinamide,Buspirone,The risk or severity of hypertension can be increased when Safinamide is combined with Buspirone.,increase,risk
Safinamide,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Safinamide.,increase,risk
Safinamide,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Safinamide.,increase,risk
Safinamide,Butaperazine,The risk or severity of extrapyramidal symptoms can be increased when Safinamide is combined with Butaperazine.,increase,risk
Safinamide,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Safinamide.,increase,risk
Safinamide,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Safinamide.,increase,risk
Safinamide,Butriptyline,Safinamide may increase the serotonergic activities of Butriptyline.,increase,no risk
Safinamide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Safinamide.,increase,risk
Safinamide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Safinamide is combined with Gabapentin enacarbil.,increase,risk
Safinamide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Safinamide.,increase,risk
Safinamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Safinamide is combined with Ganaxolone.",increase,risk
Safinamide,Gefitinib,Safinamide may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Safinamide,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Safinamide.,increase,risk
Safinamide,Glasdegib,Safinamide may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Safinamide,Glecaprevir,Safinamide may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Safinamide,Gliclazide,Safinamide may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Safinamide,Glimepiride,Safinamide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Safinamide,Glipizide,Safinamide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Safinamide,Gliquidone,Safinamide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Safinamide,Glofitamab,The serum concentration of Safinamide can be increased when it is combined with Glofitamab.,increase,no risk
Safinamide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Safinamide.,increase,risk
Safinamide,Glyburide,Safinamide may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Safinamide,Glymidine,Safinamide may increase the hypoglycemic activities of Glymidine.,increase,no risk
Safinamide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Safinamide.,increase,risk
Safinamide,Guanabenz,Safinamide may increase the hypotensive activities of Guanabenz.,increase,no risk
Safinamide,Guanadrel,Safinamide may increase the hypotensive activities of Guanadrel.,increase,no risk
Safinamide,Guanethidine,Safinamide may increase the hypotensive activities of Guanethidine.,increase,no risk
Safinamide,Guanfacine,Safinamide may increase the hypotensive activities of Guanfacine.,increase,no risk
Safinamide,Guanoxan,Safinamide may increase the hypotensive activities of Guanoxan.,increase,no risk
Safinamide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Safinamide.,increase,risk
Safinamide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Safinamide.,increase,risk
Safinamide,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Safinamide.,increase,risk
Safinamide,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Heparin.,increase,risk
Safinamide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Safinamide.,increase,risk
Safinamide,Hydralazine,Safinamide may increase the hypotensive activities of Hydralazine.,increase,no risk
Safinamide,Hydrochlorothiazide,Safinamide may increase the hypotensive activities of Hydrochlorothiazide.,increase,no risk
Safinamide,Hydrocodone,Safinamide may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Safinamide,Hydroflumethiazide,Safinamide may increase the hypotensive activities of Hydroflumethiazide.,increase,no risk
Safinamide,Hydromorphone,Safinamide may increase the serotonergic activities of Hydromorphone.,increase,no risk
Safinamide,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Safinamide.,increase,risk
Safinamide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Safinamide.,increase,no risk
Safinamide,Hyoscyamine,Safinamide may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Safinamide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Safinamide.,increase,risk
Safinamide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Safinamide.,increase,risk
Safinamide,Ketoconazole,The metabolism of Safinamide can be decreased when combined with Ketoconazole.,decrease,no risk
Safinamide,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Safinamide.,increase,risk
Safinamide,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Safinamide.,increase,risk
Safinamide,Obinutuzumab,Safinamide may increase the orthostatic hypotensive activities of Obinutuzumab.,increase,no risk
Safinamide,Olanzapine,The therapeutic efficacy of Safinamide can be decreased when used in combination with Olanzapine.,decrease,no risk
Safinamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Safinamide is combined with Oliceridine.",increase,risk
Safinamide,Olmesartan,Safinamide may increase the hypotensive activities of Olmesartan.,increase,no risk
Safinamide,Olodaterol,The risk or severity of hypertension can be increased when Safinamide is combined with Olodaterol.,increase,risk
Safinamide,Omaveloxolone,The serum concentration of Safinamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Safinamide,Ombitasvir,Safinamide may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Safinamide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Safinamide.,increase,risk
Safinamide,Opicapone,Safinamide may increase the orthostatic hypotensive activities of Opicapone.,increase,no risk
Safinamide,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Safinamide.,increase,risk
Safinamide,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Safinamide.,increase,risk
Safinamide,Orphenadrine,Safinamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Safinamide,Osimertinib,Safinamide may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Safinamide,Oxaliplatin,Safinamide may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Safinamide,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Safinamide.,increase,risk
Safinamide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Safinamide.,increase,risk
Safinamide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Safinamide.,increase,risk
Safinamide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Safinamide.,increase,risk
Safinamide,Oxprenolol,Safinamide may increase the hypotensive activities of Oxprenolol.,increase,no risk
Safinamide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Safinamide.,increase,risk
Safinamide,Oxycodone,Safinamide may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Safinamide,Oxymetazoline,The serum concentration of Oxymetazoline can be increased when it is combined with Safinamide.,increase,no risk
Safinamide,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Safinamide.,increase,risk
Safinamide,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Safinamide.,increase,risk
Safinamide,Ozanimod,Safinamide may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Safinamide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Safinamide.,increase,risk
Safinamide,Quetiapine,The therapeutic efficacy of Safinamide can be decreased when used in combination with Quetiapine.,decrease,no risk
Safinamide,Quinapril,Safinamide may increase the hypotensive activities of Quinapril.,increase,no risk
Safinamide,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Safinamide.,increase,risk
Safinamide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Safinamide.,increase,risk
Safinamide,Quinupramine,Safinamide may increase the serotonergic activities of Quinupramine.,increase,no risk
Safinamide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Safinamide.,increase,no risk
Safinamide,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Safinamide.,increase,risk
Safinamide,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Urokinase.,increase,risk
Safinamide,Vadadustat,The serum concentration of Safinamide can be increased when it is combined with Vadadustat.,increase,no risk
Safinamide,Valbenazine,The risk or severity of adverse effects can be increased when Safinamide is combined with Valbenazine.,increase,risk
Safinamide,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Safinamide.,increase,risk
Safinamide,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Valproate bismuth.,increase,risk
Safinamide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Safinamide.,increase,risk
Safinamide,Valsartan,Safinamide may increase the hypotensive activities of Valsartan.,increase,no risk
Safinamide,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Safinamide.,increase,risk
Safinamide,Velpatasvir,Safinamide may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Safinamide,Vemurafenib,Safinamide may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Safinamide,Venetoclax,The metabolism of Safinamide can be decreased when combined with Venetoclax.,decrease,no risk
Safinamide,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Venlafaxine.,increase,risk
Safinamide,Verapamil,Safinamide may increase the orthostatic hypotensive activities of Verapamil.,increase,no risk
Safinamide,Vericiguat,Safinamide may increase the orthostatic hypotensive activities of Vericiguat.,increase,no risk
Safinamide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Safinamide.,increase,risk
Safinamide,Vilanterol,The risk or severity of hypertension and cardiovascular complications can be increased when Safinamide is combined with Vilanterol.,increase,risk
Safinamide,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Safinamide.,decrease,no risk
Safinamide,Vildagliptin,Safinamide may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Safinamide,Viloxazine,The risk or severity of hypertension can be increased when Viloxazine is combined with Safinamide.,increase,risk
Safinamide,Vincristine,Safinamide may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Safinamide,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Vorapaxar.,increase,risk
Safinamide,Voriconazole,The metabolism of Safinamide can be decreased when combined with Voriconazole.,decrease,no risk
Safinamide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Safinamide.,decrease,no risk
Safinamide,Voxilaprevir,Safinamide may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Safinamide,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Warfarin.,increase,risk
Safinamide,Xamoterol,The risk or severity of hypertension can be increased when Safinamide is combined with Xamoterol.,increase,risk
Safinamide,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Safinamide is combined with Ximelagatran.,increase,risk
Safinamide,Xylometazoline,Safinamide may increase the hypertensive activities of Xylometazoline.,increase,no risk
Safinamide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Safinamide.,increase,risk
Safinamide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Safinamide.,increase,risk
Safinamide,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Safinamide.,increase,risk
Safinamide,Zidovudine,Safinamide may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Safinamide,Zimelidine,Safinamide may increase the serotonergic activities of Zimelidine.,increase,no risk
Safinamide,Ziprasidone,The risk or severity of adverse effects can be increased when Safinamide is combined with Ziprasidone.,increase,risk
Safinamide,Zofenopril,Safinamide may increase the hypotensive activities of Zofenopril.,increase,no risk
Safinamide,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Safinamide is combined with Zolmitriptan.,increase,risk
Safinamide,Zolpidem,Safinamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Safinamide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Safinamide.,increase,risk
Safinamide,Zopiclone,The risk or severity of adverse effects can be increased when Safinamide is combined with Zopiclone.,increase,risk
Safinamide,Zotepine,The therapeutic efficacy of Safinamide can be decreased when used in combination with Zotepine.,decrease,no risk
Safinamide,Zuclopenthixol,The therapeutic efficacy of Safinamide can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Safinamide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Safinamide.,increase,risk
Liraglutide,Gatifloxacin,The therapeutic efficacy of Liraglutide can be increased when used in combination with Gatifloxacin.,increase,no risk
Liraglutide,Gefapixant,The therapeutic efficacy of Liraglutide can be increased when used in combination with Gefapixant.,increase,no risk
Liraglutide,Gemifloxacin,The therapeutic efficacy of Liraglutide can be increased when used in combination with Gemifloxacin.,increase,no risk
Liraglutide,Gliclazide,Liraglutide may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Liraglutide,Glimepiride,Liraglutide may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Liraglutide,Glipizide,Liraglutide may increase the hypoglycemic activities of Glipizide.,increase,no risk
Liraglutide,Gliquidone,Liraglutide may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Liraglutide,Glyburide,Liraglutide may increase the hypoglycemic activities of Glyburide.,increase,no risk
Liraglutide,Glymidine,The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Glymidine.,increase,risk
Liraglutide,Goserelin,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Goserelin.,decrease,no risk
Liraglutide,Grepafloxacin,The therapeutic efficacy of Liraglutide can be increased when used in combination with Grepafloxacin.,increase,no risk
Liraglutide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Liraglutide.,increase,risk
Liraglutide,Haloperidol,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Haloperidol.,decrease,no risk
Liraglutide,Histrelin,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Histrelin.,decrease,no risk
Liraglutide,Hydrochlorothiazide,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Liraglutide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Liraglutide.,increase,risk
Liraglutide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Liraglutide.,increase,risk
Liraglutide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Liraglutide.,increase,risk
Liraglutide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Liraglutide.,increase,risk
Liraglutide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Liraglutide.,increase,risk
Liraglutide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Liraglutide.,increase,risk
Liraglutide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Liraglutide.,increase,risk
Liraglutide,Hydroflumethiazide,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Liraglutide,Hydroxychloroquine,The therapeutic efficacy of Liraglutide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Liraglutide,Hydroxyprogesterone caproate,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Liraglutide,Octreotide,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Octreotide.,decrease,no risk
Liraglutide,Ofloxacin,The therapeutic efficacy of Liraglutide can be increased when used in combination with Ofloxacin.,increase,no risk
Liraglutide,Olanzapine,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Olanzapine.,decrease,no risk
Liraglutide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Liraglutide.,increase,no risk
Liraglutide,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Liraglutide.,increase,no risk
Liraglutide,Oxprenolol,The therapeutic efficacy of Liraglutide can be increased when used in combination with Oxprenolol.,increase,no risk
Liraglutide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Liraglutide.,increase,no risk
Liraglutide,Quetiapine,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Quetiapine.,decrease,no risk
Liraglutide,Quinethazone,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Quinethazone.,decrease,no risk
Liraglutide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Liraglutide.,increase,risk
Liraglutide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Liraglutide.,decrease,no risk
Liraglutide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Liraglutide.,increase,risk
Liraglutide,Udenafil,The therapeutic efficacy of Liraglutide can be increased when used in combination with Udenafil.,increase,no risk
Liraglutide,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Liraglutide.,increase,risk
Liraglutide,Valdecoxib,The therapeutic efficacy of Liraglutide can be increased when used in combination with Valdecoxib.,increase,no risk
Liraglutide,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Liraglutide.,increase,risk
Liraglutide,Vemurafenib,The therapeutic efficacy of Liraglutide can be increased when used in combination with Vemurafenib.,increase,no risk
Liraglutide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Liraglutide.,increase,risk
Liraglutide,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Liraglutide.,increase,risk
Liraglutide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Vildagliptin.,increase,risk
Liraglutide,Vorinostat,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Vorinostat.,decrease,no risk
Liraglutide,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Liraglutide.,increase,risk
Liraglutide,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Liraglutide.,increase,risk
Liraglutide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Liraglutide.,increase,risk
Liraglutide,Ziprasidone,The therapeutic efficacy of Liraglutide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Liraglutide,Zonisamide,The therapeutic efficacy of Liraglutide can be increased when used in combination with Zonisamide.,increase,no risk
Rostaporfin,Verteporfin,Rostaporfin may increase the photosensitizing activities of Verteporfin.,increase,no risk
Saredutant,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Saredutant.,increase,risk
Saredutant,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Saredutant is combined with Gabapentin enacarbil.,increase,risk
Saredutant,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Saredutant.,increase,risk
Saredutant,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Saredutant is combined with Ganaxolone.",increase,risk
Saredutant,Gepirone,The risk or severity of CNS depression can be increased when Saredutant is combined with Gepirone.,increase,risk
Saredutant,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Saredutant.,increase,risk
Saredutant,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Saredutant.,increase,risk
Saredutant,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Saredutant.,increase,risk
Saredutant,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Saredutant.,increase,risk
Saredutant,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Saredutant.,increase,risk
Saredutant,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Saredutant.,increase,risk
Saredutant,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Saredutant.,increase,risk
Saredutant,Hydrocodone,Saredutant may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Saredutant,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Saredutant.,increase,risk
Saredutant,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Saredutant.,increase,no risk
Saredutant,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Saredutant.,increase,risk
Saredutant,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Saredutant.,increase,risk
Saredutant,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Saredutant.,increase,risk
Saredutant,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Saredutant is combined with Oliceridine.",increase,risk
Saredutant,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Saredutant.,increase,risk
Saredutant,Opium,The risk or severity of CNS depression can be increased when Saredutant is combined with Opium.,increase,risk
Saredutant,Orphenadrine,Saredutant may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Saredutant,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Saredutant.,increase,risk
Saredutant,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Saredutant.,increase,risk
Saredutant,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Saredutant.,increase,risk
Saredutant,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Saredutant.,increase,risk
Saredutant,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Saredutant.,increase,risk
Saredutant,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Saredutant.,increase,risk
Saredutant,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Saredutant.,increase,risk
Saredutant,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Saredutant.,increase,risk
Saredutant,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Saredutant.,increase,risk
Saredutant,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Saredutant.,increase,risk
Saredutant,Quinupramine,The risk or severity of CNS depression can be increased when Saredutant is combined with Quinupramine.,increase,risk
Saredutant,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Saredutant.,increase,risk
Saredutant,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Saredutant.,increase,risk
Saredutant,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Saredutant.,increase,risk
Saredutant,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Saredutant.,increase,risk
Saredutant,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Saredutant.,increase,risk
Saredutant,Vilazodone,The risk or severity of CNS depression can be increased when Saredutant is combined with Vilazodone.,increase,risk
Saredutant,Viloxazine,The risk or severity of CNS depression can be increased when Saredutant is combined with Viloxazine.,increase,risk
Saredutant,Vortioxetine,The risk or severity of CNS depression can be increased when Saredutant is combined with Vortioxetine.,increase,risk
Saredutant,Warfarin,The risk or severity of adverse effects can be increased when Saredutant is combined with Warfarin.,increase,risk
Saredutant,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Saredutant.,increase,risk
Saredutant,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Saredutant.,increase,risk
Saredutant,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Saredutant.,increase,risk
Saredutant,Zimelidine,The risk or severity of adverse effects can be increased when Saredutant is combined with Zimelidine.,increase,risk
Saredutant,Ziprasidone,The risk or severity of adverse effects can be increased when Saredutant is combined with Ziprasidone.,increase,risk
Saredutant,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Saredutant.,increase,risk
Saredutant,Zolpidem,Saredutant may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Saredutant,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Saredutant.,increase,risk
Saredutant,Zopiclone,The risk or severity of adverse effects can be increased when Saredutant is combined with Zopiclone.,increase,risk
Saredutant,Zotepine,The risk or severity of CNS depression can be increased when Saredutant is combined with Zotepine.,increase,risk
Saredutant,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Saredutant.,increase,risk
Saredutant,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Saredutant.,increase,risk
Abetimus,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Abetimus.,increase,risk
Abetimus,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Abetimus.,increase,risk
Abetimus,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Abetimus.,increase,risk
Abetimus,Golimumab,The risk or severity of adverse effects can be increased when Abetimus is combined with Golimumab.,increase,risk
Abetimus,Guselkumab,The risk or severity of adverse effects can be increased when Abetimus is combined with Guselkumab.,increase,risk
Abetimus,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Abetimus.,decrease,no risk
Abetimus,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Abetimus.,decrease,no risk
Abetimus,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Abetimus.,decrease,no risk
Abetimus,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Abetimus.,increase,risk
Abetimus,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Abetimus is combined with Hydrocortisone acetate.,increase,risk
Abetimus,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Abetimus is combined with Hydrocortisone butyrate.,increase,risk
Abetimus,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Abetimus is combined with Hydrocortisone succinate.,increase,risk
Abetimus,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Abetimus.,increase,risk
Abetimus,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Abetimus.,increase,risk
Abetimus,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Abetimus.,decrease,no risk
Abetimus,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Abetimus.,decrease,no risk
Abetimus,Obinutuzumab,The risk or severity of adverse effects can be increased when Abetimus is combined with Obinutuzumab.,increase,risk
Abetimus,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Abetimus.,increase,no risk
Abetimus,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Abetimus.,increase,risk
Abetimus,Olaparib,The risk or severity of adverse effects can be increased when Abetimus is combined with Olaparib.,increase,risk
Abetimus,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Abetimus.,increase,risk
Abetimus,Ozanimod,The risk or severity of adverse effects can be increased when Abetimus is combined with Ozanimod.,increase,risk
Abetimus,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Abetimus.,increase,risk
Abetimus,Upadacitinib,The risk or severity of adverse effects can be increased when Abetimus is combined with Upadacitinib.,increase,risk
Abetimus,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Abetimus.,increase,risk
Abetimus,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Abetimus.,decrease,no risk
Abetimus,Vedolizumab,The risk or severity of adverse effects can be increased when Abetimus is combined with Vedolizumab.,increase,risk
Abetimus,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Abetimus.,decrease,no risk
Abetimus,Vilanterol,The risk or severity of adverse effects can be increased when Abetimus is combined with Vilanterol.,increase,risk
Abetimus,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Abetimus.,increase,risk
Abetimus,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Abetimus.,increase,risk
Abetimus,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Abetimus.,increase,risk
Abetimus,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Abetimus.,increase,risk
Abetimus,Voclosporin,The risk or severity of adverse effects can be increased when Abetimus is combined with Voclosporin.,increase,risk
Abetimus,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Abetimus.,increase,risk
Abetimus,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Abetimus.,increase,risk
Abetimus,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Abetimus.,increase,risk
Pasireotide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Gadobenic acid.,increase,risk
Pasireotide,Galantamine,Galantamine may increase the bradycardic activities of Pasireotide.,increase,no risk
Pasireotide,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Pasireotide.,increase,risk
Pasireotide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Gemifloxacin.,increase,risk
Pasireotide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Pasireotide.,increase,no risk
Pasireotide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Gilteritinib.,increase,risk
Pasireotide,Glasdegib,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Glasdegib.,increase,risk
Pasireotide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Goserelin,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Goserelin.,increase,risk
Pasireotide,Granisetron,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Granisetron.,increase,risk
Pasireotide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Grepafloxacin.,increase,risk
Pasireotide,Guanfacine,Guanfacine may increase the bradycardic activities of Pasireotide.,increase,no risk
Pasireotide,Halofantrine,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Halofantrine.,increase,risk
Pasireotide,Haloperidol,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Haloperidol.,increase,risk
Pasireotide,Histrelin,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Histrelin.,increase,risk
Pasireotide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Pasireotide.,increase,risk
Pasireotide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pasireotide.,increase,risk
Pasireotide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Hydroxyzine.,increase,risk
Pasireotide,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Pasireotide.,increase,risk
Pasireotide,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Pasireotide.,increase,risk
Pasireotide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Pasireotide.,increase,no risk
Pasireotide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Ofloxacin.,increase,risk
Pasireotide,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Pasireotide.,increase,risk
Pasireotide,Olaparib,The metabolism of Olaparib can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Olodaterol,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Olodaterol.,increase,risk
Pasireotide,Ondansetron,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Ondansetron.,increase,risk
Pasireotide,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Pasireotide.,increase,risk
Pasireotide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Pasireotide.,increase,risk
Pasireotide,Oxatomide,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Oxatomide.,increase,risk
Pasireotide,Oxprenolol,Oxprenolol may increase the bradycardic activities of Pasireotide.,increase,no risk
Pasireotide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Pasireotide.,increase,risk
Pasireotide,Quetiapine,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Quetiapine.,increase,risk
Pasireotide,Quinidine,The metabolism of Quinidine can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Quizartinib,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Quizartinib.,increase,risk
Pasireotide,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Pasireotide is combined with Ubidecarenone.,increase,risk
Pasireotide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Pasireotide.,increase,no risk
Pasireotide,Valproic acid,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Valproic acid.,increase,risk
Pasireotide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Pasireotide.,increase,risk
Pasireotide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Pasireotide.,increase,risk
Pasireotide,Verapamil,Verapamil may increase the bradycardic activities of Pasireotide.,increase,no risk
Pasireotide,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Pasireotide.,increase,risk
Pasireotide,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Pasireotide.,increase,risk
Pasireotide,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Pasireotide.,decrease,no risk
Pasireotide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Vincristine,The metabolism of Vincristine can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Vindesine,The metabolism of Vindesine can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Pasireotide.,increase,risk
Pasireotide,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Pasireotide.,increase,risk
Pasireotide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Pasireotide.,increase,no risk
Pasireotide,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Pasireotide.,increase,no risk
Pasireotide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Pasireotide.,increase,risk
Pasireotide,Ziprasidone,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Ziprasidone.,increase,risk
Pasireotide,Zonisamide,Zonisamide may increase the bradycardic activities of Pasireotide.,increase,no risk
Pasireotide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Pasireotide.,decrease,no risk
Pasireotide,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Zuclopenthixol.,increase,risk
Odanacatib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Gemfibrozil,The metabolism of Odanacatib can be decreased when combined with Gemfibrozil.,decrease,no risk
Odanacatib,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Glasdegib,The serum concentration of Odanacatib can be increased when it is combined with Glasdegib.,increase,no risk
Odanacatib,Glecaprevir,The serum concentration of Odanacatib can be increased when it is combined with Glecaprevir.,increase,no risk
Odanacatib,Glofitamab,The serum concentration of Odanacatib can be increased when it is combined with Glofitamab.,increase,no risk
Odanacatib,Golimumab,The metabolism of Odanacatib can be increased when combined with Golimumab.,increase,no risk
Odanacatib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Halofantrine,The metabolism of Odanacatib can be decreased when combined with Halofantrine.,decrease,no risk
Odanacatib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Hydrocortisone,The metabolism of Odanacatib can be increased when combined with Hydrocortisone.,increase,no risk
Odanacatib,Hydroxychloroquine,The metabolism of Odanacatib can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Odanacatib,Ketamine,The metabolism of Odanacatib can be decreased when combined with Ketamine.,decrease,no risk
Odanacatib,Ketoconazole,The metabolism of Odanacatib can be decreased when combined with Ketoconazole.,decrease,no risk
Odanacatib,Ketoprofen,The metabolism of Odanacatib can be decreased when combined with Ketoprofen.,decrease,no risk
Odanacatib,Ketorolac,The metabolism of Odanacatib can be decreased when combined with Ketorolac.,decrease,no risk
Odanacatib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Odanacatib.,decrease,no risk
Odanacatib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Omaveloxolone,The serum concentration of Odanacatib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Odanacatib,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Odanacatib.,decrease,no risk
Odanacatib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Oxybutynin,The metabolism of Odanacatib can be decreased when combined with Oxybutynin.,decrease,no risk
Odanacatib,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Odanacatib.,decrease,no risk
Odanacatib,Quinidine,The serum concentration of Odanacatib can be increased when it is combined with Quinidine.,increase,no risk
Odanacatib,Quinine,The metabolism of Odanacatib can be decreased when combined with Quinine.,decrease,no risk
Odanacatib,Quizartinib,The serum concentration of Odanacatib can be increased when it is combined with Quizartinib.,increase,no risk
Odanacatib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Umbralisib,The serum concentration of Odanacatib can be increased when it is combined with Umbralisib.,increase,no risk
Odanacatib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Vadadustat,The serum concentration of Odanacatib can be increased when it is combined with Vadadustat.,increase,no risk
Odanacatib,Vandetanib,The serum concentration of Odanacatib can be increased when it is combined with Vandetanib.,increase,no risk
Odanacatib,Vardenafil,The serum concentration of Odanacatib can be increased when it is combined with Vardenafil.,increase,no risk
Odanacatib,Velpatasvir,The serum concentration of Odanacatib can be increased when it is combined with Velpatasvir.,increase,no risk
Odanacatib,Vemurafenib,The serum concentration of Odanacatib can be increased when it is combined with Vemurafenib.,increase,no risk
Odanacatib,Venetoclax,The metabolism of Odanacatib can be decreased when combined with Venetoclax.,decrease,no risk
Odanacatib,Verapamil,The metabolism of Odanacatib can be decreased when combined with Verapamil.,decrease,no risk
Odanacatib,Viloxazine,The metabolism of Odanacatib can be decreased when combined with Viloxazine.,decrease,no risk
Odanacatib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Odanacatib.,increase,no risk
Odanacatib,Voclosporin,The serum concentration of Odanacatib can be increased when it is combined with Voclosporin.,increase,no risk
Odanacatib,Vorapaxar,The serum concentration of Odanacatib can be increased when it is combined with Vorapaxar.,increase,no risk
Odanacatib,Voriconazole,The metabolism of Odanacatib can be decreased when combined with Voriconazole.,decrease,no risk
Odanacatib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Odanacatib.,decrease,no risk
Odanacatib,Voxilaprevir,The serum concentration of Odanacatib can be increased when it is combined with Voxilaprevir.,increase,no risk
Odanacatib,Zidovudine,The metabolism of Odanacatib can be decreased when combined with Zidovudine.,decrease,no risk
Odanacatib,Zimelidine,The metabolism of Odanacatib can be decreased when combined with Zimelidine.,decrease,no risk
Odanacatib,Ziprasidone,The metabolism of Odanacatib can be decreased when combined with Ziprasidone.,decrease,no risk
Odanacatib,Zonisamide,The serum concentration of Odanacatib can be increased when it is combined with Zonisamide.,increase,no risk
Odanacatib,Zopiclone,The metabolism of Odanacatib can be decreased when combined with Zopiclone.,decrease,no risk
Golimumab,Bepridil,The metabolism of Bepridil can be increased when combined with Golimumab.,increase,no risk
Golimumab,Besilesomab,The risk or severity of adverse effects can be increased when Golimumab is combined with Besilesomab.,increase,risk
Golimumab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Golimumab.,increase,risk
Golimumab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Golimumab.,increase,risk
Golimumab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Bezlotoxumab.,increase,risk
Golimumab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bimekizumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Bimekizumab.,increase,risk
Golimumab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Golimumab.,increase,risk
Golimumab,Blinatumomab,The risk or severity of adverse effects can be increased when Golimumab is combined with Blinatumomab.,increase,risk
Golimumab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Golimumab.,increase,no risk
Golimumab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Golimumab.",decrease,no risk
Golimumab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bosentan,The metabolism of Bosentan can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Golimumab.,increase,no risk
Golimumab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Golimumab.,increase,no risk
Golimumab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Golimumab.,increase,no risk
Golimumab,Brodalumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Brodalumab.,increase,risk
Golimumab,Brolucizumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Brolucizumab.,increase,risk
Golimumab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Golimumab.,increase,no risk
Golimumab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Golimumab.,increase,risk
Golimumab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Bupropion,The metabolism of Bupropion can be increased when combined with Golimumab.,increase,no risk
Golimumab,Burosumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Burosumab.,increase,risk
Golimumab,Buspirone,The metabolism of Buspirone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Busulfan,The metabolism of Busulfan can be increased when combined with Golimumab.,increase,no risk
Golimumab,Galantamine,The metabolism of Galantamine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Galcanezumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Galcanezumab.,increase,risk
Golimumab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Golimumab.,increase,risk
Golimumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Golimumab.,increase,risk
Golimumab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Golimumab.,increase,risk
Golimumab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Golimumab.,increase,no risk
Golimumab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Golimumab.,increase,no risk
Golimumab,Glipizide,The metabolism of Glipizide can be increased when combined with Golimumab.,increase,no risk
Golimumab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Glofitamab,The risk or severity of adverse effects can be increased when Golimumab is combined with Glofitamab.,increase,risk
Golimumab,Glyburide,The metabolism of Glyburide can be increased when combined with Golimumab.,increase,no risk
Golimumab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Golimumab.,increase,no risk
Golimumab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Golimumab.,increase,no risk
Golimumab,Guselkumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Guselkumab.,increase,risk
Golimumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Golimumab.,decrease,no risk
Golimumab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Golimumab.,increase,no risk
Golimumab,Halothane,The metabolism of Halothane can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Golimumab.,decrease,no risk
Golimumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Golimumab.,increase,risk
Golimumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Golimumab.,decrease,no risk
Golimumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Golimumab.,increase,risk
Golimumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Golimumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Golimumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Golimumab.,increase,risk
Golimumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Golimumab is combined with Human Rho(D) immune globulin.,increase,risk
Golimumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Golimumab is combined with Human varicella-zoster immune globulin.,increase,risk
Golimumab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Golimumab is combined with Hydrocortisone succinate.,increase,risk
Golimumab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Golimumab.,increase,no risk
Golimumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Golimumab.,increase,risk
Golimumab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Golimumab.,decrease,no risk
Golimumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Golimumab.,decrease,no risk
Golimumab,Ketamine,The metabolism of Ketamine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Golimumab.,increase,no risk
Golimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Golimumab.,increase,risk
Golimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Obinutuzumab.,increase,risk
Golimumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Golimumab.,increase,no risk
Golimumab,Odesivimab,The risk or severity of adverse effects can be increased when Golimumab is combined with Odesivimab.,increase,risk
Golimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Golimumab.,increase,risk
Golimumab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Olaparib,The metabolism of Olaparib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Golimumab.,increase,risk
Golimumab,Oliceridine,The metabolism of Oliceridine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Golimumab.,increase,no risk
Golimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Golimumab.,increase,risk
Golimumab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Golimumab.,increase,no risk
Golimumab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Golimumab.,increase,no risk
Golimumab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Golimumab.,increase,no risk
Golimumab,Opium,The metabolism of Opium can be increased when combined with Golimumab.,increase,no risk
Golimumab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Golimumab.,increase,no risk
Golimumab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Golimumab.,increase,no risk
Golimumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Golimumab.,increase,risk
Golimumab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Golimumab.,increase,no risk
Golimumab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Golimumab.,increase,no risk
Golimumab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Golimumab.,increase,no risk
Golimumab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Ozanimod,The risk or severity of adverse effects can be increased when Golimumab is combined with Ozanimod.,increase,risk
Golimumab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Golimumab.,increase,no risk
Golimumab,Quinidine,The metabolism of Quinidine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Quinine,The metabolism of Quinine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Golimumab.,increase,risk
Golimumab,Udenafil,The metabolism of Udenafil can be increased when combined with Golimumab.,increase,no risk
Golimumab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Golimumab.,increase,no risk
Golimumab,Upadacitinib,The risk or severity of adverse effects can be increased when Golimumab is combined with Upadacitinib.,increase,risk
Golimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Golimumab.,increase,risk
Golimumab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Golimumab.,increase,no risk
Golimumab,Valsartan,The metabolism of Valsartan can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Golimumab.,increase,no risk
Golimumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Golimumab.,increase,risk
Golimumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Golimumab.,decrease,no risk
Golimumab,Vedolizumab,The risk or severity of infection can be increased when Golimumab is combined with Vedolizumab.,increase,risk
Golimumab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Golimumab.,increase,no risk
Golimumab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Verapamil,The metabolism of Verapamil can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Golimumab.,decrease,no risk
Golimumab,Vilanterol,The risk or severity of adverse effects can be increased when Golimumab is combined with Vilanterol.,increase,risk
Golimumab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vincristine,The metabolism of Vincristine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vindesine,The metabolism of Vindesine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Voclosporin,The risk or severity of adverse effects can be increased when Golimumab is combined with Voclosporin.,increase,risk
Golimumab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Golimumab.,increase,no risk
Golimumab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Golimumab.,increase,no risk
Golimumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Golimumab.,increase,risk
Golimumab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Golimumab.,increase,no risk
Golimumab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Golimumab.,increase,no risk
Golimumab,Warfarin,The metabolism of Warfarin can be increased when combined with Golimumab.,increase,no risk
Golimumab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Golimumab.,increase,no risk
Golimumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Golimumab.,increase,risk
Golimumab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zileuton,The metabolism of Zileuton can be increased when combined with Golimumab.,increase,no risk
Golimumab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zotepine,The metabolism of Zotepine can be increased when combined with Golimumab.,increase,no risk
Golimumab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Golimumab.,increase,no risk
Amediplase,Gemcitabine,The risk or severity of bleeding can be increased when Amediplase is combined with Gemcitabine.,increase,risk
Amediplase,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Amediplase is combined with Gemtuzumab ozogamicin.,increase,risk
Amediplase,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Amediplase.,increase,risk
Amediplase,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Amediplase.,increase,no risk
Amediplase,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Amediplase.,increase,risk
Amediplase,Hemin,Hemin may increase the anticoagulant activities of Amediplase.,increase,no risk
Amediplase,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Amediplase.,increase,risk
Amediplase,Hydrochlorothiazide,The therapeutic efficacy of Amediplase can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Amediplase,Hydroflumethiazide,The therapeutic efficacy of Amediplase can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Amediplase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Amediplase.,decrease,no risk
Amediplase,Hydroxyprogesterone caproate,The therapeutic efficacy of Amediplase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Amediplase,Hydroxyurea,The risk or severity of bleeding can be increased when Amediplase is combined with Hydroxyurea.,increase,risk
Amediplase,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Amediplase.,increase,risk
Amediplase,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Amediplase.,increase,risk
Amediplase,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Amediplase is combined with Obeticholic acid.,increase,risk
Amediplase,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Amediplase is combined with Obinutuzumab.,increase,risk
Amediplase,Olaparib,The risk or severity of bleeding can be increased when Amediplase is combined with Olaparib.,increase,risk
Amediplase,Olive oil,The therapeutic efficacy of Amediplase can be decreased when used in combination with Olive oil.,decrease,no risk
Amediplase,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Amediplase.,increase,risk
Amediplase,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Amediplase is combined with Omacetaxine mepesuccinate.,increase,risk
Amediplase,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Amediplase.,increase,no risk
Amediplase,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Amediplase.,increase,risk
Amediplase,Omega-3-carboxylic acids,The therapeutic efficacy of Amediplase can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Amediplase,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Amediplase.,increase,risk
Amediplase,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Amediplase.,increase,risk
Amediplase,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Amediplase.,increase,risk
Amediplase,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Amediplase.,increase,risk
Amediplase,Quinestrol,Quinestrol may decrease the anticoagulant activities of Amediplase.,decrease,no risk
Amediplase,Quinidine,The therapeutic efficacy of Amediplase can be increased when used in combination with Quinidine.,increase,no risk
Amediplase,Quinine,The therapeutic efficacy of Amediplase can be increased when used in combination with Quinine.,increase,no risk
Belatacept,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Belatacept.,increase,risk
Belatacept,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Belatacept.,increase,risk
Belatacept,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Belatacept.,increase,risk
Belatacept,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Belatacept.,increase,risk
Belatacept,Guselkumab,The risk or severity of adverse effects can be increased when Belatacept is combined with Guselkumab.,increase,risk
Belatacept,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Belatacept.,decrease,no risk
Belatacept,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Belatacept.,decrease,no risk
Belatacept,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Belatacept.,decrease,no risk
Belatacept,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Belatacept.,increase,risk
Belatacept,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Belatacept is combined with Hydrocortisone acetate.,increase,risk
Belatacept,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Belatacept is combined with Hydrocortisone butyrate.,increase,risk
Belatacept,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Belatacept is combined with Hydrocortisone succinate.,increase,risk
Belatacept,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Belatacept.,increase,risk
Belatacept,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Belatacept.,increase,risk
Belatacept,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Belatacept.,decrease,no risk
Belatacept,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Belatacept.,decrease,no risk
Belatacept,Obinutuzumab,The risk or severity of adverse effects can be increased when Belatacept is combined with Obinutuzumab.,increase,risk
Belatacept,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Belatacept.,increase,no risk
Belatacept,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Belatacept.,increase,risk
Belatacept,Olaparib,The risk or severity of adverse effects can be increased when Belatacept is combined with Olaparib.,increase,risk
Belatacept,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Belatacept.,increase,risk
Belatacept,Ozanimod,The risk or severity of adverse effects can be increased when Belatacept is combined with Ozanimod.,increase,risk
Belatacept,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Belatacept.,increase,risk
Belatacept,Upadacitinib,The risk or severity of adverse effects can be increased when Belatacept is combined with Upadacitinib.,increase,risk
Belatacept,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Belatacept.,increase,risk
Belatacept,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Belatacept.,decrease,no risk
Belatacept,Vedolizumab,The risk or severity of adverse effects can be increased when Belatacept is combined with Vedolizumab.,increase,risk
Belatacept,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Belatacept.,decrease,no risk
Belatacept,Vilanterol,The risk or severity of adverse effects can be increased when Belatacept is combined with Vilanterol.,increase,risk
Belatacept,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Belatacept.,increase,risk
Belatacept,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Belatacept.,increase,risk
Belatacept,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Belatacept.,increase,risk
Belatacept,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belatacept.,increase,risk
Belatacept,Voclosporin,The risk or severity of adverse effects can be increased when Belatacept is combined with Voclosporin.,increase,risk
Belatacept,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Belatacept.,increase,risk
Belatacept,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Belatacept.,increase,risk
Belatacept,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Belatacept.,increase,risk
Clevudine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Clevudine.,decrease,no risk
Clevudine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Clevudine.,decrease,no risk
Clevudine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Clevudine.,decrease,no risk
Clevudine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Clevudine.,decrease,no risk
Clevudine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Clevudine.,decrease,no risk
Clevudine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Clevudine.,decrease,no risk
Clevudine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Clevudine.,decrease,no risk
Clevudine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Clevudine.,decrease,no risk
Vilazodone,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Vilazodone.,increase,risk
Vilazodone,Bromocriptine,Bromocriptine may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Vilazodone,Bromperidol,The risk or severity of adverse effects can be increased when Vilazodone is combined with Bromperidol.,increase,risk
Vilazodone,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Vilazodone.,increase,risk
Vilazodone,Bumadizone,The risk or severity of hypertension can be increased when Vilazodone is combined with Bumadizone.,increase,risk
Vilazodone,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Buprenorphine,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Vilazodone,Bupropion,The metabolism of Vilazodone can be decreased when combined with Bupropion.,decrease,no risk
Vilazodone,Buspirone,The metabolism of Buspirone can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Vilazodone.,increase,risk
Vilazodone,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Vilazodone.,increase,risk
Vilazodone,Butaperazine,The risk or severity of adverse effects can be increased when Vilazodone is combined with Butaperazine.,increase,risk
Vilazodone,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Vilazodone.,increase,risk
Vilazodone,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Vilazodone.,increase,risk
Vilazodone,Butriptyline,The risk or severity of CNS depression can be increased when Vilazodone is combined with Butriptyline.,increase,risk
Vilazodone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Vilazodone.,increase,risk
Vilazodone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Vilazodone is combined with Gabapentin enacarbil.,increase,risk
Vilazodone,Galantamine,The metabolism of Galantamine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Vilazodone.,increase,risk
Vilazodone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Vilazodone is combined with Ganaxolone.",increase,risk
Vilazodone,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Gemfibrozil,The metabolism of Vilazodone can be decreased when combined with Gemfibrozil.,decrease,no risk
Vilazodone,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Vilazodone.,increase,risk
Vilazodone,Gilteritinib,The therapeutic efficacy of Vilazodone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Vilazodone,Givosiran,The serum concentration of Vilazodone can be increased when it is combined with Givosiran.,increase,no risk
Vilazodone,Gliclazide,The metabolism of Vilazodone can be decreased when combined with Gliclazide.,decrease,no risk
Vilazodone,Glofitamab,The serum concentration of Vilazodone can be increased when it is combined with Glofitamab.,increase,no risk
Vilazodone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Vilazodone.,increase,risk
Vilazodone,Glyburide,The metabolism of Vilazodone can be decreased when combined with Glyburide.,decrease,no risk
Vilazodone,Glycerol phenylbutyrate,The metabolism of Vilazodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Vilazodone,Golimumab,The metabolism of Vilazodone can be increased when combined with Golimumab.,increase,no risk
Vilazodone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Vilazodone.,increase,risk
Vilazodone,Guanabenz,Vilazodone may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Vilazodone,Guanadrel,Vilazodone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Vilazodone,Guanethidine,Vilazodone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Vilazodone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Vilazodone.,increase,risk
Vilazodone,Guanoxan,Vilazodone may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Vilazodone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Vilazodone.,increase,risk
Vilazodone,Halofantrine,The metabolism of Vilazodone can be decreased when combined with Halofantrine.,decrease,no risk
Vilazodone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Vilazodone.,increase,risk
Vilazodone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Vilazodone.,increase,risk
Vilazodone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Vilazodone.,increase,risk
Vilazodone,Hydralazine,Vilazodone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Vilazodone,Hydrochlorothiazide,Vilazodone may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Vilazodone,Hydrocodone,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Vilazodone,Hydroflumethiazide,Vilazodone may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Vilazodone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Vilazodone.,increase,risk
Vilazodone,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Vilazodone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Vilazodone.,increase,risk
Vilazodone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Vilazodone.,increase,risk
Vilazodone,Ketoconazole,The metabolism of Vilazodone can be decreased when combined with Ketoconazole.,decrease,no risk
Vilazodone,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Vilazodone.,increase,risk
Vilazodone,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Vilazodone.,increase,risk
Vilazodone,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Vilazodone is combined with Oliceridine.",increase,risk
Vilazodone,Olmesartan,Vilazodone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Vilazodone,Olodaterol,The risk or severity of hypertension can be increased when Vilazodone is combined with Olodaterol.,increase,risk
Vilazodone,Omaveloxolone,The serum concentration of Vilazodone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Vilazodone,Omeprazole,The metabolism of Vilazodone can be decreased when combined with Omeprazole.,decrease,no risk
Vilazodone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Opium,The metabolism of Opium can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Vilazodone.,increase,risk
Vilazodone,Oritavancin,The metabolism of Vilazodone can be decreased when combined with Oritavancin.,decrease,no risk
Vilazodone,Orphenadrine,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Vilazodone,Osilodrostat,The metabolism of Vilazodone can be decreased when combined with Osilodrostat.,decrease,no risk
Vilazodone,Ospemifene,The metabolism of Vilazodone can be decreased when combined with Ospemifene.,decrease,no risk
Vilazodone,Oxamniquine,The metabolism of Vilazodone can be decreased when combined with Oxamniquine.,decrease,no risk
Vilazodone,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Vilazodone.,increase,risk
Vilazodone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Vilazodone.,increase,risk
Vilazodone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Vilazodone.,increase,risk
Vilazodone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Vilazodone.,increase,risk
Vilazodone,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Vilazodone.,increase,risk
Vilazodone,Oxybutynin,The metabolism of Vilazodone can be decreased when combined with Oxybutynin.,decrease,no risk
Vilazodone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Vilazodone.,increase,risk
Vilazodone,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Vilazodone.,increase,risk
Vilazodone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Vilazodone.,increase,risk
Vilazodone,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Quinapril,Vilazodone may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Vilazodone,Quinidine,The metabolism of Vilazodone can be decreased when combined with Quinidine.,decrease,no risk
Vilazodone,Quinine,The metabolism of Vilazodone can be decreased when combined with Quinine.,decrease,no risk
Vilazodone,Quinupramine,The risk or severity of CNS depression can be increased when Vilazodone is combined with Quinupramine.,increase,risk
Vilazodone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Vilazodone.,increase,risk
Vilazodone,Vadadustat,The serum concentration of Vilazodone can be increased when it is combined with Vadadustat.,increase,no risk
Vilazodone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Vilazodone.,increase,risk
Vilazodone,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Valproate bismuth.,increase,risk
Vilazodone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Vilazodone.,increase,risk
Vilazodone,Valsartan,Vilazodone may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Vilazodone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Vilazodone.,increase,risk
Vilazodone,Vemurafenib,The metabolism of Vilazodone can be decreased when combined with Vemurafenib.,decrease,no risk
Vilazodone,Venetoclax,The metabolism of Vilazodone can be decreased when combined with Venetoclax.,decrease,no risk
Vilazodone,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Venlafaxine.,increase,risk
Vilazodone,Verapamil,The metabolism of Vilazodone can be decreased when combined with Verapamil.,decrease,no risk
Vilazodone,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Vilazodone.,increase,risk
Vilazodone,Vilanterol,The risk or severity of hypertension can be increased when Vilazodone is combined with Vilanterol.,increase,risk
Vilazodone,Viloxazine,The metabolism of Vilazodone can be decreased when combined with Viloxazine.,decrease,no risk
Vilazodone,Vinblastine,The metabolism of Vilazodone can be decreased when combined with Vinblastine.,decrease,no risk
Vilazodone,Vinorelbine,The metabolism of Vilazodone can be decreased when combined with Vinorelbine.,decrease,no risk
Vilazodone,Vonoprazan,The metabolism of Vilazodone can be decreased when combined with Vonoprazan.,decrease,no risk
Vilazodone,Voriconazole,The metabolism of Vilazodone can be decreased when combined with Voriconazole.,decrease,no risk
Vilazodone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Warfarin,The risk or severity of adverse effects can be increased when Vilazodone is combined with Warfarin.,increase,risk
Vilazodone,Xamoterol,The risk or severity of hypertension can be increased when Vilazodone is combined with Xamoterol.,increase,risk
Vilazodone,Xylometazoline,The risk or severity of hypertension can be increased when Vilazodone is combined with Xylometazoline.,increase,risk
Vilazodone,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Zafirlukast,The metabolism of Vilazodone can be decreased when combined with Zafirlukast.,decrease,no risk
Vilazodone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Vilazodone.,increase,risk
Vilazodone,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Vilazodone.,increase,risk
Vilazodone,Zimelidine,The risk or severity of adverse effects can be increased when Vilazodone is combined with Zimelidine.,increase,risk
Vilazodone,Ziprasidone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Ziprasidone.,increase,risk
Vilazodone,Zofenopril,Vilazodone may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Vilazodone,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Vilazodone is combined with Zolmitriptan.,increase,risk
Vilazodone,Zolpidem,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Vilazodone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Vilazodone.,increase,risk
Vilazodone,Zopiclone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Zopiclone.,increase,risk
Vilazodone,Zotepine,The risk or severity of adverse effects can be increased when Vilazodone is combined with Zotepine.,increase,risk
Vilazodone,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Vilazodone.,decrease,no risk
Vilazodone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Vilazodone.,increase,risk
Laquinimod,Viloxazine,The metabolism of Laquinimod can be decreased when combined with Viloxazine.,decrease,no risk
Laquinimod,Voriconazole,The metabolism of Laquinimod can be decreased when combined with Voriconazole.,decrease,no risk
Laquinimod,Zimelidine,The metabolism of Laquinimod can be decreased when combined with Zimelidine.,decrease,no risk
Laquinimod,Ziprasidone,The metabolism of Laquinimod can be decreased when combined with Ziprasidone.,decrease,no risk
Sipuleucel-T,Gemtuzumab ozogamicin,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
Sipuleucel-T,Glatiramer,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Glatiramer.,decrease,no risk
Sipuleucel-T,Golimumab,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Golimumab.,decrease,no risk
Sipuleucel-T,Guselkumab,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Guselkumab.,decrease,no risk
Sipuleucel-T,Hydrocortisone,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Sipuleucel-T,Hydrocortisone acetate,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Sipuleucel-T,Hydrocortisone butyrate,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Sipuleucel-T,Hydrocortisone succinate,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Sipuleucel-T,Hydroxychloroquine,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Sipuleucel-T,Hydroxyurea,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Sipuleucel-T,Obinutuzumab,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Sipuleucel-T,Ocrelizumab,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ocrelizumab.,decrease,no risk
Sipuleucel-T,Ofatumumab,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ofatumumab.,decrease,no risk
Sipuleucel-T,Olaparib,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Olaparib.,decrease,no risk
Sipuleucel-T,Oxaliplatin,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Oxaliplatin.,decrease,no risk
Sipuleucel-T,Ozanimod,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ozanimod.,decrease,no risk
Sipuleucel-T,Ublituximab,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ublituximab.,decrease,no risk
Sipuleucel-T,Upadacitinib,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Upadacitinib.,decrease,no risk
Sipuleucel-T,Vedolizumab,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vedolizumab.,decrease,no risk
Sipuleucel-T,Vilanterol,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vilanterol.,decrease,no risk
Sipuleucel-T,Vinblastine,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vinblastine.,decrease,no risk
Sipuleucel-T,Vincristine,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vincristine.,decrease,no risk
Sipuleucel-T,Vindesine,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vindesine.,decrease,no risk
Sipuleucel-T,Vinorelbine,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vinorelbine.,decrease,no risk
Sipuleucel-T,Voclosporin,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Voclosporin.,decrease,no risk
Sipuleucel-T,Vorinostat,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Vorinostat.,decrease,no risk
Sipuleucel-T,Zidovudine,The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Zidovudine.,decrease,no risk
Nitrous oxide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Nitrous oxide is combined with Gabapentin enacarbil.,increase,risk
Nitrous oxide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Nitrous oxide is combined with Ganaxolone.",increase,risk
Nitrous oxide,Gepirone,The risk or severity of CNS depression can be increased when Nitrous oxide is combined with Gepirone.,increase,risk
Nitrous oxide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Guanabenz,Nitrous oxide may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Nitrous oxide,Guanadrel,Nitrous oxide may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Nitrous oxide,Guanethidine,Nitrous oxide may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Nitrous oxide,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Guanoxan,Nitrous oxide may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Nitrous oxide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Hydralazine,Nitrous oxide may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Nitrous oxide,Hydrochlorothiazide,Nitrous oxide may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Nitrous oxide,Hydrocodone,Nitrous oxide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Nitrous oxide,Hydroflumethiazide,Nitrous oxide may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Nitrous oxide,Hydromorphone,The risk or severity of myocardial depression can be increased when Hydromorphone is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Nitrous oxide.,increase,risk
Nitrous oxide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nitrous oxide.,increase,no risk
Nitrous oxide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Nitrous oxide.,increase,risk
Mepyramine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Mepyramine.,increase,risk
Mepyramine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mepyramine is combined with Gabapentin enacarbil.,increase,risk
Mepyramine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gadobenic acid.,increase,risk
Mepyramine,Galantamine,The metabolism of Galantamine can be decreased when combined with Mepyramine.,decrease,no risk
Mepyramine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Mepyramine.,increase,risk
Mepyramine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Mepyramine is combined with Ganaxolone.",increase,risk
Mepyramine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Mepyramine.,increase,risk
Mepyramine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Mepyramine.,decrease,no risk
Mepyramine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gemifloxacin.,increase,risk
Mepyramine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Mepyramine.,increase,risk
Mepyramine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Gilteritinib.,increase,risk
Mepyramine,Glasdegib,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Glasdegib.,increase,risk
Mepyramine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Mepyramine.,increase,risk
Mepyramine,Goserelin,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Goserelin.,increase,risk
Mepyramine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Mepyramine.,increase,risk
Mepyramine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Grepafloxacin.,increase,risk
Mepyramine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Mepyramine.,increase,risk
Mepyramine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Mepyramine.,increase,risk
Mepyramine,Halofantrine,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Halofantrine.,increase,risk
Mepyramine,Haloperidol,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Haloperidol.,increase,risk
Mepyramine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Mepyramine.,increase,risk
Mepyramine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Mepyramine.,increase,risk
Mepyramine,Histrelin,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Histrelin.,increase,risk
Mepyramine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Mepyramine.,increase,risk
Mepyramine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Mepyramine.,increase,risk
Mepyramine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Mepyramine.,decrease,no risk
Mepyramine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Hydroxyzine.,increase,risk
Mepyramine,Hyoscyamine,Mepyramine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Mepyramine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Mepyramine.,increase,risk
Mepyramine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Mepyramine.,increase,risk
Mepyramine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Mepyramine.,increase,risk
Mepyramine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mepyramine.,increase,risk
Mepyramine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Ofloxacin.,increase,risk
Mepyramine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Mepyramine.,increase,risk
Mepyramine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mepyramine is combined with Oliceridine.",increase,risk
Mepyramine,Olodaterol,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Olodaterol.,increase,risk
Mepyramine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Mepyramine.,increase,risk
Mepyramine,Opium,The risk or severity of CNS depression can be increased when Mepyramine is combined with Opium.,increase,risk
Mepyramine,Orphenadrine,Mepyramine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Mepyramine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mepyramine.,increase,risk
Mepyramine,Oxatomide,The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Oxatomide.,increase,risk
Mepyramine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Mepyramine.,increase,risk
Mepyramine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Mepyramine.,increase,risk
Mepyramine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Mepyramine.,increase,risk
Mepyramine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Mepyramine.,increase,risk
Mepyramine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Mepyramine.,increase,risk
Mepyramine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Mepyramine.,increase,risk
Mepyramine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Mepyramine.,increase,risk
Mepyramine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mepyramine.,increase,risk
Aprotinin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Hydrocortisone,The therapeutic efficacy of Aprotinin can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Aprotinin,Hydrocortisone acetate,The therapeutic efficacy of Aprotinin can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Aprotinin,Hydrocortisone butyrate,The therapeutic efficacy of Aprotinin can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Aprotinin,Hydrocortisone cypionate,The therapeutic efficacy of Aprotinin can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Aprotinin,Hydrocortisone succinate,The therapeutic efficacy of Aprotinin can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Aprotinin,Hydrogen peroxide,Aprotinin may increase the thrombogenic activities of Hydrogen peroxide.,increase,no risk
Aprotinin,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Oxprenolol,Aprotinin may increase the bradycardic activities of Oxprenolol.,increase,no risk
Aprotinin,Oxybuprocaine,Aprotinin may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Aprotinin,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Quinapril,Aprotinin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Aprotinin,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Vamorolone,The therapeutic efficacy of Aprotinin can be decreased when used in combination with Vamorolone.,decrease,no risk
Aprotinin,Varenicline,The risk or severity of adverse effects can be increased when Aprotinin is combined with Varenicline.,increase,risk
Aprotinin,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Von Willebrand factor human,Aprotinin may increase the thrombogenic activities of Von Willebrand factor human.,increase,no risk
Aprotinin,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Aprotinin.,decrease,no risk
Aprotinin,Zofenopril,Aprotinin may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Mevastatin,Ubidecarenone,The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Mevastatin.,decrease,risk
Mevastatin,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Vincristine is combined with Mevastatin.",increase,risk
Mevastatin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Mevastatin.,increase,no risk
Mevastatin,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Mevastatin.",increase,risk
Xylometazoline,Gallamine triethiodide,Xylometazoline may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Xylometazoline,Gliclazide,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Gliclazide.,increase,risk
Xylometazoline,Glimepiride,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Glimepiride.,increase,risk
Xylometazoline,Glipizide,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Glipizide.,increase,risk
Xylometazoline,Gliquidone,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Gliquidone.,increase,risk
Xylometazoline,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Xylometazoline.,decrease,no risk
Xylometazoline,Glyburide,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Glyburide.,increase,risk
Xylometazoline,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Xylometazoline.,decrease,no risk
Xylometazoline,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Xylometazoline.,increase,risk
Xylometazoline,Glymidine,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Glymidine.,increase,risk
Xylometazoline,Guanabenz,Xylometazoline may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Xylometazoline,Guanadrel,Xylometazoline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Xylometazoline,Guanethidine,Xylometazoline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Xylometazoline,Guanfacine,Xylometazoline may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Xylometazoline,Guanoxan,Xylometazoline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Xylometazoline,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Xylometazoline.,increase,risk
Xylometazoline,Hexocyclium,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Hexocyclium.,increase,risk
Xylometazoline,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Xylometazoline.,increase,risk
Xylometazoline,Hydralazine,Xylometazoline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Xylometazoline,Hydrochlorothiazide,Xylometazoline may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Xylometazoline,Hydroflumethiazide,Xylometazoline may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Xylometazoline,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Xylometazoline,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Xylometazoline.,increase,risk
Xylometazoline,Ketoconazole,The therapeutic efficacy of Ketoconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Xylometazoline,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Xylometazoline.,increase,risk
Xylometazoline,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Xylometazoline.,increase,risk
Xylometazoline,Olanzapine,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Olanzapine.,decrease,no risk
Xylometazoline,Olmesartan,Xylometazoline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Xylometazoline,Olodaterol,The risk or severity of hypertension can be increased when Xylometazoline is combined with Olodaterol.,increase,risk
Xylometazoline,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Xylometazoline.,increase,risk
Xylometazoline,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Xylometazoline.,increase,risk
Xylometazoline,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Xylometazoline,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Xylometazoline.,increase,no risk
Xylometazoline,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Xylometazoline.,increase,risk
Xylometazoline,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Xylometazoline,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Xylometazoline.,increase,risk
Xylometazoline,Oxymetazoline,The absorption of Xylometazoline can be decreased when combined with Oxymetazoline.,decrease,no risk
Xylometazoline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Xylometazoline.,increase,risk
Xylometazoline,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Xylometazoline.,increase,risk
Xylometazoline,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Xylometazoline.,decrease,no risk
Xylometazoline,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Xylometazoline.,increase,risk
Xylometazoline,Oxytocin,The risk or severity of hypertension can be increased when Xylometazoline is combined with Oxytocin.,increase,risk
Xylometazoline,Quetiapine,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Quetiapine.,decrease,no risk
Xylometazoline,Quinapril,Xylometazoline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Xylometazoline,Quinidine,Quinidine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Xylometazoline,Quinine,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Quinine.,increase,risk
Xylometazoline,Quinupramine,Quinupramine may increase the vasopressor activities of Xylometazoline.,increase,no risk
Xylometazoline,Umeclidinium,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Umeclidinium.,increase,risk
Xylometazoline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Xylometazoline.,increase,risk
Xylometazoline,Valsartan,Xylometazoline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Xylometazoline,Vecuronium,Xylometazoline may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Xylometazoline,Venlafaxine,Venlafaxine may increase the tachycardic activities of Xylometazoline.,increase,no risk
Xylometazoline,Verapamil,Verapamil may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Xylometazoline,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Xylometazoline,Vilanterol,The risk or severity of hypertension can be increased when Xylometazoline is combined with Vilanterol.,increase,risk
Xylometazoline,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Xylometazoline.,increase,risk
Xylometazoline,Vildagliptin,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Vildagliptin.,increase,risk
Xylometazoline,Voriconazole,The therapeutic efficacy of Voriconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Xylometazoline,Vortioxetine,The risk or severity of hypertension can be increased when Xylometazoline is combined with Vortioxetine.,increase,risk
Xylometazoline,Xamoterol,The risk or severity of hypertension can be increased when Xylometazoline is combined with Xamoterol.,increase,risk
Xylometazoline,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Xylometazoline.,increase,risk
Xylometazoline,Ziconotide,Ziconotide may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Xylometazoline,Ziprasidone,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Xylometazoline,Zofenopril,Xylometazoline may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Xylometazoline,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Xylometazoline.,increase,risk
Xylometazoline,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Xylometazoline,Zuclopenthixol,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Dabigatran etexilate,Bexarotene,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Bexarotene.,increase,risk
Dabigatran etexilate,Bicisate,Dabigatran etexilate may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Bismuth subgallate,Dabigatran etexilate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dabigatran etexilate,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Bisoprolol,The serum concentration of Dabigatran etexilate can be increased when it is combined with Bisoprolol.,increase,no risk
Dabigatran etexilate,Bisoxatin,Dabigatran etexilate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Bivalirudin,Dabigatran etexilate may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Dabigatran etexilate,Bleomycin,Bleomycin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Blinatumomab,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Blinatumomab.,increase,risk
Dabigatran etexilate,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Brivaracetam,Brivaracetam may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Bromazepam,Bromazepam may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Bromotheophylline,Bromotheophylline may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dabigatran etexilate,Budesonide,Budesonide may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Bumetanide,Bumetanide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dabigatran etexilate,Bupropion,Bupropion may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Buspirone,Buspirone may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Busulfan,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Busulfan.,increase,risk
Dabigatran etexilate,Butabarbital,Butabarbital may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gabapentin enacarbil,Dabigatran etexilate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gadodiamide,Gadodiamide may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gadofosveset trisodium,Dabigatran etexilate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gadoteric acid,Dabigatran etexilate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gadoteridol,Gadoteridol may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Ganciclovir,Ganciclovir may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Gemtuzumab ozogamicin.,increase,risk
Dabigatran etexilate,Gentamicin,Dabigatran etexilate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Gimeracil,Dabigatran etexilate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Givosiran,Givosiran may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Glasdegib,The serum concentration of Dabigatran etexilate can be increased when it is combined with Glasdegib.,increase,no risk
Dabigatran etexilate,Glecaprevir,The serum concentration of Dabigatran etexilate can be increased when it is combined with Glecaprevir.,increase,no risk
Dabigatran etexilate,Glipizide,Glipizide may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Glycerol phenylbutyrate,Dabigatran etexilate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Golodirsen,Dabigatran etexilate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Goserelin,Goserelin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Guanethidine,Guanethidine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Guanfacine,Guanfacine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Haloperidol,Haloperidol may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Hemin,Hemin may increase the anticoagulant activities of Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Heparin,Dabigatran etexilate may increase the anticoagulant activities of Heparin.,increase,no risk
Dabigatran etexilate,Hydralazine,Hydralazine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dabigatran etexilate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dabigatran etexilate,Hydromorphone,Hydromorphone may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dabigatran etexilate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Hydroxyethyl Starch,Dabigatran etexilate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Hydroxyprogesterone caproate,The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Dabigatran etexilate,Hydroxyurea,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Hydroxyurea.,increase,risk
Dabigatran etexilate,Kanamycin,Dabigatran etexilate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Ketamine,Ketamine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Ketazolam,Ketazolam may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Ketoconazole,The serum concentration of Dabigatran etexilate can be increased when it is combined with Ketoconazole.,increase,no risk
Dabigatran etexilate,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Dabigatran etexilate is combined with Obeticholic acid.,increase,risk
Dabigatran etexilate,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Dabigatran etexilate is combined with Obinutuzumab.,increase,risk
Dabigatran etexilate,Octinoxate,Dabigatran etexilate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Olaparib,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Olaparib.,increase,risk
Dabigatran etexilate,Olive oil,The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Olive oil.,decrease,no risk
Dabigatran etexilate,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Omacetaxine mepesuccinate.,increase,risk
Dabigatran etexilate,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Omega-3-carboxylic acids,The therapeutic efficacy of Dabigatran etexilate can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Dabigatran etexilate,Omeprazole,Omeprazole can cause a decrease in the absorption of Dabigatran etexilate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dabigatran etexilate,Opium,Dabigatran etexilate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Oseltamivir,Oseltamivir may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Dabigatran etexilate.,increase,no risk
Dabigatran etexilate,Oxacillin,Oxacillin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Oxazepam,Oxazepam may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Oxybenzone,Oxybenzone may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Dabigatran etexilate.,increase,risk
Dabigatran etexilate,Oxyquinoline,Dabigatran etexilate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Quetiapine,Quetiapine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.,decrease,no risk
Dabigatran etexilate,Quinestrol,Quinestrol may decrease the anticoagulant activities of Dabigatran etexilate.,decrease,no risk
Dabigatran etexilate,Quinethazone,Quinethazone may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dabigatran etexilate,Quinidine,The serum concentration of Dabigatran etexilate can be increased when it is combined with Quinidine.,increase,no risk
Dabigatran etexilate,Quinine,The serum concentration of Dabigatran etexilate can be increased when it is combined with Quinine.,increase,no risk
Dabigatran etexilate,Quizartinib,The serum concentration of Dabigatran etexilate can be increased when it is combined with Quizartinib.,increase,no risk
Arbekacin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gadodiamide,Gadodiamide may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gadoteridol,Gadoteridol may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Arbekacin.,increase,no risk
Arbekacin,Ganciclovir,Ganciclovir may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gemcitabine,Gemcitabine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gentamicin,Gentamicin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Gimeracil,Gimeracil may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Givosiran,Givosiran may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Glipizide,Glipizide may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Arbekacin.,increase,risk
Arbekacin,Golodirsen,Golodirsen may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Goserelin,Goserelin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Guanethidine,Guanethidine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Guanfacine,Guanfacine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Haloperidol,Haloperidol may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Heparin,The therapeutic efficacy of Arbekacin can be decreased when used in combination with Heparin.,decrease,no risk
Arbekacin,Hetacillin,The serum concentration of Arbekacin can be decreased when it is combined with Hetacillin.,decrease,no risk
Arbekacin,Hydralazine,Hydralazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Hydromorphone,Hydromorphone may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Kanamycin,Kanamycin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Ketamine,Ketamine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Ketazolam,Ketazolam may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Ketoprofen,Ketoprofen may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Ketorolac,Ketorolac may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Octinoxate,Octinoxate may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Arbekacin is combined with Olsalazine.,increase,risk
Arbekacin,Opium,Opium may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Oseltamivir,Oseltamivir may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Ouabain,The risk or severity of adverse effects can be increased when Arbekacin is combined with Ouabain.,increase,risk
Arbekacin,Oxacillin,Oxacillin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Arbekacin.,increase,risk
Arbekacin,Oxaprozin,Oxaprozin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Oxazepam,Oxazepam may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Arbekacin is combined with Oxetacaine.,increase,risk
Arbekacin,Oxybenzone,Oxybenzone may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Arbekacin is combined with Oxybuprocaine.,increase,risk
Arbekacin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Arbekacin.,increase,risk
Arbekacin,Quetiapine,Quetiapine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Quinidine,Arbekacin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Arbekacin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Arbekacin.,increase,risk
Arbekacin,Vaborbactam,Vaborbactam may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Valaciclovir,Valaciclovir may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Valbenazine,Valbenazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Valdecoxib,Valdecoxib may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Valganciclovir,Valganciclovir may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Vancomycin,Vancomycin may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Varenicline,Varenicline may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Arbekacin.,increase,no risk
Arbekacin,Venlafaxine,Venlafaxine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Verapamil,Verapamil may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Arbekacin.,decrease,no risk
Arbekacin,Vilanterol,Vilanterol may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Viloxazine,Viloxazine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Arbekacin is combined with Viomycin.,increase,risk
Arbekacin,Vortioxetine,Vortioxetine may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Warfarin,Arbekacin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Arbekacin,Zaleplon,Zaleplon may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Zanamivir,Zanamivir may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Arbekacin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Arbekacin is combined with Zoledronic acid.,increase,risk
Arbekacin,Zonisamide,Zonisamide may decrease the excretion rate of Arbekacin which could result in a higher serum level.,decrease,no risk
Artemether,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Artemether.,increase,risk
Artemether,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Artemether.,increase,risk
Artemether,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Artemether.,increase,risk
Artemether,Gefitinib,The metabolism of Artemether can be decreased when combined with Gefitinib.,decrease,no risk
Artemether,Gemfibrozil,The metabolism of Artemether can be decreased when combined with Gemfibrozil.,decrease,no risk
Artemether,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Artemether.,increase,risk
Artemether,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Artemether.,increase,risk
Artemether,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Artemether.,increase,risk
Artemether,Ginkgo biloba,The metabolism of Artemether can be decreased when combined with Ginkgo biloba.,decrease,no risk
Artemether,Glasdegib,The risk or severity of QTc prolongation can be increased when Artemether is combined with Glasdegib.,increase,risk
Artemether,Gliclazide,The metabolism of Artemether can be decreased when combined with Gliclazide.,decrease,no risk
Artemether,Glimepiride,The metabolism of Artemether can be decreased when combined with Glimepiride.,decrease,no risk
Artemether,Glipizide,The metabolism of Artemether can be decreased when combined with Glipizide.,decrease,no risk
Artemether,Gliquidone,The metabolism of Artemether can be decreased when combined with Gliquidone.,decrease,no risk
Artemether,Glofitamab,The serum concentration of Artemether can be increased when it is combined with Glofitamab.,increase,no risk
Artemether,Glyburide,The metabolism of Artemether can be decreased when combined with Glyburide.,decrease,no risk
Artemether,Golimumab,The metabolism of Artemether can be increased when combined with Golimumab.,increase,no risk
Artemether,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Artemether.,increase,risk
Artemether,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Artemether.,increase,risk
Artemether,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Artemether.,increase,risk
Artemether,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Artemether.,increase,risk
Artemether,Haloperidol,The risk or severity of QTc prolongation can be increased when Artemether is combined with Haloperidol.,increase,risk
Artemether,Halothane,The metabolism of Artemether can be decreased when combined with Halothane.,decrease,no risk
Artemether,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Artemether.,increase,risk
Artemether,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Artemether.,increase,risk
Artemether,Hydrocodone,The metabolism of Artemether can be decreased when combined with Hydrocodone.,decrease,no risk
Artemether,Hydrocortisone,The metabolism of Artemether can be increased when combined with Hydrocortisone.,increase,no risk
Artemether,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Artemether.,decrease,no risk
Artemether,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Artemether.,decrease,no risk
Artemether,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Artemether.,decrease,no risk
Artemether,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Artemether.,decrease,no risk
Artemether,Hydromorphone,The metabolism of Artemether can be decreased when combined with Hydromorphone.,decrease,no risk
Artemether,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Artemether.,increase,risk
Artemether,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Artemether.,decrease,no risk
Artemether,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Artemether is combined with Hydroxyzine.,increase,risk
Artemether,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Artemether.,increase,risk
Artemether,Ketamine,The metabolism of Artemether can be decreased when combined with Ketamine.,decrease,no risk
Artemether,Ketoconazole,The metabolism of Artemether can be decreased when combined with Ketoconazole.,decrease,no risk
Artemether,Ketorolac,The metabolism of Artemether can be decreased when combined with Ketorolac.,decrease,no risk
Artemether,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Artemether.,increase,risk
Artemether,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Artemether.,increase,risk
Artemether,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Artemether.,increase,risk
Artemether,Olaparib,The metabolism of Olaparib can be decreased when combined with Artemether.,decrease,no risk
Artemether,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Artemether.,decrease,no risk
Artemether,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Artemether.,increase,risk
Artemether,Omaveloxolone,The serum concentration of Artemether can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Artemether,Omeprazole,The metabolism of Artemether can be decreased when combined with Omeprazole.,decrease,no risk
Artemether,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Artemether.,increase,risk
Artemether,Oritavancin,The metabolism of Artemether can be decreased when combined with Oritavancin.,decrease,no risk
Artemether,Orphenadrine,The metabolism of Artemether can be decreased when combined with Orphenadrine.,decrease,no risk
Artemether,Osilodrostat,The metabolism of Artemether can be decreased when combined with Osilodrostat.,decrease,no risk
Artemether,Ospemifene,The metabolism of Artemether can be decreased when combined with Ospemifene.,decrease,no risk
Artemether,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Artemether.,increase,risk
Artemether,Oxandrolone,The metabolism of Artemether can be decreased when combined with Oxandrolone.,decrease,no risk
Artemether,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Artemether.,increase,risk
Artemether,Oxcarbazepine,The metabolism of Artemether can be increased when combined with Oxcarbazepine.,increase,no risk
Artemether,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Artemether is combined with Oxetacaine.,increase,risk
Artemether,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Artemether is combined with Oxybuprocaine.,increase,risk
Artemether,Oxybutynin,The metabolism of Artemether can be decreased when combined with Oxybutynin.,decrease,no risk
Artemether,Oxycodone,The metabolism of Artemether can be decreased when combined with Oxycodone.,decrease,no risk
Artemether,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Artemether.,increase,risk
Artemether,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Artemether.,increase,risk
Artemether,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Artemether.,increase,risk
Artemether,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Artemether.,increase,risk
Artemether,Quizartinib,The risk or severity of QTc prolongation can be increased when Artemether is combined with Quizartinib.,increase,risk
Artemether,Udenafil,The metabolism of Artemether can be decreased when combined with Udenafil.,decrease,no risk
Artemether,Vadadustat,The serum concentration of Artemether can be decreased when it is combined with Vadadustat.,decrease,no risk
Artemether,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Artemether.,decrease,no risk
Artemether,Valdecoxib,The metabolism of Artemether can be decreased when combined with Valdecoxib.,decrease,no risk
Artemether,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Artemether.,increase,risk
Artemether,Valsartan,The metabolism of Artemether can be decreased when combined with Valsartan.,decrease,no risk
Artemether,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Artemether.,increase,risk
Artemether,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Artemether.,increase,risk
Artemether,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Artemether.,decrease,no risk
Artemether,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Artemether.,increase,risk
Artemether,Venetoclax,The metabolism of Artemether can be decreased when combined with Venetoclax.,decrease,no risk
Artemether,Verapamil,The metabolism of Artemether can be decreased when combined with Verapamil.,decrease,no risk
Artemether,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Artemether.,increase,risk
Artemether,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Artemether.,increase,risk
Artemether,Vilazodone,The metabolism of Artemether can be decreased when combined with Vilazodone.,decrease,no risk
Artemether,Viloxazine,The metabolism of Artemether can be decreased when combined with Viloxazine.,decrease,no risk
Artemether,Vincristine,The metabolism of Vincristine can be decreased when combined with Artemether.,decrease,no risk
Artemether,Vonoprazan,The metabolism of Artemether can be decreased when combined with Vonoprazan.,decrease,no risk
Artemether,Voriconazole,The metabolism of Artemether can be decreased when combined with Voriconazole.,decrease,no risk
Artemether,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Artemether.,increase,risk
Artemether,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Artemether.,decrease,no risk
Artemether,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Artemether.,decrease,no risk
Artemether,Warfarin,The metabolism of Warfarin can be increased when combined with Artemether.,increase,no risk
Artemether,Ximelagatran,The metabolism of Artemether can be decreased when combined with Ximelagatran.,decrease,no risk
Artemether,Zafirlukast,The metabolism of Artemether can be decreased when combined with Zafirlukast.,decrease,no risk
Artemether,Zaleplon,The metabolism of Artemether can be decreased when combined with Zaleplon.,decrease,no risk
Artemether,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Artemether.,decrease,no risk
Artemether,Zidovudine,The metabolism of Artemether can be decreased when combined with Zidovudine.,decrease,no risk
Artemether,Zileuton,The metabolism of Artemether can be decreased when combined with Zileuton.,decrease,no risk
Artemether,Zimelidine,The metabolism of Artemether can be decreased when combined with Zimelidine.,decrease,no risk
Artemether,Ziprasidone,The risk or severity of QTc prolongation can be increased when Artemether is combined with Ziprasidone.,increase,risk
Artemether,Zolpidem,The metabolism of Artemether can be decreased when combined with Zolpidem.,decrease,no risk
Artemether,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Artemether.,increase,risk
Artemether,Zopiclone,The metabolism of Artemether can be decreased when combined with Zopiclone.,decrease,no risk
Artemether,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Artemether.,increase,risk
Artemether,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Artemether.,decrease,no risk
Betahistine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Betahistine.,decrease,no risk
Betahistine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Betahistine.,decrease,no risk
Betahistine,Orphenadrine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Orphenadrine.,decrease,no risk
Betahistine,Oxatomide,The therapeutic efficacy of Betahistine can be decreased when used in combination with Oxatomide.,decrease,no risk
Betahistine,Quetiapine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Quetiapine.,decrease,no risk
Betahistine,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Betahistine.,decrease,no risk
Betahistine,Ziprasidone,The therapeutic efficacy of Betahistine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Betahistine,Zuclopenthixol,The therapeutic efficacy of Betahistine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Degarelix,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Gadobenic acid.,increase,risk
Degarelix,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Degarelix.,increase,risk
Degarelix,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Degarelix.,increase,risk
Degarelix,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Gemifloxacin.,increase,risk
Degarelix,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Degarelix.,increase,risk
Degarelix,Gilteritinib,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Gilteritinib.,increase,risk
Degarelix,Glasdegib,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Glasdegib.,increase,risk
Degarelix,Goserelin,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Goserelin.,increase,risk
Degarelix,Granisetron,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Granisetron.,increase,risk
Degarelix,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Grepafloxacin.,increase,risk
Degarelix,Halofantrine,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Halofantrine.,increase,risk
Degarelix,Haloperidol,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Haloperidol.,increase,risk
Degarelix,Histrelin,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Histrelin.,increase,risk
Degarelix,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Degarelix.,increase,risk
Degarelix,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Degarelix.,increase,risk
Degarelix,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Hydroxyzine.,increase,risk
Degarelix,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Degarelix.,increase,risk
Degarelix,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Degarelix.,increase,risk
Degarelix,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Degarelix.,increase,risk
Degarelix,Ofloxacin,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Ofloxacin.,increase,risk
Degarelix,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Degarelix.,increase,risk
Degarelix,Olodaterol,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Olodaterol.,increase,risk
Degarelix,Ondansetron,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Ondansetron.,increase,risk
Degarelix,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Degarelix.,increase,risk
Degarelix,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Degarelix.,increase,risk
Degarelix,Oxatomide,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Oxatomide.,increase,risk
Degarelix,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Degarelix is combined with Oxetacaine.,increase,risk
Degarelix,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Degarelix is combined with Oxybuprocaine.,increase,risk
Degarelix,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Degarelix.,increase,risk
Degarelix,Quetiapine,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Quetiapine.,increase,risk
Degarelix,Quinidine,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Quinidine.,increase,risk
Degarelix,Quinine,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Quinine.,increase,risk
Degarelix,Quizartinib,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Quizartinib.,increase,risk
Degarelix,Valproic acid,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Valproic acid.,increase,risk
Degarelix,Vandetanib,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Vandetanib.,increase,risk
Degarelix,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Degarelix.,increase,risk
Degarelix,Vemurafenib,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Vemurafenib.,increase,risk
Degarelix,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Degarelix.,increase,risk
Degarelix,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Degarelix.,increase,risk
Degarelix,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Degarelix.,increase,risk
Degarelix,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Degarelix.,increase,risk
Degarelix,Ziprasidone,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Ziprasidone.,increase,risk
Degarelix,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Degarelix.,increase,risk
Degarelix,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Degarelix is combined with Zuclopenthixol.,increase,risk
Desvenlafaxine,Bacitracin,Bacitracin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine.,increase,no risk
Desvenlafaxine,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Balsalazide.,increase,risk
Desvenlafaxine,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Beclomethasone dipropionate,The metabolism of Beclomethasone dipropionate can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bedaquiline,The metabolism of Bedaquiline can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bemiparin,The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Bemiparin.,increase,risk
Desvenlafaxine,Bendroflumethiazide,The risk or severity of hyponatremia can be increased when Desvenlafaxine is combined with Bendroflumethiazide.,increase,risk
Desvenlafaxine,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Benorilate.,increase,risk
Desvenlafaxine,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Benoxaprofen.,increase,risk
Desvenlafaxine,Benperidol,The risk or severity of adverse effects can be increased when Benperidol is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Benserazide,Desvenlafaxine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Benzatropine,The serum concentration of Benzatropine can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Benzhydrocodone,The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Benznidazole,Desvenlafaxine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Benzphetamine.,increase,risk
Desvenlafaxine,Benzthiazide,The risk or severity of hyponatremia can be increased when Desvenlafaxine is combined with Benzthiazide.,increase,risk
Desvenlafaxine,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Benzydamine.,increase,risk
Desvenlafaxine,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Bepotastine,Bepotastine may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Berotralstat,The metabolism of Desvenlafaxine can be decreased when combined with Berotralstat.,decrease,no risk
Desvenlafaxine,Betamethasone,The metabolism of Betamethasone can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Bethanidine,Desvenlafaxine may increase the tachycardic activities of Bethanidine.,increase,no risk
Desvenlafaxine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Desvenlafaxine is combined with Bexagliflozin.,increase,risk
Desvenlafaxine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bicisate,Desvenlafaxine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bimekizumab,The metabolism of Desvenlafaxine can be increased when combined with Bimekizumab.,increase,no risk
Desvenlafaxine,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Bismuth subgallate,Desvenlafaxine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Bisoxatin,Desvenlafaxine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Bivalirudin,The risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Bivalirudin.,increase,risk
Desvenlafaxine,Bleomycin,Bleomycin may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.,decrease,no risk
Desvenlafaxine,Boceprevir,The metabolism of Desvenlafaxine can be decreased when combined with Boceprevir.,decrease,no risk
Desvenlafaxine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Bosentan,The metabolism of Bosentan can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine.,increase,no risk
Desvenlafaxine,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Desvenlafaxine,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Budesonide,The metabolism of Budesonide can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Bumadizone.,increase,risk
Desvenlafaxine,Bumetanide,Bumetanide may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Desvenlafaxine,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Desvenlafaxine.,increase,no risk
Desvenlafaxine,Buprenorphine,Desvenlafaxine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Desvenlafaxine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Buspirone,The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Buspirone.,increase,risk
Desvenlafaxine,Busulfan,The metabolism of Busulfan can be decreased when combined with Desvenlafaxine.,decrease,no risk
Desvenlafaxine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Desvenlafaxine.,increase,risk
Desvenlafaxine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Butorphanol.,increase,risk
Desvenlafaxine,Butriptyline,The risk or severity of serotonin syndrome can be increased when Desvenlafaxine is combined with Butriptyline.,increase,risk
Desvenlafaxine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Desvenlafaxine is combined with Butylscopolamine.,increase,risk
Dexmethylphenidate,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Dexmethylphenidate is combined with Gabapentin enacarbil.,increase,risk
Dexmethylphenidate,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dexmethylphenidate is combined with Ganaxolone.",increase,risk
Dexmethylphenidate,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Gilteritinib,The therapeutic efficacy of Dexmethylphenidate can be decreased when used in combination with Gilteritinib.,decrease,no risk
Dexmethylphenidate,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Guanabenz,Dexmethylphenidate may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Dexmethylphenidate,Guanadrel,Dexmethylphenidate may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Dexmethylphenidate,Guanethidine,Dexmethylphenidate may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Dexmethylphenidate,Guanfacine,Dexmethylphenidate may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Dexmethylphenidate,Guanoxan,Dexmethylphenidate may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Dexmethylphenidate,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Halothane,Dexmethylphenidate may increase the hypertensive activities of Halothane.,increase,no risk
Dexmethylphenidate,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Hydralazine,Dexmethylphenidate may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Dexmethylphenidate,Hydrochlorothiazide,Dexmethylphenidate may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Dexmethylphenidate,Hydrocodone,Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dexmethylphenidate,Hydroflumethiazide,Dexmethylphenidate may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Dexmethylphenidate,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Dexmethylphenidate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Dexmethylphenidate,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dexmethylphenidate.,increase,no risk
Dexmethylphenidate,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Olanzapine,The therapeutic efficacy of Dexmethylphenidate can be decreased when used in combination with Olanzapine.,decrease,no risk
Dexmethylphenidate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dexmethylphenidate is combined with Oliceridine.",increase,risk
Dexmethylphenidate,Olmesartan,Dexmethylphenidate may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Dexmethylphenidate,Olodaterol,The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Olodaterol.,increase,risk
Dexmethylphenidate,Omeprazole,Omeprazole can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Dexmethylphenidate,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Opicapone,The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Opicapone.,increase,risk
Dexmethylphenidate,Opium,The risk or severity of CNS depression can be increased when Dexmethylphenidate is combined with Opium.,increase,risk
Dexmethylphenidate,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Orphenadrine,Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dexmethylphenidate,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxprenolol,Dexmethylphenidate may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Dexmethylphenidate,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Quinapril,Dexmethylphenidate may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Dexmethylphenidate,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Dexmethylphenidate.,increase,no risk
Dexmethylphenidate,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Dexmethylphenidate is combined with Valproate bismuth.,increase,risk
Dexmethylphenidate,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Valsartan,Dexmethylphenidate may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Dexmethylphenidate,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Dexmethylphenidate is combined with Venlafaxine.,increase,risk
Dexmethylphenidate,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Vilanterol,The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Vilanterol.,increase,risk
Dexmethylphenidate,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Viloxazine,The risk or severity of CNS depression can be increased when Dexmethylphenidate is combined with Viloxazine.,increase,risk
Dexmethylphenidate,Vonoprazan,Vonoprazan can cause an increase in the absorption of Dexmethylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Dexmethylphenidate,Vortioxetine,The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Vortioxetine.,increase,risk
Dexmethylphenidate,Warfarin,The serum concentration of the active metabolites of Warfarin can be increased when Warfarin is used in combination with Dexmethylphenidate.,increase,no risk
Dexmethylphenidate,Xamoterol,The risk or severity of hypertension can be increased when Dexmethylphenidate is combined with Xamoterol.,increase,risk
Dexmethylphenidate,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Zimelidine,The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Zimelidine.,increase,risk
Dexmethylphenidate,Ziprasidone,The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Ziprasidone.,increase,risk
Dexmethylphenidate,Zofenopril,Dexmethylphenidate may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Dexmethylphenidate,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Zolpidem,Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dexmethylphenidate,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Zopiclone,The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Zopiclone.,increase,risk
Dexmethylphenidate,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Dexmethylphenidate.,increase,risk
Dexmethylphenidate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dexmethylphenidate.,increase,risk
Fesoterodine,Betaxolol,The metabolism of Fesoterodine can be decreased when combined with Betaxolol.,decrease,no risk
Fesoterodine,Bethanidine,The risk or severity of Tachycardia can be increased when Bethanidine is combined with Fesoterodine.,increase,risk
Fesoterodine,Bicisate,Fesoterodine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Fesoterodine,Bimekizumab,The metabolism of Fesoterodine can be increased when combined with Bimekizumab.,increase,no risk
Fesoterodine,Biperiden,The metabolism of Fesoterodine can be decreased when combined with Biperiden.,decrease,no risk
Fesoterodine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Fesoterodine.,decrease,no risk
Fesoterodine,Bismuth subgallate,Fesoterodine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Fesoterodine,Bisoprolol,Bisoprolol may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Fesoterodine.,decrease,no risk
Fesoterodine,Bleomycin,Bleomycin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Boceprevir,The metabolism of Fesoterodine can be decreased when combined with Boceprevir.,decrease,no risk
Fesoterodine,Bortezomib,The metabolism of Fesoterodine can be decreased when combined with Bortezomib.,decrease,no risk
Fesoterodine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Botulinum toxin type A.,increase,risk
Fesoterodine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Botulinum toxin type B.,increase,risk
Fesoterodine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Fesoterodine.,decrease,no risk
Fesoterodine,Brivaracetam,Brivaracetam may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Bromazepam,Bromazepam may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Bromocriptine,The risk or severity of Tachycardia can be increased when Bromocriptine is combined with Fesoterodine.,increase,risk
Fesoterodine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fesoterodine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Fesoterodine.,increase,risk
Fesoterodine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Fesoterodine.,increase,risk
Fesoterodine,Budesonide,Budesonide may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Bumadizone,Bumadizone may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Bumetanide,Bumetanide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fesoterodine,Bupivacaine,The metabolism of Fesoterodine can be decreased when combined with Bupivacaine.,decrease,no risk
Fesoterodine,Buprenorphine,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Buprenorphine.,increase,risk
Fesoterodine,Bupropion,The metabolism of Fesoterodine can be decreased when combined with Bupropion.,decrease,no risk
Fesoterodine,Buspirone,Buspirone may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Fesoterodine.,increase,risk
Fesoterodine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Fesoterodine.,increase,risk
Fesoterodine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Fesoterodine.,increase,risk
Fesoterodine,Butorphanol,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Butorphanol.,increase,risk
Fesoterodine,Butriptyline,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Butriptyline.,increase,risk
Fesoterodine,Butylscopolamine,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Butylscopolamine.,increase,risk
Fesoterodine,Gabapentin enacarbil,Fesoterodine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gadodiamide,Gadodiamide may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gadofosveset trisodium,Fesoterodine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gadoteric acid,Fesoterodine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gadoteridol,Gadoteridol may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Galantamine,The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Galantamine.,decrease,no risk
Fesoterodine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Fesoterodine.,increase,risk
Fesoterodine,Ganciclovir,Ganciclovir may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gefitinib,The metabolism of Fesoterodine can be decreased when combined with Gefitinib.,decrease,no risk
Fesoterodine,Gemcitabine,Gemcitabine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gentamicin,Fesoterodine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Fesoterodine,Gimeracil,Fesoterodine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Fesoterodine,Ginkgo biloba,The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Fesoterodine,Givosiran,The serum concentration of Fesoterodine can be increased when it is combined with Givosiran.,increase,no risk
Fesoterodine,Glipizide,Glipizide may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Glofitamab,The serum concentration of Fesoterodine can be increased when it is combined with Glofitamab.,increase,no risk
Fesoterodine,Glucagon,Fesoterodine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Fesoterodine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Fesoterodine.,decrease,no risk
Fesoterodine,Glycerol phenylbutyrate,The metabolism of Fesoterodine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Fesoterodine,Glycopyrronium,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Glycopyrronium.,increase,risk
Fesoterodine,Golimumab,The metabolism of Fesoterodine can be increased when combined with Golimumab.,increase,no risk
Fesoterodine,Golodirsen,Fesoterodine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Fesoterodine,Goserelin,Goserelin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Fesoterodine.,increase,risk
Fesoterodine,Guanethidine,Guanethidine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Guanfacine,Guanfacine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Halofantrine,The metabolism of Fesoterodine can be decreased when combined with Halofantrine.,decrease,no risk
Fesoterodine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fesoterodine.,increase,no risk
Fesoterodine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Fesoterodine.,increase,risk
Fesoterodine,Hexocyclium,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Hexocyclium.,increase,risk
Fesoterodine,Homatropine,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Homatropine.,increase,risk
Fesoterodine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Fesoterodine.,increase,risk
Fesoterodine,Huperzine A,The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Huperzine A.,decrease,no risk
Fesoterodine,Hydralazine,Hydralazine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fesoterodine,Hydrocodone,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Hydrocodone.,increase,risk
Fesoterodine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fesoterodine,Hydromorphone,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Hydromorphone.,increase,risk
Fesoterodine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Hydroxychloroquine,The metabolism of Fesoterodine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Fesoterodine,Hydroxyethyl Starch,Fesoterodine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Fesoterodine,Hydroxyzine,The metabolism of Fesoterodine can be decreased when combined with Hydroxyzine.,decrease,no risk
Fesoterodine,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Fesoterodine.,increase,risk
Fesoterodine,Kanamycin,Fesoterodine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Fesoterodine,Ketamine,The therapeutic efficacy of Fesoterodine can be decreased when used in combination with Ketamine.,decrease,no risk
Fesoterodine,Ketazolam,Ketazolam may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Ketoconazole,The metabolism of Fesoterodine can be decreased when combined with Ketoconazole.,decrease,no risk
Fesoterodine,Ketoprofen,Ketoprofen may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Ketorolac,Ketorolac may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Octinoxate,Fesoterodine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Fesoterodine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Fesoterodine.,increase,risk
Fesoterodine,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Fesoterodine is combined with Oliceridine.",increase,risk
Fesoterodine,Olodaterol,The risk or severity of Tachycardia can be increased when Fesoterodine is combined with Olodaterol.,increase,risk
Fesoterodine,Olsalazine,Olsalazine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Omaveloxolone,The serum concentration of Fesoterodine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Fesoterodine,Ondansetron,The metabolism of Fesoterodine can be decreased when combined with Ondansetron.,decrease,no risk
Fesoterodine,Opium,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Opium.,increase,risk
Fesoterodine,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Fesoterodine.,increase,risk
Fesoterodine,Oritavancin,The metabolism of Fesoterodine can be decreased when combined with Oritavancin.,decrease,no risk
Fesoterodine,Orphenadrine,The metabolism of Fesoterodine can be decreased when combined with Orphenadrine.,decrease,no risk
Fesoterodine,Oseltamivir,Oseltamivir may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Osilodrostat,The metabolism of Fesoterodine can be decreased when combined with Osilodrostat.,decrease,no risk
Fesoterodine,Ospemifene,The metabolism of Fesoterodine can be decreased when combined with Ospemifene.,decrease,no risk
Fesoterodine,Oxacillin,Oxacillin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Oxamniquine,The metabolism of Fesoterodine can be decreased when combined with Oxamniquine.,decrease,no risk
Fesoterodine,Oxaprozin,Oxaprozin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Oxazepam,Oxazepam may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Oxprenolol,The metabolism of Fesoterodine can be decreased when combined with Oxprenolol.,decrease,no risk
Fesoterodine,Oxybenzone,Oxybenzone may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Oxybutynin,The metabolism of Fesoterodine can be decreased when combined with Oxybutynin.,decrease,no risk
Fesoterodine,Oxycodone,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Oxycodone.,increase,risk
Fesoterodine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Fesoterodine.,increase,risk
Fesoterodine,Oxymorphone,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Oxymorphone.,increase,risk
Fesoterodine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Fesoterodine.,increase,risk
Fesoterodine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Fesoterodine.,decrease,no risk
Fesoterodine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Fesoterodine.,increase,risk
Fesoterodine,Oxyquinoline,Fesoterodine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Fesoterodine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Fesoterodine.,increase,risk
Fesoterodine,Quinethazone,Quinethazone may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fesoterodine,Quinidine,The metabolism of Fesoterodine can be decreased when combined with Quinidine.,decrease,no risk
Fesoterodine,Quinine,The metabolism of Fesoterodine can be decreased when combined with Quinine.,decrease,no risk
Fesoterodine,Quinupramine,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Quinupramine.,increase,risk
Fesoterodine,Umeclidinium,The risk or severity of adverse effects can be increased when Fesoterodine is combined with Umeclidinium.,increase,risk
Fesoterodine,Vaborbactam,Fesoterodine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Fesoterodine,Vadadustat,The serum concentration of Fesoterodine can be increased when it is combined with Vadadustat.,increase,no risk
Fesoterodine,Valaciclovir,Valaciclovir may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Valbenazine,Fesoterodine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Valdecoxib,Valdecoxib may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Valganciclovir,Valganciclovir may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Vancomycin,Fesoterodine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Fesoterodine,Varenicline,Varenicline may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Fesoterodine.,increase,risk
Fesoterodine,Vemurafenib,The metabolism of Fesoterodine can be decreased when combined with Vemurafenib.,decrease,no risk
Fesoterodine,Venetoclax,The metabolism of Fesoterodine can be decreased when combined with Venetoclax.,decrease,no risk
Fesoterodine,Venlafaxine,The metabolism of Fesoterodine can be decreased when combined with Venlafaxine.,decrease,no risk
Fesoterodine,Verapamil,The metabolism of Fesoterodine can be decreased when combined with Verapamil.,decrease,no risk
Fesoterodine,Vernakalant,The metabolism of Fesoterodine can be decreased when combined with Vernakalant.,decrease,no risk
Fesoterodine,Vibegron,Fesoterodine may increase the smooth muscle relaxing activities of Vibegron.,increase,no risk
Fesoterodine,Vilanterol,Fesoterodine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Fesoterodine,Vilazodone,The metabolism of Fesoterodine can be decreased when combined with Vilazodone.,decrease,no risk
Fesoterodine,Viloxazine,The metabolism of Fesoterodine can be decreased when combined with Viloxazine.,decrease,no risk
Fesoterodine,Vinblastine,The metabolism of Fesoterodine can be decreased when combined with Vinblastine.,decrease,no risk
Fesoterodine,Vinorelbine,The metabolism of Fesoterodine can be decreased when combined with Vinorelbine.,decrease,no risk
Fesoterodine,Voriconazole,The metabolism of Fesoterodine can be decreased when combined with Voriconazole.,decrease,no risk
Fesoterodine,Vortioxetine,Fesoterodine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Warfarin,Fesoterodine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Fesoterodine,Xamoterol,The risk or severity of Tachycardia can be increased when Fesoterodine is combined with Xamoterol.,increase,risk
Fesoterodine,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Fesoterodine.,increase,risk
Fesoterodine,Yohimbine,The metabolism of Fesoterodine can be decreased when combined with Yohimbine.,decrease,no risk
Fesoterodine,Zaleplon,Zaleplon may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Zanamivir,Zanamivir may decrease the excretion rate of Fesoterodine which could result in a higher serum level.,decrease,no risk
Fesoterodine,Zimelidine,The metabolism of Fesoterodine can be decreased when combined with Zimelidine.,decrease,no risk
Fesoterodine,Ziprasidone,The metabolism of Fesoterodine can be decreased when combined with Ziprasidone.,decrease,no risk
Fesoterodine,Zolpidem,The metabolism of Fesoterodine can be decreased when combined with Zolpidem.,decrease,no risk
Fesoterodine,Zonisamide,Zonisamide may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Fesoterodine,Zuclopenthixol,The metabolism of Fesoterodine can be decreased when combined with Zuclopenthixol.,decrease,no risk
Iobenguane,Benzphetamine,Benzphetamine can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iobenguane,Bethanidine,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Bethanidine.,decrease,no risk
Iobenguane,Bromocriptine,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Bromocriptine.,decrease,no risk
Iobenguane,Butriptyline,Butriptyline may decrease effectiveness of Iobenguane as a diagnostic agent.,decrease,no risk
Iobenguane,Guanabenz,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Guanabenz.,decrease,no risk
Iobenguane,Guanfacine,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Guanfacine.,decrease,no risk
Iobenguane,Orciprenaline,Orciprenaline can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iobenguane,Oxymetazoline,Oxymetazoline can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iobenguane,Quinupramine,Quinupramine may decrease effectiveness of Iobenguane as a diagnostic agent.,decrease,no risk
Iobenguane,Venlafaxine,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Venlafaxine.,decrease,no risk
Iobenguane,Viloxazine,Viloxazine can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iobenguane,Xylometazoline,The therapeutic efficacy of Iobenguane can be decreased when used in combination with Xylometazoline.,decrease,no risk
Iobenguane,Zimelidine,Zimelidine may decrease effectiveness of Iobenguane as a diagnostic agent.,decrease,no risk
Gadofosveset trisodium,Gabapentin enacarbil,Gadofosveset trisodium may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gadodiamide,Gadodiamide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gadoteric acid,Gadofosveset trisodium may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gadoteridol,Gadoteridol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Ganciclovir,Ganciclovir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gemcitabine,Gemcitabine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gentamicin,Gadofosveset trisodium may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Gimeracil,Gadofosveset trisodium may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Givosiran,Givosiran may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Glipizide,Glipizide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Glycerol phenylbutyrate,Gadofosveset trisodium may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Golodirsen,Gadofosveset trisodium may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Goserelin,Goserelin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Guanethidine,Guanethidine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Guanfacine,Guanfacine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Haloperidol,Haloperidol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Hydralazine,Hydralazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gadofosveset trisodium,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gadofosveset trisodium,Hydromorphone,Hydromorphone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Hydroxyethyl Starch,Gadofosveset trisodium may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Kanamycin,Gadofosveset trisodium may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Ketamine,Ketamine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Ketazolam,Ketazolam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Ketoprofen,Ketoprofen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Ketorolac,Ketorolac may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Octinoxate,Gadofosveset trisodium may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Olsalazine,Olsalazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Opium,Gadofosveset trisodium may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Oseltamivir,Oseltamivir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Oxacillin,Oxacillin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Oxaprozin,Oxaprozin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Oxazepam,Oxazepam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Oxybenzone,Oxybenzone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Oxyquinoline,Gadofosveset trisodium may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Quetiapine,Quetiapine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gadofosveset trisodium,Quinethazone,Quinethazone may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gadofosveset trisodium,Quinidine,Gadofosveset trisodium may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Isometheptene,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Isometheptene.,increase,risk
Isometheptene,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Isometheptene.,increase,risk
Isometheptene,Guanabenz,Isometheptene may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Isometheptene,Guanadrel,Isometheptene may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Isometheptene,Guanethidine,Isometheptene may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Isometheptene,Guanfacine,Isometheptene may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Isometheptene,Guanoxan,Isometheptene may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Isometheptene,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Isometheptene.,increase,risk
Isometheptene,Hexocyclium,The risk or severity of Tachycardia can be increased when Isometheptene is combined with Hexocyclium.,increase,risk
Isometheptene,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Isometheptene.,increase,risk
Isometheptene,Hydralazine,Isometheptene may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Isometheptene,Hydrochlorothiazide,Isometheptene may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Isometheptene,Hydroflumethiazide,Isometheptene may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Isometheptene,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Isometheptene.,increase,risk
Isometheptene,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Isometheptene.,increase,risk
Isometheptene,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Isometheptene.,increase,risk
Isometheptene,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Isometheptene.,increase,risk
Isometheptene,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Isometheptene.,increase,risk
Isometheptene,Olanzapine,The therapeutic efficacy of Isometheptene can be decreased when used in combination with Olanzapine.,decrease,no risk
Isometheptene,Olmesartan,Isometheptene may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Isometheptene,Olodaterol,The risk or severity of hypertension can be increased when Isometheptene is combined with Olodaterol.,increase,risk
Isometheptene,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Isometheptene.,increase,risk
Isometheptene,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Isometheptene.,increase,risk
Isometheptene,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Isometheptene.,increase,risk
Isometheptene,Oxprenolol,The therapeutic efficacy of Isometheptene can be decreased when used in combination with Oxprenolol.,decrease,no risk
Isometheptene,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Isometheptene.,increase,risk
Isometheptene,Oxymetazoline,Isometheptene may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Isometheptene,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Isometheptene.,increase,risk
Isometheptene,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Isometheptene.,increase,risk
Isometheptene,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Isometheptene.,increase,risk
Isometheptene,Quetiapine,The therapeutic efficacy of Isometheptene can be decreased when used in combination with Quetiapine.,decrease,no risk
Isometheptene,Quinapril,Isometheptene may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Isometheptene,Quinidine,The therapeutic efficacy of Isometheptene can be decreased when used in combination with Quinidine.,decrease,no risk
Isometheptene,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Isometheptene.,increase,risk
Isometheptene,Quinupramine,Quinupramine may increase the vasopressor activities of Isometheptene.,increase,no risk
Isometheptene,Umeclidinium,The risk or severity of Tachycardia can be increased when Isometheptene is combined with Umeclidinium.,increase,risk
Isometheptene,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Isometheptene.,increase,risk
Isometheptene,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Isometheptene.,increase,risk
Isometheptene,Valsartan,Isometheptene may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Isometheptene,Venlafaxine,Venlafaxine may increase the tachycardic activities of Isometheptene.,increase,no risk
Isometheptene,Verapamil,The therapeutic efficacy of Isometheptene can be decreased when used in combination with Verapamil.,decrease,no risk
Isometheptene,Vilanterol,The risk or severity of hypertension can be increased when Isometheptene is combined with Vilanterol.,increase,risk
Isometheptene,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Isometheptene.,increase,risk
Isometheptene,Vortioxetine,The risk or severity of hypertension can be increased when Isometheptene is combined with Vortioxetine.,increase,risk
Isometheptene,Xamoterol,The risk or severity of hypertension can be increased when Isometheptene is combined with Xamoterol.,increase,risk
Isometheptene,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Isometheptene.,increase,risk
Isometheptene,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Isometheptene.,increase,risk
Isometheptene,Ziprasidone,The therapeutic efficacy of Isometheptene can be decreased when used in combination with Ziprasidone.,decrease,no risk
Isometheptene,Zofenopril,Isometheptene may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Isometheptene,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Isometheptene.,increase,risk
Isometheptene,Zopiclone,The risk or severity of methemoglobinemia can be increased when Zopiclone is combined with Isometheptene.,increase,risk
Isometheptene,Zuclopenthixol,The therapeutic efficacy of Isometheptene can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Levonordefrin,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Levonordefrin.,increase,risk
Levonordefrin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Levonordefrin.,decrease,no risk
Levonordefrin,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Levonordefrin.,increase,risk
Levonordefrin,Guanabenz,Levonordefrin may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Levonordefrin,Guanadrel,Levonordefrin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Levonordefrin,Guanethidine,Levonordefrin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Levonordefrin,Guanfacine,Levonordefrin may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Levonordefrin,Guanoxan,Levonordefrin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Levonordefrin,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Levonordefrin.,increase,risk
Levonordefrin,Hexocyclium,The risk or severity of Tachycardia can be increased when Levonordefrin is combined with Hexocyclium.,increase,risk
Levonordefrin,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Levonordefrin.,increase,risk
Levonordefrin,Hydralazine,Levonordefrin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Levonordefrin,Hydrochlorothiazide,The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Hydrochlorothiazide.,increase,risk
Levonordefrin,Hydroflumethiazide,The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Hydroflumethiazide.,increase,risk
Levonordefrin,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Levonordefrin.,increase,risk
Levonordefrin,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Levonordefrin.,increase,risk
Levonordefrin,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Levonordefrin.,increase,risk
Levonordefrin,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Levonordefrin.,increase,risk
Levonordefrin,Ketotifen,The therapeutic efficacy of Levonordefrin can be increased when used in combination with Ketotifen.,increase,no risk
Levonordefrin,Olanzapine,The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Olanzapine.,decrease,no risk
Levonordefrin,Olmesartan,Levonordefrin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Levonordefrin,Olodaterol,The risk or severity of hypertension can be increased when Levonordefrin is combined with Olodaterol.,increase,risk
Levonordefrin,Orciprenaline,The therapeutic efficacy of Orciprenaline can be increased when used in combination with Levonordefrin.,increase,no risk
Levonordefrin,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Levonordefrin.,increase,risk
Levonordefrin,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Ouabain.,increase,risk
Levonordefrin,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Levonordefrin.,increase,risk
Levonordefrin,Oxatomide,The therapeutic efficacy of Levonordefrin can be increased when used in combination with Oxatomide.,increase,no risk
Levonordefrin,Oxprenolol,The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Oxprenolol.,decrease,no risk
Levonordefrin,Oxtriphylline,The risk or severity of adverse effects can be increased when Levonordefrin is combined with Oxtriphylline.,increase,risk
Levonordefrin,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Levonordefrin.,increase,risk
Levonordefrin,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be increased when used in combination with Levonordefrin.,increase,no risk
Levonordefrin,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Levonordefrin.,increase,risk
Levonordefrin,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Levonordefrin.,increase,risk
Levonordefrin,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Levonordefrin.,increase,risk
Levonordefrin,Oxytocin,The risk or severity of hypertension can be increased when Levonordefrin is combined with Oxytocin.,increase,risk
Levonordefrin,Quetiapine,The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Quetiapine.,decrease,no risk
Levonordefrin,Quinapril,Levonordefrin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Levonordefrin,Quinethazone,The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Quinethazone.,increase,risk
Levonordefrin,Quinidine,The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Quinidine.,decrease,no risk
Levonordefrin,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Levonordefrin.,increase,risk
Levonordefrin,Umeclidinium,The risk or severity of Tachycardia can be increased when Levonordefrin is combined with Umeclidinium.,increase,risk
Levonordefrin,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Levonordefrin.,increase,risk
Levonordefrin,Valsartan,Levonordefrin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Levonordefrin,Vasopressin,Vasopressin may increase the hypertensive activities of Levonordefrin.,increase,no risk
Levonordefrin,Venlafaxine,Venlafaxine may increase the tachycardic activities of Levonordefrin.,increase,no risk
Levonordefrin,Verapamil,Verapamil may decrease the hypertensive activities of Levonordefrin.,decrease,no risk
Levonordefrin,Vilanterol,The risk or severity of hypertension can be increased when Levonordefrin is combined with Vilanterol.,increase,risk
Levonordefrin,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Levonordefrin.,increase,risk
Levonordefrin,Vortioxetine,The risk or severity of hypertension can be increased when Levonordefrin is combined with Vortioxetine.,increase,risk
Levonordefrin,Xamoterol,The risk or severity of hypertension can be increased when Levonordefrin is combined with Xamoterol.,increase,risk
Levonordefrin,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Levonordefrin.,increase,risk
Levonordefrin,Yohimbine,Yohimbine may decrease the hypertensive activities of Levonordefrin.,decrease,no risk
Levonordefrin,Ziprasidone,The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Levonordefrin,Zofenopril,Levonordefrin may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Levonordefrin,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Levonordefrin.,increase,risk
Levonordefrin,Zonisamide,The risk or severity of Cardiac Arrhythmia can be increased when Levonordefrin is combined with Zonisamide.,increase,risk
Levonordefrin,Zuclopenthixol,The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Lumefantrine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Lumefantrine.,increase,risk
Lumefantrine,Galantamine,The metabolism of Galantamine can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lumefantrine.,increase,risk
Lumefantrine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Lumefantrine.,increase,risk
Lumefantrine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Lumefantrine.,increase,risk
Lumefantrine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Lumefantrine.,increase,risk
Lumefantrine,Glasdegib,The risk or severity of QTc prolongation can be increased when Lumefantrine is combined with Glasdegib.,increase,risk
Lumefantrine,Glofitamab,The serum concentration of Lumefantrine can be increased when it is combined with Glofitamab.,increase,no risk
Lumefantrine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lumefantrine.,increase,risk
Lumefantrine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Lumefantrine.,increase,risk
Lumefantrine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Lumefantrine.,increase,risk
Lumefantrine,Halofantrine,Lumefantrine may increase the QTc-prolonging activities of Halofantrine.,increase,no risk
Lumefantrine,Haloperidol,The risk or severity of QTc prolongation can be increased when Lumefantrine is combined with Haloperidol.,increase,risk
Lumefantrine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lumefantrine.,increase,risk
Lumefantrine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Lumefantrine.,increase,risk
Lumefantrine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Lumefantrine.,increase,risk
Lumefantrine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lumefantrine is combined with Hydroxyzine.,increase,risk
Lumefantrine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lumefantrine.,increase,risk
Lumefantrine,Ketoconazole,The metabolism of Lumefantrine can be decreased when combined with Ketoconazole.,decrease,no risk
Lumefantrine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lumefantrine.,increase,risk
Lumefantrine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Lumefantrine.,increase,risk
Lumefantrine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Lumefantrine.,increase,no risk
Lumefantrine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Lumefantrine.,increase,risk
Lumefantrine,Omaveloxolone,The serum concentration of Lumefantrine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lumefantrine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Opium,The metabolism of Opium can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Lumefantrine.,increase,risk
Lumefantrine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Lumefantrine.,increase,risk
Lumefantrine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Lumefantrine.,increase,risk
Lumefantrine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lumefantrine is combined with Oxetacaine.,increase,risk
Lumefantrine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lumefantrine is combined with Oxybuprocaine.,increase,risk
Lumefantrine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lumefantrine.,increase,risk
Lumefantrine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Lumefantrine.,increase,risk
Lumefantrine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Lumefantrine.,increase,risk
Lumefantrine,Quizartinib,The risk or severity of QTc prolongation can be increased when Lumefantrine is combined with Quizartinib.,increase,risk
Lumefantrine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Vadadustat,The serum concentration of Lumefantrine can be increased when it is combined with Vadadustat.,increase,no risk
Lumefantrine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Lumefantrine.,increase,risk
Lumefantrine,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Lumefantrine.,increase,risk
Lumefantrine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lumefantrine.,increase,risk
Lumefantrine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Lumefantrine.,increase,risk
Lumefantrine,Venetoclax,The metabolism of Lumefantrine can be decreased when combined with Venetoclax.,decrease,no risk
Lumefantrine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Verapamil,The metabolism of Lumefantrine can be decreased when combined with Verapamil.,decrease,no risk
Lumefantrine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Lumefantrine.,increase,risk
Lumefantrine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Viloxazine,The metabolism of Lumefantrine can be decreased when combined with Viloxazine.,decrease,no risk
Lumefantrine,Voriconazole,The metabolism of Lumefantrine can be decreased when combined with Voriconazole.,decrease,no risk
Lumefantrine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Lumefantrine.,increase,risk
Lumefantrine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Zimelidine,The metabolism of Lumefantrine can be decreased when combined with Zimelidine.,decrease,no risk
Lumefantrine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Lumefantrine is combined with Ziprasidone.,increase,risk
Lumefantrine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Lumefantrine.,decrease,no risk
Lumefantrine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Lumefantrine.,increase,risk
Lumefantrine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Lumefantrine.,decrease,no risk
Methacholine,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Methacholine.,increase,risk
Methacholine,Gallamine triethiodide,Gallamine triethiodide may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Gentamicin,The therapeutic efficacy of Methacholine can be decreased when used in combination with Gentamicin.,decrease,no risk
Methacholine,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Methacholine.,increase,risk
Methacholine,Glycopyrronium,Glycopyrronium may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Hexafluronium,Hexafluronium may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Hexocyclium,Hexocyclium may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Homatropine,Homatropine may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Homatropine methylbromide,Homatropine methylbromide may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Methacholine.,increase,risk
Methacholine,Hydrocortisone,Hydrocortisone may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Hydrocortisone butyrate,Hydrocortisone butyrate may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Hydrocortisone cypionate,Hydrocortisone cypionate may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Hyoscyamine,Hyoscyamine may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Kanamycin,The therapeutic efficacy of Methacholine can be decreased when used in combination with Kanamycin.,decrease,no risk
Methacholine,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Methacholine.,increase,risk
Methacholine,Olanzapine,Olanzapine may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Olodaterol,Olodaterol may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Orciprenaline,Orciprenaline may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Orphenadrine,Orphenadrine may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Oxprenolol,Oxprenolol may increase the bronchoconstrictory activities of Methacholine.,increase,no risk
Methacholine,Oxybutynin,Oxybutynin may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Oxyphencyclimine,Oxyphencyclimine may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Oxyphenonium,Oxyphenonium may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Quetiapine,Quetiapine may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Quinidine,Quinidine may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Umeclidinium,Umeclidinium may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Vamorolone,Vamorolone may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Vecuronium,Vecuronium may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Vilanterol,Vilanterol may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methacholine,Ziprasidone,Ziprasidone may decrease effectiveness of Methacholine as a diagnostic agent.,decrease,no risk
Methyltestosterone,Bromocriptine,Methyltestosterone may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Methyltestosterone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyltestosterone,Brompheniramine,The metabolism of Methyltestosterone can be decreased when combined with Brompheniramine.,decrease,no risk
Methyltestosterone,Budesonide,The risk or severity of edema formation can be increased when Methyltestosterone is combined with Budesonide.,increase,risk
Methyltestosterone,Bumadizone,Bumadizone may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Bumetanide,Bumetanide may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyltestosterone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Methyltestosterone is combined with Bupivacaine.,increase,risk
Methyltestosterone,Bupropion,The metabolism of Methyltestosterone can be decreased when combined with Bupropion.,decrease,no risk
Methyltestosterone,Buspirone,Buspirone may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Butabarbital,Butabarbital may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Butacaine,The risk or severity of methemoglobinemia can be increased when Methyltestosterone is combined with Butacaine.,increase,risk
Methyltestosterone,Butamben,The risk or severity of methemoglobinemia can be increased when Methyltestosterone is combined with Butamben.,increase,risk
Methyltestosterone,Gabapentin enacarbil,Methyltestosterone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gadodiamide,Gadodiamide may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gadoteric acid,Methyltestosterone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gadoteridol,Gadoteridol may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Ganciclovir,Ganciclovir may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gemcitabine,Gemcitabine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gentamicin,Methyltestosterone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gimeracil,Methyltestosterone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Givosiran,Givosiran may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Gliclazide,Methyltestosterone may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Methyltestosterone,Glimepiride,Methyltestosterone may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Methyltestosterone,Glipizide,Methyltestosterone may increase the hypoglycemic activities of Glipizide.,increase,no risk
Methyltestosterone,Gliquidone,Methyltestosterone may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Methyltestosterone,Glofitamab,The serum concentration of Methyltestosterone can be increased when it is combined with Glofitamab.,increase,no risk
Methyltestosterone,Glyburide,Methyltestosterone may increase the hypoglycemic activities of Glyburide.,increase,no risk
Methyltestosterone,Glycerol phenylbutyrate,Methyltestosterone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Glymidine,Methyltestosterone may increase the hypoglycemic activities of Glymidine.,increase,no risk
Methyltestosterone,Golimumab,The metabolism of Methyltestosterone can be increased when combined with Golimumab.,increase,no risk
Methyltestosterone,Golodirsen,Methyltestosterone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Goserelin,Goserelin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Guanethidine,Guanethidine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Guanfacine,Guanfacine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Methyltestosterone.,increase,no risk
Methyltestosterone,Halothane,The metabolism of Methyltestosterone can be decreased when combined with Halothane.,decrease,no risk
Methyltestosterone,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Methyltestosterone.,increase,no risk
Methyltestosterone,Hydralazine,Hydralazine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyltestosterone,Hydrocodone,The metabolism of Methyltestosterone can be decreased when combined with Hydrocodone.,decrease,no risk
Methyltestosterone,Hydrocortisone,The risk or severity of edema formation can be increased when Methyltestosterone is combined with Hydrocortisone.,increase,risk
Methyltestosterone,Hydrocortisone acetate,The risk or severity of edema formation can be increased when Methyltestosterone is combined with Hydrocortisone acetate.,increase,risk
Methyltestosterone,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when Methyltestosterone is combined with Hydrocortisone butyrate.,increase,risk
Methyltestosterone,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when Methyltestosterone is combined with Hydrocortisone cypionate.,increase,risk
Methyltestosterone,Hydrocortisone succinate,The risk or severity of edema formation can be increased when Methyltestosterone is combined with Hydrocortisone succinate.,increase,risk
Methyltestosterone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyltestosterone,Hydromorphone,Hydromorphone may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Hydroxyethyl Starch,Methyltestosterone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Kanamycin,Methyltestosterone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Ketamine,The metabolism of Methyltestosterone can be decreased when combined with Ketamine.,decrease,no risk
Methyltestosterone,Ketazolam,Ketazolam may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Ketoconazole,The metabolism of Methyltestosterone can be decreased when combined with Ketoconazole.,decrease,no risk
Methyltestosterone,Ketoprofen,Ketoprofen may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Ketorolac,Ketorolac may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Octinoxate,Methyltestosterone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Olsalazine,Olsalazine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Omaveloxolone,The serum concentration of Methyltestosterone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Methyltestosterone,Opium,Methyltestosterone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Orphenadrine,The metabolism of Methyltestosterone can be decreased when combined with Orphenadrine.,decrease,no risk
Methyltestosterone,Oseltamivir,The excretion of Oseltamivir can be increased when combined with Methyltestosterone.,increase,no risk
Methyltestosterone,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Methyltestosterone.,decrease,no risk
Methyltestosterone,Ospemifene,The metabolism of Methyltestosterone can be decreased when combined with Ospemifene.,decrease,no risk
Methyltestosterone,Oxacillin,Oxacillin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Oxaprozin,Oxaprozin may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Oxazepam,Oxazepam may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Methyltestosterone is combined with Oxetacaine.,increase,risk
Methyltestosterone,Oxybenzone,Oxybenzone may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Methyltestosterone is combined with Oxybuprocaine.,increase,risk
Methyltestosterone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Oxyquinoline,Methyltestosterone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Oxytetracycline,The excretion of Oxytetracycline can be increased when combined with Methyltestosterone.,increase,no risk
Methyltestosterone,Quetiapine,Quetiapine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Quinapril,The excretion of Quinapril can be increased when combined with Methyltestosterone.,increase,no risk
Methyltestosterone,Quinethazone,Quinethazone may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methyltestosterone,Quinidine,Methyltestosterone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Quinine,Methyltestosterone may increase the hypoglycemic activities of Quinine.,increase,no risk
Methyltestosterone,Vaborbactam,Methyltestosterone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Vadadustat,The serum concentration of Methyltestosterone can be decreased when it is combined with Vadadustat.,decrease,no risk
Methyltestosterone,Valaciclovir,The excretion of Valaciclovir can be increased when combined with Methyltestosterone.,increase,no risk
Methyltestosterone,Valbenazine,Methyltestosterone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Valdecoxib,Valdecoxib may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Valganciclovir,Valganciclovir may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Valproic acid,The excretion of Valproic acid can be increased when combined with Methyltestosterone.,increase,no risk
Methyltestosterone,Vamorolone,The risk or severity of edema formation can be increased when Methyltestosterone is combined with Vamorolone.,increase,risk
Methyltestosterone,Vancomycin,Methyltestosterone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Varenicline,Varenicline may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Methyltestosterone.,decrease,no risk
Methyltestosterone,Venetoclax,The metabolism of Methyltestosterone can be decreased when combined with Venetoclax.,decrease,no risk
Methyltestosterone,Venlafaxine,Venlafaxine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Verapamil,The metabolism of Methyltestosterone can be decreased when combined with Verapamil.,decrease,no risk
Methyltestosterone,Vilanterol,Methyltestosterone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Vildagliptin,Methyltestosterone may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Methyltestosterone,Viloxazine,The metabolism of Methyltestosterone can be decreased when combined with Viloxazine.,decrease,no risk
Methyltestosterone,Voriconazole,The metabolism of Methyltestosterone can be decreased when combined with Voriconazole.,decrease,no risk
Methyltestosterone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Methyltestosterone.,decrease,no risk
Methyltestosterone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Methyltestosterone.,decrease,no risk
Methyltestosterone,Warfarin,Methyltestosterone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Zaleplon,Zaleplon may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Zanamivir,Zanamivir may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.,decrease,no risk
Methyltestosterone,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Methyltestosterone.,decrease,no risk
Methyltestosterone,Zidovudine,The excretion of Zidovudine can be increased when combined with Methyltestosterone.,increase,no risk
Methyltestosterone,Zimelidine,The metabolism of Methyltestosterone can be decreased when combined with Zimelidine.,decrease,no risk
Methyltestosterone,Ziprasidone,The metabolism of Methyltestosterone can be decreased when combined with Ziprasidone.,decrease,no risk
Norelgestromin,Gabapentin,The metabolism of Norelgestromin can be increased when combined with Gabapentin.,increase,no risk
Norelgestromin,Ganaxolone,The metabolism of Norelgestromin can be increased when combined with Ganaxolone.,increase,no risk
Norelgestromin,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Glofitamab,The serum concentration of Norelgestromin can be increased when it is combined with Glofitamab.,increase,no risk
Norelgestromin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Glycerol phenylbutyrate,The metabolism of Norelgestromin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Norelgestromin,Griseofulvin,The metabolism of Norelgestromin can be increased when combined with Griseofulvin.,increase,no risk
Norelgestromin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Norelgestromin.,increase,no risk
Norelgestromin,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Hetacillin,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Hetacillin.,decrease,no risk
Norelgestromin,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Norelgestromin is combined with Human C1-esterase inhibitor.,increase,risk
Norelgestromin,Hydrocortamate,The metabolism of Norelgestromin can be increased when combined with Hydrocortamate.,increase,no risk
Norelgestromin,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Norelgestromin.,increase,no risk
Norelgestromin,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Norelgestromin.,increase,no risk
Norelgestromin,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Norelgestromin.,increase,no risk
Norelgestromin,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Norelgestromin.,increase,no risk
Norelgestromin,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Norelgestromin.,increase,no risk
Norelgestromin,Ketoconazole,The metabolism of Norelgestromin can be decreased when combined with Ketoconazole.,decrease,no risk
Norelgestromin,Olutasidenib,The metabolism of Norelgestromin can be increased when combined with Olutasidenib.,increase,no risk
Norelgestromin,Omadacycline,The serum concentration of Norelgestromin can be decreased when it is combined with Omadacycline.,decrease,no risk
Norelgestromin,Omaveloxolone,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Norelgestromin,Oritavancin,The metabolism of Norelgestromin can be increased when combined with Oritavancin.,increase,no risk
Norelgestromin,Oxacillin,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Oxacillin.,decrease,no risk
Norelgestromin,Oxcarbazepine,The metabolism of Norelgestromin can be increased when combined with Oxcarbazepine.,increase,no risk
Norelgestromin,Oxytetracycline,The serum concentration of Norelgestromin can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Norelgestromin,Quinine,The metabolism of Norelgestromin can be increased when combined with Quinine.,increase,no risk
Norelgestromin,Ulipristal,The therapeutic efficacy of Norelgestromin can be decreased when used in combination with Ulipristal.,decrease,no risk
Norelgestromin,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Vadadustat,The serum concentration of Norelgestromin can be increased when it is combined with Vadadustat.,increase,no risk
Norelgestromin,Valproic acid,The metabolism of Norelgestromin can be increased when combined with Valproic acid.,increase,no risk
Norelgestromin,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Norelgestromin.,increase,no risk
Norelgestromin,Vemurafenib,The metabolism of Norelgestromin can be increased when combined with Vemurafenib.,increase,no risk
Norelgestromin,Venetoclax,The metabolism of Norelgestromin can be decreased when combined with Venetoclax.,decrease,no risk
Norelgestromin,Verapamil,The metabolism of Norelgestromin can be decreased when combined with Verapamil.,decrease,no risk
Norelgestromin,Vigabatrin,The metabolism of Norelgestromin can be increased when combined with Vigabatrin.,increase,no risk
Norelgestromin,Viloxazine,The metabolism of Norelgestromin can be decreased when combined with Viloxazine.,decrease,no risk
Norelgestromin,Vinblastine,The metabolism of Norelgestromin can be increased when combined with Vinblastine.,increase,no risk
Norelgestromin,Vitamin E,The metabolism of Norelgestromin can be increased when combined with Vitamin E.,increase,no risk
Norelgestromin,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Voriconazole,The metabolism of Norelgestromin can be decreased when combined with Voriconazole.,decrease,no risk
Norelgestromin,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Norelgestromin.,decrease,no risk
Norelgestromin,Zaleplon,The metabolism of Norelgestromin can be increased when combined with Zaleplon.,increase,no risk
Norelgestromin,Zimelidine,The metabolism of Norelgestromin can be decreased when combined with Zimelidine.,decrease,no risk
Norelgestromin,Ziprasidone,The metabolism of Norelgestromin can be decreased when combined with Ziprasidone.,decrease,no risk
Norelgestromin,Zonisamide,The metabolism of Norelgestromin can be increased when combined with Zonisamide.,increase,no risk
Propylhexedrine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Propylhexedrine.,increase,no risk
Propylhexedrine,Verapamil,The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Verapamil.,decrease,no risk
Propylhexedrine,Yohimbine,The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Yohimbine.,decrease,no risk
Propylhexedrine,Ziprasidone,The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Propylhexedrine,Zuclopenthixol,The therapeutic efficacy of Propylhexedrine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Potassium Iodide,Gefitinib,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Gefitinib.,decrease,no risk
Potassium Iodide,Gilteritinib,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Gilteritinib.,decrease,no risk
Potassium Iodide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Potassium Iodide.,decrease,no risk
Potassium Iodide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Potassium Iodide.,decrease,no risk
Potassium Iodide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Potassium Iodide.,decrease,no risk
Potassium Iodide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Potassium Iodide.,decrease,no risk
Potassium Iodide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Potassium Iodide.,decrease,no risk
Potassium Iodide,Heparin,Potassium Iodide may increase the anticoagulant activities of Heparin.,increase,no risk
Potassium Iodide,Ketoconazole,Potassium Iodide may increase the hyperkalemic activities of Ketoconazole.,increase,no risk
Potassium Iodide,Ketoprofen,Potassium Iodide may increase the hyperkalemic activities of Ketoprofen.,increase,no risk
Potassium Iodide,Ketorolac,Potassium Iodide may increase the hyperkalemic activities of Ketorolac.,increase,no risk
Potassium Iodide,Olmesartan,Potassium Iodide may increase the hyperkalemic activities of Olmesartan.,increase,no risk
Potassium Iodide,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Potassium Iodide.,increase,risk
Potassium Iodide,Osimertinib,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Osimertinib.,decrease,no risk
Potassium Iodide,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Potassium Iodide.,increase,no risk
Potassium Iodide,Oxaprozin,Potassium Iodide may increase the hyperkalemic activities of Oxaprozin.,increase,no risk
Potassium Iodide,Oxprenolol,Potassium Iodide may increase the hyperkalemic activities of Oxprenolol.,increase,no risk
Potassium Iodide,Oxtriphylline,Potassium Iodide may decrease the excretion rate of Oxtriphylline which could result in a higher serum level.,decrease,no risk
Potassium Iodide,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Potassium Iodide.,increase,risk
Potassium Iodide,Oxyphenbutazone,Potassium Iodide may increase the hyperkalemic activities of Oxyphenbutazone.,increase,no risk
Potassium Iodide,Quinapril,The risk or severity of hyperkalemia can be increased when Potassium Iodide is combined with Quinapril.,increase,risk
Potassium Iodide,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Potassium Iodide is combined with Quinupramine.,increase,risk
Potassium Iodide,Quizartinib,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Quizartinib.,decrease,no risk
Potassium Iodide,Urokinase,Potassium Iodide may increase the anticoagulant activities of Urokinase.,increase,no risk
Potassium Iodide,Valdecoxib,Potassium Iodide may increase the hyperkalemic activities of Valdecoxib.,increase,no risk
Potassium Iodide,Valsartan,Potassium Iodide may increase the hyperkalemic activities of Valsartan.,increase,no risk
Potassium Iodide,Vandetanib,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Vandetanib.,decrease,no risk
Potassium Iodide,Vemurafenib,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Vemurafenib.,decrease,no risk
Potassium Iodide,Vorapaxar,Potassium Iodide may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Potassium Iodide,Warfarin,Potassium Iodide may increase the anticoagulant activities of Warfarin.,increase,no risk
Potassium Iodide,Ximelagatran,Potassium Iodide may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Potassium Iodide,Zanubrutinib,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Potassium Iodide,Zimelidine,The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Zimelidine.,decrease,no risk
Potassium Iodide,Zofenopril,The risk or severity of hyperkalemia can be increased when Potassium Iodide is combined with Zofenopril.,increase,risk
Potassium Iodide,Zonisamide,Potassium Iodide may increase the hyperkalemic activities of Zonisamide.,increase,no risk
Fosaprepitant,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Gestrinone,The metabolism of Gestrinone can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Ginkgo biloba,The metabolism of Fosaprepitant can be decreased when combined with Ginkgo biloba.,decrease,no risk
Fosaprepitant,Glecaprevir,The metabolism of Fosaprepitant can be decreased when combined with Glecaprevir.,decrease,no risk
Fosaprepitant,Glofitamab,The serum concentration of Fosaprepitant can be increased when it is combined with Glofitamab.,increase,no risk
Fosaprepitant,Glyburide,The metabolism of Fosaprepitant can be decreased when combined with Glyburide.,decrease,no risk
Fosaprepitant,Glycerol phenylbutyrate,The metabolism of Fosaprepitant can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Fosaprepitant,Golimumab,The metabolism of Fosaprepitant can be increased when combined with Golimumab.,increase,no risk
Fosaprepitant,Grapefruit,The metabolism of Fosaprepitant can be decreased when combined with Grapefruit.,decrease,no risk
Fosaprepitant,Griseofulvin,The metabolism of Fosaprepitant can be increased when combined with Griseofulvin.,increase,no risk
Fosaprepitant,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Hydralazine,The metabolism of Fosaprepitant can be decreased when combined with Hydralazine.,decrease,no risk
Fosaprepitant,Hydrocortamate,The metabolism of Fosaprepitant can be increased when combined with Hydrocortamate.,increase,no risk
Fosaprepitant,Hydrocortisone,The metabolism of Fosaprepitant can be increased when combined with Hydrocortisone.,increase,no risk
Fosaprepitant,Hydrocortisone acetate,The metabolism of Fosaprepitant can be increased when combined with Hydrocortisone acetate.,increase,no risk
Fosaprepitant,Hydrocortisone butyrate,The metabolism of Fosaprepitant can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Fosaprepitant,Hydrocortisone succinate,The metabolism of Fosaprepitant can be increased when combined with Hydrocortisone succinate.,increase,no risk
Fosaprepitant,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Ketazolam,The metabolism of Fosaprepitant can be decreased when combined with Ketazolam.,decrease,no risk
Fosaprepitant,Ketoconazole,The metabolism of Fosaprepitant can be decreased when combined with Ketoconazole.,decrease,no risk
Fosaprepitant,Octreotide,The metabolism of Fosaprepitant can be decreased when combined with Octreotide.,decrease,no risk
Fosaprepitant,Olaparib,The metabolism of Olaparib can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Fosaprepitant.,decrease,no risk
Fosaprepitant,Olutasidenib,The metabolism of Fosaprepitant can be increased when combined with Olutasidenib.,increase,no risk
Fosaprepitant,Omaveloxolone,The serum concentration of Fosaprepitant can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Fosaprepitant,Oritavancin,The metabolism of Fosaprepitant can be increased when combined with Oritavancin.,increase,no risk
Fosaprepitant,Orphenadrine,The metabolism of Fosaprepitant can be decreased when combined with Orphenadrine.,decrease,no risk
Fosaprepitant,Osilodrostat,The metabolism of Fosaprepitant can be decreased when combined with Osilodrostat.,decrease,no risk
Fosaprepitant,Osimertinib,The metabolism of Osimertinib can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Oxcarbazepine,The metabolism of Fosaprepitant can be increased when combined with Oxcarbazepine.,increase,no risk
Fosaprepitant,Oxybutynin,The metabolism of Fosaprepitant can be decreased when combined with Oxybutynin.,decrease,no risk
Fosaprepitant,Quinidine,The metabolism of Quinidine can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Quinine,The metabolism of Fosaprepitant can be increased when combined with Quinine.,increase,no risk
Fosaprepitant,Quinupristin,The metabolism of Fosaprepitant can be decreased when combined with Quinupristin.,decrease,no risk
Fosaprepitant,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Ulipristal,The metabolism of Ulipristal can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Vadadustat,The serum concentration of Fosaprepitant can be increased when it is combined with Vadadustat.,increase,no risk
Fosaprepitant,Valproic acid,The metabolism of Fosaprepitant can be decreased when combined with Valproic acid.,decrease,no risk
Fosaprepitant,Vandetanib,The metabolism of Vandetanib can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Fosaprepitant.,decrease,no risk
Fosaprepitant,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Venetoclax,The metabolism of Venetoclax can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Verapamil,The metabolism of Fosaprepitant can be decreased when combined with Verapamil.,decrease,no risk
Fosaprepitant,Viloxazine,The metabolism of Fosaprepitant can be decreased when combined with Viloxazine.,decrease,no risk
Fosaprepitant,Vinblastine,The metabolism of Vinblastine can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Vincristine,The metabolism of Vincristine can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Vindesine,The metabolism of Vindesine can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Vinflunine,The metabolism of Vinflunine can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Vitamin E,The metabolism of Fosaprepitant can be increased when combined with Vitamin E.,increase,no risk
Fosaprepitant,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Voriconazole,The metabolism of Fosaprepitant can be decreased when combined with Voriconazole.,decrease,no risk
Fosaprepitant,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Zafirlukast,The metabolism of Fosaprepitant can be decreased when combined with Zafirlukast.,decrease,no risk
Fosaprepitant,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Zimelidine,The metabolism of Fosaprepitant can be decreased when combined with Zimelidine.,decrease,no risk
Fosaprepitant,Ziprasidone,The metabolism of Fosaprepitant can be decreased when combined with Ziprasidone.,decrease,no risk
Fosaprepitant,Zolpidem,The metabolism of Zolpidem can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Fosaprepitant.,decrease,no risk
Fosaprepitant,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Fosaprepitant.,increase,no risk
Fosaprepitant,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Fosaprepitant.,decrease,no risk
Stanozolol,Vamorolone,The risk or severity of fluid retention can be increased when Vamorolone is combined with Stanozolol.,increase,risk
Stanozolol,Vildagliptin,Stanozolol may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Stanozolol,Warfarin,Stanozolol may increase the anticoagulant activities of Warfarin.,increase,no risk
Buserelin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Gadobenic acid.,increase,risk
Buserelin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Buserelin.,increase,risk
Buserelin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Buserelin.,increase,risk
Buserelin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Gemifloxacin.,increase,risk
Buserelin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Buserelin.,increase,risk
Buserelin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Gilteritinib.,increase,risk
Buserelin,Glasdegib,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Glasdegib.,increase,risk
Buserelin,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Goserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Goserelin.,increase,risk
Buserelin,Granisetron,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Granisetron.,increase,risk
Buserelin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Grepafloxacin.,increase,risk
Buserelin,Halofantrine,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Halofantrine.,increase,risk
Buserelin,Haloperidol,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Haloperidol.,increase,risk
Buserelin,Histrelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Histrelin.,increase,risk
Buserelin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Buserelin.,increase,risk
Buserelin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Buserelin.,increase,risk
Buserelin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Hydroxyzine.,increase,risk
Buserelin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Buserelin.,increase,risk
Buserelin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Buserelin.,increase,risk
Buserelin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Buserelin.,increase,risk
Buserelin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ofloxacin.,increase,risk
Buserelin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Buserelin.,increase,risk
Buserelin,Olodaterol,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Olodaterol.,increase,risk
Buserelin,Ondansetron,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ondansetron.,increase,risk
Buserelin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Buserelin.,increase,risk
Buserelin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Buserelin.,increase,risk
Buserelin,Oxatomide,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Oxatomide.,increase,risk
Buserelin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Oxetacaine.,increase,risk
Buserelin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Oxybuprocaine.,increase,risk
Buserelin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Buserelin.,increase,risk
Buserelin,Quetiapine,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Quetiapine.,increase,risk
Buserelin,Quinidine,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Quinidine.,increase,risk
Buserelin,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Quizartinib,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Quizartinib.,increase,risk
Buserelin,Valproic acid,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Valproic acid.,increase,risk
Buserelin,Vandetanib,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Vandetanib.,increase,risk
Buserelin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Buserelin.,increase,risk
Buserelin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Vemurafenib.,increase,risk
Buserelin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Buserelin.,increase,risk
Buserelin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Buserelin.,increase,risk
Buserelin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Buserelin.,decrease,no risk
Buserelin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Buserelin.,increase,risk
Buserelin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Buserelin.,increase,risk
Buserelin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Ziprasidone.,increase,risk
Buserelin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Buserelin.,increase,risk
Buserelin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Zuclopenthixol.,increase,risk
Gimatecan,Valsartan,The excretion of Gimatecan can be decreased when combined with Valsartan.,decrease,no risk
Gimatecan,Velpatasvir,The excretion of Gimatecan can be decreased when combined with Velpatasvir.,decrease,no risk
Gimatecan,Venetoclax,The excretion of Gimatecan can be decreased when combined with Venetoclax.,decrease,no risk
Gimatecan,Vinblastine,The excretion of Gimatecan can be decreased when combined with Vinblastine.,decrease,no risk
Gimatecan,Vincristine,The excretion of Gimatecan can be decreased when combined with Vincristine.,decrease,no risk
Gimatecan,Voxilaprevir,The excretion of Gimatecan can be decreased when combined with Voxilaprevir.,decrease,no risk
Aluminum hydroxide,Gatifloxacin,Aluminum hydroxide can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Gefitinib,Aluminum hydroxide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Gemifloxacin,Aluminum hydroxide can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Aluminum hydroxide.,decrease,no risk
Aluminum hydroxide,Grepafloxacin,Aluminum hydroxide can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Halofantrine,Aluminum hydroxide can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Hydrocortisone,The bioavailability of Hydrocortisone can be decreased when combined with Aluminum hydroxide.,decrease,no risk
Aluminum hydroxide,Hydrocortisone butyrate,The bioavailability of Hydrocortisone butyrate can be decreased when combined with Aluminum hydroxide.,decrease,no risk
Aluminum hydroxide,Hydrocortisone cypionate,The bioavailability of Hydrocortisone cypionate can be decreased when combined with Aluminum hydroxide.,decrease,no risk
Aluminum hydroxide,Hydroxychloroquine,Aluminum hydroxide can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Hyoscyamine,Aluminum hydroxide can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Ketoconazole,Aluminum hydroxide can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Obeticholic acid,Aluminum hydroxide can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Octreotide,Aluminum hydroxide can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Ofloxacin,Aluminum hydroxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Omadacycline,Aluminum hydroxide can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Oteseconazole,Aluminum hydroxide can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Ox bile extract,The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum hydroxide.,decrease,no risk
Aluminum hydroxide,Oxytetracycline,Aluminum hydroxide can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Quinidine,Aluminum hydroxide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Aluminum hydroxide,Quinine,Aluminum hydroxide can cause a decrease in the absorption of Quinine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Ursodeoxycholic acid,Aluminum hydroxide can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Aluminum hydroxide.,decrease,no risk
Aluminum hydroxide,Vamorolone,The bioavailability of Vamorolone can be decreased when combined with Aluminum hydroxide.,decrease,no risk
Aluminum hydroxide,Vitamin D,The serum concentration of Aluminum hydroxide can be increased when it is combined with Vitamin D.,increase,no risk
Aluminum hydroxide,Voriconazole,Aluminum hydroxide can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Aluminum hydroxide,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Aluminum hydroxide.,decrease,no risk
Calcium carbonate,Gefitinib,Calcium carbonate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Gemifloxacin,Calcium carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Calcium carbonate.,decrease,no risk
Calcium carbonate,Grepafloxacin,Calcium carbonate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Calcium carbonate which could result in a higher serum level.,decrease,no risk
Calcium carbonate,Hydrocortisone,The bioavailability of Hydrocortisone can be decreased when combined with Calcium carbonate.,decrease,no risk
Calcium carbonate,Hydrocortisone butyrate,The bioavailability of Hydrocortisone butyrate can be decreased when combined with Calcium carbonate.,decrease,no risk
Calcium carbonate,Hydrocortisone cypionate,The bioavailability of Hydrocortisone cypionate can be decreased when combined with Calcium carbonate.,decrease,no risk
Calcium carbonate,Hydroflumethiazide,Hydroflumethiazide may decrease the excretion rate of Calcium carbonate which could result in a higher serum level.,decrease,no risk
Calcium carbonate,Hydroxychloroquine,Calcium carbonate can cause a decrease in the absorption of Hydroxychloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Hyoscyamine,Calcium carbonate can cause a decrease in the absorption of Hyoscyamine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Ketoconazole,Calcium carbonate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Octreotide,Calcium carbonate can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Ofloxacin,Calcium carbonate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Omadacycline,Calcium carbonate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Oteseconazole,Calcium carbonate can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Ouabain,Calcium carbonate may increase the arrhythmogenic and cardiotoxic activities of Ouabain.,increase,no risk
Calcium carbonate,Oxprenolol,The therapeutic efficacy of Oxprenolol can be decreased when used in combination with Calcium carbonate.,decrease,no risk
Calcium carbonate,Oxytetracycline,Calcium carbonate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Quinethazone,Quinethazone may decrease the excretion rate of Calcium carbonate which could result in a higher serum level.,decrease,no risk
Calcium carbonate,Quinidine,Calcium carbonate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Calcium carbonate,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Calcium carbonate.,decrease,no risk
Calcium carbonate,Vamorolone,The bioavailability of Vamorolone can be decreased when combined with Calcium carbonate.,decrease,no risk
Calcium carbonate,Voriconazole,Calcium carbonate can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Calcium carbonate,Zoledronic acid,The serum concentration of Zoledronic acid can be decreased when it is combined with Calcium carbonate.,decrease,no risk
Lornoxicam,Bendazac,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Bendazac.,increase,risk
Lornoxicam,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Benorilate,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Benorilate.,increase,risk
Lornoxicam,Benoxaprofen,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Lornoxicam.,increase,risk
Lornoxicam,Benserazide,Lornoxicam may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Lornoxicam,Benzatropine,Lornoxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Lornoxicam,Benznidazole,Lornoxicam may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Lornoxicam,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Lornoxicam.,increase,risk
Lornoxicam,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Benzydamine,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Benzydamine.,increase,risk
Lornoxicam,Bepotastine,Lornoxicam may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Lornoxicam,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Lornoxicam.,increase,risk
Lornoxicam,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Lornoxicam.,increase,risk
Lornoxicam,Betaxolol,Lornoxicam may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Lornoxicam,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Lornoxicam.,increase,risk
Lornoxicam,Betulinic Acid,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Betulinic Acid.,increase,risk
Lornoxicam,Bexarotene,The metabolism of Lornoxicam can be decreased when combined with Bexarotene.,decrease,no risk
Lornoxicam,Bicisate,Lornoxicam may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Lornoxicam,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Bimekizumab,The metabolism of Lornoxicam can be increased when combined with Bimekizumab.,increase,no risk
Lornoxicam,Bismuth subgallate,Lornoxicam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lornoxicam,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Bisoprolol,Lornoxicam may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Lornoxicam,Bisoxatin,Lornoxicam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lornoxicam,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Lornoxicam is combined with Bivalirudin.,increase,risk
Lornoxicam,Bleomycin,Lornoxicam may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Lornoxicam,Bortezomib,The metabolism of Lornoxicam can be decreased when combined with Bortezomib.,decrease,no risk
Lornoxicam,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Brexpiprazole,The risk or severity of hypertension can be increased when Lornoxicam is combined with Brexpiprazole.,increase,risk
Lornoxicam,Brivaracetam,Lornoxicam may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Lornoxicam,Bromazepam,Lornoxicam may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Lornoxicam,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Lornoxicam.,increase,risk
Lornoxicam,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Lornoxicam.,increase,risk
Lornoxicam,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Lornoxicam.,increase,risk
Lornoxicam,Bufexamac,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Bufexamac.,increase,risk
Lornoxicam,Bumadizone,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Bumadizone.,increase,risk
Lornoxicam,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Lornoxicam.,decrease,no risk
Lornoxicam,Buprenorphine,The metabolism of Lornoxicam can be decreased when combined with Buprenorphine.,decrease,no risk
Lornoxicam,Bupropion,Lornoxicam may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Lornoxicam,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Lornoxicam.,increase,risk
Lornoxicam,Butabarbital,Lornoxicam may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Lornoxicam,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Lornoxicam.,increase,risk
Lornoxicam,Gabapentin enacarbil,Lornoxicam may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gadobenic acid,Lornoxicam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gadodiamide,Lornoxicam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gadofosveset trisodium,Lornoxicam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gadopentetic acid,Lornoxicam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gadoteric acid,Lornoxicam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gadoteridol,Lornoxicam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Lornoxicam,Ganciclovir,Lornoxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gatifloxacin,Lornoxicam may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Lornoxicam,Gemcitabine,Lornoxicam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gemfibrozil,The metabolism of Lornoxicam can be decreased when combined with Gemfibrozil.,decrease,no risk
Lornoxicam,Gemifloxacin,Lornoxicam may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Lornoxicam,Gentamicin,Lornoxicam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Lornoxicam,Gimeracil,Lornoxicam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Lornoxicam,Ginkgo biloba,The metabolism of Lornoxicam can be decreased when combined with Ginkgo biloba.,decrease,no risk
Lornoxicam,Givosiran,The risk or severity of nephrotoxicity can be increased when Lornoxicam is combined with Givosiran.,increase,risk
Lornoxicam,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Lornoxicam.,decrease,no risk
Lornoxicam,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Lornoxicam.,decrease,no risk
Lornoxicam,Glipizide,The protein binding of Glipizide can be decreased when combined with Lornoxicam.,decrease,no risk
Lornoxicam,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Lornoxicam.,decrease,no risk
Lornoxicam,Glofitamab,The serum concentration of Lornoxicam can be increased when it is combined with Glofitamab.,increase,no risk
Lornoxicam,Glyburide,The protein binding of Glyburide can be decreased when combined with Lornoxicam.,decrease,no risk
Lornoxicam,Glycerol phenylbutyrate,Lornoxicam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Lornoxicam,Glycol salicylate,The risk or severity of adverse effects can be increased when Lornoxicam is combined with Glycol salicylate.,increase,risk
Lornoxicam,Golimumab,The metabolism of Lornoxicam can be increased when combined with Golimumab.,increase,no risk
Lornoxicam,Golodirsen,Lornoxicam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Lornoxicam,Goserelin,Lornoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Lornoxicam,Grepafloxacin,Lornoxicam may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Bufuralol,Galantamine,Galantamine may increase the bradycardic activities of Bufuralol.,increase,no risk
Bufuralol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Bufuralol.,increase,no risk
Bufuralol,Gefitinib,The metabolism of Bufuralol can be decreased when combined with Gefitinib.,decrease,no risk
Bufuralol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Bufuralol.,increase,no risk
Bufuralol,Givosiran,The serum concentration of Bufuralol can be increased when it is combined with Givosiran.,increase,no risk
Bufuralol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Bufuralol.,increase,no risk
Bufuralol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Bufuralol.,increase,no risk
Bufuralol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Bufuralol.,increase,no risk
Bufuralol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Bufuralol.,increase,no risk
Bufuralol,Glucagon,The therapeutic efficacy of Bufuralol can be decreased when used in combination with Glucagon.,decrease,no risk
Bufuralol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Bufuralol.,increase,no risk
Bufuralol,Glycerol phenylbutyrate,The metabolism of Bufuralol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Bufuralol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Bufuralol.,decrease,no risk
Bufuralol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Bufuralol.,increase,no risk
Bufuralol,Golimumab,The metabolism of Bufuralol can be increased when combined with Golimumab.,increase,no risk
Bufuralol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Bufuralol.,decrease,no risk
Bufuralol,Guanethidine,Guanethidine may increase the hypotensive activities of Bufuralol.,increase,no risk
Bufuralol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bufuralol.,decrease,no risk
Bufuralol,Halofantrine,The metabolism of Bufuralol can be decreased when combined with Halofantrine.,decrease,no risk
Bufuralol,Haloperidol,The serum concentration of Bufuralol can be increased when it is combined with Haloperidol.,increase,no risk
Bufuralol,Halothane,Halothane may increase the cardiodepressant activities of Bufuralol.,increase,no risk
Bufuralol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Bufuralol.,increase,risk
Bufuralol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Bufuralol.,increase,no risk
Bufuralol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Bufuralol.,increase,risk
Bufuralol,Huperzine A,Huperzine A may increase the bradycardic activities of Bufuralol.,increase,no risk
Bufuralol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bufuralol.,decrease,risk
Bufuralol,Hydroxyzine,The metabolism of Bufuralol can be decreased when combined with Hydroxyzine.,decrease,no risk
Bufuralol,Ketamine,Ketamine may increase the bradycardic activities of Bufuralol.,increase,no risk
Bufuralol,Ketoconazole,The metabolism of Bufuralol can be decreased when combined with Ketoconazole.,decrease,no risk
Bufuralol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Bufuralol.,decrease,no risk
Bufuralol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Bufuralol.,decrease,no risk
Bufuralol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Bufuralol.,increase,risk
Bufuralol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Bufuralol.,increase,no risk
Bufuralol,Olanzapine,Bufuralol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Bufuralol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Bufuralol.,decrease,no risk
Bufuralol,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Bufuralol.,increase,risk
Bufuralol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Bufuralol.,decrease,no risk
Bufuralol,Ondansetron,The metabolism of Bufuralol can be decreased when combined with Ondansetron.,decrease,no risk
Bufuralol,Opium,The metabolism of Opium can be decreased when combined with Bufuralol.,decrease,no risk
Bufuralol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Bufuralol.,decrease,no risk
Bufuralol,Oritavancin,The metabolism of Bufuralol can be decreased when combined with Oritavancin.,decrease,no risk
Bufuralol,Orphenadrine,The metabolism of Bufuralol can be decreased when combined with Orphenadrine.,decrease,no risk
Bufuralol,Osilodrostat,The metabolism of Bufuralol can be decreased when combined with Osilodrostat.,decrease,no risk
Bufuralol,Ospemifene,The metabolism of Bufuralol can be decreased when combined with Ospemifene.,decrease,no risk
Bufuralol,Ouabain,Bufuralol may increase the bradycardic activities of Ouabain.,increase,no risk
Bufuralol,Oxamniquine,The metabolism of Bufuralol can be decreased when combined with Oxamniquine.,decrease,no risk
Bufuralol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Bufuralol.,decrease,no risk
Bufuralol,Oxprenolol,The metabolism of Bufuralol can be decreased when combined with Oxprenolol.,decrease,no risk
Bufuralol,Oxtriphylline,The risk or severity of adverse effects can be increased when Bufuralol is combined with Oxtriphylline.,increase,risk
Bufuralol,Oxybutynin,The metabolism of Bufuralol can be decreased when combined with Oxybutynin.,decrease,no risk
Bufuralol,Oxycodone,The metabolism of Bufuralol can be decreased when combined with Oxycodone.,decrease,no risk
Bufuralol,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Bufuralol.,decrease,no risk
Bufuralol,Oxymorphone,The metabolism of Bufuralol can be decreased when combined with Oxymorphone.,decrease,no risk
Bufuralol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Bufuralol.,decrease,no risk
Bufuralol,Quetiapine,Bufuralol may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Bufuralol,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Bufuralol.,increase,risk
Bufuralol,Quinidine,The metabolism of Bufuralol can be decreased when combined with Quinidine.,decrease,no risk
Sparteine,Galantamine,The metabolism of Galantamine can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Givosiran,The serum concentration of Sparteine can be increased when it is combined with Givosiran.,increase,no risk
Sparteine,Glycerol phenylbutyrate,The metabolism of Sparteine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Sparteine,Golimumab,The metabolism of Sparteine can be increased when combined with Golimumab.,increase,no risk
Sparteine,Halofantrine,The metabolism of Sparteine can be decreased when combined with Halofantrine.,decrease,no risk
Sparteine,Haloperidol,The serum concentration of Sparteine can be increased when it is combined with Haloperidol.,increase,no risk
Sparteine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Hydroxychloroquine,The metabolism of Sparteine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Sparteine,Hydroxyzine,The metabolism of Sparteine can be decreased when combined with Hydroxyzine.,decrease,no risk
Sparteine,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Ketoconazole,The metabolism of Sparteine can be decreased when combined with Ketoconazole.,decrease,no risk
Sparteine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Opium,The metabolism of Opium can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Oritavancin,The metabolism of Sparteine can be decreased when combined with Oritavancin.,decrease,no risk
Sparteine,Orphenadrine,The metabolism of Sparteine can be decreased when combined with Orphenadrine.,decrease,no risk
Sparteine,Osilodrostat,The metabolism of Sparteine can be decreased when combined with Osilodrostat.,decrease,no risk
Sparteine,Ospemifene,The metabolism of Sparteine can be decreased when combined with Ospemifene.,decrease,no risk
Sparteine,Oxamniquine,The metabolism of Sparteine can be decreased when combined with Oxamniquine.,decrease,no risk
Sparteine,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Oxybutynin,The metabolism of Sparteine can be decreased when combined with Oxybutynin.,decrease,no risk
Sparteine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Quinidine,Quinidine may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Quinine,The metabolism of Sparteine can be decreased when combined with Quinine.,decrease,no risk
Sparteine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Vemurafenib,The metabolism of Sparteine can be decreased when combined with Vemurafenib.,decrease,no risk
Sparteine,Venlafaxine,The metabolism of Sparteine can be decreased when combined with Venlafaxine.,decrease,no risk
Sparteine,Verapamil,Verapamil may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Vilazodone,The metabolism of Sparteine can be decreased when combined with Vilazodone.,decrease,no risk
Sparteine,Viloxazine,The metabolism of Sparteine can be decreased when combined with Viloxazine.,decrease,no risk
Sparteine,Vinblastine,The metabolism of Sparteine can be decreased when combined with Vinblastine.,decrease,no risk
Sparteine,Vinorelbine,The metabolism of Sparteine can be decreased when combined with Vinorelbine.,decrease,no risk
Sparteine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Xylometazoline,Xylometazoline may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Ziconotide,Ziconotide may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sparteine.,decrease,no risk
Sparteine,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Sparteine.,increase,no risk
Sparteine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Sparteine.,decrease,no risk
Aniline,Benzocaine,The metabolism of Aniline can be decreased when combined with Benzocaine.,decrease,no risk
Aniline,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Aniline.,decrease,no risk
Aniline,Bifonazole,The metabolism of Aniline can be decreased when combined with Bifonazole.,decrease,no risk
Aniline,Bimekizumab,The metabolism of Aniline can be increased when combined with Bimekizumab.,increase,no risk
Aniline,Bromazepam,The metabolism of Aniline can be decreased when combined with Bromazepam.,decrease,no risk
Aniline,Glycerin,The metabolism of Aniline can be increased when combined with Glycerin.,increase,no risk
Aniline,Golimumab,The metabolism of Aniline can be increased when combined with Golimumab.,increase,no risk
Aniline,Halothane,The metabolism of Aniline can be decreased when combined with Halothane.,decrease,no risk
Aniline,Orphenadrine,The metabolism of Aniline can be decreased when combined with Orphenadrine.,decrease,no risk
Aniline,Vayarin,The metabolism of Aniline can be decreased when combined with Vayarin.,decrease,no risk
Sulfaphenazole,Galantamine,The metabolism of Galantamine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Glipizide,The metabolism of Glipizide can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Glyburide,The metabolism of Glyburide can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfaphenazole.,increase,no risk
Sulfaphenazole,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sulfaphenazole.,increase,no risk
Sulfaphenazole,Halothane,The metabolism of Halothane can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Ketamine,The metabolism of Ketamine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfaphenazole.,increase,risk
Sulfaphenazole,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Sulfaphenazole.,increase,no risk
Sulfaphenazole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Opium,The metabolism of Opium can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Quinine,The metabolism of Quinine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Valsartan,The metabolism of Valsartan can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfaphenazole.,increase,no risk
Sulfaphenazole,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Warfarin,The metabolism of Warfarin can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Zileuton,The metabolism of Zileuton can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sulfaphenazole.,decrease,no risk
Sulfaphenazole,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Sulfaphenazole.,decrease,no risk
Gestodene,Gabapentin,The metabolism of Gestodene can be increased when combined with Gabapentin.,increase,no risk
Gestodene,Ganaxolone,The metabolism of Gestodene can be increased when combined with Ganaxolone.,increase,no risk
Gestodene,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Glofitamab,The serum concentration of Gestodene can be increased when it is combined with Glofitamab.,increase,no risk
Gestodene,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Glycerol phenylbutyrate,The metabolism of Gestodene can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Gestodene,Griseofulvin,The metabolism of Gestodene can be increased when combined with Griseofulvin.,increase,no risk
Gestodene,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Gestodene.,increase,no risk
Gestodene,Heparin,The risk or severity of adverse effects can be increased when Gestodene is combined with Heparin.,increase,risk
Gestodene,Hetacillin,The therapeutic efficacy of Gestodene can be decreased when used in combination with Hetacillin.,decrease,no risk
Gestodene,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Gestodene is combined with Human C1-esterase inhibitor.,increase,risk
Gestodene,Hydrocortamate,The metabolism of Gestodene can be increased when combined with Hydrocortamate.,increase,no risk
Gestodene,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Gestodene.,increase,no risk
Gestodene,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Gestodene.,increase,no risk
Gestodene,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Gestodene.,increase,no risk
Gestodene,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Gestodene.,increase,no risk
Gestodene,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Gestodene.,increase,no risk
Gestodene,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Ketoconazole,The metabolism of Gestodene can be decreased when combined with Ketoconazole.,decrease,no risk
Gestodene,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Octreotide,The therapeutic efficacy of Gestodene can be decreased when used in combination with Octreotide.,decrease,no risk
Gestodene,Olaparib,The metabolism of Olaparib can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Olutasidenib,The metabolism of Gestodene can be increased when combined with Olutasidenib.,increase,no risk
Gestodene,Omadacycline,The serum concentration of Gestodene can be decreased when it is combined with Omadacycline.,decrease,no risk
Gestodene,Omaveloxolone,The therapeutic efficacy of Gestodene can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Gestodene,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Oritavancin,The metabolism of Gestodene can be increased when combined with Oritavancin.,increase,no risk
Gestodene,Ox bile extract,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Oxacillin,The therapeutic efficacy of Gestodene can be decreased when used in combination with Oxacillin.,decrease,no risk
Gestodene,Oxcarbazepine,The metabolism of Gestodene can be increased when combined with Oxcarbazepine.,increase,no risk
Gestodene,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Oxytetracycline,The serum concentration of Gestodene can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Gestodene,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Quinidine,The metabolism of Quinidine can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Quinine,The metabolism of Gestodene can be increased when combined with Quinine.,increase,no risk
Gestodene,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Udenafil,The metabolism of Udenafil can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Ulipristal,The therapeutic efficacy of Gestodene can be decreased when used in combination with Ulipristal.,decrease,no risk
Gestodene,Urokinase,The risk or severity of adverse effects can be increased when Gestodene is combined with Urokinase.,increase,risk
Gestodene,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Gestodene.,decrease,no risk
Gestodene,Vadadustat,The serum concentration of Gestodene can be increased when it is combined with Vadadustat.,increase,no risk
Gestodene,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Valproic acid,The metabolism of Gestodene can be increased when combined with Valproic acid.,increase,no risk
Gestodene,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Gestodene.,increase,no risk
Gestodene,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Vemurafenib,The metabolism of Gestodene can be increased when combined with Vemurafenib.,increase,no risk
Gestodene,Venetoclax,The metabolism of Gestodene can be decreased when combined with Venetoclax.,decrease,no risk
Gestodene,Verapamil,The metabolism of Gestodene can be decreased when combined with Verapamil.,decrease,no risk
Gestodene,Vigabatrin,The metabolism of Gestodene can be increased when combined with Vigabatrin.,increase,no risk
Gestodene,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Viloxazine,The metabolism of Gestodene can be decreased when combined with Viloxazine.,decrease,no risk
Gestodene,Vinblastine,The metabolism of Gestodene can be increased when combined with Vinblastine.,increase,no risk
Gestodene,Vincristine,The metabolism of Vincristine can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Vitamin A,The therapeutic efficacy of Gestodene can be decreased when used in combination with Vitamin A.,decrease,no risk
Gestodene,Vitamin E,The metabolism of Gestodene can be increased when combined with Vitamin E.,increase,no risk
Gestodene,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Vorapaxar,The risk or severity of adverse effects can be increased when Gestodene is combined with Vorapaxar.,increase,risk
Gestodene,Voriconazole,The metabolism of Gestodene can be decreased when combined with Voriconazole.,decrease,no risk
Gestodene,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Gestodene.,decrease,no risk
Gestodene,Warfarin,The risk or severity of adverse effects can be increased when Gestodene is combined with Warfarin.,increase,risk
Gestodene,Ximelagatran,The risk or severity of adverse effects can be increased when Gestodene is combined with Ximelagatran.,increase,risk
Gestodene,Zaleplon,The metabolism of Gestodene can be increased when combined with Zaleplon.,increase,no risk
Gestodene,Zimelidine,The metabolism of Gestodene can be decreased when combined with Zimelidine.,decrease,no risk
Gestodene,Ziprasidone,The metabolism of Gestodene can be decreased when combined with Ziprasidone.,decrease,no risk
Gestodene,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Gestodene.,decrease,no risk
Seproxetine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Seproxetine.,increase,no risk
Seproxetine,Betrixaban,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Betrixaban.,increase,risk
Seproxetine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Seproxetine.,increase,no risk
Seproxetine,Bivalirudin,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Bivalirudin.,increase,risk
Seproxetine,Boceprevir,The metabolism of Boceprevir can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bosentan,The metabolism of Bosentan can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Seproxetine.,increase,risk
Seproxetine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Seproxetine.,increase,risk
Seproxetine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Seproxetine.,increase,risk
Seproxetine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Seproxetine.,increase,no risk
Seproxetine,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Seproxetine.,increase,risk
Seproxetine,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Seproxetine.,increase,risk
Seproxetine,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Seproxetine.,increase,risk
Seproxetine,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Seproxetine.,increase,risk
Seproxetine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Seproxetine.,increase,risk
Seproxetine,Budesonide,The metabolism of Budesonide can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Bumadizone.,increase,risk
Seproxetine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Seproxetine.,increase,risk
Seproxetine,Buprenorphine,Seproxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Seproxetine,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Seproxetine.,increase,risk
Seproxetine,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Seproxetine.,increase,risk
Seproxetine,Busulfan,The metabolism of Busulfan can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Seproxetine.,increase,risk
Seproxetine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Seproxetine.,increase,risk
Seproxetine,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Seproxetine.,increase,risk
Seproxetine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Seproxetine.,increase,risk
Seproxetine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Seproxetine.,increase,risk
Seproxetine,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Seproxetine.,increase,risk
Seproxetine,Gabapentin,The risk or severity of adverse effects can be increased when Gabapentin is combined with Seproxetine.,increase,risk
Seproxetine,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Gabapentin enacarbil is combined with Seproxetine.,increase,risk
Seproxetine,Galantamine,The metabolism of Galantamine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Seproxetine.,increase,risk
Seproxetine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Seproxetine is combined with Ganaxolone.",increase,risk
Seproxetine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Seproxetine.,increase,no risk
Seproxetine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Gilteritinib,The therapeutic efficacy of Seproxetine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Seproxetine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Glipizide,The metabolism of Glipizide can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Glutethimide,The risk or severity of adverse effects can be increased when Glutethimide is combined with Seproxetine.,increase,risk
Seproxetine,Glyburide,The metabolism of Glyburide can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Glycol salicylate.,increase,risk
Seproxetine,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Seproxetine.,increase,risk
Seproxetine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Seproxetine.,increase,risk
Seproxetine,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Seproxetine.,increase,risk
Seproxetine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Seproxetine.,increase,risk
Seproxetine,Halothane,The risk or severity of adverse effects can be increased when Halothane is combined with Seproxetine.,increase,risk
Seproxetine,Heparin,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Heparin.,increase,risk
Seproxetine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Seproxetine.,increase,risk
Seproxetine,Hydrochlorothiazide,The risk or severity of hyponatremia can be increased when Seproxetine is combined with Hydrochlorothiazide.,increase,risk
Seproxetine,Hydrocodone,Seproxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Seproxetine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydroflumethiazide,The risk or severity of hyponatremia can be increased when Seproxetine is combined with Hydroflumethiazide.,increase,risk
Seproxetine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Seproxetine.,increase,risk
Seproxetine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Seproxetine.,increase,no risk
Seproxetine,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Seproxetine.,increase,risk
Seproxetine,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Seproxetine.,increase,risk
Seproxetine,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Ketoprofen.,increase,risk
Seproxetine,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Ketorolac.,increase,risk
Seproxetine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Seproxetine.,increase,risk
Seproxetine,Olaparib,The metabolism of Olaparib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Seproxetine is combined with Oliceridine.",increase,risk
Seproxetine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Seproxetine.,increase,no risk
Seproxetine,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Seproxetine.,increase,risk
Seproxetine,Opium,The risk or severity of serotonin syndrome can be increased when Opium is combined with Seproxetine.,increase,risk
Seproxetine,Orphenadrine,Seproxetine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Seproxetine,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Oxaprozin.,increase,risk
Seproxetine,Oxazepam,The risk or severity of adverse effects can be increased when Oxazepam is combined with Seproxetine.,increase,risk
Seproxetine,Oxcarbazepine,The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Seproxetine.,increase,risk
Seproxetine,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Seproxetine.,increase,risk
Seproxetine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Seproxetine.,increase,risk
Seproxetine,Oxybuprocaine,The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Seproxetine.,increase,risk
Seproxetine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Seproxetine.,increase,risk
Seproxetine,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Seproxetine.,increase,risk
Seproxetine,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Oxyphenbutazone.,increase,risk
Seproxetine,Quazepam,The risk or severity of adverse effects can be increased when Quazepam is combined with Seproxetine.,increase,risk
Seproxetine,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Seproxetine.,increase,risk
Seproxetine,Quinethazone,The risk or severity of hyponatremia can be increased when Seproxetine is combined with Quinethazone.,increase,risk
Seproxetine,Quinidine,The metabolism of Quinidine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Seproxetine.,increase,risk
Seproxetine,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Seproxetine.,increase,risk
Seproxetine,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Seproxetine.,increase,no risk
Seproxetine,Udenafil,The metabolism of Udenafil can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Urethane,The risk or severity of adverse effects can be increased when Urethane is combined with Seproxetine.,increase,risk
Seproxetine,Urokinase,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Urokinase.,increase,risk
Seproxetine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Seproxetine is combined with Valdecoxib.,increase,risk
Seproxetine,Valproic acid,The risk or severity of adverse effects can be increased when Valproic acid is combined with Seproxetine.,increase,risk
Seproxetine,Valsartan,The metabolism of Valsartan can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vasopressin,Seproxetine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Seproxetine,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Seproxetine.,increase,risk
Seproxetine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Seproxetine.,increase,risk
Seproxetine,Verapamil,The metabolism of Verapamil can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vigabatrin,The risk or severity of adverse effects can be increased when Vigabatrin is combined with Seproxetine.,increase,risk
Seproxetine,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Seproxetine.,increase,risk
Seproxetine,Viloxazine,The risk or severity of adverse effects can be increased when Viloxazine is combined with Seproxetine.,increase,risk
Seproxetine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vincristine,The metabolism of Vincristine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vindesine,The metabolism of Vindesine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vorapaxar,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Vorapaxar.,increase,risk
Seproxetine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Seproxetine.,increase,risk
Seproxetine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Seproxetine.,increase,no risk
Seproxetine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Seproxetine.,increase,no risk
Seproxetine,Ximelagatran,The risk or severity of hemorrhage can be increased when Seproxetine is combined with Ximelagatran.,increase,risk
Seproxetine,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Seproxetine.,increase,risk
Seproxetine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Zaleplon,The risk or severity of adverse effects can be increased when Zaleplon is combined with Seproxetine.,increase,risk
Seproxetine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Ziconotide,The risk or severity of adverse effects can be increased when Ziconotide is combined with Seproxetine.,increase,risk
Seproxetine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Zileuton,The metabolism of Zileuton can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Zimelidine,The risk or severity of adverse effects can be increased when Zimelidine is combined with Seproxetine.,increase,risk
Seproxetine,Ziprasidone,The risk or severity of adverse effects can be increased when Seproxetine is combined with Ziprasidone.,increase,risk
Seproxetine,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Seproxetine is combined with Zolmitriptan.,increase,risk
Seproxetine,Zolpidem,Seproxetine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Seproxetine,Zonisamide,The risk or severity of adverse effects can be increased when Zonisamide is combined with Seproxetine.,increase,risk
Seproxetine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Seproxetine.,decrease,no risk
Seproxetine,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Seproxetine.,increase,risk
Seproxetine,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Seproxetine.,increase,risk
Seproxetine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Seproxetine.,increase,risk
beta-Naphthoflavone,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Quinine,The metabolism of Quinine can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Verapamil,The metabolism of Verapamil can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Warfarin,The metabolism of Warfarin can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Zileuton,The metabolism of Zileuton can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Zolpidem,The metabolism of Zolpidem can be increased when combined with beta-Naphthoflavone.,increase,no risk
beta-Naphthoflavone,Zotepine,The metabolism of Zotepine can be increased when combined with beta-Naphthoflavone.,increase,no risk
Bafilomycin A1,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Bafilomycin A1.,increase,no risk
Enclomiphene,Galantamine,The metabolism of Enclomiphene can be decreased when combined with Galantamine.,decrease,no risk
Enclomiphene,Gefitinib,The metabolism of Enclomiphene can be decreased when combined with Gefitinib.,decrease,no risk
Enclomiphene,Givosiran,The serum concentration of Enclomiphene can be increased when it is combined with Givosiran.,increase,no risk
Enclomiphene,Glycerol phenylbutyrate,The metabolism of Enclomiphene can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Enclomiphene,Golimumab,The metabolism of Enclomiphene can be increased when combined with Golimumab.,increase,no risk
Enclomiphene,Halofantrine,The metabolism of Enclomiphene can be decreased when combined with Halofantrine.,decrease,no risk
Enclomiphene,Haloperidol,The serum concentration of Enclomiphene can be increased when it is combined with Haloperidol.,increase,no risk
Enclomiphene,Hydroxychloroquine,The metabolism of Enclomiphene can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Enclomiphene,Hydroxyzine,The metabolism of Enclomiphene can be decreased when combined with Hydroxyzine.,decrease,no risk
Enclomiphene,Ketoconazole,The metabolism of Enclomiphene can be decreased when combined with Ketoconazole.,decrease,no risk
Enclomiphene,Olanzapine,The metabolism of Enclomiphene can be decreased when combined with Olanzapine.,decrease,no risk
Enclomiphene,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Enclomiphene.,decrease,no risk
Enclomiphene,Ondansetron,The metabolism of Enclomiphene can be decreased when combined with Ondansetron.,decrease,no risk
Enclomiphene,Opium,The metabolism of Opium can be decreased when combined with Enclomiphene.,decrease,no risk
Enclomiphene,Oritavancin,The metabolism of Enclomiphene can be decreased when combined with Oritavancin.,decrease,no risk
Enclomiphene,Orphenadrine,The metabolism of Enclomiphene can be decreased when combined with Orphenadrine.,decrease,no risk
Enclomiphene,Osilodrostat,The metabolism of Enclomiphene can be decreased when combined with Osilodrostat.,decrease,no risk
Enclomiphene,Ospemifene,The risk or severity of adverse effects can be increased when Enclomiphene is combined with Ospemifene.,increase,risk
Enclomiphene,Oxamniquine,The metabolism of Enclomiphene can be decreased when combined with Oxamniquine.,decrease,no risk
Enclomiphene,Oxprenolol,The metabolism of Enclomiphene can be decreased when combined with Oxprenolol.,decrease,no risk
Enclomiphene,Oxybutynin,The metabolism of Enclomiphene can be decreased when combined with Oxybutynin.,decrease,no risk
Enclomiphene,Oxycodone,The metabolism of Enclomiphene can be decreased when combined with Oxycodone.,decrease,no risk
Enclomiphene,Oxymorphone,The metabolism of Enclomiphene can be decreased when combined with Oxymorphone.,decrease,no risk
Enclomiphene,Quetiapine,The metabolism of Enclomiphene can be decreased when combined with Quetiapine.,decrease,no risk
Enclomiphene,Quinidine,The metabolism of Enclomiphene can be decreased when combined with Quinidine.,decrease,no risk
Enclomiphene,Quinine,The metabolism of Enclomiphene can be decreased when combined with Quinine.,decrease,no risk
Enclomiphene,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Enclomiphene.,decrease,no risk
Enclomiphene,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Enclomiphene.,decrease,no risk
Enclomiphene,Vemurafenib,The metabolism of Enclomiphene can be decreased when combined with Vemurafenib.,decrease,no risk
Enclomiphene,Venlafaxine,The metabolism of Enclomiphene can be decreased when combined with Venlafaxine.,decrease,no risk
Enclomiphene,Verapamil,The metabolism of Enclomiphene can be decreased when combined with Verapamil.,decrease,no risk
Enclomiphene,Vernakalant,The metabolism of Enclomiphene can be decreased when combined with Vernakalant.,decrease,no risk
Enclomiphene,Vilazodone,The metabolism of Enclomiphene can be decreased when combined with Vilazodone.,decrease,no risk
Enclomiphene,Viloxazine,The metabolism of Enclomiphene can be decreased when combined with Viloxazine.,decrease,no risk
Enclomiphene,Vinblastine,The metabolism of Enclomiphene can be decreased when combined with Vinblastine.,decrease,no risk
Enclomiphene,Vinorelbine,The metabolism of Enclomiphene can be decreased when combined with Vinorelbine.,decrease,no risk
Enclomiphene,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Enclomiphene.,decrease,no risk
Enclomiphene,Yohimbine,The metabolism of Enclomiphene can be decreased when combined with Yohimbine.,decrease,no risk
Enclomiphene,Zolpidem,The metabolism of Enclomiphene can be decreased when combined with Zolpidem.,decrease,no risk
Enclomiphene,Zuclopenthixol,The metabolism of Enclomiphene can be decreased when combined with Zuclopenthixol.,decrease,no risk
Aceclofenac,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Aceclofenac.,decrease,no risk
Aceclofenac,Bismuth subgallate,Aceclofenac may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Aceclofenac,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Aceclofenac.,decrease,no risk
Aceclofenac,Bisoprolol,Aceclofenac may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Aceclofenac,Bisoxatin,Aceclofenac may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Aceclofenac,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Bivalirudin.,increase,risk
Aceclofenac,Bleomycin,Aceclofenac may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Aceclofenac,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Aceclofenac.,decrease,no risk
Aceclofenac,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Aceclofenac.,decrease,no risk
Aceclofenac,Brexpiprazole,The risk or severity of hypertension can be increased when Aceclofenac is combined with Brexpiprazole.,increase,risk
Aceclofenac,Brivaracetam,Aceclofenac may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Aceclofenac,Bromazepam,Aceclofenac may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Aceclofenac,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Aceclofenac.,increase,risk
Aceclofenac,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Aceclofenac.,increase,risk
Aceclofenac,Bromotheophylline,Bromotheophylline may increase the excretion rate of Aceclofenac which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aceclofenac,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Aceclofenac.,increase,risk
Aceclofenac,Bufexamac,The risk or severity of adverse effects can be increased when Aceclofenac is combined with Bufexamac.,increase,risk
Aceclofenac,Bumadizone,The risk or severity of adverse effects can be increased when Aceclofenac is combined with Bumadizone.,increase,risk
Aceclofenac,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Aceclofenac.,decrease,no risk
Aceclofenac,Bupropion,Aceclofenac may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Aceclofenac,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Aceclofenac.,increase,risk
Aceclofenac,Butabarbital,Aceclofenac may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Aceclofenac,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Aceclofenac.,increase,risk
Zaltoprofen,Bendazac,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Bendazac.,increase,risk
Zaltoprofen,Bendroflumethiazide,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Zaltoprofen,Benorilate,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Benorilate.,increase,risk
Zaltoprofen,Benoxaprofen,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Benserazide,Zaltoprofen may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Benzatropine,Zaltoprofen may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Benznidazole,Zaltoprofen may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Benzthiazide,The therapeutic efficacy of Zaltoprofen can be decreased when used in combination with Benzthiazide.,decrease,no risk
Zaltoprofen,Benzydamine,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Benzydamine.,increase,risk
Zaltoprofen,Bepotastine,Zaltoprofen may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Zaltoprofen.,decrease,no risk
Zaltoprofen,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Betaxolol,Zaltoprofen may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Zaltoprofen,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Zaltoprofen.,decrease,no risk
Zaltoprofen,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Betulinic Acid,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Betulinic Acid.,increase,risk
Zaltoprofen,Bexarotene,The metabolism of Zaltoprofen can be decreased when combined with Bexarotene.,decrease,no risk
Zaltoprofen,Bicisate,Zaltoprofen may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Zaltoprofen.,decrease,no risk
Zaltoprofen,Bimekizumab,The metabolism of Zaltoprofen can be increased when combined with Bimekizumab.,increase,no risk
Zaltoprofen,Bismuth subgallate,Zaltoprofen may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Bisoprolol,Zaltoprofen may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Zaltoprofen,Bisoxatin,Zaltoprofen may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Zaltoprofen is combined with Bivalirudin.,increase,risk
Zaltoprofen,Bleomycin,Zaltoprofen may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Bortezomib,The metabolism of Zaltoprofen can be decreased when combined with Bortezomib.,decrease,no risk
Zaltoprofen,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Zaltoprofen.,decrease,no risk
Zaltoprofen,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Zaltoprofen.,decrease,no risk
Zaltoprofen,Brexpiprazole,The risk or severity of hypertension can be increased when Zaltoprofen is combined with Brexpiprazole.,increase,risk
Zaltoprofen,Brivaracetam,Zaltoprofen may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Bromazepam,Zaltoprofen may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Bufexamac,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Bufexamac.,increase,risk
Zaltoprofen,Bumadizone,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Bumadizone.,increase,risk
Zaltoprofen,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Zaltoprofen.,decrease,no risk
Zaltoprofen,Buprenorphine,The metabolism of Zaltoprofen can be decreased when combined with Buprenorphine.,decrease,no risk
Zaltoprofen,Bupropion,Zaltoprofen may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Butabarbital,Zaltoprofen may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Zaltoprofen.,increase,risk
Zaltoprofen,Gabapentin enacarbil,Zaltoprofen may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gadobenic acid,Zaltoprofen may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gadodiamide,Zaltoprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gadofosveset trisodium,Zaltoprofen may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gadopentetic acid,Zaltoprofen may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gadoteric acid,Zaltoprofen may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gadoteridol,Zaltoprofen may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Ganciclovir,Zaltoprofen may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gatifloxacin,Zaltoprofen may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Zaltoprofen,Gemcitabine,Zaltoprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gemfibrozil,The metabolism of Zaltoprofen can be decreased when combined with Gemfibrozil.,decrease,no risk
Zaltoprofen,Gemifloxacin,Zaltoprofen may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Zaltoprofen,Gentamicin,Zaltoprofen may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Gimeracil,Zaltoprofen may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Ginkgo biloba,The metabolism of Zaltoprofen can be decreased when combined with Ginkgo biloba.,decrease,no risk
Zaltoprofen,Givosiran,The risk or severity of nephrotoxicity can be increased when Zaltoprofen is combined with Givosiran.,increase,risk
Zaltoprofen,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Zaltoprofen.,decrease,no risk
Zaltoprofen,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Zaltoprofen.,decrease,no risk
Zaltoprofen,Glipizide,The protein binding of Glipizide can be decreased when combined with Zaltoprofen.,decrease,no risk
Zaltoprofen,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Zaltoprofen.,decrease,no risk
Zaltoprofen,Glofitamab,The serum concentration of Zaltoprofen can be increased when it is combined with Glofitamab.,increase,no risk
Zaltoprofen,Glyburide,The protein binding of Glyburide can be decreased when combined with Zaltoprofen.,decrease,no risk
Zaltoprofen,Glycerol phenylbutyrate,Zaltoprofen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Glycol salicylate,The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Glycol salicylate.,increase,risk
Zaltoprofen,Golimumab,The metabolism of Zaltoprofen can be increased when combined with Golimumab.,increase,no risk
Zaltoprofen,Golodirsen,Zaltoprofen may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Zaltoprofen,Goserelin,Zaltoprofen may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Seratrodast,Gemfibrozil,The metabolism of Seratrodast can be decreased when combined with Gemfibrozil.,decrease,no risk
Seratrodast,Gestrinone,The metabolism of Gestrinone can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Ginkgo biloba,The metabolism of Seratrodast can be decreased when combined with Ginkgo biloba.,decrease,no risk
Seratrodast,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Gliclazide,The metabolism of Seratrodast can be decreased when combined with Gliclazide.,decrease,no risk
Seratrodast,Glimepiride,The metabolism of Seratrodast can be decreased when combined with Glimepiride.,decrease,no risk
Seratrodast,Glipizide,The metabolism of Seratrodast can be decreased when combined with Glipizide.,decrease,no risk
Seratrodast,Gliquidone,The metabolism of Seratrodast can be decreased when combined with Gliquidone.,decrease,no risk
Seratrodast,Glofitamab,The serum concentration of Seratrodast can be increased when it is combined with Glofitamab.,increase,no risk
Seratrodast,Glyburide,The metabolism of Seratrodast can be decreased when combined with Glyburide.,decrease,no risk
Seratrodast,Golimumab,The metabolism of Seratrodast can be increased when combined with Golimumab.,increase,no risk
Seratrodast,Halofantrine,The metabolism of Seratrodast can be decreased when combined with Halofantrine.,decrease,no risk
Seratrodast,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Seratrodast.,increase,no risk
Seratrodast,Halothane,The metabolism of Seratrodast can be decreased when combined with Halothane.,decrease,no risk
Seratrodast,Hydrocodone,The metabolism of Seratrodast can be decreased when combined with Hydrocodone.,decrease,no risk
Seratrodast,Hydrocortisone,The metabolism of Seratrodast can be increased when combined with Hydrocortisone.,increase,no risk
Seratrodast,Hydromorphone,The metabolism of Seratrodast can be decreased when combined with Hydromorphone.,decrease,no risk
Seratrodast,Hydroxychloroquine,The metabolism of Seratrodast can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Seratrodast,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Ketamine,The metabolism of Seratrodast can be decreased when combined with Ketamine.,decrease,no risk
Seratrodast,Ketoconazole,The metabolism of Seratrodast can be decreased when combined with Ketoconazole.,decrease,no risk
Seratrodast,Ketoprofen,The metabolism of Seratrodast can be decreased when combined with Ketoprofen.,decrease,no risk
Seratrodast,Ketorolac,The metabolism of Seratrodast can be decreased when combined with Ketorolac.,decrease,no risk
Seratrodast,Olanzapine,The metabolism of Seratrodast can be decreased when combined with Olanzapine.,decrease,no risk
Seratrodast,Olaparib,The metabolism of Olaparib can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Seratrodast.,decrease,no risk
Seratrodast,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Omaveloxolone,The serum concentration of Seratrodast can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Seratrodast,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Omeprazole,The metabolism of Seratrodast can be decreased when combined with Omeprazole.,decrease,no risk
Seratrodast,Ondansetron,The metabolism of Seratrodast can be decreased when combined with Ondansetron.,decrease,no risk
Seratrodast,Oritavancin,The metabolism of Seratrodast can be decreased when combined with Oritavancin.,decrease,no risk
Seratrodast,Orphenadrine,The metabolism of Seratrodast can be decreased when combined with Orphenadrine.,decrease,no risk
Seratrodast,Osilodrostat,The metabolism of Seratrodast can be decreased when combined with Osilodrostat.,decrease,no risk
Seratrodast,Osimertinib,The metabolism of Osimertinib can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Ospemifene,The metabolism of Seratrodast can be decreased when combined with Ospemifene.,decrease,no risk
Seratrodast,Oxandrolone,The metabolism of Seratrodast can be decreased when combined with Oxandrolone.,decrease,no risk
Seratrodast,Oxcarbazepine,The metabolism of Seratrodast can be decreased when combined with Oxcarbazepine.,decrease,no risk
Seratrodast,Oxybutynin,The metabolism of Seratrodast can be decreased when combined with Oxybutynin.,decrease,no risk
Seratrodast,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Quinidine,The metabolism of Quinidine can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Quinine,The metabolism of Seratrodast can be decreased when combined with Quinine.,decrease,no risk
Seratrodast,Ulipristal,The metabolism of Ulipristal can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Vadadustat,The serum concentration of Seratrodast can be decreased when it is combined with Vadadustat.,decrease,no risk
Seratrodast,Valdecoxib,The metabolism of Seratrodast can be decreased when combined with Valdecoxib.,decrease,no risk
Seratrodast,Valproic acid,The metabolism of Seratrodast can be decreased when combined with Valproic acid.,decrease,no risk
Seratrodast,Valsartan,The metabolism of Seratrodast can be decreased when combined with Valsartan.,decrease,no risk
Seratrodast,Vandetanib,The metabolism of Vandetanib can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Vardenafil,The metabolism of Seratrodast can be decreased when combined with Vardenafil.,decrease,no risk
Seratrodast,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Venetoclax,The metabolism of Venetoclax can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Verapamil,The metabolism of Seratrodast can be decreased when combined with Verapamil.,decrease,no risk
Seratrodast,Vilazodone,The metabolism of Seratrodast can be decreased when combined with Vilazodone.,decrease,no risk
Seratrodast,Viloxazine,The metabolism of Seratrodast can be decreased when combined with Viloxazine.,decrease,no risk
Seratrodast,Vinblastine,The metabolism of Vinblastine can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Vincristine,The metabolism of Vincristine can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Vindesine,The metabolism of Vindesine can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Vinflunine,The metabolism of Vinflunine can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Vonoprazan,The metabolism of Seratrodast can be decreased when combined with Vonoprazan.,decrease,no risk
Seratrodast,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Voriconazole,The metabolism of Seratrodast can be decreased when combined with Voriconazole.,decrease,no risk
Seratrodast,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Seratrodast.,decrease,no risk
Seratrodast,Warfarin,The metabolism of Warfarin can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Ximelagatran,The metabolism of Seratrodast can be decreased when combined with Ximelagatran.,decrease,no risk
Seratrodast,Zafirlukast,The metabolism of Seratrodast can be decreased when combined with Zafirlukast.,decrease,no risk
Seratrodast,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Zidovudine,The metabolism of Seratrodast can be decreased when combined with Zidovudine.,decrease,no risk
Seratrodast,Zileuton,The metabolism of Seratrodast can be decreased when combined with Zileuton.,decrease,no risk
Seratrodast,Zimelidine,The metabolism of Seratrodast can be decreased when combined with Zimelidine.,decrease,no risk
Seratrodast,Ziprasidone,The metabolism of Seratrodast can be decreased when combined with Ziprasidone.,decrease,no risk
Seratrodast,Zolpidem,The metabolism of Zolpidem can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Zonisamide,The metabolism of Seratrodast can be decreased when combined with Zonisamide.,decrease,no risk
Seratrodast,Zopiclone,The metabolism of Seratrodast can be decreased when combined with Zopiclone.,decrease,no risk
Seratrodast,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Seratrodast.,increase,no risk
Seratrodast,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Seratrodast.,decrease,no risk
Gavestinel,Gemfibrozil,The metabolism of Gavestinel can be decreased when combined with Gemfibrozil.,decrease,no risk
Gavestinel,Glecaprevir,The metabolism of Gavestinel can be decreased when combined with Glecaprevir.,decrease,no risk
Gavestinel,Ketoconazole,The metabolism of Gavestinel can be decreased when combined with Ketoconazole.,decrease,no risk
Gavestinel,Ombitasvir,The metabolism of Gavestinel can be decreased when combined with Ombitasvir.,decrease,no risk
Gavestinel,Quizartinib,The metabolism of Gavestinel can be decreased when combined with Quizartinib.,decrease,no risk
Gavestinel,Valproic acid,The metabolism of Gavestinel can be decreased when combined with Valproic acid.,decrease,no risk
Gavestinel,Zidovudine,The metabolism of Gavestinel can be increased when combined with Zidovudine.,increase,no risk
Ambroxol,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Ambroxol.,increase,risk
Ambroxol,Ganaxolone,The risk or severity of methemoglobinemia can be increased when Ganaxolone is combined with Ambroxol.,increase,risk
Ambroxol,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Ambroxol.,increase,risk
Ambroxol,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Ambroxol.,increase,risk
Ambroxol,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Ambroxol.,increase,risk
Ambroxol,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Ambroxol.,increase,risk
Ambroxol,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Ambroxol.,increase,risk
Ambroxol,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Ambroxol.,increase,risk
Ambroxol,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Ambroxol.,increase,risk
Ambroxol,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Ambroxol.,increase,risk
Ambroxol,Glofitamab,The serum concentration of Ambroxol can be increased when it is combined with Glofitamab.,increase,no risk
Ambroxol,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Ambroxol.,increase,risk
Ambroxol,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Ambroxol.,increase,risk
Ambroxol,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Ambroxol.,increase,risk
Ambroxol,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Ambroxol.,increase,risk
Ambroxol,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ambroxol.,increase,no risk
Ambroxol,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Ambroxol.,increase,risk
Ambroxol,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Ambroxol.,increase,risk
Ambroxol,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Ambroxol.,increase,risk
Ambroxol,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Ambroxol.,increase,risk
Ambroxol,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Ambroxol.,increase,risk
Ambroxol,Ketoconazole,The metabolism of Ambroxol can be decreased when combined with Ketoconazole.,decrease,no risk
Ambroxol,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Ambroxol.,increase,risk
Ambroxol,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Ambroxol.,increase,risk
Ambroxol,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Ambroxol.,increase,risk
Ambroxol,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Ambroxol.,increase,risk
Ambroxol,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Ambroxol.,increase,risk
Ambroxol,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Ambroxol.,increase,risk
Ambroxol,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Ambroxol.,increase,risk
Ambroxol,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Ambroxol.,increase,risk
Ambroxol,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Ambroxol.,increase,risk
Ambroxol,Omaveloxolone,The serum concentration of Ambroxol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ambroxol,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Ambroxol.,increase,risk
Ambroxol,Osimertinib,The risk or severity of methemoglobinemia can be increased when Osimertinib is combined with Ambroxol.,increase,risk
Ambroxol,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Ambroxol.,increase,risk
Ambroxol,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Ambroxol.,increase,risk
Ambroxol,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Ambroxol.,increase,risk
Ambroxol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ambroxol is combined with Oxetacaine.,increase,risk
Ambroxol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Ambroxol.,increase,risk
Ambroxol,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Ambroxol.,increase,risk
Ambroxol,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Ambroxol.,increase,risk
Ambroxol,Quinine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Ambroxol.,increase,risk
Ambroxol,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Ambroxol.,increase,risk
Ambroxol,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Ambroxol.,increase,risk
Ambroxol,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Ambroxol.,increase,risk
Ambroxol,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Ambroxol.,increase,risk
Ambroxol,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Ambroxol.,increase,risk
Ambroxol,Vadadustat,The serum concentration of Ambroxol can be increased when it is combined with Vadadustat.,increase,no risk
Ambroxol,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Ambroxol.,increase,risk
Ambroxol,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Ambroxol.,increase,risk
Ambroxol,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Ambroxol.,increase,risk
Ambroxol,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Ambroxol.,increase,risk
Ambroxol,Vemurafenib,The risk or severity of methemoglobinemia can be increased when Vemurafenib is combined with Ambroxol.,increase,risk
Ambroxol,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Ambroxol.,increase,risk
Ambroxol,Verapamil,The metabolism of Ambroxol can be decreased when combined with Verapamil.,decrease,no risk
Ambroxol,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Ambroxol.,increase,risk
Ambroxol,Viloxazine,The metabolism of Ambroxol can be decreased when combined with Viloxazine.,decrease,no risk
Ambroxol,Vinblastine,The risk or severity of methemoglobinemia can be increased when Vinblastine is combined with Ambroxol.,increase,risk
Ambroxol,Vincristine,The risk or severity of methemoglobinemia can be increased when Vincristine is combined with Ambroxol.,increase,risk
Ambroxol,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Ambroxol.,increase,risk
Ambroxol,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Ambroxol.,increase,risk
Ambroxol,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Ambroxol.,increase,risk
Ambroxol,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Ambroxol.,increase,risk
Ambroxol,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Ambroxol.,increase,risk
Ambroxol,Voriconazole,The metabolism of Ambroxol can be decreased when combined with Voriconazole.,decrease,no risk
Ambroxol,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Ambroxol.,increase,risk
Ambroxol,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Ambroxol.,increase,risk
Ambroxol,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Ambroxol.,increase,risk
Ambroxol,Zimelidine,The metabolism of Ambroxol can be decreased when combined with Zimelidine.,decrease,no risk
Ambroxol,Ziprasidone,The metabolism of Ambroxol can be decreased when combined with Ziprasidone.,decrease,no risk
Ambroxol,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Ambroxol.,increase,risk
Ginsenoside C,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ginsenoside C is combined with Benzocaine.,increase,risk
Ginsenoside C,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ginsenoside C is combined with Benzyl alcohol.,increase,risk
Ginsenoside C,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ginsenoside C is combined with Bupivacaine.,increase,risk
Ginsenoside C,Butacaine,The risk or severity of methemoglobinemia can be increased when Ginsenoside C is combined with Butacaine.,increase,risk
Ginsenoside C,Butamben,The risk or severity of methemoglobinemia can be increased when Ginsenoside C is combined with Butamben.,increase,risk
Ginsenoside C,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ginsenoside C is combined with Oxetacaine.,increase,risk
Ginsenoside C,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ginsenoside C is combined with Oxybuprocaine.,increase,risk
Ginsenoside Rb1,Belantamab mafodotin,The excretion of Belantamab mafodotin can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Bempedoic acid,The excretion of Bempedoic acid can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Ginsenoside Rb1.,increase,no risk
Ginsenoside Rb1,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Ouabain,The excretion of Ouabain can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Valsartan,The excretion of Valsartan can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Ginsenoside Rb1.,decrease,no risk
Ginsenoside Rb1,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Ginsenoside Rb1.,increase,no risk
Triclofos,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Triclofos.,increase,risk
Triclofos,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Triclofos is combined with Gabapentin enacarbil.,increase,risk
Triclofos,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Triclofos.,increase,risk
Triclofos,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Triclofos is combined with Ganaxolone.",increase,risk
Triclofos,Gepirone,The risk or severity of CNS depression can be increased when Triclofos is combined with Gepirone.,increase,risk
Triclofos,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Triclofos.,increase,risk
Triclofos,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Triclofos.,increase,risk
Triclofos,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Triclofos.,increase,risk
Triclofos,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Triclofos.,increase,risk
Triclofos,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Triclofos.,increase,risk
Triclofos,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Triclofos.,increase,risk
Triclofos,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Triclofos.,increase,risk
Triclofos,Hydrocodone,Triclofos may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Triclofos,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Triclofos.,increase,risk
Triclofos,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triclofos.,increase,no risk
Triclofos,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Triclofos.,increase,risk
Triclofos,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Triclofos.,increase,risk
Triclofos,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Triclofos.,increase,risk
Triclofos,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Triclofos is combined with Oliceridine.",increase,risk
Triclofos,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Triclofos.,increase,risk
Triclofos,Opium,The risk or severity of CNS depression can be increased when Triclofos is combined with Opium.,increase,risk
Triclofos,Orphenadrine,Triclofos may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Triclofos,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Triclofos.,increase,risk
Triclofos,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Triclofos.,increase,risk
Triclofos,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Triclofos.,increase,risk
Triclofos,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Triclofos.,increase,risk
Triclofos,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Triclofos.,increase,risk
Triclofos,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Triclofos.,increase,risk
Triclofos,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Triclofos.,increase,risk
Triclofos,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Triclofos.,increase,risk
Triclofos,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Triclofos.,increase,risk
Triclofos,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Triclofos.,increase,risk
Triclofos,Quinupramine,The risk or severity of CNS depression can be increased when Triclofos is combined with Quinupramine.,increase,risk
Triclofos,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Triclofos.,increase,risk
Triclofos,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Triclofos.,increase,risk
Triclofos,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Triclofos.,increase,risk
Triclofos,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Triclofos.,increase,risk
Triclofos,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Triclofos.,increase,risk
Triclofos,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Triclofos.,increase,risk
Triclofos,Viloxazine,The risk or severity of CNS depression can be increased when Triclofos is combined with Viloxazine.,increase,risk
Triclofos,Vortioxetine,The risk or severity of CNS depression can be increased when Triclofos is combined with Vortioxetine.,increase,risk
Triclofos,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Triclofos.,increase,risk
Triclofos,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Triclofos.,increase,risk
Triclofos,Ziconotide,The risk or severity of CNS depression can be increased when Triclofos is combined with Ziconotide.,increase,risk
Triclofos,Zimelidine,The risk or severity of adverse effects can be increased when Triclofos is combined with Zimelidine.,increase,risk
Triclofos,Ziprasidone,The risk or severity of adverse effects can be increased when Triclofos is combined with Ziprasidone.,increase,risk
Triclofos,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Triclofos.,increase,risk
Triclofos,Zolpidem,Triclofos may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Triclofos,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Triclofos.,increase,risk
Triclofos,Zopiclone,The risk or severity of adverse effects can be increased when Triclofos is combined with Zopiclone.,increase,risk
Triclofos,Zotepine,The risk or severity of CNS depression can be increased when Triclofos is combined with Zotepine.,increase,risk
Triclofos,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Triclofos.,increase,risk
Triclofos,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Triclofos.,increase,risk
Danaparoid,Gemcitabine,The risk or severity of bleeding can be increased when Danaparoid is combined with Gemcitabine.,increase,risk
Danaparoid,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Danaparoid is combined with Gemtuzumab ozogamicin.,increase,risk
Danaparoid,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Danaparoid.,decrease,no risk
Danaparoid,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Danaparoid.,increase,risk
Danaparoid,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Danaparoid.,increase,no risk
Danaparoid,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Danaparoid.,increase,risk
Danaparoid,Hemin,Hemin may increase the anticoagulant activities of Danaparoid.,increase,no risk
Danaparoid,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Danaparoid.,increase,risk
Danaparoid,Hydrochlorothiazide,The therapeutic efficacy of Danaparoid can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Danaparoid,Hydroflumethiazide,The therapeutic efficacy of Danaparoid can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Danaparoid,Hydroxyprogesterone caproate,The therapeutic efficacy of Danaparoid can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Danaparoid,Hydroxyurea,The risk or severity of bleeding can be increased when Danaparoid is combined with Hydroxyurea.,increase,risk
Danaparoid,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Danaparoid.,decrease,no risk
Danaparoid,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Danaparoid.,increase,risk
Danaparoid,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Danaparoid.,increase,risk
Danaparoid,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Danaparoid.,increase,risk
Danaparoid,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Danaparoid is combined with Obeticholic acid.,increase,risk
Danaparoid,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Danaparoid is combined with Obinutuzumab.,increase,risk
Danaparoid,Olaparib,The risk or severity of bleeding can be increased when Danaparoid is combined with Olaparib.,increase,risk
Danaparoid,Olive oil,The therapeutic efficacy of Danaparoid can be decreased when used in combination with Olive oil.,decrease,no risk
Danaparoid,Olmesartan,The risk or severity of hyperkalemia can be increased when Danaparoid is combined with Olmesartan.,increase,risk
Danaparoid,Olsalazine,The risk or severity of bleeding can be increased when Danaparoid is combined with Olsalazine.,increase,risk
Danaparoid,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Danaparoid is combined with Omacetaxine mepesuccinate.,increase,risk
Danaparoid,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Danaparoid.,increase,no risk
Danaparoid,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Danaparoid.,increase,risk
Danaparoid,Omega-3-carboxylic acids,The therapeutic efficacy of Danaparoid can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Danaparoid,Oritavancin,The therapeutic efficacy of Danaparoid can be decreased when used in combination with Oritavancin.,decrease,no risk
Danaparoid,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Danaparoid.,increase,risk
Danaparoid,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Danaparoid.,increase,risk
Danaparoid,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Danaparoid.,increase,risk
Danaparoid,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Danaparoid.,increase,risk
Danaparoid,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Danaparoid.,increase,risk
Danaparoid,Quinestrol,Quinestrol may decrease the anticoagulant activities of Danaparoid.,decrease,no risk
Danaparoid,Quinidine,The therapeutic efficacy of Danaparoid can be increased when used in combination with Quinidine.,increase,no risk
Danaparoid,Quinine,The therapeutic efficacy of Danaparoid can be increased when used in combination with Quinine.,increase,no risk
Danaparoid,Ulipristal,The therapeutic efficacy of Danaparoid can be decreased when used in combination with Ulipristal.,decrease,no risk
Danaparoid,Urokinase,Urokinase may increase the anticoagulant activities of Danaparoid.,increase,no risk
Danaparoid,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Danaparoid is combined with Ursodeoxycholic acid.,increase,risk
Danaparoid,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Danaparoid.,increase,risk
Danaparoid,Valsartan,The risk or severity of hyperkalemia can be increased when Danaparoid is combined with Valsartan.,increase,risk
Danaparoid,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Danaparoid.,decrease,no risk
Danaparoid,Venlafaxine,The risk or severity of bleeding can be increased when Danaparoid is combined with Venlafaxine.,increase,risk
Danaparoid,Vinblastine,The risk or severity of bleeding can be increased when Danaparoid is combined with Vinblastine.,increase,risk
Danaparoid,Vindesine,The risk or severity of bleeding can be increased when Danaparoid is combined with Vindesine.,increase,risk
Danaparoid,Vinorelbine,The risk or severity of bleeding can be increased when Danaparoid is combined with Vinorelbine.,increase,risk
Danaparoid,Vitamin E,Vitamin E may increase the anticoagulant activities of Danaparoid.,increase,no risk
Danaparoid,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Danaparoid.,decrease,no risk
Danaparoid,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Danaparoid.,increase,risk
Danaparoid,Vorinostat,The risk or severity of bleeding can be increased when Danaparoid is combined with Vorinostat.,increase,risk
Danaparoid,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Danaparoid.,increase,risk
Danaparoid,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Danaparoid.,increase,risk
Danaparoid,Zidovudine,The risk or severity of bleeding can be increased when Danaparoid is combined with Zidovudine.,increase,risk
Danaparoid,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Danaparoid.,increase,risk
Danaparoid,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Danaparoid.,increase,risk
Danaparoid,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Danaparoid.,increase,risk
Beta carotene,Orlistat,Orlistat can cause a decrease in the absorption of Beta carotene resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Betaine,Hydrocortisone succinate,The therapeutic efficacy of Betaine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Betaine,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Oxprenolol,Betaine may increase the bradycardic activities of Oxprenolol.,increase,no risk
Betaine,Oxybuprocaine,Betaine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Betaine,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Quinidine,The therapeutic efficacy of Quinidine can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Vamorolone,The therapeutic efficacy of Betaine can be decreased when used in combination with Vamorolone.,decrease,no risk
Betaine,Varenicline,The risk or severity of adverse effects can be increased when Betaine is combined with Varenicline.,increase,risk
Betaine,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Betaine.,decrease,no risk
Betaine,Vigabatrin,The therapeutic efficacy of Betaine can be decreased when used in combination with Vigabatrin.,decrease,no risk
Betaine,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Betaine.,decrease,no risk
Beractant,Bendroflumethiazide,Bendroflumethiazide may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Bepridil,Bepridil may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Betaxolol,Betaxolol may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Bisoprolol,Bisoprolol may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Bretylium,Bretylium may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Galantamine,Galantamine may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Guanfacine,Guanfacine may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Beractant.,increase,no risk
Beractant,Oxprenolol,Oxprenolol may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Verapamil,Verapamil may increase the bradycardic activities of Beractant.,increase,no risk
Beractant,Zonisamide,Zonisamide may increase the bradycardic activities of Beractant.,increase,no risk
Pinacidil,Glofitamab,The serum concentration of Pinacidil can be increased when it is combined with Glofitamab.,increase,no risk
Pinacidil,Glycol salicylate,The therapeutic efficacy of Pinacidil can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Pinacidil,Guanabenz,Guanabenz may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Guanadrel,Guanadrel may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Guanethidine,Guanethidine may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Guanfacine,Guanfacine may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Guanoxan,Pinacidil may increase the hypotensive activities of Guanoxan.,increase,no risk
Pinacidil,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Pinacidil.,increase,no risk
Pinacidil,Halothane,Halothane may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Hydralazine,Hydralazine may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Hydrochlorothiazide,The therapeutic efficacy of Pinacidil can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Pinacidil,Hydroflumethiazide,The therapeutic efficacy of Pinacidil can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Pinacidil,Ketoconazole,The metabolism of Pinacidil can be decreased when combined with Ketoconazole.,decrease,no risk
Pinacidil,Ketoprofen,The therapeutic efficacy of Pinacidil can be decreased when used in combination with Ketoprofen.,decrease,no risk
Pinacidil,Ketorolac,The therapeutic efficacy of Pinacidil can be decreased when used in combination with Ketorolac.,decrease,no risk
Pinacidil,Obinutuzumab,Pinacidil may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Pinacidil,Olanzapine,Olanzapine may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Olmesartan,Olmesartan may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Olodaterol,Olodaterol may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Omaveloxolone,The serum concentration of Pinacidil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Pinacidil,Opicapone,Opicapone may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Oxaprozin,The therapeutic efficacy of Pinacidil can be decreased when used in combination with Oxaprozin.,decrease,no risk
Pinacidil,Oxprenolol,Oxprenolol may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Oxymetazoline,The therapeutic efficacy of Pinacidil can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Pinacidil,Oxyphenbutazone,The therapeutic efficacy of Pinacidil can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Pinacidil,Quetiapine,Quetiapine may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Quinapril,Quinapril may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Quinidine,Quinidine may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Quinine,Quinine may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Quinupramine,Quinupramine may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Udenafil,Udenafil may increase the antihypertensive activities of Pinacidil.,increase,no risk
Pinacidil,Unoprostone,Pinacidil may increase the hypotensive activities of Unoprostone.,increase,no risk
Pinacidil,Vadadustat,The serum concentration of Pinacidil can be increased when it is combined with Vadadustat.,increase,no risk
Pinacidil,Valdecoxib,The therapeutic efficacy of Pinacidil can be decreased when used in combination with Valdecoxib.,decrease,no risk
Pinacidil,Valsartan,Valsartan may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Vardenafil,Vardenafil may increase the antihypertensive activities of Pinacidil.,increase,no risk
Pinacidil,Venetoclax,The metabolism of Pinacidil can be decreased when combined with Venetoclax.,decrease,no risk
Pinacidil,Verapamil,The metabolism of Pinacidil can be decreased when combined with Verapamil.,decrease,no risk
Pinacidil,Vericiguat,Vericiguat may increase the hypotensive activities of Pinacidil.,increase,no risk
Pinacidil,Vilanterol,Vilanterol may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Vilazodone,Vilazodone may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Viloxazine,The metabolism of Pinacidil can be decreased when combined with Viloxazine.,decrease,no risk
Pinacidil,Voriconazole,The metabolism of Pinacidil can be decreased when combined with Voriconazole.,decrease,no risk
Pinacidil,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Xamoterol,Xamoterol may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Yohimbine,Yohimbine may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Zimelidine,The metabolism of Pinacidil can be decreased when combined with Zimelidine.,decrease,no risk
Pinacidil,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Pinacidil.,increase,no risk
Pinacidil,Zofenopril,Pinacidil may increase the hypotensive activities of Zofenopril.,increase,no risk
Pinacidil,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Pinacidil,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Pinacidil.,decrease,no risk
Saralasin,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Glycol salicylate.",increase,risk
Saralasin,Guanabenz,Saralasin may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Saralasin,Guanadrel,Saralasin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Saralasin,Guanethidine,Saralasin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Saralasin,Guanfacine,Saralasin may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Saralasin,Guanoxan,Saralasin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Saralasin,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Saralasin.,increase,risk
Saralasin,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Saralasin.,increase,risk
Saralasin,Hydralazine,Saralasin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Saralasin,Hydrochlorothiazide,Hydrochlorothiazide may increase the hypotensive and Electrolyte Disturbance activities of Saralasin.,increase,no risk
Saralasin,Hydroflumethiazide,Hydroflumethiazide may increase the hypotensive and Electrolyte Disturbance activities of Saralasin.,increase,no risk
Saralasin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Saralasin.,increase,risk
Saralasin,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Ketoprofen.",increase,risk
Saralasin,Ketorolac,The therapeutic efficacy of Saralasin can be decreased when used in combination with Ketorolac.,decrease,no risk
Saralasin,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Olmesartan is combined with Saralasin.",increase,risk
Saralasin,Olodaterol,The risk or severity of hypertension can be increased when Saralasin is combined with Olodaterol.,increase,risk
Saralasin,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Saralasin.,increase,risk
Saralasin,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Oxaprozin.",increase,risk
Saralasin,Oxprenolol,Saralasin may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Saralasin,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Saralasin.,increase,risk
Saralasin,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Oxyphenbutazone.",increase,risk
Saralasin,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Saralasin.,increase,risk
Saralasin,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Quinapril is combined with Saralasin.",increase,risk
Saralasin,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Saralasin.,increase,risk
Saralasin,Quinupramine,The risk or severity of hypertension can be increased when Saralasin is combined with Quinupramine.,increase,risk
Saralasin,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Saralasin is combined with Valdecoxib.",increase,risk
Saralasin,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Valsartan is combined with Saralasin.",increase,risk
Saralasin,Vilanterol,The risk or severity of hypertension can be increased when Saralasin is combined with Vilanterol.,increase,risk
Saralasin,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Saralasin.,increase,risk
Saralasin,Vortioxetine,The risk or severity of hypertension can be increased when Saralasin is combined with Vortioxetine.,increase,risk
Saralasin,Xamoterol,The risk or severity of hypertension can be increased when Saralasin is combined with Xamoterol.,increase,risk
Saralasin,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Saralasin.,increase,risk
Saralasin,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Saralasin.,increase,risk
Saralasin,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Saralasin.,increase,risk
Saralasin,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Zofenopril is combined with Saralasin.",increase,risk
Saralasin,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Saralasin.,increase,risk
Saralasin,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Saralasin.,increase,risk
Saralasin,Zuclopenthixol,The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Saralasin.,increase,risk
Tetryzoline,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Tetryzoline.,increase,risk
Tetryzoline,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Tetryzoline.,decrease,no risk
Tetryzoline,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Tetryzoline.,increase,risk
Tetryzoline,Guanabenz,Tetryzoline may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Tetryzoline,Guanadrel,Tetryzoline may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Tetryzoline,Guanethidine,Tetryzoline may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Tetryzoline,Guanfacine,Tetryzoline may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Tetryzoline,Guanoxan,Tetryzoline may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Tetryzoline,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Tetryzoline.,increase,risk
Tetryzoline,Hexocyclium,The risk or severity of Tachycardia can be increased when Tetryzoline is combined with Hexocyclium.,increase,risk
Tetryzoline,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Tetryzoline.,increase,risk
Tetryzoline,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Tetryzoline.,increase,risk
Tetryzoline,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Tetryzoline.,increase,risk
Tetryzoline,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Tetryzoline.,increase,risk
Tetryzoline,Hydralazine,Tetryzoline may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Tetryzoline,Hydrochlorothiazide,Tetryzoline may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Tetryzoline,Hydroflumethiazide,Tetryzoline may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Tetryzoline,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Tetryzoline.,increase,risk
Tetryzoline,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Tetryzoline.,increase,risk
Tetryzoline,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Tetryzoline.,increase,risk
Tetryzoline,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Tetryzoline.,increase,risk
Tetryzoline,Olanzapine,The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Olanzapine.,decrease,no risk
Tetryzoline,Olmesartan,Tetryzoline may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Tetryzoline,Olodaterol,The risk or severity of hypertension can be increased when Tetryzoline is combined with Olodaterol.,increase,risk
Tetryzoline,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Tetryzoline.,increase,risk
Tetryzoline,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Tetryzoline.,increase,risk
Tetryzoline,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Tetryzoline.,increase,risk
Tetryzoline,Oxprenolol,The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Oxprenolol.,decrease,no risk
Tetryzoline,Oxtriphylline,The risk or severity of adverse effects can be increased when Tetryzoline is combined with Oxtriphylline.,increase,risk
Tetryzoline,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Tetryzoline.,increase,risk
Tetryzoline,Oxymetazoline,The absorption of Tetryzoline can be decreased when combined with Oxymetazoline.,decrease,no risk
Tetryzoline,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Tetryzoline.,increase,risk
Tetryzoline,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Tetryzoline.,increase,risk
Tetryzoline,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Tetryzoline.,increase,risk
Tetryzoline,Oxytocin,The risk or severity of hypertension can be increased when Tetryzoline is combined with Oxytocin.,increase,risk
Tetryzoline,Quetiapine,The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Quetiapine.,decrease,no risk
Tetryzoline,Quinapril,Tetryzoline may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Tetryzoline,Quinidine,The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Quinidine.,decrease,no risk
Tetryzoline,Quinupramine,Quinupramine may increase the vasopressor activities of Tetryzoline.,increase,no risk
Tetryzoline,Umeclidinium,The risk or severity of Tachycardia can be increased when Tetryzoline is combined with Umeclidinium.,increase,risk
Tetryzoline,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Tetryzoline.,increase,risk
Tetryzoline,Valsartan,Tetryzoline may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Tetryzoline,Venlafaxine,Venlafaxine may increase the tachycardic activities of Tetryzoline.,increase,no risk
Tetryzoline,Verapamil,The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Verapamil.,decrease,no risk
Tetryzoline,Vilanterol,The risk or severity of hypertension can be increased when Tetryzoline is combined with Vilanterol.,increase,risk
Tetryzoline,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Tetryzoline.,increase,risk
Tetryzoline,Vortioxetine,The risk or severity of hypertension can be increased when Tetryzoline is combined with Vortioxetine.,increase,risk
Tetryzoline,Xamoterol,The risk or severity of hypertension can be increased when Tetryzoline is combined with Xamoterol.,increase,risk
Tetryzoline,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Tetryzoline.,increase,risk
Tetryzoline,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Tetryzoline.,increase,risk
Tetryzoline,Ziprasidone,The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Ziprasidone.,decrease,no risk
Tetryzoline,Zofenopril,Tetryzoline may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Tetryzoline,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tetryzoline.,increase,risk
Tetryzoline,Zuclopenthixol,The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Alcaftadine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Bedaquiline.,increase,risk
Alcaftadine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Alcaftadine.,increase,risk
Alcaftadine,Glasdegib,The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Glasdegib.,increase,risk
Alcaftadine,Haloperidol,The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Haloperidol.,increase,risk
Alcaftadine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Hydroxyzine.,increase,risk
Alcaftadine,Hyoscyamine,Alcaftadine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Alcaftadine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Alcaftadine.,increase,risk
Alcaftadine,Quizartinib,The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Quizartinib.,increase,risk
Alcaftadine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Alcaftadine.,increase,risk
Alcaftadine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Ziprasidone.,increase,risk
Ammonium chloride,Gabapentin enacarbil,Ammonium chloride may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gadodiamide,Gadodiamide may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gadoteric acid,Ammonium chloride may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gadoteridol,Gadoteridol may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Ganciclovir,Ganciclovir may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gemcitabine,Gemcitabine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gentamicin,Ammonium chloride may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Gimeracil,Ammonium chloride may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Givosiran,Givosiran may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Glipizide,Glipizide may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Glycerol phenylbutyrate,Ammonium chloride may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Golodirsen,Ammonium chloride may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Goserelin,Goserelin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Guanethidine,Guanethidine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Guanfacine,Guanfacine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Haloperidol,Haloperidol may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Hydralazine,Hydralazine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ammonium chloride,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ammonium chloride,Hydromorphone,Hydromorphone may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Hydroxyethyl Starch,Ammonium chloride may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Kanamycin,Ammonium chloride may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Ketamine,Ketamine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Ketazolam,Ketazolam may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Octinoxate,Ammonium chloride may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Olsalazine,The serum concentration of Olsalazine can be increased when it is combined with Ammonium chloride.,increase,no risk
Ammonium chloride,Opium,Ammonium chloride may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Oseltamivir,Oseltamivir may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Oxacillin,Oxacillin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Oxazepam,Oxazepam may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Oxybenzone,Oxybenzone may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Oxyquinoline,Ammonium chloride may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Quetiapine,Quetiapine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.,decrease,no risk
Ammonium chloride,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Ammonium chloride.,increase,risk
Ammonium chloride,Quinethazone,Quinethazone may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ammonium chloride,Quinidine,Ammonium chloride may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Bendamustine,Butacaine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Butacaine.,increase,risk
Bendamustine,Butamben,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Butamben.,increase,risk
Bendamustine,Gatifloxacin,The metabolism of Bendamustine can be decreased when combined with Gatifloxacin.,decrease,no risk
Bendamustine,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bendamustine.,increase,risk
Bendamustine,Gemfibrozil,The metabolism of Bendamustine can be decreased when combined with Gemfibrozil.,decrease,no risk
Bendamustine,Gemifloxacin,The metabolism of Bendamustine can be decreased when combined with Gemifloxacin.,decrease,no risk
Bendamustine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Bendamustine.,increase,risk
Bendamustine,Gilteritinib,The serum concentration of Bendamustine can be increased when it is combined with Gilteritinib.,increase,no risk
Bendamustine,Givosiran,The serum concentration of Bendamustine can be increased when it is combined with Givosiran.,increase,no risk
Bendamustine,Glasdegib,The serum concentration of Bendamustine can be increased when it is combined with Glasdegib.,increase,no risk
Bendamustine,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Bendamustine.,increase,risk
Bendamustine,Glecaprevir,The serum concentration of Bendamustine can be increased when it is combined with Glecaprevir.,increase,no risk
Bendamustine,Glofitamab,The serum concentration of Bendamustine can be increased when it is combined with Glofitamab.,increase,no risk
Bendamustine,Golimumab,The metabolism of Bendamustine can be increased when combined with Golimumab.,increase,no risk
Bendamustine,Grazoprevir,The serum concentration of Bendamustine can be increased when it is combined with Grazoprevir.,increase,no risk
Bendamustine,Grepafloxacin,The metabolism of Bendamustine can be decreased when combined with Grepafloxacin.,decrease,no risk
Bendamustine,Guanabenz,The metabolism of Bendamustine can be decreased when combined with Guanabenz.,decrease,no risk
Bendamustine,Guselkumab,The risk or severity of adverse effects can be increased when Bendamustine is combined with Guselkumab.,increase,risk
Bendamustine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Bendamustine.,decrease,no risk
Bendamustine,Haloperidol,The metabolism of Bendamustine can be decreased when combined with Haloperidol.,decrease,no risk
Bendamustine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Bendamustine.,increase,risk
Bendamustine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Bendamustine.,decrease,no risk
Bendamustine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Bendamustine.,decrease,no risk
Bendamustine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Bendamustine.,increase,risk
Bendamustine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Bendamustine.,increase,risk
Bendamustine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Bendamustine is combined with Hydrocortisone acetate.,increase,risk
Bendamustine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Bendamustine is combined with Hydrocortisone butyrate.,increase,risk
Bendamustine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Bendamustine is combined with Hydrocortisone succinate.,increase,risk
Bendamustine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Bendamustine.,increase,risk
Bendamustine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Bendamustine.,increase,risk
Bendamustine,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Bendamustine.,increase,risk
Bendamustine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Bendamustine.,decrease,no risk
Bendamustine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Bendamustine.,decrease,no risk
Bendamustine,Ketoconazole,The serum concentration of Bendamustine can be increased when it is combined with Ketoconazole.,increase,no risk
Bendamustine,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Bendamustine.,increase,risk
Bendamustine,Obinutuzumab,The risk or severity of adverse effects can be increased when Bendamustine is combined with Obinutuzumab.,increase,risk
Bendamustine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Bendamustine.,increase,no risk
Bendamustine,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Bendamustine.,increase,risk
Bendamustine,Olanzapine,The metabolism of Bendamustine can be decreased when combined with Olanzapine.,decrease,no risk
Bendamustine,Olaparib,The risk or severity of adverse effects can be increased when Bendamustine is combined with Olaparib.,increase,risk
Bendamustine,Omadacycline,The serum concentration of Bendamustine can be increased when it is combined with Omadacycline.,increase,no risk
Bendamustine,Ombitasvir,The serum concentration of Bendamustine can be increased when it is combined with Ombitasvir.,increase,no risk
Bendamustine,Ondansetron,The metabolism of Bendamustine can be decreased when combined with Ondansetron.,decrease,no risk
Bendamustine,Orphenadrine,The metabolism of Bendamustine can be decreased when combined with Orphenadrine.,decrease,no risk
Bendamustine,Osilodrostat,The serum concentration of Bendamustine can be increased when it is combined with Osilodrostat.,increase,no risk
Bendamustine,Osimertinib,The serum concentration of Bendamustine can be decreased when it is combined with Osimertinib.,decrease,no risk
Bendamustine,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Bendamustine.,increase,risk
Bendamustine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Oxetacaine.,increase,risk
Bendamustine,Oxtriphylline,The metabolism of Bendamustine can be decreased when combined with Oxtriphylline.,decrease,no risk
Bendamustine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Oxybuprocaine.,increase,risk
Bendamustine,Ozanimod,The risk or severity of adverse effects can be increased when Bendamustine is combined with Ozanimod.,increase,risk
Bendamustine,Quinidine,The serum concentration of Bendamustine can be increased when it is combined with Quinidine.,increase,no risk
Bendamustine,Quinine,The serum concentration of Bendamustine can be increased when it is combined with Quinine.,increase,no risk
Bendamustine,Quizartinib,The serum concentration of Bendamustine can be increased when it is combined with Quizartinib.,increase,no risk
Benzyl alcohol,Belzutifan,The risk or severity of methemoglobinemia can be increased when Belzutifan is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bendamustine,The risk or severity of methemoglobinemia can be increased when Bendamustine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Benperidol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Benperidol.,increase,risk
Benzyl alcohol,Benzatropine,The metabolism of Benzyl alcohol can be decreased when combined with Benzatropine.,decrease,no risk
Benzyl alcohol,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Benzylpenicillin,The risk or severity of methemoglobinemia can be increased when Benzylpenicillin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Benzylpenicilloyl polylysine,The risk or severity of methemoglobinemia can be increased when Benzylpenicilloyl polylysine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bepridil,The metabolism of Benzyl alcohol can be decreased when combined with Bepridil.,decrease,no risk
Benzyl alcohol,Berotralstat,The metabolism of Benzyl alcohol can be decreased when combined with Berotralstat.,decrease,no risk
Benzyl alcohol,Besifloxacin,The risk or severity of methemoglobinemia can be increased when Besifloxacin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Betamethasone,The metabolism of Benzyl alcohol can be increased when combined with Betamethasone.,increase,no risk
Benzyl alcohol,Betaxolol,The metabolism of Benzyl alcohol can be decreased when combined with Betaxolol.,decrease,no risk
Benzyl alcohol,Bevacizumab,The risk or severity of methemoglobinemia can be increased when Bevacizumab is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bexarotene,The risk or severity of methemoglobinemia can be increased when Bexarotene is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bezafibrate,The metabolism of Benzyl alcohol can be decreased when combined with Bezafibrate.,decrease,no risk
Benzyl alcohol,Bicalutamide,The risk or severity of methemoglobinemia can be increased when Bicalutamide is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bifonazole,The metabolism of Benzyl alcohol can be decreased when combined with Bifonazole.,decrease,no risk
Benzyl alcohol,Bimekizumab,The metabolism of Benzyl alcohol can be increased when combined with Bimekizumab.,increase,no risk
Benzyl alcohol,Binimetinib,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Biperiden,The metabolism of Benzyl alcohol can be decreased when combined with Biperiden.,decrease,no risk
Benzyl alcohol,Bleomycin,The risk or severity of methemoglobinemia can be increased when Bleomycin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Blinatumomab,The risk or severity of methemoglobinemia can be increased when Blinatumomab is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bortezomib,The risk or severity of methemoglobinemia can be increased when Bortezomib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bortezomib D-mannitol,The risk or severity of methemoglobinemia can be increased when Bortezomib D-mannitol is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bosutinib,The risk or severity of methemoglobinemia can be increased when Bosutinib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Brentuximab vedotin,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Brexanolone,The risk or severity of methemoglobinemia can be increased when Brexanolone is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Brexpiprazole,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Brexpiprazole.,increase,risk
Benzyl alcohol,Brexucabtagene autoleucel,The risk or severity of methemoglobinemia can be increased when Brexucabtagene autoleucel is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Brigatinib,The risk or severity of methemoglobinemia can be increased when Brigatinib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.,increase,no risk
Benzyl alcohol,Brivaracetam,The risk or severity of methemoglobinemia can be increased when Brivaracetam is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Bromperidol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Bromperidol.,increase,risk
Benzyl alcohol,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Bupivacaine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Buprenorphine,Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Benzyl alcohol,Bupropion,The metabolism of Benzyl alcohol can be decreased when combined with Bupropion.,decrease,no risk
Benzyl alcohol,Buserelin,The risk or severity of methemoglobinemia can be increased when Buserelin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Busulfan,The risk or severity of methemoglobinemia can be increased when Busulfan is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Butacaine,The risk or severity of methemoglobinemia can be increased when Benzyl alcohol is combined with Butacaine.,increase,risk
Benzyl alcohol,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Butamben,The risk or severity of methemoglobinemia can be increased when Benzyl alcohol is combined with Butamben.,increase,risk
Benzyl alcohol,Butaperazine,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Butaperazine.,increase,risk
Benzyl alcohol,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Butriptyline,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Butriptyline.,increase,risk
Benzyl alcohol,Gabapentin,The risk or severity of methemoglobinemia can be increased when Gabapentin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Gabapentin enacarbil.,increase,risk
Benzyl alcohol,Galantamine,The metabolism of Benzyl alcohol can be decreased when combined with Galantamine.,decrease,no risk
Benzyl alcohol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Benzyl alcohol is combined with Ganaxolone.",increase,risk
Benzyl alcohol,Gatifloxacin,The risk or severity of methemoglobinemia can be increased when Gatifloxacin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gefitinib,The risk or severity of methemoglobinemia can be increased when Gefitinib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gemcitabine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gemfibrozil,The metabolism of Benzyl alcohol can be decreased when combined with Gemfibrozil.,decrease,no risk
Benzyl alcohol,Gemifloxacin,The risk or severity of methemoglobinemia can be increased when Gemifloxacin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gemtuzumab ozogamicin,The risk or severity of methemoglobinemia can be increased when Gemtuzumab ozogamicin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gentamicin,The risk or severity of methemoglobinemia can be increased when Gentamicin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gepirone,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Gepirone.,increase,risk
Benzyl alcohol,Gilteritinib,The risk or severity of methemoglobinemia can be increased when Gilteritinib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Givosiran,The serum concentration of Benzyl alcohol can be increased when it is combined with Givosiran.,increase,no risk
Benzyl alcohol,Glasdegib,The risk or severity of methemoglobinemia can be increased when Glasdegib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Glofitamab,The serum concentration of Benzyl alcohol can be increased when it is combined with Glofitamab.,increase,no risk
Benzyl alcohol,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Glycerin,The metabolism of Benzyl alcohol can be increased when combined with Glycerin.,increase,no risk
Benzyl alcohol,Glycerol phenylbutyrate,The metabolism of Benzyl alcohol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Benzyl alcohol,Golimumab,The metabolism of Benzyl alcohol can be increased when combined with Golimumab.,increase,no risk
Benzyl alcohol,Goserelin,The risk or severity of methemoglobinemia can be increased when Goserelin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Gramicidin D,The risk or severity of methemoglobinemia can be increased when Gramicidin D is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Grepafloxacin,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Guanabenz,The metabolism of Benzyl alcohol can be decreased when combined with Guanabenz.,decrease,no risk
Benzyl alcohol,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Halofantrine,The risk or severity of methemoglobinemia can be increased when Halofantrine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Hetacillin,The risk or severity of methemoglobinemia can be increased when Hetacillin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Hyaluronidase,Hyaluronidase can cause an increase in the absorption of Benzyl alcohol resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Benzyl alcohol,Hyaluronidase (human recombinant),Hyaluronidase (human recombinant) can cause an increase in the absorption of Benzyl alcohol resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Benzyl alcohol,Hyaluronidase (ovine),Hyaluronidase (ovine) can cause an increase in the absorption of Benzyl alcohol resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Benzyl alcohol,Hydrocodone,Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Benzyl alcohol,Hydrocortisone,The metabolism of Benzyl alcohol can be increased when combined with Hydrocortisone.,increase,no risk
Benzyl alcohol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Hydroxychloroquine,The risk or severity of methemoglobinemia can be increased when Hydroxychloroquine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Hydroxyprogesterone caproate,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Hydroxyurea is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benzyl alcohol.,increase,no risk
Benzyl alcohol,Kanamycin,The risk or severity of methemoglobinemia can be increased when Kanamycin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ketoconazole,The metabolism of Benzyl alcohol can be decreased when combined with Ketoconazole.,decrease,no risk
Benzyl alcohol,Ketoprofen,The metabolism of Benzyl alcohol can be decreased when combined with Ketoprofen.,decrease,no risk
Benzyl alcohol,Ketorolac,The metabolism of Benzyl alcohol can be decreased when combined with Ketorolac.,decrease,no risk
Benzyl alcohol,Obeticholic acid,The metabolism of Benzyl alcohol can be decreased when combined with Obeticholic acid.,decrease,no risk
Benzyl alcohol,Obinutuzumab,The risk or severity of methemoglobinemia can be increased when Obinutuzumab is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Octreotide,The risk or severity of methemoglobinemia can be increased when Octreotide is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ofatumumab,The risk or severity of methemoglobinemia can be increased when Ofatumumab is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ofloxacin,The risk or severity of methemoglobinemia can be increased when Ofloxacin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Olaparib,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Olaratumab,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Benzyl alcohol is combined with Oliceridine.",increase,risk
Benzyl alcohol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Olutasidenib,The risk or severity of methemoglobinemia can be increased when Olutasidenib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Omacetaxine mepesuccinate,The risk or severity of methemoglobinemia can be increased when Omacetaxine mepesuccinate is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Omadacycline,The risk or severity of methemoglobinemia can be increased when Omadacycline is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Omaveloxolone,The serum concentration of Benzyl alcohol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Benzyl alcohol,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Opium,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Opium.,increase,risk
Benzyl alcohol,Oritavancin,The risk or severity of methemoglobinemia can be increased when Oritavancin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Orphenadrine,Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Benzyl alcohol,Osilodrostat,The metabolism of Benzyl alcohol can be decreased when combined with Osilodrostat.,decrease,no risk
Benzyl alcohol,Osimertinib,The serum concentration of Benzyl alcohol can be decreased when it is combined with Osimertinib.,decrease,no risk
Benzyl alcohol,Ospemifene,The metabolism of Benzyl alcohol can be decreased when combined with Ospemifene.,decrease,no risk
Benzyl alcohol,Oxacillin,The risk or severity of methemoglobinemia can be increased when Oxacillin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxaliplatin,The risk or severity of methemoglobinemia can be increased when Oxaliplatin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxamniquine,The metabolism of Benzyl alcohol can be decreased when combined with Oxamniquine.,decrease,no risk
Benzyl alcohol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxcarbazepine,The risk or severity of methemoglobinemia can be increased when Oxcarbazepine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Benzyl alcohol is combined with Oxetacaine.,increase,risk
Benzyl alcohol,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxtriphylline,The metabolism of Benzyl alcohol can be decreased when combined with Oxtriphylline.,decrease,no risk
Benzyl alcohol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Oxybuprocaine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxybutynin,The metabolism of Benzyl alcohol can be decreased when combined with Oxybutynin.,decrease,no risk
Benzyl alcohol,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Oxytetracycline,The risk or severity of methemoglobinemia can be increased when Oxytetracycline is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Quinidine,The risk or severity of methemoglobinemia can be increased when Quinidine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Quinine,The metabolism of Benzyl alcohol can be decreased when combined with Quinine.,decrease,no risk
Benzyl alcohol,Quinupramine,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Quinupramine.,increase,risk
Benzyl alcohol,Quinupristin,The risk or severity of methemoglobinemia can be increased when Quinupristin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Quizartinib,The risk or severity of methemoglobinemia can be increased when Quizartinib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Umbralisib,The risk or severity of methemoglobinemia can be increased when Umbralisib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Uracil mustard,The risk or severity of methemoglobinemia can be increased when Uracil mustard is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Urethane,The risk or severity of methemoglobinemia can be increased when Urethane is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vadadustat,The serum concentration of Benzyl alcohol can be increased when it is combined with Vadadustat.,increase,no risk
Benzyl alcohol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Valrubicin,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vancomycin,The risk or severity of methemoglobinemia can be increased when Vancomycin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vandetanib,The risk or severity of methemoglobinemia can be increased when Vandetanib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vayarin,The metabolism of Benzyl alcohol can be decreased when combined with Vayarin.,decrease,no risk
Benzyl alcohol,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Vemurafenib,The serum concentration of Benzyl alcohol can be increased when it is combined with Vemurafenib.,increase,no risk
Benzyl alcohol,Venetoclax,The risk or severity of methemoglobinemia can be increased when Venetoclax is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Venlafaxine,The metabolism of Benzyl alcohol can be decreased when combined with Venlafaxine.,decrease,no risk
Benzyl alcohol,Verapamil,The metabolism of Benzyl alcohol can be decreased when combined with Verapamil.,decrease,no risk
Benzyl alcohol,Vernakalant,The metabolism of Benzyl alcohol can be decreased when combined with Vernakalant.,decrease,no risk
Benzyl alcohol,Vigabatrin,The risk or severity of methemoglobinemia can be increased when Vigabatrin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vilazodone,The metabolism of Benzyl alcohol can be decreased when combined with Vilazodone.,decrease,no risk
Benzyl alcohol,Viloxazine,The metabolism of Benzyl alcohol can be decreased when combined with Viloxazine.,decrease,no risk
Benzyl alcohol,Vindesine,The risk or severity of methemoglobinemia can be increased when Vindesine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vinflunine,The risk or severity of methemoglobinemia can be increased when Vinflunine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vinorelbine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Viomycin,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vismodegib,The risk or severity of methemoglobinemia can be increased when Vismodegib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vorinostat,The risk or severity of methemoglobinemia can be increased when Vorinostat is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Vortioxetine,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Vortioxetine.,increase,risk
Benzyl alcohol,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Benzyl alcohol.,decrease,no risk
Benzyl alcohol,Warfarin,The metabolism of Benzyl alcohol can be decreased when combined with Warfarin.,decrease,no risk
Benzyl alcohol,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Zaleplon,The risk or severity of methemoglobinemia can be increased when Zaleplon is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Zanubrutinib,The risk or severity of methemoglobinemia can be increased when Zanubrutinib is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Zidovudine,The metabolism of Benzyl alcohol can be decreased when combined with Zidovudine.,decrease,no risk
Benzyl alcohol,Zileuton,The metabolism of Benzyl alcohol can be decreased when combined with Zileuton.,decrease,no risk
Benzyl alcohol,Zimelidine,The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zimelidine.,increase,risk
Benzyl alcohol,Ziprasidone,The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Ziprasidone.,increase,risk
Benzyl alcohol,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Zolpidem,Benzyl alcohol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Benzyl alcohol,Zonisamide,The risk or severity of methemoglobinemia can be increased when Zonisamide is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Zopiclone,The risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Zopiclone.,increase,risk
Benzyl alcohol,Zotepine,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Zotepine.,increase,risk
Benzyl alcohol,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Benzyl alcohol.,increase,risk
Benzyl alcohol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Benzyl alcohol.,increase,risk
Cabazitaxel,Bicalutamide,The metabolism of Cabazitaxel can be decreased when combined with Bicalutamide.,decrease,no risk
Cabazitaxel,Bifonazole,The metabolism of Cabazitaxel can be decreased when combined with Bifonazole.,decrease,no risk
Cabazitaxel,Bimekizumab,The metabolism of Cabazitaxel can be increased when combined with Bimekizumab.,increase,no risk
Cabazitaxel,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Blinatumomab,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Blinatumomab.,increase,risk
Cabazitaxel,Boceprevir,The metabolism of Cabazitaxel can be decreased when combined with Boceprevir.,decrease,no risk
Cabazitaxel,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Cabazitaxel.",decrease,no risk
Cabazitaxel,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Bosentan,The metabolism of Cabazitaxel can be increased when combined with Bosentan.,increase,no risk
Cabazitaxel,Bosutinib,The metabolism of Cabazitaxel can be decreased when combined with Bosutinib.,decrease,no risk
Cabazitaxel,Brentuximab vedotin,The serum concentration of Cabazitaxel can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Cabazitaxel,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Cabazitaxel.,decrease,no risk
Cabazitaxel,Brodalumab,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Brodalumab.,increase,risk
Cabazitaxel,Budesonide,The metabolism of Cabazitaxel can be increased when combined with Budesonide.,increase,no risk
Cabazitaxel,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Cabazitaxel is combined with Bupivacaine.,increase,risk
Cabazitaxel,Buprenorphine,The metabolism of Cabazitaxel can be decreased when combined with Buprenorphine.,decrease,no risk
Cabazitaxel,Buspirone,The metabolism of Cabazitaxel can be decreased when combined with Buspirone.,decrease,no risk
Cabazitaxel,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Butacaine,The risk or severity of methemoglobinemia can be increased when Cabazitaxel is combined with Butacaine.,increase,risk
Cabazitaxel,Butalbital,The metabolism of Cabazitaxel can be increased when combined with Butalbital.,increase,no risk
Cabazitaxel,Butamben,The risk or severity of methemoglobinemia can be increased when Cabazitaxel is combined with Butamben.,increase,risk
Cabazitaxel,Gefitinib,The metabolism of Cabazitaxel can be decreased when combined with Gefitinib.,decrease,no risk
Cabazitaxel,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Gemfibrozil,The metabolism of Cabazitaxel can be decreased when combined with Gemfibrozil.,decrease,no risk
Cabazitaxel,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Gilteritinib,The metabolism of Cabazitaxel can be decreased when combined with Gilteritinib.,decrease,no risk
Cabazitaxel,Ginkgo biloba,The metabolism of Cabazitaxel can be decreased when combined with Ginkgo biloba.,decrease,no risk
Cabazitaxel,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Cabazitaxel.,decrease,no risk
Cabazitaxel,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Glecaprevir,The metabolism of Cabazitaxel can be decreased when combined with Glecaprevir.,decrease,no risk
Cabazitaxel,Glofitamab,The serum concentration of Cabazitaxel can be increased when it is combined with Glofitamab.,increase,no risk
Cabazitaxel,Glyburide,The metabolism of Cabazitaxel can be decreased when combined with Glyburide.,decrease,no risk
Cabazitaxel,Glycerol phenylbutyrate,The metabolism of Cabazitaxel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Cabazitaxel,Golimumab,The metabolism of Cabazitaxel can be increased when combined with Golimumab.,increase,no risk
Cabazitaxel,Grapefruit,The serum concentration of Cabazitaxel can be increased when it is combined with Grapefruit.,increase,no risk
Cabazitaxel,Griseofulvin,The metabolism of Cabazitaxel can be increased when combined with Griseofulvin.,increase,no risk
Cabazitaxel,Guselkumab,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Guselkumab.,increase,risk
Cabazitaxel,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Cabazitaxel.,decrease,no risk
Cabazitaxel,Halofantrine,The metabolism of Cabazitaxel can be decreased when combined with Halofantrine.,decrease,no risk
Cabazitaxel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cabazitaxel.,increase,no risk
Cabazitaxel,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Cabazitaxel.,decrease,no risk
Cabazitaxel,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Cabazitaxel.,decrease,no risk
Cabazitaxel,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Hydralazine,The serum concentration of Cabazitaxel can be increased when it is combined with Hydralazine.,increase,no risk
Cabazitaxel,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Hydrocortamate,The metabolism of Cabazitaxel can be increased when combined with Hydrocortamate.,increase,no risk
Cabazitaxel,Hydrocortisone,The metabolism of Cabazitaxel can be increased when combined with Hydrocortisone.,increase,no risk
Cabazitaxel,Hydrocortisone acetate,The metabolism of Cabazitaxel can be increased when combined with Hydrocortisone acetate.,increase,no risk
Cabazitaxel,Hydrocortisone butyrate,The metabolism of Cabazitaxel can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Cabazitaxel,Hydrocortisone cypionate,The metabolism of Cabazitaxel can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Cabazitaxel,Hydrocortisone phosphate,The metabolism of Cabazitaxel can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Cabazitaxel,Hydrocortisone succinate,The metabolism of Cabazitaxel can be increased when combined with Hydrocortisone succinate.,increase,no risk
Cabazitaxel,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Hydroxyprogesterone caproate,The metabolism of Cabazitaxel can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Cabazitaxel,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Hydroxyzine,The metabolism of Cabazitaxel can be decreased when combined with Hydroxyzine.,decrease,no risk
Cabazitaxel,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Cabazitaxel.,decrease,no risk
Cabazitaxel,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Cabazitaxel.,decrease,no risk
Cabazitaxel,Ketamine,The metabolism of Cabazitaxel can be decreased when combined with Ketamine.,decrease,no risk
Cabazitaxel,Ketazolam,The serum concentration of Cabazitaxel can be increased when it is combined with Ketazolam.,increase,no risk
Cabazitaxel,Ketoconazole,The metabolism of Cabazitaxel can be decreased when combined with Ketoconazole.,decrease,no risk
Cabazitaxel,Ketoprofen,The metabolism of Cabazitaxel can be decreased when combined with Ketoprofen.,decrease,no risk
Cabazitaxel,Ketorolac,The metabolism of Cabazitaxel can be decreased when combined with Ketorolac.,decrease,no risk
Cabazitaxel,Obinutuzumab,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Obinutuzumab.,increase,risk
Cabazitaxel,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Cabazitaxel.,increase,no risk
Cabazitaxel,Octreotide,The serum concentration of Cabazitaxel can be increased when it is combined with Octreotide.,increase,no risk
Cabazitaxel,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Olaparib,The metabolism of Cabazitaxel can be decreased when combined with Olaparib.,decrease,no risk
Cabazitaxel,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Cabazitaxel.,decrease,no risk
Cabazitaxel,Olutasidenib,The metabolism of Cabazitaxel can be increased when combined with Olutasidenib.,increase,no risk
Cabazitaxel,Omaveloxolone,The serum concentration of Cabazitaxel can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cabazitaxel,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Cabazitaxel.,decrease,no risk
Cabazitaxel,Ondansetron,The metabolism of Cabazitaxel can be decreased when combined with Ondansetron.,decrease,no risk
Cabazitaxel,Oritavancin,The metabolism of Cabazitaxel can be increased when combined with Oritavancin.,increase,no risk
Cabazitaxel,Orphenadrine,The metabolism of Cabazitaxel can be decreased when combined with Orphenadrine.,decrease,no risk
Cabazitaxel,Osilodrostat,The metabolism of Cabazitaxel can be decreased when combined with Osilodrostat.,decrease,no risk
Cabazitaxel,Osimertinib,The metabolism of Cabazitaxel can be decreased when combined with Osimertinib.,decrease,no risk
Cabazitaxel,Ouabain,Ouabain may decrease the cardiotoxic activities of Cabazitaxel.,decrease,no risk
Cabazitaxel,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Oxcarbazepine,The metabolism of Cabazitaxel can be increased when combined with Oxcarbazepine.,increase,no risk
Cabazitaxel,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cabazitaxel is combined with Oxetacaine.,increase,risk
Cabazitaxel,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cabazitaxel is combined with Oxybuprocaine.,increase,risk
Cabazitaxel,Oxybutynin,The serum concentration of Cabazitaxel can be increased when it is combined with Oxybutynin.,increase,no risk
Cabazitaxel,Oxycodone,The metabolism of Cabazitaxel can be decreased when combined with Oxycodone.,decrease,no risk
Cabazitaxel,Ozanimod,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Ozanimod.,increase,risk
Cabazitaxel,Quetiapine,The metabolism of Cabazitaxel can be decreased when combined with Quetiapine.,decrease,no risk
Cabazitaxel,Quinidine,The metabolism of Cabazitaxel can be decreased when combined with Quinidine.,decrease,no risk
Cabazitaxel,Quinine,The metabolism of Cabazitaxel can be increased when combined with Quinine.,increase,no risk
Cabazitaxel,Quinupristin,The metabolism of Cabazitaxel can be decreased when combined with Quinupristin.,decrease,no risk
Cabazitaxel,Quizartinib,The metabolism of Cabazitaxel can be decreased when combined with Quizartinib.,decrease,no risk
Cabazitaxel,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Udenafil,The metabolism of Cabazitaxel can be decreased when combined with Udenafil.,decrease,no risk
Cabazitaxel,Upadacitinib,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Upadacitinib.,increase,risk
Cabazitaxel,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Vadadustat,The serum concentration of Cabazitaxel can be increased when it is combined with Vadadustat.,increase,no risk
Cabazitaxel,Valbenazine,The metabolism of Cabazitaxel can be decreased when combined with Valbenazine.,decrease,no risk
Cabazitaxel,Valproic acid,The serum concentration of Cabazitaxel can be increased when it is combined with Valproic acid.,increase,no risk
Cabazitaxel,Vardenafil,The metabolism of Cabazitaxel can be decreased when combined with Vardenafil.,decrease,no risk
Cabazitaxel,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Cabazitaxel.,decrease,no risk
Cabazitaxel,Vedolizumab,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Vedolizumab.,increase,risk
Cabazitaxel,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Cabazitaxel.,decrease,no risk
Cabazitaxel,Vemurafenib,The metabolism of Cabazitaxel can be increased when combined with Vemurafenib.,increase,no risk
Cabazitaxel,Venetoclax,The metabolism of Cabazitaxel can be decreased when combined with Venetoclax.,decrease,no risk
Cabazitaxel,Verapamil,The metabolism of Cabazitaxel can be decreased when combined with Verapamil.,decrease,no risk
Cabazitaxel,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cabazitaxel.,decrease,no risk
Cabazitaxel,Vilanterol,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Vilanterol.,increase,risk
Cabazitaxel,Viloxazine,The metabolism of Cabazitaxel can be decreased when combined with Viloxazine.,decrease,no risk
Cabazitaxel,Vinblastine,The metabolism of Cabazitaxel can be increased when combined with Vinblastine.,increase,no risk
Cabazitaxel,Vincristine,The metabolism of Cabazitaxel can be decreased when combined with Vincristine.,decrease,no risk
Cabazitaxel,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Vitamin E,The metabolism of Cabazitaxel can be increased when combined with Vitamin E.,increase,no risk
Cabazitaxel,Voclosporin,The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Voclosporin.,increase,risk
Cabazitaxel,Vonoprazan,The metabolism of Cabazitaxel can be decreased when combined with Vonoprazan.,decrease,no risk
Cabazitaxel,Vorapaxar,The metabolism of Cabazitaxel can be decreased when combined with Vorapaxar.,decrease,no risk
Cabazitaxel,Voriconazole,The metabolism of Cabazitaxel can be decreased when combined with Voriconazole.,decrease,no risk
Cabazitaxel,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Vortioxetine,The metabolism of Cabazitaxel can be decreased when combined with Vortioxetine.,decrease,no risk
Cabazitaxel,Voxelotor,The serum concentration of Cabazitaxel can be increased when it is combined with Voxelotor.,increase,no risk
Cabazitaxel,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Cabazitaxel.,decrease,no risk
Cabazitaxel,Warfarin,The metabolism of Cabazitaxel can be increased when combined with Warfarin.,increase,no risk
Cabazitaxel,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Zafirlukast,The serum concentration of Cabazitaxel can be increased when it is combined with Zafirlukast.,increase,no risk
Cabazitaxel,Zaleplon,The metabolism of Cabazitaxel can be decreased when combined with Zaleplon.,decrease,no risk
Cabazitaxel,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Cabazitaxel.,increase,risk
Cabazitaxel,Zimelidine,The metabolism of Cabazitaxel can be decreased when combined with Zimelidine.,decrease,no risk
Cabazitaxel,Ziprasidone,The metabolism of Cabazitaxel can be decreased when combined with Ziprasidone.,decrease,no risk
Cabazitaxel,Zonisamide,The metabolism of Cabazitaxel can be decreased when combined with Zonisamide.,decrease,no risk
Cabazitaxel,Zopiclone,The metabolism of Cabazitaxel can be decreased when combined with Zopiclone.,decrease,no risk
Cabazitaxel,Zuclopenthixol,The metabolism of Cabazitaxel can be decreased when combined with Zuclopenthixol.,decrease,no risk
Human calcitonin,Zoledronic acid,The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Zoledronic acid.,increase,risk
Chenodeoxycholic acid,Gemfibrozil,The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Chenodeoxycholic acid,Gestrinone,The therapeutic efficacy of Chenodeoxycholic acid can be decreased when used in combination with Gestrinone.,decrease,no risk
Chenodeoxycholic acid,Glofitamab,The serum concentration of Chenodeoxycholic acid can be increased when it is combined with Glofitamab.,increase,no risk
Chenodeoxycholic acid,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Chenodeoxycholic acid.,increase,no risk
Chenodeoxycholic acid,Heparin,The risk or severity of bleeding and bruising can be increased when Heparin is combined with Chenodeoxycholic acid.,increase,risk
Chenodeoxycholic acid,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Chenodeoxycholic acid.,decrease,no risk
Chenodeoxycholic acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Chenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Chenodeoxycholic acid,Kaolin,Kaolin can cause a decrease in the absorption of Chenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Chenodeoxycholic acid,Ketoconazole,The metabolism of Chenodeoxycholic acid can be decreased when combined with Ketoconazole.,decrease,no risk
Chenodeoxycholic acid,Omaveloxolone,The serum concentration of Chenodeoxycholic acid can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Chenodeoxycholic acid,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Chenodeoxycholic acid.,decrease,no risk
Chenodeoxycholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Chenodeoxycholic acid.,increase,risk
Chenodeoxycholic acid,Vadadustat,The serum concentration of Chenodeoxycholic acid can be increased when it is combined with Vadadustat.,increase,no risk
Chenodeoxycholic acid,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Chenodeoxycholic acid.,decrease,no risk
Chenodeoxycholic acid,Venetoclax,The metabolism of Chenodeoxycholic acid can be decreased when combined with Venetoclax.,decrease,no risk
Chenodeoxycholic acid,Verapamil,The metabolism of Chenodeoxycholic acid can be decreased when combined with Verapamil.,decrease,no risk
Chenodeoxycholic acid,Viloxazine,The metabolism of Chenodeoxycholic acid can be decreased when combined with Viloxazine.,decrease,no risk
Chenodeoxycholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Chenodeoxycholic acid.,increase,risk
Chenodeoxycholic acid,Voriconazole,The metabolism of Chenodeoxycholic acid can be decreased when combined with Voriconazole.,decrease,no risk
Chenodeoxycholic acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Chenodeoxycholic acid.,increase,risk
Chenodeoxycholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Chenodeoxycholic acid.,increase,risk
Chenodeoxycholic acid,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Chenodeoxycholic acid.,decrease,no risk
Chenodeoxycholic acid,Zimelidine,The metabolism of Chenodeoxycholic acid can be decreased when combined with Zimelidine.,decrease,no risk
Chenodeoxycholic acid,Ziprasidone,The metabolism of Chenodeoxycholic acid can be decreased when combined with Ziprasidone.,decrease,no risk
Dalteparin,Gemcitabine,The risk or severity of bleeding can be increased when Dalteparin is combined with Gemcitabine.,increase,risk
Dalteparin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Dalteparin is combined with Gemtuzumab ozogamicin.,increase,risk
Dalteparin,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Dalteparin.,decrease,no risk
Dalteparin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Dalteparin.,increase,risk
Dalteparin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Dalteparin.,increase,no risk
Dalteparin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Dalteparin.,increase,risk
Dalteparin,Hemin,Hemin may increase the anticoagulant activities of Dalteparin.,increase,no risk
Dalteparin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Dalteparin.,increase,risk
Dalteparin,Hydrochlorothiazide,The therapeutic efficacy of Dalteparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Dalteparin,Hydroflumethiazide,The therapeutic efficacy of Dalteparin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Dalteparin,Hydroxyprogesterone caproate,The therapeutic efficacy of Dalteparin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Dalteparin,Hydroxyurea,The risk or severity of bleeding can be increased when Dalteparin is combined with Hydroxyurea.,increase,risk
Dalteparin,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Dalteparin.,decrease,no risk
Dalteparin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Dalteparin.,increase,risk
Dalteparin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Dalteparin.,increase,risk
Dalteparin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Dalteparin.,increase,risk
Dalteparin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Dalteparin is combined with Obeticholic acid.,increase,risk
Dalteparin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Dalteparin is combined with Obinutuzumab.,increase,risk
Dalteparin,Olaparib,The risk or severity of bleeding can be increased when Dalteparin is combined with Olaparib.,increase,risk
Dalteparin,Olive oil,The therapeutic efficacy of Dalteparin can be decreased when used in combination with Olive oil.,decrease,no risk
Dalteparin,Olmesartan,The risk or severity of hyperkalemia can be increased when Dalteparin is combined with Olmesartan.,increase,risk
Dalteparin,Olsalazine,The risk or severity of bleeding can be increased when Dalteparin is combined with Olsalazine.,increase,risk
Dalteparin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Dalteparin is combined with Omacetaxine mepesuccinate.,increase,risk
Dalteparin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Dalteparin.,increase,no risk
Dalteparin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Dalteparin.,increase,risk
Dalteparin,Omega-3-carboxylic acids,The therapeutic efficacy of Dalteparin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Dalteparin,Oritavancin,The therapeutic efficacy of Dalteparin can be decreased when used in combination with Oritavancin.,decrease,no risk
Dalteparin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Dalteparin.,increase,risk
Dalteparin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Dalteparin.,increase,risk
Dalteparin,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Dalteparin.,increase,risk
Dalteparin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Dalteparin.,increase,risk
Dalteparin,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Dalteparin.,increase,risk
Dalteparin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Dalteparin.,decrease,no risk
Dalteparin,Quinidine,The therapeutic efficacy of Dalteparin can be increased when used in combination with Quinidine.,increase,no risk
Dalteparin,Quinine,The therapeutic efficacy of Dalteparin can be increased when used in combination with Quinine.,increase,no risk
Dalteparin,Ulipristal,The therapeutic efficacy of Dalteparin can be decreased when used in combination with Ulipristal.,decrease,no risk
Dalteparin,Urokinase,Urokinase may increase the anticoagulant activities of Dalteparin.,increase,no risk
Dalteparin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Dalteparin is combined with Ursodeoxycholic acid.,increase,risk
Dalteparin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Dalteparin.,increase,risk
Dalteparin,Valsartan,The risk or severity of hyperkalemia can be increased when Dalteparin is combined with Valsartan.,increase,risk
Dalteparin,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Dalteparin.,decrease,no risk
Dalteparin,Venlafaxine,The risk or severity of bleeding can be increased when Dalteparin is combined with Venlafaxine.,increase,risk
Dalteparin,Vinblastine,The risk or severity of bleeding can be increased when Dalteparin is combined with Vinblastine.,increase,risk
Dalteparin,Vindesine,The risk or severity of bleeding can be increased when Dalteparin is combined with Vindesine.,increase,risk
Dalteparin,Vinorelbine,The risk or severity of bleeding can be increased when Dalteparin is combined with Vinorelbine.,increase,risk
Dalteparin,Vitamin E,Vitamin E may increase the anticoagulant activities of Dalteparin.,increase,no risk
Dalteparin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Dalteparin.,decrease,no risk
Dalteparin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Dalteparin.,increase,risk
Dalteparin,Vorinostat,The risk or severity of bleeding can be increased when Dalteparin is combined with Vorinostat.,increase,risk
Dalteparin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Dalteparin.,increase,risk
Dalteparin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Dalteparin.,increase,risk
Dalteparin,Zidovudine,The risk or severity of bleeding can be increased when Dalteparin is combined with Zidovudine.,increase,risk
Dalteparin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Dalteparin.,increase,risk
Dalteparin,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Dalteparin.,increase,risk
Dalteparin,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Dalteparin.,increase,risk
Desoxycorticosterone acetate,Viloxazine,The metabolism of Desoxycorticosterone acetate can be decreased when combined with Viloxazine.,decrease,no risk
Desoxycorticosterone acetate,Voriconazole,The metabolism of Desoxycorticosterone acetate can be decreased when combined with Voriconazole.,decrease,no risk
Desoxycorticosterone acetate,Zimelidine,The metabolism of Desoxycorticosterone acetate can be decreased when combined with Zimelidine.,decrease,no risk
Desoxycorticosterone acetate,Ziprasidone,The metabolism of Desoxycorticosterone acetate can be decreased when combined with Ziprasidone.,decrease,no risk
Difluprednate,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Difluprednate.,increase,risk
Difluprednate,Vadadustat,The serum concentration of Difluprednate can be increased when it is combined with Vadadustat.,increase,no risk
Difluprednate,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Difluprednate.,decrease,no risk
Difluprednate,Vildagliptin,The risk or severity of hyperglycemia can be increased when Difluprednate is combined with Vildagliptin.,increase,risk
Difluprednate,Viloxazine,The metabolism of Difluprednate can be decreased when combined with Viloxazine.,decrease,no risk
Difluprednate,Voriconazole,The serum concentration of Difluprednate can be increased when it is combined with Voriconazole.,increase,no risk
Dimercaprol,Gabapentin enacarbil,Dimercaprol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gadodiamide,Gadodiamide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gadoteric acid,Dimercaprol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gadoteridol,Gadoteridol may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Ganciclovir,Ganciclovir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gemcitabine,Gemcitabine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gentamicin,Dimercaprol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Dimercaprol,Gimeracil,Dimercaprol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Dimercaprol,Givosiran,Givosiran may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Glipizide,Glipizide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Glycerol phenylbutyrate,Dimercaprol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Dimercaprol,Golodirsen,Dimercaprol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Dimercaprol,Goserelin,Goserelin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Guanethidine,Guanethidine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Guanfacine,Guanfacine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Haloperidol,Haloperidol may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Hydralazine,Hydralazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dimercaprol,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dimercaprol,Hydromorphone,Hydromorphone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Hydroxyethyl Starch,Dimercaprol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Dimercaprol,Kanamycin,Dimercaprol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Dimercaprol,Ketamine,Ketamine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Ketazolam,Ketazolam may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Ketoprofen,Ketoprofen may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Ketorolac,Ketorolac may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Octinoxate,Dimercaprol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Dimercaprol,Olsalazine,Olsalazine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Opium,Dimercaprol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Dimercaprol,Oseltamivir,Oseltamivir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Oxacillin,Oxacillin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Oxaprozin,Oxaprozin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Oxazepam,Oxazepam may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Oxybenzone,Oxybenzone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Oxyquinoline,Dimercaprol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Dimercaprol,Quetiapine,Quetiapine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Quinethazone,Quinethazone may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dimercaprol,Quinidine,Dimercaprol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Dimercaprol,Vaborbactam,Dimercaprol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Dimercaprol,Valaciclovir,Valaciclovir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Valbenazine,Dimercaprol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Dimercaprol,Valdecoxib,Valdecoxib may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Valganciclovir,Valganciclovir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Vancomycin,Dimercaprol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Dimercaprol,Varenicline,Varenicline may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Venlafaxine,Venlafaxine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Verapamil,Verapamil may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Vilanterol,Dimercaprol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Viloxazine,Dimercaprol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Dimercaprol,Vortioxetine,Dimercaprol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Dimercaprol,Warfarin,Dimercaprol may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Dimercaprol,Zaleplon,Zaleplon may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Zanamivir,Zanamivir may decrease the excretion rate of Dimercaprol which could result in a higher serum level.,decrease,no risk
Dimercaprol,Zonisamide,Zonisamide may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prussian blue,Gatifloxacin,Prussian blue can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Gemifloxacin,Prussian blue can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Grepafloxacin,Prussian blue can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Ofloxacin,Prussian blue can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Olanzapine,Olanzapine can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Omadacycline,Omadacycline can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Omeprazole,The absorption of Prussian blue can be decreased when combined with Omeprazole.,decrease,no risk
Prussian blue,Oxytetracycline,Oxytetracycline can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Prussian blue.,decrease,no risk
Prussian blue,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Prussian blue resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prussian blue,Zoledronic acid,Prussian blue can cause a decrease in the absorption of Zoledronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Halcinonide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Halcinonide.,increase,risk
Halcinonide,Vadadustat,The serum concentration of Halcinonide can be increased when it is combined with Vadadustat.,increase,no risk
Halcinonide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Halcinonide.,decrease,no risk
Halcinonide,Vildagliptin,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Vildagliptin.,increase,risk
Halcinonide,Viloxazine,The metabolism of Halcinonide can be decreased when combined with Viloxazine.,decrease,no risk
Halcinonide,Voriconazole,The serum concentration of Halcinonide can be increased when it is combined with Voriconazole.,increase,no risk
Hexocyclium,Galantamine,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Galantamine.,decrease,no risk
Hexocyclium,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Hexocyclium.,increase,risk
Hexocyclium,Ginkgo biloba,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Hexocyclium,Glucagon,Hexocyclium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Hexocyclium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Hexocyclium.,decrease,no risk
Hexocyclium,Glycopyrronium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Glycopyrronium.,increase,risk
Hexocyclium,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Hexocyclium.,increase,risk
Hexocyclium,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Hexocyclium.,increase,risk
Hexocyclium,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Hexocyclium.,increase,risk
Hexocyclium,Homatropine,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Homatropine.,increase,risk
Hexocyclium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Hexocyclium.,increase,risk
Hexocyclium,Huperzine A,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Huperzine A.,decrease,no risk
Hexocyclium,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Hexocyclium.,increase,no risk
Hexocyclium,Hydrocodone,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Hydrocodone.,increase,risk
Hexocyclium,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Hexocyclium.,increase,no risk
Hexocyclium,Hydromorphone,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Hydromorphone.,increase,risk
Hexocyclium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Hexocyclium.,increase,risk
Hexocyclium,Ketamine,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Ketamine.,decrease,no risk
Hexocyclium,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Hexocyclium.,increase,risk
Hexocyclium,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Hexocyclium is combined with Oliceridine.",increase,risk
Hexocyclium,Olodaterol,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Olodaterol.,increase,risk
Hexocyclium,Opium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Opium.,increase,risk
Hexocyclium,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Hexocyclium.,increase,risk
Hexocyclium,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Hexocyclium.,increase,risk
Hexocyclium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hexocyclium.,increase,risk
Hexocyclium,Oxycodone,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Oxycodone.,increase,risk
Hexocyclium,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Hexocyclium.,increase,risk
Hexocyclium,Oxymorphone,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Oxymorphone.,increase,risk
Hexocyclium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hexocyclium.,increase,risk
Hexocyclium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Hexocyclium.,decrease,no risk
Hexocyclium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Hexocyclium.,increase,risk
Hexocyclium,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Hexocyclium.,increase,risk
Hexocyclium,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Hexocyclium.,increase,no risk
Hexocyclium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Hexocyclium.,increase,risk
Hexocyclium,Quinupramine,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Quinupramine.,increase,risk
Hexocyclium,Umeclidinium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Umeclidinium.,increase,risk
Hexocyclium,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Hexocyclium.,increase,risk
Hexocyclium,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Hexocyclium.,increase,risk
Hexocyclium,Vilanterol,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Vilanterol.,increase,risk
Hexocyclium,Xamoterol,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Xamoterol.,increase,risk
Hexocyclium,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Hexocyclium.,increase,risk
Hexocyclium,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Hexocyclium.,increase,risk
Histrelin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Gadobenic acid.,increase,risk
Histrelin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Histrelin.,increase,risk
Histrelin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Histrelin.,increase,risk
Histrelin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Gemifloxacin.,increase,risk
Histrelin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Histrelin.,increase,risk
Histrelin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Gilteritinib.,increase,risk
Histrelin,Glasdegib,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Glasdegib.,increase,risk
Histrelin,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Goserelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Goserelin.,increase,risk
Histrelin,Granisetron,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Granisetron.,increase,risk
Histrelin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Grepafloxacin.,increase,risk
Histrelin,Halofantrine,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Halofantrine.,increase,risk
Histrelin,Haloperidol,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Haloperidol.,increase,risk
Histrelin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Histrelin.,increase,risk
Histrelin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Histrelin.,increase,risk
Histrelin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Hydroxyzine.,increase,risk
Histrelin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Histrelin.,increase,risk
Histrelin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Histrelin.,increase,risk
Histrelin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Histrelin.,increase,risk
Histrelin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ofloxacin.,increase,risk
Histrelin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Histrelin.,increase,risk
Histrelin,Olodaterol,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Olodaterol.,increase,risk
Histrelin,Ondansetron,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ondansetron.,increase,risk
Histrelin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Histrelin.,increase,risk
Histrelin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Histrelin.,increase,risk
Histrelin,Oxatomide,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Oxatomide.,increase,risk
Histrelin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Histrelin.,increase,risk
Histrelin,Quetiapine,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quetiapine.,increase,risk
Histrelin,Quinidine,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quinidine.,increase,risk
Histrelin,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Quizartinib,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Quizartinib.,increase,risk
Histrelin,Valproic acid,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Valproic acid.,increase,risk
Histrelin,Vandetanib,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Vandetanib.,increase,risk
Histrelin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Histrelin.,increase,risk
Histrelin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Vemurafenib.,increase,risk
Histrelin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Histrelin.,increase,risk
Histrelin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Histrelin.,increase,risk
Histrelin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Histrelin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Histrelin.,increase,risk
Histrelin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Histrelin.,increase,risk
Histrelin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Ziprasidone.,increase,risk
Histrelin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Histrelin.,increase,risk
Histrelin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Zuclopenthixol.,increase,risk
Hydroxyprogesterone caproate,Gabapentin,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Gabapentin.,increase,no risk
Hydroxyprogesterone caproate,Ganaxolone,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Ganaxolone.,increase,no risk
Hydroxyprogesterone caproate,Gefitinib,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Gefitinib.,decrease,no risk
Hydroxyprogesterone caproate,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Glofitamab,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Glofitamab.,increase,no risk
Hydroxyprogesterone caproate,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Glycerol phenylbutyrate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Hydroxyprogesterone caproate,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Golimumab,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Golimumab.,increase,no risk
Hydroxyprogesterone caproate,Griseofulvin,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Griseofulvin.,increase,no risk
Hydroxyprogesterone caproate,Halofantrine,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Halofantrine.,decrease,no risk
Hydroxyprogesterone caproate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Hydroxyprogesterone caproate,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Hetacillin,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Hetacillin.,decrease,no risk
Hydroxyprogesterone caproate,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Hydroxyprogesterone caproate is combined with Human C1-esterase inhibitor.,increase,risk
Hydroxyprogesterone caproate,Hydrocortamate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Hydrocortamate.,increase,no risk
Hydroxyprogesterone caproate,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Hydroxyprogesterone caproate,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Hydroxyprogesterone caproate,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Hydroxyprogesterone caproate,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Hydroxyprogesterone caproate,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Hydroxyprogesterone caproate,Hydroxyzine,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Hydroxyzine.,decrease,no risk
Hydroxyprogesterone caproate,Ketoconazole,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ketoconazole.,decrease,no risk
Hydroxyprogesterone caproate,Olaparib,The metabolism of Olaparib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Olutasidenib,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Olutasidenib.,increase,no risk
Hydroxyprogesterone caproate,Omadacycline,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Omadacycline.,decrease,no risk
Hydroxyprogesterone caproate,Omaveloxolone,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Hydroxyprogesterone caproate,Ondansetron,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ondansetron.,decrease,no risk
Hydroxyprogesterone caproate,Oritavancin,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Oritavancin.,increase,no risk
Hydroxyprogesterone caproate,Osilodrostat,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Osilodrostat.,decrease,no risk
Hydroxyprogesterone caproate,Oxacillin,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Oxacillin.,decrease,no risk
Hydroxyprogesterone caproate,Oxcarbazepine,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Oxcarbazepine.,increase,no risk
Hydroxyprogesterone caproate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Oxetacaine.,increase,risk
Hydroxyprogesterone caproate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Hydroxyprogesterone caproate is combined with Oxybuprocaine.,increase,risk
Hydroxyprogesterone caproate,Oxybutynin,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Oxybutynin.,decrease,no risk
Hydroxyprogesterone caproate,Oxycodone,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Oxycodone.,decrease,no risk
Hydroxyprogesterone caproate,Oxytetracycline,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Hydroxyprogesterone caproate,Quetiapine,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Quetiapine.,decrease,no risk
Hydroxyprogesterone caproate,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Udenafil,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Udenafil.,decrease,no risk
Hydroxyprogesterone caproate,Ulipristal,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Ulipristal.,decrease,no risk
Hydroxyprogesterone caproate,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Vadadustat,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Vadadustat.,increase,no risk
Hydroxyprogesterone caproate,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Valproic acid,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Valproic acid.,increase,no risk
Hydroxyprogesterone caproate,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Hydroxyprogesterone caproate,Vardenafil,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Vardenafil.,decrease,no risk
Hydroxyprogesterone caproate,Vemurafenib,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Vemurafenib.,increase,no risk
Hydroxyprogesterone caproate,Venetoclax,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Venetoclax.,decrease,no risk
Hydroxyprogesterone caproate,Verapamil,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Verapamil.,decrease,no risk
Hydroxyprogesterone caproate,Vigabatrin,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Vigabatrin.,increase,no risk
Hydroxyprogesterone caproate,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Viloxazine,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Viloxazine.,decrease,no risk
Hydroxyprogesterone caproate,Vinblastine,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Vinblastine.,increase,no risk
Hydroxyprogesterone caproate,Vincristine,The metabolism of Vincristine can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Vitamin A,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Vitamin A.,decrease,no risk
Hydroxyprogesterone caproate,Vitamin E,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Vitamin E.,increase,no risk
Hydroxyprogesterone caproate,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Voriconazole,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Voriconazole.,decrease,no risk
Hydroxyprogesterone caproate,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Hydroxyprogesterone caproate,Zaleplon,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Zaleplon.,increase,no risk
Hydroxyprogesterone caproate,Zimelidine,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Zimelidine.,decrease,no risk
Hydroxyprogesterone caproate,Ziprasidone,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ziprasidone.,decrease,no risk
Iron sucrose,Gatifloxacin,Iron sucrose can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron sucrose,Gemifloxacin,Iron sucrose can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron sucrose,Grepafloxacin,Iron sucrose can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron sucrose,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron sucrose,Ofloxacin,Iron sucrose can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron sucrose,Olanzapine,Olanzapine can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron sucrose,Omadacycline,The serum concentration of Omadacycline can be decreased when it is combined with Iron sucrose.,decrease,no risk
Iron sucrose,Omeprazole,The absorption of Iron sucrose can be decreased when combined with Omeprazole.,decrease,no risk
Iron sucrose,Oxytetracycline,The serum concentration of Oxytetracycline can be decreased when it is combined with Iron sucrose.,decrease,no risk
Iron sucrose,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Iron sucrose.,decrease,no risk
Iron sucrose,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Iron sucrose resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Iron sucrose,Zoledronic acid,Iron sucrose can cause a decrease in the absorption of Zoledronic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanreotide,Galantamine,Galantamine may increase the bradycardic activities of Lanreotide.,increase,no risk
Lanreotide,Gatifloxacin,The risk or severity of hypoglycemia can be increased when Gatifloxacin is combined with Lanreotide.,increase,risk
Lanreotide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Lanreotide.,increase,no risk
Lanreotide,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Lanreotide.,decrease,no risk
Lanreotide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Lanreotide.,decrease,no risk
Lanreotide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Lanreotide.,decrease,no risk
Lanreotide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Lanreotide.,decrease,no risk
Lanreotide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Lanreotide.,decrease,no risk
Lanreotide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Lanreotide.,decrease,no risk
Lanreotide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Lanreotide.,decrease,no risk
Lanreotide,Guanfacine,Guanfacine may increase the bradycardic activities of Lanreotide.,increase,no risk
Lanreotide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Lanreotide.,increase,no risk
Lanreotide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Lanreotide.,increase,no risk
Lanreotide,Olaparib,The metabolism of Olaparib can be decreased when combined with Lanreotide.,decrease,no risk
Lanreotide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Lanreotide.,decrease,no risk
Lanreotide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lanreotide is combined with Oxetacaine.,increase,risk
Lanreotide,Oxprenolol,Oxprenolol may increase the bradycardic activities of Lanreotide.,increase,no risk
Lanreotide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lanreotide is combined with Oxybuprocaine.,increase,risk
Lanreotide,Quinidine,The metabolism of Quinidine can be decreased when combined with Lanreotide.,decrease,no risk
Lanreotide,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Lanreotide.,decrease,no risk
Lanthanum carbonate,Benazepril,Lanthanum carbonate can cause a decrease in the absorption of Benazepril resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanthanum carbonate,Gatifloxacin,Lanthanum carbonate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanthanum carbonate,Gemifloxacin,Lanthanum carbonate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanthanum carbonate,Grepafloxacin,Lanthanum carbonate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanthanum carbonate,Halofantrine,Lanthanum carbonate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanthanum carbonate,Ofloxacin,Lanthanum carbonate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanthanum carbonate,Omadacycline,The serum concentration of Omadacycline can be decreased when it is combined with Lanthanum carbonate.,decrease,no risk
Lanthanum carbonate,Oxytetracycline,The serum concentration of Oxytetracycline can be decreased when it is combined with Lanthanum carbonate.,decrease,no risk
Lanthanum carbonate,Quinapril,Lanthanum carbonate can cause a decrease in the absorption of Quinapril resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lanthanum carbonate,Zofenopril,Lanthanum carbonate can cause a decrease in the absorption of Zofenopril resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levopropoxyphene,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Levopropoxyphene.,increase,risk
Levopropoxyphene,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Levopropoxyphene.,increase,risk
Levopropoxyphene,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Levopropoxyphene,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Levopropoxyphene.,decrease,no risk
Mafenide,Benzylpenicillin,Mafenide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gabapentin enacarbil,Mangafodipir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gadodiamide,Gadodiamide may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gadoteric acid,Mangafodipir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gadoteridol,Gadoteridol may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Ganciclovir,Ganciclovir may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gemcitabine,Gemcitabine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gentamicin,Mangafodipir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Mangafodipir,Gimeracil,Mangafodipir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Mangafodipir,Givosiran,Givosiran may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Glipizide,Glipizide may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Glycerol phenylbutyrate,Mangafodipir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Mangafodipir,Golodirsen,Mangafodipir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Mangafodipir,Goserelin,Goserelin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Guanethidine,Guanethidine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Guanfacine,Guanfacine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Haloperidol,Haloperidol may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Hydralazine,Hydralazine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mangafodipir,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mangafodipir,Hydromorphone,Hydromorphone may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Hydroxyethyl Starch,Mangafodipir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Mangafodipir,Kanamycin,Mangafodipir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Mangafodipir,Ketamine,Ketamine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Ketazolam,Ketazolam may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Ketoprofen,Ketoprofen may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Ketorolac,Ketorolac may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Octinoxate,Mangafodipir may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Mangafodipir,Olsalazine,Olsalazine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Opium,Mangafodipir may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Mangafodipir,Oseltamivir,Oseltamivir may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Oxacillin,Oxacillin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Oxaprozin,Oxaprozin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Oxazepam,Oxazepam may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Oxybenzone,Oxybenzone may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Oxyquinoline,Mangafodipir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Mangafodipir,Quetiapine,Quetiapine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.,decrease,no risk
Mangafodipir,Quinethazone,Quinethazone may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mangafodipir,Quinidine,Mangafodipir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Mebutamate,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Mebutamate.,increase,risk
Mebutamate,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mebutamate is combined with Gabapentin enacarbil.,increase,risk
Mebutamate,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Mebutamate.,increase,risk
Mebutamate,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Mebutamate is combined with Ganaxolone.",increase,risk
Mebutamate,Gepirone,The risk or severity of CNS depression can be increased when Mebutamate is combined with Gepirone.,increase,risk
Mebutamate,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Mebutamate.,increase,risk
Mebutamate,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Mebutamate.,increase,risk
Mebutamate,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Mebutamate.,increase,risk
Mebutamate,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Mebutamate.,increase,risk
Mebutamate,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Mebutamate.,increase,risk
Mebutamate,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Mebutamate.,increase,risk
Mebutamate,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Mebutamate.,increase,risk
Mebutamate,Hydrocodone,Mebutamate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Mebutamate,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Mebutamate.,increase,risk
Mebutamate,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mebutamate.,increase,no risk
Mebutamate,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Mebutamate.,increase,risk
Mebutamate,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Mebutamate.,increase,risk
Mebutamate,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Mebutamate.,increase,risk
Mebutamate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mebutamate is combined with Oliceridine.",increase,risk
Mebutamate,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Mebutamate.,increase,risk
Mebutamate,Opium,The risk or severity of CNS depression can be increased when Mebutamate is combined with Opium.,increase,risk
Mebutamate,Orphenadrine,Mebutamate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Mebutamate,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Mebutamate.,increase,risk
Mebutamate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Mebutamate.,increase,risk
Mebutamate,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Mebutamate.,increase,risk
Mebutamate,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Mebutamate.,increase,risk
Mebutamate,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Mebutamate.,increase,risk
Mebutamate,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Mebutamate.,increase,risk
Mebutamate,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Mebutamate.,increase,risk
Mebutamate,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Mebutamate.,increase,risk
Mebutamate,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Mebutamate.,increase,risk
Mebutamate,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Mebutamate.,increase,risk
Mebutamate,Quinupramine,The risk or severity of CNS depression can be increased when Mebutamate is combined with Quinupramine.,increase,risk
Mebutamate,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Mebutamate.,increase,risk
Mebutamate,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Mebutamate.,increase,risk
Mebutamate,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Mebutamate.,increase,risk
Mebutamate,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Mebutamate.,increase,risk
Mebutamate,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Mebutamate.,increase,risk
Mebutamate,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Mebutamate.,increase,risk
Mebutamate,Viloxazine,The risk or severity of CNS depression can be increased when Mebutamate is combined with Viloxazine.,increase,risk
Mebutamate,Vortioxetine,The risk or severity of CNS depression can be increased when Mebutamate is combined with Vortioxetine.,increase,risk
Mebutamate,Yohimbine,The therapeutic efficacy of Mebutamate can be increased when used in combination with Yohimbine.,increase,no risk
Mebutamate,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Mebutamate.,increase,risk
Mebutamate,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Mebutamate.,increase,risk
Mebutamate,Zimelidine,The risk or severity of adverse effects can be increased when Mebutamate is combined with Zimelidine.,increase,risk
Mebutamate,Ziprasidone,The risk or severity of adverse effects can be increased when Mebutamate is combined with Ziprasidone.,increase,risk
Mebutamate,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Mebutamate.,increase,risk
Mebutamate,Zolpidem,Mebutamate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Mebutamate,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Mebutamate.,increase,risk
Mebutamate,Zopiclone,The risk or severity of adverse effects can be increased when Mebutamate is combined with Zopiclone.,increase,risk
Mebutamate,Zotepine,The risk or severity of CNS depression can be increased when Mebutamate is combined with Zotepine.,increase,risk
Mebutamate,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Mebutamate.,increase,risk
Mebutamate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Mebutamate.,increase,risk
Methylnaltrexone,Gabapentin enacarbil,Methylnaltrexone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gadodiamide,Gadodiamide may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gadoteric acid,Methylnaltrexone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gadoteridol,Gadoteridol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Ganciclovir,Ganciclovir may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gemcitabine,Gemcitabine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gentamicin,Methylnaltrexone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Gimeracil,Methylnaltrexone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Givosiran,Givosiran may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Glipizide,Glipizide may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Glycerol phenylbutyrate,Methylnaltrexone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Golodirsen,Methylnaltrexone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Goserelin,Goserelin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Guanethidine,Guanethidine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Guanfacine,Guanfacine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Haloperidol,Haloperidol may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Hydralazine,Hydralazine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methylnaltrexone,Hydrocodone,The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Methylnaltrexone.,decrease,no risk
Methylnaltrexone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methylnaltrexone,Hydromorphone,The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Methylnaltrexone.,decrease,no risk
Methylnaltrexone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Hydroxyethyl Starch,Methylnaltrexone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Kanamycin,Methylnaltrexone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Ketamine,Ketamine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Ketazolam,Ketazolam may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Ketoprofen,Ketoprofen may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Ketorolac,Ketorolac may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Octinoxate,Methylnaltrexone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Oliceridine,The therapeutic efficacy of Oliceridine can be decreased when used in combination with Methylnaltrexone.,decrease,no risk
Methylnaltrexone,Olsalazine,Olsalazine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Opium,The therapeutic efficacy of Opium can be decreased when used in combination with Methylnaltrexone.,decrease,no risk
Methylnaltrexone,Oseltamivir,Oseltamivir may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Oxacillin,Oxacillin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Oxaprozin,Oxaprozin may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Oxazepam,Oxazepam may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Oxybenzone,Oxybenzone may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Oxycodone,The therapeutic efficacy of Oxycodone can be decreased when used in combination with Methylnaltrexone.,decrease,no risk
Methylnaltrexone,Oxymorphone,The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Methylnaltrexone.,decrease,no risk
Methylnaltrexone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Oxyquinoline,Methylnaltrexone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Quetiapine,Quetiapine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Quinethazone,Quinethazone may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Methylnaltrexone,Quinidine,Methylnaltrexone may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Vaborbactam,Methylnaltrexone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Valaciclovir,Valaciclovir may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Valbenazine,Methylnaltrexone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Valdecoxib,Valdecoxib may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Valganciclovir,Valganciclovir may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Vancomycin,Methylnaltrexone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Varenicline,Varenicline may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Venlafaxine,Venlafaxine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Verapamil,Verapamil may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Vilanterol,Methylnaltrexone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Viloxazine,Methylnaltrexone may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Vortioxetine,Methylnaltrexone may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Warfarin,Methylnaltrexone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Zaleplon,Zaleplon may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Zanamivir,Zanamivir may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.,decrease,no risk
Methylnaltrexone,Zonisamide,Zonisamide may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nepafenac,Balsalazide,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Nepafenac.,decrease,no risk
Nepafenac,Bendazac,The risk or severity of adverse effects can be increased when Nepafenac is combined with Bendazac.,increase,risk
Nepafenac,Benorilate,The risk or severity of adverse effects can be increased when Nepafenac is combined with Benorilate.,increase,risk
Nepafenac,Benoxaprofen,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Nepafenac.,increase,risk
Nepafenac,Benzydamine,The risk or severity of adverse effects can be increased when Nepafenac is combined with Benzydamine.,increase,risk
Nepafenac,Betulinic Acid,The risk or severity of adverse effects can be increased when Nepafenac is combined with Betulinic Acid.,increase,risk
Nepafenac,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nepafenac.,decrease,no risk
Nepafenac,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Nepafenac.,increase,risk
Nepafenac,Bufexamac,The risk or severity of adverse effects can be increased when Nepafenac is combined with Bufexamac.,increase,risk
Nepafenac,Bumadizone,The risk or severity of adverse effects can be increased when Nepafenac is combined with Bumadizone.,increase,risk
Nepafenac,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Nepafenac.,increase,risk
Nepafenac,Glycol salicylate,The risk or severity of adverse effects can be increased when Nepafenac is combined with Glycol salicylate.,increase,risk
Nepafenac,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Nepafenac.,increase,risk
Nepafenac,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Nepafenac.,increase,risk
Nepafenac,Olsalazine,The risk or severity of nephrotoxicity can be increased when Nepafenac is combined with Olsalazine.,increase,risk
Nepafenac,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Nepafenac.,increase,risk
Nepafenac,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Nepafenac.,increase,risk
Nepafenac,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Nepafenac.,increase,risk
Nepafenac,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Nepafenac.,increase,risk
Nepafenac,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Nepafenac.,increase,risk
Nepafenac,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Nepafenac.,decrease,no risk
Nepafenac,Voriconazole,The serum concentration of Nepafenac can be increased when it is combined with Voriconazole.,increase,no risk
Niclosamide,Gemfibrozil,The metabolism of Niclosamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Niclosamide,Ginkgo biloba,The metabolism of Niclosamide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Niclosamide,Gliclazide,The metabolism of Niclosamide can be decreased when combined with Gliclazide.,decrease,no risk
Niclosamide,Glimepiride,The metabolism of Niclosamide can be decreased when combined with Glimepiride.,decrease,no risk
Niclosamide,Glipizide,The metabolism of Niclosamide can be decreased when combined with Glipizide.,decrease,no risk
Niclosamide,Gliquidone,The metabolism of Niclosamide can be decreased when combined with Gliquidone.,decrease,no risk
Niclosamide,Glofitamab,The serum concentration of Niclosamide can be increased when it is combined with Glofitamab.,increase,no risk
Niclosamide,Glyburide,The metabolism of Niclosamide can be decreased when combined with Glyburide.,decrease,no risk
Niclosamide,Golimumab,The metabolism of Niclosamide can be increased when combined with Golimumab.,increase,no risk
Niclosamide,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Halothane,The metabolism of Niclosamide can be decreased when combined with Halothane.,decrease,no risk
Niclosamide,Hydromorphone,The metabolism of Niclosamide can be decreased when combined with Hydromorphone.,decrease,no risk
Niclosamide,Ketamine,The metabolism of Niclosamide can be decreased when combined with Ketamine.,decrease,no risk
Niclosamide,Ketorolac,The metabolism of Niclosamide can be decreased when combined with Ketorolac.,decrease,no risk
Niclosamide,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Oritavancin,The metabolism of Niclosamide can be decreased when combined with Oritavancin.,decrease,no risk
Niclosamide,Ospemifene,The metabolism of Niclosamide can be decreased when combined with Ospemifene.,decrease,no risk
Niclosamide,Oxandrolone,The metabolism of Niclosamide can be decreased when combined with Oxandrolone.,decrease,no risk
Niclosamide,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Quinidine,The metabolism of Niclosamide can be decreased when combined with Quinidine.,decrease,no risk
Niclosamide,Quinine,The metabolism of Quinine can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Vadadustat,The metabolism of Niclosamide can be decreased when combined with Vadadustat.,decrease,no risk
Niclosamide,Valdecoxib,The metabolism of Niclosamide can be decreased when combined with Valdecoxib.,decrease,no risk
Niclosamide,Valproic acid,The metabolism of Niclosamide can be decreased when combined with Valproic acid.,decrease,no risk
Niclosamide,Valsartan,The metabolism of Niclosamide can be decreased when combined with Valsartan.,decrease,no risk
Niclosamide,Vardenafil,The metabolism of Niclosamide can be decreased when combined with Vardenafil.,decrease,no risk
Niclosamide,Vemurafenib,The metabolism of Niclosamide can be decreased when combined with Vemurafenib.,decrease,no risk
Niclosamide,Verapamil,The metabolism of Verapamil can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Voriconazole,The metabolism of Niclosamide can be decreased when combined with Voriconazole.,decrease,no risk
Niclosamide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Warfarin,The metabolism of Warfarin can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Ximelagatran,The metabolism of Niclosamide can be decreased when combined with Ximelagatran.,decrease,no risk
Niclosamide,Zafirlukast,The metabolism of Niclosamide can be decreased when combined with Zafirlukast.,decrease,no risk
Niclosamide,Zidovudine,The metabolism of Niclosamide can be decreased when combined with Zidovudine.,decrease,no risk
Niclosamide,Zileuton,The metabolism of Zileuton can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Niclosamide.,decrease,no risk
Niclosamide,Zopiclone,The metabolism of Niclosamide can be decreased when combined with Zopiclone.,decrease,no risk
Niclosamide,Zotepine,The metabolism of Zotepine can be decreased when combined with Niclosamide.,decrease,no risk
Nonoxynol-9,Belzutifan,The therapeutic efficacy of Nonoxynol-9 can be decreased when used in combination with Belzutifan.,decrease,no risk
Nonoxynol-9,Brexanolone,The metabolism of Nonoxynol-9 can be increased when combined with Brexanolone.,increase,no risk
Nonoxynol-9,Brivaracetam,The metabolism of Nonoxynol-9 can be increased when combined with Brivaracetam.,increase,no risk
Nonoxynol-9,Butalbital,The metabolism of Nonoxynol-9 can be increased when combined with Butalbital.,increase,no risk
Nonoxynol-9,Gabapentin,The metabolism of Nonoxynol-9 can be increased when combined with Gabapentin.,increase,no risk
Nonoxynol-9,Ganaxolone,The metabolism of Nonoxynol-9 can be increased when combined with Ganaxolone.,increase,no risk
Nonoxynol-9,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Nonoxynol-9,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Nonoxynol-9,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Nonoxynol-9,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Nonoxynol-9,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Nonoxynol-9.,decrease,no risk
Nonoxynol-9,Omaveloxolone,The therapeutic efficacy of Nonoxynol-9 can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Nonoxynol-9,Oxcarbazepine,The metabolism of Nonoxynol-9 can be increased when combined with Oxcarbazepine.,increase,no risk
Nonoxynol-9,Valproic acid,The metabolism of Nonoxynol-9 can be increased when combined with Valproic acid.,increase,no risk
Nonoxynol-9,Vigabatrin,The metabolism of Nonoxynol-9 can be increased when combined with Vigabatrin.,increase,no risk
Nonoxynol-9,Zaleplon,The metabolism of Nonoxynol-9 can be increased when combined with Zaleplon.,increase,no risk
Nonoxynol-9,Zonisamide,The metabolism of Nonoxynol-9 can be increased when combined with Zonisamide.,increase,no risk
Phenyl aminosalicylate,Gliclazide,Phenyl aminosalicylate may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Phenyl aminosalicylate,Glimepiride,Phenyl aminosalicylate may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Phenyl aminosalicylate,Glipizide,Phenyl aminosalicylate may increase the hypoglycemic activities of Glipizide.,increase,no risk
Phenyl aminosalicylate,Gliquidone,Phenyl aminosalicylate may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Phenyl aminosalicylate,Glyburide,Phenyl aminosalicylate may increase the hypoglycemic activities of Glyburide.,increase,no risk
Phenyl aminosalicylate,Glymidine,Phenyl aminosalicylate may increase the hypoglycemic activities of Glymidine.,increase,no risk
Phenyl aminosalicylate,Heparin,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Heparin.,increase,risk
Phenyl aminosalicylate,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Phenyl aminosalicylate.,decrease,no risk
Phenyl aminosalicylate,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Phenyl aminosalicylate.,decrease,no risk
Phenyl aminosalicylate,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Phenyl aminosalicylate.,decrease,no risk
Phenyl aminosalicylate,Hydrocortisone,The serum concentration of Phenyl aminosalicylate can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Phenyl aminosalicylate,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Phenyl aminosalicylate is combined with Ketoprofen.,increase,risk
Phenyl aminosalicylate,Ketorolac,The therapeutic efficacy of Phenyl aminosalicylate can be decreased when used in combination with Ketorolac.,decrease,no risk
Phenyl aminosalicylate,Olsalazine,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Olsalazine is combined with Phenyl aminosalicylate.",increase,risk
Phenyl aminosalicylate,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Phenyl aminosalicylate.,decrease,no risk
Phenyl aminosalicylate,Oxaprozin,The therapeutic efficacy of Phenyl aminosalicylate can be decreased when used in combination with Oxaprozin.,decrease,no risk
Phenyl aminosalicylate,Quinapril,The risk or severity of renal failure can be increased when Phenyl aminosalicylate is combined with Quinapril.,increase,risk
Phenyl aminosalicylate,Quinine,Phenyl aminosalicylate may increase the hypoglycemic activities of Quinine.,increase,no risk
Phenyl aminosalicylate,Urokinase,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Urokinase.,increase,risk
Phenyl aminosalicylate,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Phenyl aminosalicylate.,increase,no risk
Phenyl aminosalicylate,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Phenyl aminosalicylate is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Phenyl aminosalicylate,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Phenyl aminosalicylate.,increase,risk
Phenyl aminosalicylate,Vildagliptin,Phenyl aminosalicylate may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Phenyl aminosalicylate,Vorapaxar,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Vorapaxar.,increase,risk
Phenyl aminosalicylate,Warfarin,Phenyl aminosalicylate may increase the anticoagulant activities of Warfarin.,increase,no risk
Phenyl aminosalicylate,Ximelagatran,The risk or severity of bleeding can be increased when Phenyl aminosalicylate is combined with Ximelagatran.,increase,risk
Phenyl aminosalicylate,Zofenopril,The risk or severity of renal failure can be increased when Phenyl aminosalicylate is combined with Zofenopril.,increase,risk
Phenyl aminosalicylate,Zonisamide,The risk or severity of adverse effects can be increased when Phenyl aminosalicylate is combined with Zonisamide.,increase,risk
Plerixafor,Gabapentin enacarbil,Plerixafor may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Plerixafor,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Gadodiamide,Gadodiamide may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Gadoteric acid,Plerixafor may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Plerixafor,Gadoteridol,Gadoteridol may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Ganciclovir,Ganciclovir may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Gemcitabine,Gemcitabine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Gentamicin,Plerixafor may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Plerixafor,Gimeracil,Plerixafor may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Plerixafor,Givosiran,Givosiran may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Glipizide,Glipizide may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Glycerol phenylbutyrate,Plerixafor may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Plerixafor,Golodirsen,Plerixafor may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Plerixafor,Goserelin,Goserelin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Guanethidine,Guanethidine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Guanfacine,Guanfacine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Haloperidol,Haloperidol may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Hydralazine,Hydralazine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Plerixafor,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Plerixafor,Hydromorphone,Hydromorphone may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Hydroxyethyl Starch,Plerixafor may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Plerixafor,Kanamycin,Plerixafor may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Plerixafor,Ketamine,Ketamine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Ketazolam,Ketazolam may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Ketoprofen,Ketoprofen may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Ketorolac,Ketorolac may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Octinoxate,Plerixafor may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Plerixafor,Olsalazine,Olsalazine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Opium,Plerixafor may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Plerixafor,Oseltamivir,Oseltamivir may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Oxacillin,Oxacillin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Oxaprozin,Oxaprozin may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Oxazepam,Oxazepam may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Oxybenzone,Oxybenzone may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Oxyquinoline,Plerixafor may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Plerixafor,Quetiapine,Quetiapine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Quinethazone,Quinethazone may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Plerixafor,Quinidine,Plerixafor may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Plerixafor,Vaborbactam,Plerixafor may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Plerixafor,Valaciclovir,Valaciclovir may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Valbenazine,Plerixafor may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Plerixafor,Valdecoxib,Valdecoxib may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Valganciclovir,Valganciclovir may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Vancomycin,Plerixafor may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Plerixafor,Varenicline,Varenicline may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Venlafaxine,Venlafaxine may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Verapamil,Verapamil may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Vilanterol,Plerixafor may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Plerixafor,Viloxazine,Plerixafor may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Plerixafor,Vortioxetine,Plerixafor may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Plerixafor,Warfarin,Plerixafor may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Plerixafor,Zaleplon,Zaleplon may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Zanamivir,Zanamivir may decrease the excretion rate of Plerixafor which could result in a higher serum level.,decrease,no risk
Plerixafor,Zonisamide,Zonisamide may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Plicamycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Benzocaine.,increase,risk
Plicamycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Benzyl alcohol.,increase,risk
Plicamycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Bupivacaine.,increase,risk
Plicamycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Butacaine.,increase,risk
Plicamycin,Butamben,The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Butamben.,increase,risk
Plicamycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Oxetacaine.,increase,risk
Plicamycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Plicamycin is combined with Oxybuprocaine.,increase,risk
Protokylol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Protokylol.,increase,risk
Protokylol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Protokylol.,increase,risk
Protokylol,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Protokylol.,increase,risk
Protokylol,Guanadrel,The therapeutic efficacy of Protokylol can be decreased when used in combination with Guanadrel.,decrease,no risk
Protokylol,Guanethidine,The therapeutic efficacy of Protokylol can be decreased when used in combination with Guanethidine.,decrease,no risk
Protokylol,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Protokylol.,increase,risk
Protokylol,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Protokylol.,increase,risk
Protokylol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Protokylol.,increase,risk
Protokylol,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Protokylol is combined with Hydrochlorothiazide.,increase,risk
Protokylol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Protokylol.,increase,risk
Protokylol,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Protokylol.,increase,risk
Protokylol,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Protokylol.,increase,risk
Protokylol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Protokylol.,increase,risk
Protokylol,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Protokylol.,increase,risk
Protokylol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Protokylol is combined with Hydroflumethiazide.,increase,risk
Protokylol,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Protokylol.,increase,risk
Protokylol,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Protokylol.,increase,risk
Protokylol,Ketotifen,The therapeutic efficacy of Protokylol can be increased when used in combination with Ketotifen.,increase,no risk
Protokylol,Olanzapine,The therapeutic efficacy of Protokylol can be decreased when used in combination with Olanzapine.,decrease,no risk
Protokylol,Olodaterol,The risk or severity of adverse effects can be increased when Protokylol is combined with Olodaterol.,increase,risk
Protokylol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be increased when used in combination with Protokylol.,increase,no risk
Protokylol,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Protokylol.,increase,risk
Protokylol,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Protokylol is combined with Ouabain.,increase,risk
Protokylol,Oxatomide,The therapeutic efficacy of Protokylol can be increased when used in combination with Oxatomide.,increase,no risk
Protokylol,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Protokylol.,decrease,no risk
Protokylol,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Protokylol.,increase,risk
Protokylol,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Protokylol.,increase,risk
Protokylol,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be increased when used in combination with Protokylol.,increase,no risk
Protokylol,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Protokylol.,increase,risk
Protokylol,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Protokylol.,increase,risk
Protokylol,Quetiapine,The therapeutic efficacy of Protokylol can be decreased when used in combination with Quetiapine.,decrease,no risk
Protokylol,Quinethazone,The risk or severity of Cardiac Arrhythmia can be increased when Protokylol is combined with Quinethazone.,increase,risk
Protokylol,Quinidine,The therapeutic efficacy of Protokylol can be decreased when used in combination with Quinidine.,decrease,no risk
Protokylol,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Protokylol.,increase,risk
Protokylol,Umeclidinium,The risk or severity of Tachycardia can be increased when Protokylol is combined with Umeclidinium.,increase,risk
Protokylol,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Protokylol.,increase,risk
Protokylol,Vasopressin,Vasopressin may increase the hypertensive activities of Protokylol.,increase,no risk
Protokylol,Venlafaxine,Venlafaxine may increase the tachycardic activities of Protokylol.,increase,no risk
Protokylol,Verapamil,Verapamil may decrease the hypertensive activities of Protokylol.,decrease,no risk
Protokylol,Vilanterol,The risk or severity of adverse effects can be increased when Protokylol is combined with Vilanterol.,increase,risk
Protokylol,Xamoterol,The risk or severity of Tachycardia can be increased when Protokylol is combined with Xamoterol.,increase,risk
Protokylol,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Protokylol.,increase,risk
Protokylol,Yohimbine,Yohimbine may decrease the hypertensive activities of Protokylol.,decrease,no risk
Protokylol,Ziprasidone,The therapeutic efficacy of Protokylol can be decreased when used in combination with Ziprasidone.,decrease,no risk
Protokylol,Zonisamide,The risk or severity of Cardiac Arrhythmia can be increased when Protokylol is combined with Zonisamide.,increase,risk
Protokylol,Zuclopenthixol,The therapeutic efficacy of Protokylol can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Sulconazole,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sulconazole.,increase,no risk
Sulconazole,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Sulconazole.,increase,no risk
Sulfameter,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sulfameter.,decrease,no risk
Sulfameter,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfameter.,increase,no risk
Sulfameter,Warfarin,The risk or severity of bleeding can be increased when Sulfameter is combined with Warfarin.,increase,risk
Tinzaparin,Gemcitabine,The risk or severity of bleeding can be increased when Tinzaparin is combined with Gemcitabine.,increase,risk
Tinzaparin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Tinzaparin is combined with Gemtuzumab ozogamicin.,increase,risk
Tinzaparin,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Tinzaparin.,decrease,no risk
Tinzaparin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Tinzaparin.,increase,risk
Tinzaparin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Tinzaparin.,increase,no risk
Tinzaparin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Tinzaparin.,increase,risk
Tinzaparin,Hemin,Hemin may increase the anticoagulant activities of Tinzaparin.,increase,no risk
Tinzaparin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Tinzaparin.,increase,risk
Tinzaparin,Hydrochlorothiazide,The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Tinzaparin,Hydroflumethiazide,The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Tinzaparin,Hydroxyprogesterone caproate,The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Tinzaparin,Hydroxyurea,The risk or severity of bleeding can be increased when Tinzaparin is combined with Hydroxyurea.,increase,risk
Tinzaparin,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Tinzaparin.,decrease,no risk
Tinzaparin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Tinzaparin.,increase,risk
Tinzaparin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Tinzaparin.,increase,risk
Tinzaparin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Tinzaparin.,increase,risk
Tinzaparin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Tinzaparin is combined with Obeticholic acid.,increase,risk
Tinzaparin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Tinzaparin is combined with Obinutuzumab.,increase,risk
Tinzaparin,Olaparib,The risk or severity of bleeding can be increased when Tinzaparin is combined with Olaparib.,increase,risk
Tinzaparin,Olive oil,The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Olive oil.,decrease,no risk
Tinzaparin,Olmesartan,The risk or severity of hyperkalemia can be increased when Tinzaparin is combined with Olmesartan.,increase,risk
Tinzaparin,Olsalazine,The risk or severity of bleeding can be increased when Tinzaparin is combined with Olsalazine.,increase,risk
Tinzaparin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Tinzaparin is combined with Omacetaxine mepesuccinate.,increase,risk
Tinzaparin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Tinzaparin.,increase,no risk
Tinzaparin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Tinzaparin.,increase,risk
Tinzaparin,Omega-3-carboxylic acids,The therapeutic efficacy of Tinzaparin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Tinzaparin,Oritavancin,The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Oritavancin.,decrease,no risk
Tinzaparin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Tinzaparin.,increase,risk
Tinzaparin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Tinzaparin.,increase,risk
Tinzaparin,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Tinzaparin.,increase,risk
Tinzaparin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Tinzaparin.,increase,risk
Tinzaparin,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Tinzaparin.,increase,risk
Tinzaparin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Tinzaparin.,decrease,no risk
Tinzaparin,Quinidine,The therapeutic efficacy of Tinzaparin can be increased when used in combination with Quinidine.,increase,no risk
Tinzaparin,Quinine,The therapeutic efficacy of Tinzaparin can be increased when used in combination with Quinine.,increase,no risk
Tinzaparin,Ulipristal,The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Ulipristal.,decrease,no risk
Tinzaparin,Urokinase,Urokinase may increase the anticoagulant activities of Tinzaparin.,increase,no risk
Tinzaparin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Tinzaparin is combined with Ursodeoxycholic acid.,increase,risk
Tinzaparin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Tinzaparin.,increase,risk
Tinzaparin,Valsartan,The risk or severity of hyperkalemia can be increased when Tinzaparin is combined with Valsartan.,increase,risk
Tinzaparin,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Tinzaparin.,decrease,no risk
Tinzaparin,Venlafaxine,The risk or severity of bleeding can be increased when Tinzaparin is combined with Venlafaxine.,increase,risk
Tinzaparin,Vinblastine,The risk or severity of bleeding can be increased when Tinzaparin is combined with Vinblastine.,increase,risk
Tinzaparin,Vindesine,The risk or severity of bleeding can be increased when Tinzaparin is combined with Vindesine.,increase,risk
Tinzaparin,Vinorelbine,The risk or severity of bleeding can be increased when Tinzaparin is combined with Vinorelbine.,increase,risk
Tinzaparin,Vitamin E,Vitamin E may increase the anticoagulant activities of Tinzaparin.,increase,no risk
Tinzaparin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Tinzaparin.,decrease,no risk
Tinzaparin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Tinzaparin.,increase,risk
Tinzaparin,Vorinostat,The risk or severity of bleeding can be increased when Tinzaparin is combined with Vorinostat.,increase,risk
Tinzaparin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Tinzaparin.,increase,risk
Tinzaparin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Tinzaparin.,increase,risk
Tinzaparin,Zidovudine,The risk or severity of bleeding can be increased when Tinzaparin is combined with Zidovudine.,increase,risk
Tinzaparin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Tinzaparin.,increase,risk
Tinzaparin,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Tinzaparin.,increase,risk
Tinzaparin,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Tinzaparin.,increase,risk
Tiopronin,Gabapentin enacarbil,Tiopronin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Tiopronin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gadodiamide,Gadodiamide may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gadoteric acid,Tiopronin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tiopronin,Gadoteridol,Gadoteridol may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Ganciclovir,Ganciclovir may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gemcitabine,Gemcitabine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gentamicin,Tiopronin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tiopronin,Gimeracil,Tiopronin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tiopronin,Givosiran,Givosiran may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Glipizide,Glipizide may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Glycerol phenylbutyrate,Tiopronin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tiopronin,Golodirsen,Tiopronin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tiopronin,Goserelin,Goserelin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Guanethidine,Guanethidine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Guanfacine,Guanfacine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Haloperidol,Haloperidol may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Hydralazine,Hydralazine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tiopronin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tiopronin,Hydromorphone,Hydromorphone may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Hydroxyethyl Starch,Tiopronin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tiopronin,Kanamycin,Tiopronin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tiopronin,Ketamine,Ketamine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Ketazolam,Ketazolam may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Ketoprofen,Ketoprofen may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Ketorolac,Ketorolac may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Octinoxate,Tiopronin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tiopronin,Olsalazine,Olsalazine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Opium,Tiopronin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tiopronin,Oseltamivir,Oseltamivir may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Oxacillin,Oxacillin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Oxaprozin,Oxaprozin may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Oxazepam,Oxazepam may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Oxybenzone,Oxybenzone may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Oxyquinoline,Tiopronin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tiopronin,Quetiapine,Quetiapine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Quinethazone,Quinethazone may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tiopronin,Quinidine,Tiopronin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tiopronin,Vaborbactam,Tiopronin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tiopronin,Valaciclovir,Valaciclovir may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Valbenazine,Tiopronin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tiopronin,Valdecoxib,Valdecoxib may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Valganciclovir,Valganciclovir may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Vancomycin,Tiopronin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tiopronin,Varenicline,Varenicline may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Venlafaxine,Venlafaxine may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Verapamil,Verapamil may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Vilanterol,Tiopronin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Tiopronin,Viloxazine,Tiopronin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Tiopronin,Vortioxetine,Tiopronin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Tiopronin,Warfarin,Tiopronin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Tiopronin,Zaleplon,Zaleplon may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Zanamivir,Zanamivir may decrease the excretion rate of Tiopronin which could result in a higher serum level.,decrease,no risk
Tiopronin,Zonisamide,Zonisamide may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triethylenetetramine,Gabapentin enacarbil,Triethylenetetramine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gadodiamide,Gadodiamide may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gadoteric acid,Triethylenetetramine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gadoteridol,Gadoteridol may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Ganciclovir,Ganciclovir may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gemcitabine,Gemcitabine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gentamicin,Triethylenetetramine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Gimeracil,Triethylenetetramine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Givosiran,Givosiran may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Glipizide,Glipizide may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Glycerol phenylbutyrate,Triethylenetetramine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Golodirsen,Triethylenetetramine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Goserelin,Goserelin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Guanethidine,Guanethidine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Guanfacine,Guanfacine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Haloperidol,Haloperidol may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Hydralazine,Hydralazine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triethylenetetramine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triethylenetetramine,Hydromorphone,Hydromorphone may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Triethylenetetramine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Hydroxyethyl Starch,Triethylenetetramine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Kanamycin,Triethylenetetramine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Ketamine,Ketamine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Ketazolam,Ketazolam may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Ketoprofen,Ketoprofen may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Ketorolac,Ketorolac may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Octinoxate,Triethylenetetramine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Olsalazine,Olsalazine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Opium,Triethylenetetramine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Oseltamivir,Oseltamivir may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Oxacillin,Oxacillin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Oxaprozin,Oxaprozin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Oxazepam,Oxazepam may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Oxybenzone,Oxybenzone may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Oxyquinoline,Triethylenetetramine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Quetiapine,Quetiapine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Quinethazone,Quinethazone may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triethylenetetramine,Quinidine,Triethylenetetramine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Vaborbactam,Triethylenetetramine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Valaciclovir,Valaciclovir may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Valbenazine,Triethylenetetramine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Valdecoxib,Valdecoxib may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Valganciclovir,Valganciclovir may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Vancomycin,Triethylenetetramine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Varenicline,Varenicline may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Venlafaxine,Venlafaxine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Verapamil,Verapamil may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Vilanterol,Triethylenetetramine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Viloxazine,Triethylenetetramine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Vortioxetine,Triethylenetetramine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Warfarin,Triethylenetetramine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Zaleplon,Zaleplon may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Zanamivir,Zanamivir may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.,decrease,no risk
Triethylenetetramine,Zinc,The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc.,decrease,no risk
Triethylenetetramine,Zinc acetate,The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc acetate.,decrease,no risk
Triethylenetetramine,Zinc ascorbate,The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc ascorbate.,decrease,no risk
Triethylenetetramine,Zinc chloride,The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc chloride.,decrease,no risk
Triethylenetetramine,Zinc gluconate,The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc gluconate.,decrease,no risk
Triethylenetetramine,Zinc oxide,The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc oxide.,decrease,no risk
Triethylenetetramine,Zinc sulfate,The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc sulfate.,decrease,no risk
Triethylenetetramine,"Zinc sulfate, unspecified form","The serum concentration of Triethylenetetramine can be decreased when it is combined with Zinc sulfate, unspecified form.",decrease,no risk
Triethylenetetramine,Zonisamide,The excretion of Triethylenetetramine can be increased when combined with Zonisamide.,increase,no risk
Triptorelin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Gadobenic acid.,increase,risk
Triptorelin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Triptorelin.,increase,risk
Triptorelin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Triptorelin.,increase,risk
Triptorelin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Gemifloxacin.,increase,risk
Triptorelin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Triptorelin.,increase,risk
Triptorelin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Gilteritinib.,increase,risk
Triptorelin,Glasdegib,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Glasdegib.,increase,risk
Triptorelin,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Goserelin,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Goserelin.,increase,risk
Triptorelin,Granisetron,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Granisetron.,increase,risk
Triptorelin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Grepafloxacin.,increase,risk
Triptorelin,Halofantrine,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Halofantrine.,increase,risk
Triptorelin,Haloperidol,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Haloperidol.,increase,risk
Triptorelin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Triptorelin.,increase,risk
Triptorelin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Triptorelin.,increase,risk
Triptorelin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Triptorelin.,increase,risk
Triptorelin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Hydroxyzine.,increase,risk
Triptorelin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Triptorelin.,increase,risk
Triptorelin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Triptorelin.,increase,risk
Triptorelin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Triptorelin.,increase,risk
Triptorelin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Ofloxacin.,increase,risk
Triptorelin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Triptorelin.,increase,risk
Triptorelin,Olodaterol,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Olodaterol.,increase,risk
Triptorelin,Ondansetron,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Ondansetron.,increase,risk
Triptorelin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Triptorelin.,increase,risk
Triptorelin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Triptorelin.,increase,risk
Triptorelin,Oxatomide,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Oxatomide.,increase,risk
Triptorelin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Triptorelin is combined with Oxetacaine.,increase,risk
Triptorelin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Triptorelin is combined with Oxybuprocaine.,increase,risk
Triptorelin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Triptorelin.,increase,risk
Triptorelin,Quetiapine,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Quetiapine.,increase,risk
Triptorelin,Quinidine,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Quinidine.,increase,risk
Triptorelin,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Quizartinib,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Quizartinib.,increase,risk
Triptorelin,Valproic acid,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Valproic acid.,increase,risk
Triptorelin,Vandetanib,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Vandetanib.,increase,risk
Triptorelin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Triptorelin.,increase,risk
Triptorelin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Triptorelin.,increase,risk
Triptorelin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Triptorelin.,increase,risk
Triptorelin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Triptorelin.,increase,risk
Triptorelin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Triptorelin.,decrease,no risk
Triptorelin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Triptorelin.,increase,risk
Triptorelin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Triptorelin.,increase,risk
Triptorelin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Ziprasidone.,increase,risk
Triptorelin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Triptorelin.,increase,risk
Triptorelin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Zuclopenthixol.,increase,risk
Unoprostone,Olmesartan,Olmesartan may increase the hypotensive activities of Unoprostone.,increase,no risk
Unoprostone,Oxaprozin,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Oxaprozin.,decrease,no risk
Unoprostone,Oxprenolol,Oxprenolol may increase the hypotensive activities of Unoprostone.,increase,no risk
Unoprostone,Oxyphenbutazone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Unoprostone,Quetiapine,Quetiapine may increase the hypotensive activities of Unoprostone.,increase,no risk
Unoprostone,Quinapril,Quinapril may increase the hypotensive activities of Unoprostone.,increase,no risk
Unoprostone,Quinine,Quinine may increase the hypotensive activities of Unoprostone.,increase,no risk
Unoprostone,Valdecoxib,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Valdecoxib.,decrease,no risk
Unoprostone,Valsartan,Valsartan may increase the hypotensive activities of Unoprostone.,increase,no risk
Unoprostone,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Unoprostone.,increase,no risk
Unoprostone,Zofenopril,Unoprostone may increase the hypotensive activities of Zofenopril.,increase,no risk
Viomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Oxetacaine.,increase,risk
Viomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Viomycin is combined with Oxybuprocaine.,increase,risk
Viomycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Viomycin.,increase,risk
Viomycin,Quinidine,The risk or severity of neuromuscular blockade can be increased when Quinidine is combined with Viomycin.,increase,risk
Viomycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Viomycin.,increase,risk
Viomycin,Quinupramine,Viomycin may increase the neurotoxic activities of Quinupramine.,increase,no risk
Viomycin,Valproate bismuth,Viomycin may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Viomycin,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Vancomycin is combined with Viomycin.,increase,risk
Viomycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Viomycin.,increase,no risk
Viomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Viomycin.,decrease,no risk
Viomycin,Vincristine,Vincristine may increase the neurotoxic activities of Viomycin.,increase,no risk
Viomycin,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Viomycin.,increase,no risk
Viomycin,Warfarin,The risk or severity of bleeding can be increased when Viomycin is combined with Warfarin.,increase,risk
Viomycin,Ziprasidone,Ziprasidone may increase the neurotoxic activities of Viomycin.,increase,no risk
Viomycin,Zotepine,Viomycin may increase the neurotoxic activities of Zotepine.,increase,no risk
Viomycin,Zuclopenthixol,Zuclopenthixol may increase the neurotoxic activities of Viomycin.,increase,no risk
Hymecromone,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Hymecromone.,increase,no risk
Hymecromone,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Hymecromone.,increase,no risk
Hymecromone,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Hymecromone.,increase,no risk
Hymecromone,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Hymecromone.,increase,no risk
Hymecromone,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Hymecromone.,increase,no risk
Veliparib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Veliparib is combined with Benzocaine.,increase,risk
Veliparib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Veliparib is combined with Benzyl alcohol.,increase,risk
Veliparib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Veliparib is combined with Bupivacaine.,increase,risk
Veliparib,Butacaine,The risk or severity of methemoglobinemia can be increased when Veliparib is combined with Butacaine.,increase,risk
Veliparib,Butamben,The risk or severity of methemoglobinemia can be increased when Veliparib is combined with Butamben.,increase,risk
Veliparib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Veliparib is combined with Oxetacaine.,increase,risk
Veliparib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Veliparib is combined with Oxybuprocaine.,increase,risk
Brefeldin A,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Brefeldin A is combined with Oxetacaine.,increase,risk
Brefeldin A,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Brefeldin A.,decrease,no risk
Brefeldin A,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Brefeldin A is combined with Oxybuprocaine.,increase,risk
Brefeldin A,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Quinine,The serum concentration of Quinine can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Brefeldin A.,decrease,no risk
Brefeldin A,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Brefeldin A.,decrease,no risk
Brefeldin A,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vincristine,The excretion of Vincristine can be decreased when combined with Brefeldin A.,decrease,no risk
Brefeldin A,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Brefeldin A.,decrease,no risk
Brefeldin A,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Brefeldin A.,increase,no risk
Brefeldin A,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Brefeldin A.,decrease,no risk
Brefeldin A,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Brefeldin A.,decrease,no risk
Brefeldin A,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Brefeldin A.,decrease,no risk
Anisomycin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Anisomycin.,decrease,no risk
Anisomycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Anisomycin is combined with Benzocaine.,increase,risk
Anisomycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Anisomycin is combined with Benzyl alcohol.,increase,risk
Anisomycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Anisomycin is combined with Bupivacaine.,increase,risk
Anisomycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Anisomycin is combined with Butacaine.,increase,risk
Anisomycin,Butamben,The risk or severity of methemoglobinemia can be increased when Anisomycin is combined with Butamben.,increase,risk
Anisomycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Anisomycin is combined with Oxetacaine.,increase,risk
Anisomycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Anisomycin is combined with Oxybuprocaine.,increase,risk
Anisomycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Anisomycin.,decrease,no risk
Anisomycin,Warfarin,The risk or severity of bleeding can be increased when Anisomycin is combined with Warfarin.,increase,risk
Androstenedione,Omaveloxolone,The serum concentration of Androstenedione can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Androstenedione,Vadadustat,The serum concentration of Androstenedione can be increased when it is combined with Vadadustat.,increase,no risk
Androstenedione,Vamorolone,The risk or severity of edema formation can be increased when Androstenedione is combined with Vamorolone.,increase,risk
Androstenedione,Venetoclax,The metabolism of Androstenedione can be decreased when combined with Venetoclax.,decrease,no risk
Androstenedione,Verapamil,The metabolism of Androstenedione can be decreased when combined with Verapamil.,decrease,no risk
Androstenedione,Viloxazine,The metabolism of Androstenedione can be decreased when combined with Viloxazine.,decrease,no risk
Androstenedione,Voriconazole,The metabolism of Androstenedione can be decreased when combined with Voriconazole.,decrease,no risk
Androstenedione,Zimelidine,The metabolism of Androstenedione can be decreased when combined with Zimelidine.,decrease,no risk
Androstenedione,Ziprasidone,The metabolism of Androstenedione can be decreased when combined with Ziprasidone.,decrease,no risk
Azapropazone,Bismuth subgallate,Azapropazone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Azapropazone,Bisoprolol,Azapropazone may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Azapropazone,Bisoxatin,Azapropazone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Azapropazone,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Azapropazone is combined with Bivalirudin.,increase,risk
Azapropazone,Bleomycin,Azapropazone may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Azapropazone,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Azapropazone.,decrease,no risk
Azapropazone,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Azapropazone.,decrease,no risk
Azapropazone,Brexpiprazole,The risk or severity of hypertension can be increased when Azapropazone is combined with Brexpiprazole.,increase,risk
Azapropazone,Brivaracetam,Azapropazone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Azapropazone,Bromazepam,Azapropazone may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Azapropazone,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Azapropazone.,increase,risk
Azapropazone,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Azapropazone.,increase,risk
Azapropazone,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Azapropazone.,increase,risk
Azapropazone,Bufexamac,The risk or severity of adverse effects can be increased when Azapropazone is combined with Bufexamac.,increase,risk
Azapropazone,Bumadizone,The risk or severity of adverse effects can be increased when Azapropazone is combined with Bumadizone.,increase,risk
Azapropazone,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Azapropazone.,decrease,no risk
Azapropazone,Bupropion,Azapropazone may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Azapropazone,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Azapropazone.,increase,risk
Azapropazone,Butabarbital,Azapropazone may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Azapropazone,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Azapropazone.,increase,risk
5beta-dihydrotestosterone,Bemiparin,5beta-dihydrotestosterone may increase the anticoagulant activities of Bemiparin.,increase,no risk
5beta-dihydrotestosterone,Betrixaban,5beta-dihydrotestosterone may increase the anticoagulant activities of Betrixaban.,increase,no risk
5beta-dihydrotestosterone,Bivalirudin,5beta-dihydrotestosterone may increase the anticoagulant activities of Bivalirudin.,increase,no risk
5beta-dihydrotestosterone,Heparin,5beta-dihydrotestosterone may increase the anticoagulant activities of Heparin.,increase,no risk
5beta-dihydrotestosterone,Urokinase,5beta-dihydrotestosterone may increase the anticoagulant activities of Urokinase.,increase,no risk
5beta-dihydrotestosterone,Vorapaxar,5beta-dihydrotestosterone may increase the anticoagulant activities of Vorapaxar.,increase,no risk
5beta-dihydrotestosterone,Warfarin,5beta-dihydrotestosterone may increase the anticoagulant activities of Warfarin.,increase,no risk
5beta-dihydrotestosterone,Ximelagatran,5beta-dihydrotestosterone may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Felbinac,Balsalazide,The risk or severity of adverse effects can be increased when Balsalazide is combined with Felbinac.,increase,risk
Felbinac,Bendazac,The risk or severity of adverse effects can be increased when Felbinac is combined with Bendazac.,increase,risk
Felbinac,Benorilate,The risk or severity of adverse effects can be increased when Felbinac is combined with Benorilate.,increase,risk
Felbinac,Benoxaprofen,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Felbinac.,increase,risk
Felbinac,Benzydamine,The risk or severity of adverse effects can be increased when Felbinac is combined with Benzydamine.,increase,risk
Felbinac,Betulinic Acid,The risk or severity of adverse effects can be increased when Felbinac is combined with Betulinic Acid.,increase,risk
Felbinac,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Felbinac.,increase,risk
Felbinac,Bufexamac,The risk or severity of adverse effects can be increased when Felbinac is combined with Bufexamac.,increase,risk
Felbinac,Bumadizone,The risk or severity of adverse effects can be increased when Felbinac is combined with Bumadizone.,increase,risk
Felbinac,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Felbinac.,increase,risk
Felbinac,Glycol salicylate,The risk or severity of adverse effects can be increased when Felbinac is combined with Glycol salicylate.,increase,risk
Felbinac,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Felbinac.,increase,risk
Felbinac,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Felbinac.,increase,risk
Felbinac,Olsalazine,The risk or severity of nephrotoxicity can be increased when Felbinac is combined with Olsalazine.,increase,risk
Felbinac,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Felbinac.,increase,risk
Felbinac,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Felbinac.,increase,risk
Felbinac,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Felbinac.,increase,risk
Felbinac,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Felbinac.,increase,risk
Felbinac,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Felbinac.,increase,risk
Felbinac,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Felbinac.,decrease,no risk
Felbinac,Voriconazole,The serum concentration of Felbinac can be increased when it is combined with Voriconazole.,increase,no risk
Chloropyramine,Benzphetamine,Benzphetamine may decrease the sedative activities of Chloropyramine.,decrease,no risk
Chloropyramine,Benzylpenicilloyl polylysine,Chloropyramine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Chloropyramine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Chloropyramine.,decrease,no risk
Chloropyramine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chloropyramine.,decrease,no risk
Chloropyramine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Chloropyramine.,decrease,no risk
Chloropyramine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Chloropyramine.,decrease,no risk
Chloropyramine,Hyoscyamine,Chloropyramine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Chloramphenicol succinate,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Chloramphenicol succinate.,decrease,no risk
Chloramphenicol succinate,Benzocaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Benzocaine.,increase,risk
Chloramphenicol succinate,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Benzyl alcohol.,increase,risk
Chloramphenicol succinate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Bupivacaine.,increase,risk
Chloramphenicol succinate,Butacaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Butacaine.,increase,risk
Chloramphenicol succinate,Butamben,The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Butamben.,increase,risk
Chloramphenicol succinate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Oxetacaine.,increase,risk
Chloramphenicol succinate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol succinate is combined with Oxybuprocaine.,increase,risk
Chloramphenicol succinate,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Chloramphenicol succinate.,decrease,no risk
Chloramphenicol succinate,Warfarin,The risk or severity of bleeding can be increased when Chloramphenicol succinate is combined with Warfarin.,increase,risk
Tranilast,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Tranilast is combined with Bismuth subsalicylate.,increase,risk
Tranilast,Bisoprolol,The therapeutic efficacy of Tranilast can be increased when used in combination with Bisoprolol.,increase,no risk
Tranilast,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Tranilast.,decrease,no risk
Tranilast,Bivalirudin,The risk or severity of bleeding can be increased when Tranilast is combined with Bivalirudin.,increase,risk
Tranilast,Blinatumomab,The risk or severity of bleeding can be increased when Tranilast is combined with Blinatumomab.,increase,risk
Tranilast,Boceprevir,The serum concentration of Tranilast can be increased when it is combined with Boceprevir.,increase,no risk
Tranilast,Bortezomib,The risk or severity of bleeding can be increased when Tranilast is combined with Bortezomib.,increase,risk
Tranilast,Bosentan,The metabolism of Tranilast can be increased when combined with Bosentan.,increase,no risk
Tranilast,Bosutinib,The risk or severity of bleeding can be increased when Tranilast is combined with Bosutinib.,increase,risk
Tranilast,Bretylium,Bretylium may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Brexpiprazole,The risk or severity of hypotension can be increased when Brexpiprazole is combined with Tranilast.,increase,risk
Tranilast,Brivaracetam,The metabolism of Tranilast can be decreased when combined with Brivaracetam.,decrease,no risk
Tranilast,Bromocriptine,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Bromocriptine.,increase,risk
Tranilast,Bumadizone,The risk or severity of bleeding can be increased when Bumadizone is combined with Tranilast.,increase,risk
Tranilast,Buprenorphine,The metabolism of Tranilast can be decreased when combined with Buprenorphine.,decrease,no risk
Tranilast,Bupropion,The metabolism of Tranilast can be decreased when combined with Bupropion.,decrease,no risk
Tranilast,Busulfan,The risk or severity of bleeding can be increased when Tranilast is combined with Busulfan.,increase,risk
Tranilast,Butabarbital,The metabolism of Tranilast can be increased when combined with Butabarbital.,increase,no risk
Tranilast,Butalbital,The metabolism of Tranilast can be increased when combined with Butalbital.,increase,no risk
Tranilast,Galantamine,Galantamine may increase the bradycardic activities of Tranilast.,increase,no risk
Tranilast,Gallamine triethiodide,Tranilast may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Tranilast,Gemcitabine,The risk or severity of bleeding can be increased when Tranilast is combined with Gemcitabine.,increase,risk
Tranilast,Gemfibrozil,The metabolism of Tranilast can be decreased when combined with Gemfibrozil.,decrease,no risk
Tranilast,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Tranilast is combined with Gemtuzumab ozogamicin.,increase,risk
Tranilast,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Tranilast.,increase,no risk
Tranilast,Gliclazide,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Gliclazide.,increase,risk
Tranilast,Glimepiride,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Glimepiride.,increase,risk
Tranilast,Glipizide,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Glipizide.,increase,risk
Tranilast,Gliquidone,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Gliquidone.,increase,risk
Tranilast,Glofitamab,The serum concentration of Tranilast can be increased when it is combined with Glofitamab.,increase,no risk
Tranilast,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Tranilast.,decrease,no risk
Tranilast,Glucosamine,Glucosamine may increase the antiplatelet activities of Tranilast.,increase,no risk
Tranilast,Glyburide,The metabolism of Tranilast can be decreased when combined with Glyburide.,decrease,no risk
Tranilast,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Tranilast.,decrease,no risk
Tranilast,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Tranilast.,increase,risk
Tranilast,Glymidine,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Glymidine.,increase,risk
Tranilast,Golimumab,The metabolism of Tranilast can be increased when combined with Golimumab.,increase,no risk
Tranilast,Guanfacine,Guanfacine may increase the bradycardic activities of Tranilast.,increase,no risk
Tranilast,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tranilast.,increase,no risk
Tranilast,Halothane,The metabolism of Tranilast can be decreased when combined with Halothane.,decrease,no risk
Tranilast,Heparin,The risk or severity of bleeding can be increased when Tranilast is combined with Heparin.,increase,risk
Tranilast,Hydromorphone,The metabolism of Tranilast can be decreased when combined with Hydromorphone.,decrease,no risk
Tranilast,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Tranilast.,increase,risk
Tranilast,Hydroxyurea,The risk or severity of bleeding can be increased when Tranilast is combined with Hydroxyurea.,increase,risk
Tranilast,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Ketamine,The metabolism of Tranilast can be decreased when combined with Ketamine.,decrease,no risk
Tranilast,Ketoconazole,The metabolism of Tranilast can be decreased when combined with Ketoconazole.,decrease,no risk
Tranilast,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Tranilast.,increase,risk
Tranilast,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Tranilast.,increase,risk
Tranilast,Obeticholic acid,The risk or severity of adverse effects can be increased when Tranilast is combined with Obeticholic acid.,increase,risk
Tranilast,Obinutuzumab,The risk or severity of adverse effects can be increased when Tranilast is combined with Obinutuzumab.,increase,risk
Tranilast,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Tranilast.,increase,no risk
Tranilast,Olanzapine,The risk or severity of hypotension can be increased when Olanzapine is combined with Tranilast.,increase,risk
Tranilast,Olaparib,The risk or severity of bleeding can be increased when Tranilast is combined with Olaparib.,increase,risk
Tranilast,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Tranilast.,increase,risk
Tranilast,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Tranilast.,decrease,no risk
Tranilast,Olsalazine,The risk or severity of bleeding can be increased when Tranilast is combined with Olsalazine.,increase,risk
Tranilast,Omaveloxolone,The serum concentration of Tranilast can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tranilast,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Tranilast.,increase,no risk
Tranilast,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Tranilast.,increase,risk
Tranilast,Ondansetron,The metabolism of Tranilast can be decreased when combined with Ondansetron.,decrease,no risk
Tranilast,Oritavancin,The metabolism of Tranilast can be decreased when combined with Oritavancin.,decrease,no risk
Tranilast,Ospemifene,The metabolism of Tranilast can be decreased when combined with Ospemifene.,decrease,no risk
Tranilast,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Tranilast.,increase,no risk
Tranilast,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Tranilast.,increase,no risk
Tranilast,Oxaliplatin,The risk or severity of bleeding can be increased when Tranilast is combined with Oxaliplatin.,increase,risk
Tranilast,Oxandrolone,The metabolism of Tranilast can be decreased when combined with Oxandrolone.,decrease,no risk
Tranilast,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Tranilast.,increase,risk
Tranilast,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Tranilast.,increase,risk
Tranilast,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Tranilast.,decrease,no risk
Tranilast,Quetiapine,The risk or severity of hypotension can be increased when Quetiapine is combined with Tranilast.,increase,risk
Tranilast,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Tranilast.,increase,risk
Tranilast,Quinidine,Quinidine may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Quinine,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Quinine.,increase,risk
Tranilast,Urokinase,Tranilast may increase the anticoagulant activities of Urokinase.,increase,no risk
Tranilast,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Tranilast is combined with Ursodeoxycholic acid.,increase,risk
Tranilast,Vadadustat,The serum concentration of Tranilast can be increased when it is combined with Vadadustat.,increase,no risk
Tranilast,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Tranilast.,increase,risk
Tranilast,Valproic acid,The metabolism of Tranilast can be decreased when combined with Valproic acid.,decrease,no risk
Tranilast,Valsartan,The metabolism of Tranilast can be decreased when combined with Valsartan.,decrease,no risk
Tranilast,Vardenafil,The metabolism of Tranilast can be decreased when combined with Vardenafil.,decrease,no risk
Tranilast,Vecuronium,Tranilast may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Tranilast,Vemurafenib,The metabolism of Tranilast can be decreased when combined with Vemurafenib.,decrease,no risk
Tranilast,Venetoclax,The metabolism of Tranilast can be decreased when combined with Venetoclax.,decrease,no risk
Tranilast,Venlafaxine,The risk or severity of bleeding can be increased when Tranilast is combined with Venlafaxine.,increase,risk
Tranilast,Verapamil,Verapamil may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Vildagliptin,The risk or severity of hypoglycemia can be increased when Tranilast is combined with Vildagliptin.,increase,risk
Tranilast,Viloxazine,The metabolism of Tranilast can be decreased when combined with Viloxazine.,decrease,no risk
Tranilast,Vinblastine,The risk or severity of bleeding can be increased when Tranilast is combined with Vinblastine.,increase,risk
Tranilast,Vindesine,The risk or severity of bleeding can be increased when Tranilast is combined with Vindesine.,increase,risk
Tranilast,Vinorelbine,The risk or severity of bleeding can be increased when Tranilast is combined with Vinorelbine.,increase,risk
Tranilast,Vitamin E,Vitamin E may increase the antiplatelet activities of Tranilast.,increase,no risk
Tranilast,Vorapaxar,The risk or severity of bleeding can be increased when Tranilast is combined with Vorapaxar.,increase,risk
Tranilast,Voriconazole,The metabolism of Tranilast can be decreased when combined with Voriconazole.,decrease,no risk
Tranilast,Vorinostat,The risk or severity of bleeding can be increased when Tranilast is combined with Vorinostat.,increase,risk
Tranilast,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Tranilast.,increase,risk
Tranilast,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Tranilast.,decrease,no risk
Tranilast,Warfarin,The risk or severity of bleeding can be increased when Tranilast is combined with Warfarin.,increase,risk
Tranilast,Ximelagatran,The risk or severity of bleeding can be increased when Tranilast is combined with Ximelagatran.,increase,risk
Tranilast,Xylometazoline,Xylometazoline may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Zafirlukast,The metabolism of Tranilast can be decreased when combined with Zafirlukast.,decrease,no risk
Tranilast,Ziconotide,Ziconotide may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Zidovudine,The risk or severity of bleeding can be increased when Tranilast is combined with Zidovudine.,increase,risk
Tranilast,Zileuton,The metabolism of Tranilast can be decreased when combined with Zileuton.,decrease,no risk
Tranilast,Zimelidine,The metabolism of Tranilast can be decreased when combined with Zimelidine.,decrease,no risk
Tranilast,Ziprasidone,The metabolism of Tranilast can be decreased when combined with Ziprasidone.,decrease,no risk
Tranilast,Zofenopril,The risk or severity of hyperkalemia can be increased when Tranilast is combined with Zofenopril.,increase,risk
Tranilast,Zolpidem,The metabolism of Tranilast can be decreased when combined with Zolpidem.,decrease,no risk
Tranilast,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Tranilast.,increase,no risk
Tranilast,Zopiclone,The metabolism of Tranilast can be decreased when combined with Zopiclone.,decrease,no risk
Tranilast,Zuclopenthixol,The risk or severity of hypotension can be increased when Zuclopenthixol is combined with Tranilast.,increase,risk
Dibromotyrosine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Dibromotyrosine.,decrease,no risk
Dibromotyrosine,Heparin,Dibromotyrosine may increase the anticoagulant activities of Heparin.,increase,no risk
Dibromotyrosine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Dibromotyrosine.,increase,risk
Dibromotyrosine,Osimertinib,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Osimertinib.,decrease,no risk
Dibromotyrosine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Dibromotyrosine.,increase,no risk
Dibromotyrosine,Oxtriphylline,Dibromotyrosine may decrease the excretion rate of Oxtriphylline which could result in a higher serum level.,decrease,no risk
Dibromotyrosine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Dibromotyrosine.,increase,risk
Dibromotyrosine,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Dibromotyrosine is combined with Quinupramine.,increase,risk
Dibromotyrosine,Quizartinib,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Quizartinib.,decrease,no risk
Dibromotyrosine,Urokinase,Dibromotyrosine may increase the anticoagulant activities of Urokinase.,increase,no risk
Dibromotyrosine,Vandetanib,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Vandetanib.,decrease,no risk
Dibromotyrosine,Vemurafenib,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Vemurafenib.,decrease,no risk
Dibromotyrosine,Vorapaxar,Dibromotyrosine may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Dibromotyrosine,Warfarin,Dibromotyrosine may increase the anticoagulant activities of Warfarin.,increase,no risk
Dibromotyrosine,Ximelagatran,Dibromotyrosine may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Dibromotyrosine,Zanubrutinib,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Dibromotyrosine,Zimelidine,The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Zimelidine.,decrease,no risk
2-Hydroxyestradiol,Opicapone,The metabolism of 2-Hydroxyestradiol can be decreased when combined with Opicapone.,decrease,no risk
Emodin,Gallamine triethiodide,The therapeutic efficacy of Emodin can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Emodin,Glycerin,The risk or severity of adverse effects can be increased when Emodin is combined with Glycerin.,increase,risk
Emodin,Glycopyrronium,The therapeutic efficacy of Emodin can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Emodin,Hexafluronium,The therapeutic efficacy of Emodin can be decreased when used in combination with Hexafluronium.,decrease,no risk
Emodin,Hexocyclium,The therapeutic efficacy of Emodin can be decreased when used in combination with Hexocyclium.,decrease,no risk
Emodin,Homatropine,The therapeutic efficacy of Emodin can be decreased when used in combination with Homatropine.,decrease,no risk
Emodin,Homatropine methylbromide,The therapeutic efficacy of Emodin can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Emodin,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Emodin.,increase,risk
Emodin,Hydrocodone,The therapeutic efficacy of Emodin can be decreased when used in combination with Hydrocodone.,decrease,no risk
Emodin,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Emodin.,increase,risk
Emodin,Hydromorphone,The therapeutic efficacy of Emodin can be decreased when used in combination with Hydromorphone.,decrease,no risk
Emodin,Hyoscyamine,The therapeutic efficacy of Emodin can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Emodin,Olanzapine,The therapeutic efficacy of Emodin can be decreased when used in combination with Olanzapine.,decrease,no risk
Emodin,Oliceridine,The therapeutic efficacy of Emodin can be decreased when used in combination with Oliceridine.,decrease,no risk
Emodin,Opium,The therapeutic efficacy of Emodin can be decreased when used in combination with Opium.,decrease,no risk
Emodin,Orphenadrine,The therapeutic efficacy of Emodin can be decreased when used in combination with Orphenadrine.,decrease,no risk
Emodin,Oxybutynin,The therapeutic efficacy of Emodin can be decreased when used in combination with Oxybutynin.,decrease,no risk
Emodin,Oxycodone,The therapeutic efficacy of Emodin can be decreased when used in combination with Oxycodone.,decrease,no risk
Emodin,Oxymorphone,The therapeutic efficacy of Emodin can be decreased when used in combination with Oxymorphone.,decrease,no risk
Emodin,Oxyphencyclimine,The therapeutic efficacy of Emodin can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Emodin,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Emodin is combined with Oxyphenisatin acetate.,increase,risk
Emodin,Oxyphenonium,The therapeutic efficacy of Emodin can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Emodin,Quetiapine,The therapeutic efficacy of Emodin can be decreased when used in combination with Quetiapine.,decrease,no risk
Emodin,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Emodin.,increase,risk
Emodin,Quinidine,The therapeutic efficacy of Emodin can be decreased when used in combination with Quinidine.,decrease,no risk
Emodin,Umeclidinium,The therapeutic efficacy of Emodin can be decreased when used in combination with Umeclidinium.,decrease,no risk
Emodin,Vecuronium,The therapeutic efficacy of Emodin can be decreased when used in combination with Vecuronium.,decrease,no risk
Emodin,Verapamil,The therapeutic efficacy of Emodin can be decreased when used in combination with Verapamil.,decrease,no risk
Emodin,Xylometazoline,The therapeutic efficacy of Emodin can be decreased when used in combination with Xylometazoline.,decrease,no risk
Emodin,Ziconotide,The therapeutic efficacy of Emodin can be decreased when used in combination with Ziconotide.,decrease,no risk
Emodin,Ziprasidone,The therapeutic efficacy of Emodin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Emodin,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Emodin.,increase,risk
Epibatidine,Betaine,The risk or severity of adverse effects can be increased when Betaine is combined with Epibatidine.,increase,risk
Epibatidine,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Epibatidine.,increase,risk
Epibatidine,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Epibatidine.,increase,risk
Epibatidine,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Epibatidine.,increase,risk
Epibatidine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Epibatidine.,increase,risk
Epibatidine,Gentamicin,The therapeutic efficacy of Epibatidine can be decreased when used in combination with Gentamicin.,decrease,no risk
Epibatidine,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Epibatidine.,increase,risk
Epibatidine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Epibatidine.,increase,risk
Epibatidine,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Epibatidine.,increase,risk
Epibatidine,Kanamycin,The therapeutic efficacy of Epibatidine can be decreased when used in combination with Kanamycin.,decrease,no risk
Epibatidine,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Epibatidine.,increase,risk
Epibatidine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Epibatidine.,increase,risk
Ferulic acid,Gemcitabine,The risk or severity of bleeding can be increased when Ferulic acid is combined with Gemcitabine.,increase,risk
Ferulic acid,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ferulic acid is combined with Gemtuzumab ozogamicin.,increase,risk
Ferulic acid,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Ferulic acid.,increase,risk
Ferulic acid,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Ferulic acid.,increase,no risk
Ferulic acid,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Ferulic acid.,increase,risk
Ferulic acid,Guanabenz,Guanabenz may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Guanadrel,Guanadrel may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Guanethidine,Guanethidine may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Guanfacine,Guanfacine may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Guanoxan,Ferulic acid may increase the hypotensive activities of Guanoxan.,increase,no risk
Ferulic acid,Halothane,Halothane may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Hemin,Hemin may increase the anticoagulant activities of Ferulic acid.,increase,no risk
Ferulic acid,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ferulic acid.,increase,risk
Ferulic acid,Hydralazine,Hydralazine may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Hydrochlorothiazide,The therapeutic efficacy of Ferulic acid can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Ferulic acid,Hydroflumethiazide,The therapeutic efficacy of Ferulic acid can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Ferulic acid,Hydroxyprogesterone caproate,The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Ferulic acid,Hydroxyurea,The risk or severity of bleeding can be increased when Ferulic acid is combined with Hydroxyurea.,increase,risk
Ferulic acid,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ferulic acid.,increase,risk
Ferulic acid,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ferulic acid.,increase,risk
Ferulic acid,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Ferulic acid is combined with Obeticholic acid.,increase,risk
Ferulic acid,Obinutuzumab,Ferulic acid may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Ferulic acid,Olanzapine,Olanzapine may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Olaparib,The risk or severity of bleeding can be increased when Ferulic acid is combined with Olaparib.,increase,risk
Ferulic acid,Olive oil,The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Olive oil.,decrease,no risk
Ferulic acid,Olmesartan,Olmesartan may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Olodaterol,Olodaterol may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Ferulic acid.,increase,risk
Ferulic acid,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ferulic acid is combined with Omacetaxine mepesuccinate.,increase,risk
Ferulic acid,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Ferulic acid.,increase,no risk
Ferulic acid,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ferulic acid.,increase,risk
Ferulic acid,Omega-3-carboxylic acids,The therapeutic efficacy of Ferulic acid can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Ferulic acid,Opicapone,Opicapone may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ferulic acid.,increase,risk
Ferulic acid,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Ferulic acid.,increase,risk
Ferulic acid,Oxprenolol,Oxprenolol may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Oxymetazoline,The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Ferulic acid,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Ferulic acid.,increase,risk
Ferulic acid,Quetiapine,Quetiapine may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Quinapril,Quinapril may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Quinestrol,Quinestrol may decrease the anticoagulant activities of Ferulic acid.,decrease,no risk
Ferulic acid,Quinidine,The therapeutic efficacy of Ferulic acid can be increased when used in combination with Quinidine.,increase,no risk
Ferulic acid,Quinine,The therapeutic efficacy of Ferulic acid can be increased when used in combination with Quinine.,increase,no risk
Ferulic acid,Quinupramine,Quinupramine may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Udenafil,Udenafil may increase the antihypertensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Ulipristal,The therapeutic efficacy of Ferulic acid can be decreased when used in combination with Ulipristal.,decrease,no risk
Ferulic acid,Unoprostone,Unoprostone may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Urokinase,Urokinase may increase the anticoagulant activities of Ferulic acid.,increase,no risk
Ferulic acid,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Ferulic acid is combined with Ursodeoxycholic acid.,increase,risk
Ferulic acid,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Ferulic acid.,increase,risk
Ferulic acid,Valsartan,Valsartan may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Vardenafil,Vardenafil may increase the antihypertensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Venlafaxine,The risk or severity of bleeding can be increased when Ferulic acid is combined with Venlafaxine.,increase,risk
Ferulic acid,Verapamil,Verapamil may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Vericiguat,Vericiguat may increase the hypotensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Vilanterol,Vilanterol may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Vilazodone,Vilazodone may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Vinblastine,The risk or severity of bleeding can be increased when Ferulic acid is combined with Vinblastine.,increase,risk
Ferulic acid,Vindesine,The risk or severity of bleeding can be increased when Ferulic acid is combined with Vindesine.,increase,risk
Ferulic acid,Vinorelbine,The risk or severity of bleeding can be increased when Ferulic acid is combined with Vinorelbine.,increase,risk
Ferulic acid,Vitamin E,Vitamin E may increase the anticoagulant activities of Ferulic acid.,increase,no risk
Ferulic acid,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Ferulic acid.,decrease,no risk
Ferulic acid,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ferulic acid.,increase,risk
Ferulic acid,Vorinostat,The risk or severity of bleeding can be increased when Ferulic acid is combined with Vorinostat.,increase,risk
Ferulic acid,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Ferulic acid.,increase,risk
Ferulic acid,Xamoterol,Xamoterol may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ferulic acid.,increase,risk
Ferulic acid,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Yohimbine,Yohimbine may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Zidovudine,The risk or severity of bleeding can be increased when Ferulic acid is combined with Zidovudine.,increase,risk
Ferulic acid,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ferulic acid.,increase,risk
Ferulic acid,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Ferulic acid.,increase,no risk
Ferulic acid,Zofenopril,Ferulic acid may increase the hypotensive activities of Zofenopril.,increase,no risk
Ferulic acid,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Ferulic acid,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Ferulic acid.,decrease,no risk
Epitestosterone,Beclomethasone dipropionate,The risk or severity of edema formation can be increased when Epitestosterone is combined with Beclomethasone dipropionate.,increase,risk
Epitestosterone,Betamethasone,The risk or severity of edema formation can be increased when Epitestosterone is combined with Betamethasone.,increase,risk
Epitestosterone,Betamethasone phosphate,The risk or severity of edema formation can be increased when Epitestosterone is combined with Betamethasone phosphate.,increase,risk
Epitestosterone,Budesonide,The risk or severity of edema formation can be increased when Epitestosterone is combined with Budesonide.,increase,risk
Epitestosterone,Hydrocortisone,The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone.,increase,risk
Epitestosterone,Hydrocortisone acetate,The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone acetate.,increase,risk
Epitestosterone,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone butyrate.,increase,risk
Epitestosterone,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone cypionate.,increase,risk
Epitestosterone,Hydrocortisone succinate,The risk or severity of edema formation can be increased when Epitestosterone is combined with Hydrocortisone succinate.,increase,risk
Farnesyl diphosphate,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Gadobenic acid.,increase,risk
Farnesyl diphosphate,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Gemifloxacin.,increase,risk
Farnesyl diphosphate,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Gilteritinib,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Gilteritinib.,increase,risk
Farnesyl diphosphate,Glasdegib,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Glasdegib.,increase,risk
Farnesyl diphosphate,Goserelin,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Goserelin.,increase,risk
Farnesyl diphosphate,Granisetron,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Granisetron.,increase,risk
Farnesyl diphosphate,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Grepafloxacin.,increase,risk
Farnesyl diphosphate,Halofantrine,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Halofantrine.,increase,risk
Farnesyl diphosphate,Haloperidol,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Haloperidol.,increase,risk
Farnesyl diphosphate,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Hydroxyzine.,increase,risk
Farnesyl diphosphate,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Farnesyl diphosphate.,increase,risk
Farnesyl diphosphate,Ofloxacin,The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Ofloxacin.,increase,risk
Geranylgeranyl diphosphate,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Gadobenic acid.,increase,risk
Geranylgeranyl diphosphate,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Geranylgeranyl diphosphate.,increase,risk
Geranylgeranyl diphosphate,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Geranylgeranyl diphosphate.,increase,risk
Geranylgeranyl diphosphate,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Gemifloxacin.,increase,risk
Geranylgeranyl diphosphate,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Geranylgeranyl diphosphate.,increase,risk
Geranylgeranyl diphosphate,Gilteritinib,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Gilteritinib.,increase,risk
Geranylgeranyl diphosphate,Glasdegib,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Glasdegib.,increase,risk
Geranylgeranyl diphosphate,Goserelin,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Goserelin.,increase,risk
Geranylgeranyl diphosphate,Granisetron,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Granisetron.,increase,risk
Geranylgeranyl diphosphate,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Grepafloxacin.,increase,risk
Geranylgeranyl diphosphate,Halofantrine,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Halofantrine.,increase,risk
Geranylgeranyl diphosphate,Haloperidol,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Haloperidol.,increase,risk
Geranylgeranyl diphosphate,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Geranylgeranyl diphosphate.,increase,risk
Geranylgeranyl diphosphate,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Geranylgeranyl diphosphate.,increase,risk
Geranylgeranyl diphosphate,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Geranylgeranyl diphosphate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Geranylgeranyl diphosphate,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Geranylgeranyl diphosphate.,increase,risk
Geranylgeranyl diphosphate,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Hydroxyzine.,increase,risk
Geranylgeranyl diphosphate,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Geranylgeranyl diphosphate.,increase,risk
Geranylgeranyl diphosphate,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Geranylgeranyl diphosphate.,increase,risk
Hexestrol,Galcanezumab,Hexestrol may increase the thrombogenic activities of Galcanezumab.,increase,no risk
Hexestrol,Gemtuzumab ozogamicin,Hexestrol may increase the thrombogenic activities of Gemtuzumab ozogamicin.,increase,no risk
Hexestrol,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Glofitamab,Hexestrol may increase the thrombogenic activities of Glofitamab.,increase,no risk
Hexestrol,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Golimumab,Hexestrol may increase the thrombogenic activities of Golimumab.,increase,no risk
Hexestrol,Guselkumab,Hexestrol may increase the thrombogenic activities of Guselkumab.,increase,no risk
Hexestrol,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Hepatitis B immune globulin,Hexestrol may increase the thrombogenic activities of Hepatitis B immune globulin.,increase,no risk
Hexestrol,Human cytomegalovirus immune globulin,Hexestrol may increase the thrombogenic activities of Human cytomegalovirus immune globulin.,increase,no risk
Hexestrol,Human immunoglobulin G,Hexestrol may increase the thrombogenic activities of Human immunoglobulin G.,increase,no risk
Hexestrol,Human Rho(D) immune globulin,Hexestrol may increase the thrombogenic activities of Human Rho(D) immune globulin.,increase,no risk
Hexestrol,Human varicella-zoster immune globulin,Hexestrol may increase the thrombogenic activities of Human varicella-zoster immune globulin.,increase,no risk
Hexestrol,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Hexestrol.,decrease,no risk
Hexestrol,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Hexestrol.,increase,no risk
Hexestrol,Obiltoxaximab,Hexestrol may increase the thrombogenic activities of Obiltoxaximab.,increase,no risk
Hexestrol,Obinutuzumab,Hexestrol may increase the thrombogenic activities of Obinutuzumab.,increase,no risk
Hexestrol,Ocrelizumab,Hexestrol may increase the thrombogenic activities of Ocrelizumab.,increase,no risk
Hexestrol,Odesivimab,Hexestrol may increase the thrombogenic activities of Odesivimab.,increase,no risk
Hexestrol,Ofatumumab,Hexestrol may increase the thrombogenic activities of Ofatumumab.,increase,no risk
Hexestrol,Olaratumab,Hexestrol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Hexestrol,Omalizumab,Hexestrol may increase the thrombogenic activities of Omalizumab.,increase,no risk
Hexestrol,Ombitasvir,The risk or severity of liver enzyme elevations can be increased when Hexestrol is combined with Ombitasvir.,increase,risk
Hexestrol,Ospemifene,The risk or severity of adverse effects can be increased when Hexestrol is combined with Ospemifene.,increase,risk
Hexestrol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Hexestrol is combined with Oxetacaine.,increase,risk
Hexestrol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Hexestrol is combined with Oxybuprocaine.,increase,risk
Hexestrol,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Hexestrol.,increase,no risk
Hexestrol,Ublituximab,Hexestrol may increase the thrombogenic activities of Ublituximab.,increase,no risk
Hexestrol,Urokinase,Hexestrol may decrease the anticoagulant activities of Urokinase.,decrease,no risk
Hexestrol,Ustekinumab,Hexestrol may increase the thrombogenic activities of Ustekinumab.,increase,no risk
Hexestrol,Valdecoxib,Valdecoxib may increase the thrombogenic activities of Hexestrol.,increase,no risk
Hexestrol,Vedolizumab,Hexestrol may increase the thrombogenic activities of Vedolizumab.,increase,no risk
Hexestrol,Vorapaxar,Hexestrol may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Hexestrol,Warfarin,Hexestrol may decrease the anticoagulant activities of Warfarin.,decrease,no risk
Hexestrol,Ximelagatran,Hexestrol may decrease the anticoagulant activities of Ximelagatran.,decrease,no risk
Hexestrol,Zinc ascorbate,The serum concentration of Zinc ascorbate can be decreased when it is combined with Hexestrol.,decrease,no risk
3-isobutyl-1-methyl-7H-xanthine,Ofloxacin,The metabolism of 3-isobutyl-1-methyl-7H-xanthine can be decreased when combined with Ofloxacin.,decrease,no risk
3-isobutyl-1-methyl-7H-xanthine,Olodaterol,3-isobutyl-1-methyl-7H-xanthine may increase the hyperkalemic activities of Olodaterol.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with 3-isobutyl-1-methyl-7H-xanthine.,increase,risk
3-isobutyl-1-methyl-7H-xanthine,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine.,decrease,no risk
3-isobutyl-1-methyl-7H-xanthine,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with 3-isobutyl-1-methyl-7H-xanthine.,increase,risk
3-isobutyl-1-methyl-7H-xanthine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with 3-isobutyl-1-methyl-7H-xanthine.,increase,risk
3-isobutyl-1-methyl-7H-xanthine,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with 3-isobutyl-1-methyl-7H-xanthine.,decrease,no risk
3-isobutyl-1-methyl-7H-xanthine,Quinidine,The serum concentration of 3-isobutyl-1-methyl-7H-xanthine can be increased when it is combined with Quinidine.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Quinine,The serum concentration of 3-isobutyl-1-methyl-7H-xanthine can be increased when it is combined with Quinine.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Valproic acid,Valproic acid may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Vigabatrin,Vigabatrin may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Vilanterol,The risk or severity of hypokalemia can be increased when 3-isobutyl-1-methyl-7H-xanthine is combined with Vilanterol.,increase,risk
3-isobutyl-1-methyl-7H-xanthine,Viloxazine,The serum concentration of 3-isobutyl-1-methyl-7H-xanthine can be increased when it is combined with Viloxazine.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with 3-isobutyl-1-methyl-7H-xanthine.,decrease,no risk
3-isobutyl-1-methyl-7H-xanthine,Zaleplon,Zaleplon may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
3-isobutyl-1-methyl-7H-xanthine,Zonisamide,Zonisamide may increase the excretion rate of 3-isobutyl-1-methyl-7H-xanthine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Benzylpenicillin,5-(2-methylpiperazine-1-sulfonyl)isoquinoline may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
5-(2-methylpiperazine-1-sulfonyl)isoquinoline,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with 5-(2-methylpiperazine-1-sulfonyl)isoquinoline.,increase,no risk
Wortmannin,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Wortmannin.,increase,risk
Wortmannin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Wortmannin is combined with Gabapentin enacarbil.,increase,risk
Wortmannin,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Wortmannin.,increase,risk
Wortmannin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Wortmannin is combined with Ganaxolone.",increase,risk
Wortmannin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Wortmannin.,increase,risk
Wortmannin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Wortmannin.,increase,risk
Wortmannin,Gepirone,The risk or severity of CNS depression can be increased when Wortmannin is combined with Gepirone.,increase,risk
Wortmannin,Gilteritinib,The therapeutic efficacy of Wortmannin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Wortmannin,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Wortmannin.,increase,risk
Wortmannin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Wortmannin.,increase,risk
Wortmannin,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Wortmannin.,increase,risk
Wortmannin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Wortmannin.,increase,risk
Wortmannin,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Wortmannin.,increase,risk
Wortmannin,Guselkumab,The risk or severity of adverse effects can be increased when Wortmannin is combined with Guselkumab.,increase,risk
Wortmannin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Wortmannin.,decrease,no risk
Wortmannin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Wortmannin.,increase,risk
Wortmannin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Wortmannin.,increase,risk
Wortmannin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Wortmannin.,increase,risk
Wortmannin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Wortmannin.,decrease,no risk
Wortmannin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Wortmannin.,decrease,no risk
Wortmannin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Wortmannin.,increase,risk
Wortmannin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Wortmannin.,increase,risk
Wortmannin,Hydrocodone,Wortmannin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Wortmannin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Wortmannin is combined with Hydrocortisone acetate.,increase,risk
Wortmannin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Wortmannin is combined with Hydrocortisone butyrate.,increase,risk
Wortmannin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Wortmannin is combined with Hydrocortisone succinate.,increase,risk
Wortmannin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Wortmannin.,increase,risk
Wortmannin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Wortmannin.,increase,risk
Wortmannin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Wortmannin.,increase,risk
Wortmannin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Wortmannin.,increase,no risk
Wortmannin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Wortmannin.,decrease,no risk
Wortmannin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Wortmannin.,decrease,no risk
Wortmannin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Wortmannin.,increase,risk
Wortmannin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Wortmannin.,increase,risk
Wortmannin,Obinutuzumab,The risk or severity of adverse effects can be increased when Wortmannin is combined with Obinutuzumab.,increase,risk
Wortmannin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Wortmannin.,increase,no risk
Wortmannin,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Wortmannin.,increase,risk
Wortmannin,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Wortmannin.,increase,risk
Wortmannin,Olaparib,The risk or severity of adverse effects can be increased when Wortmannin is combined with Olaparib.,increase,risk
Wortmannin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Wortmannin is combined with Oliceridine.",increase,risk
Wortmannin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Wortmannin.,increase,risk
Wortmannin,Opium,The risk or severity of CNS depression can be increased when Wortmannin is combined with Opium.,increase,risk
Wortmannin,Orphenadrine,Wortmannin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Wortmannin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Wortmannin.,increase,risk
Wortmannin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Wortmannin.,increase,risk
Wortmannin,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Wortmannin.,increase,risk
Wortmannin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Wortmannin.,increase,risk
Wortmannin,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Wortmannin.,increase,risk
Wortmannin,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Wortmannin.,increase,risk
Wortmannin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Wortmannin.,increase,risk
Wortmannin,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Wortmannin.,increase,risk
Wortmannin,Ozanimod,The risk or severity of adverse effects can be increased when Wortmannin is combined with Ozanimod.,increase,risk
Wortmannin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Wortmannin.,increase,risk
Wortmannin,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Wortmannin.,increase,risk
Wortmannin,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Wortmannin.,increase,risk
Wortmannin,Quinupramine,The risk or severity of CNS depression can be increased when Wortmannin is combined with Quinupramine.,increase,risk
Wortmannin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Wortmannin.,increase,risk
Wortmannin,Upadacitinib,The risk or severity of adverse effects can be increased when Wortmannin is combined with Upadacitinib.,increase,risk
Wortmannin,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Wortmannin.,increase,risk
Wortmannin,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Wortmannin.,increase,risk
Wortmannin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Wortmannin.,increase,risk
Wortmannin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Wortmannin.,decrease,no risk
Wortmannin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Wortmannin.,increase,risk
Wortmannin,Vedolizumab,The risk or severity of adverse effects can be increased when Wortmannin is combined with Vedolizumab.,increase,risk
Wortmannin,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Wortmannin.,increase,risk
Wortmannin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Wortmannin.,decrease,no risk
Wortmannin,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Wortmannin.,increase,risk
Wortmannin,Vilanterol,The risk or severity of adverse effects can be increased when Wortmannin is combined with Vilanterol.,increase,risk
Wortmannin,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Wortmannin.,increase,risk
Wortmannin,Viloxazine,The risk or severity of CNS depression can be increased when Wortmannin is combined with Viloxazine.,increase,risk
Wortmannin,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Wortmannin.,increase,risk
Wortmannin,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Wortmannin.,increase,risk
Wortmannin,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Wortmannin.,increase,risk
Wortmannin,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Wortmannin.,increase,risk
Wortmannin,Voclosporin,The risk or severity of adverse effects can be increased when Wortmannin is combined with Voclosporin.,increase,risk
Wortmannin,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Wortmannin.,increase,risk
Wortmannin,Vortioxetine,The risk or severity of CNS depression can be increased when Wortmannin is combined with Vortioxetine.,increase,risk
Wortmannin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Wortmannin.,increase,no risk
Wortmannin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Wortmannin.,increase,risk
Wortmannin,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Wortmannin.,increase,risk
Wortmannin,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Wortmannin.,increase,risk
Wortmannin,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Wortmannin.,increase,risk
Wortmannin,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Wortmannin.,increase,risk
Wortmannin,Zimelidine,The risk or severity of adverse effects can be increased when Wortmannin is combined with Zimelidine.,increase,risk
Wortmannin,Ziprasidone,The risk or severity of adverse effects can be increased when Wortmannin is combined with Ziprasidone.,increase,risk
Wortmannin,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Wortmannin.,increase,risk
Wortmannin,Zolpidem,Wortmannin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Wortmannin,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Wortmannin.,increase,risk
Wortmannin,Zopiclone,The risk or severity of adverse effects can be increased when Wortmannin is combined with Zopiclone.,increase,risk
Wortmannin,Zotepine,The risk or severity of CNS depression can be increased when Wortmannin is combined with Zotepine.,increase,risk
Wortmannin,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Wortmannin.,increase,risk
Wortmannin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Wortmannin.,increase,risk
Fasudil,Gallamine triethiodide,Fasudil may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Fasudil,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Fasudil.,decrease,no risk
Fasudil,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Fasudil.,decrease,no risk
Fasudil,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Fasudil.,increase,risk
Fasudil,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Ketoconazole,The therapeutic efficacy of Ketoconazole can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fasudil.,increase,risk
Fasudil,Olanzapine,The risk or severity of hypotension can be increased when Olanzapine is combined with Fasudil.,increase,risk
Fasudil,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Fasudil.,increase,no risk
Fasudil,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Fasudil.,decrease,no risk
Fasudil,Quetiapine,The risk or severity of hypotension can be increased when Quetiapine is combined with Fasudil.,increase,risk
Fasudil,Quinidine,Quinidine may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Vecuronium,Fasudil may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Fasudil,Verapamil,Verapamil may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Voriconazole,The therapeutic efficacy of Voriconazole can be increased when used in combination with Fasudil.,increase,no risk
Fasudil,Xylometazoline,Xylometazoline may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Ziconotide,Ziconotide may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Ziprasidone,The risk or severity of hypotension can be increased when Ziprasidone is combined with Fasudil.,increase,risk
Fasudil,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Fasudil.,increase,no risk
Fasudil,Zuclopenthixol,The risk or severity of hypotension can be increased when Zuclopenthixol is combined with Fasudil.,increase,risk
Methylthioninium,Olanzapine,The risk or severity of serotonin syndrome can be increased when Olanzapine is combined with Methylthioninium.,increase,risk
Methylthioninium,Oliceridine,The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Oliceridine.,increase,risk
Methylthioninium,Ondansetron,The risk or severity of serotonin syndrome can be increased when Ondansetron is combined with Methylthioninium.,increase,risk
Methylthioninium,Opium,The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Opium.,increase,risk
Methylthioninium,Oxycodone,The risk or severity of serotonin syndrome can be increased when Oxycodone is combined with Methylthioninium.,increase,risk
Methylthioninium,Oxymorphone,The risk or severity of serotonin syndrome can be increased when Oxymorphone is combined with Methylthioninium.,increase,risk
Methylthioninium,Quetiapine,The risk or severity of serotonin syndrome can be increased when Quetiapine is combined with Methylthioninium.,increase,risk
Methylthioninium,Quinupramine,The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Quinupramine.,increase,risk
Methylthioninium,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Valproate bismuth.,increase,risk
Methylthioninium,Valproic acid,The risk or severity of serotonin syndrome can be increased when Valproic acid is combined with Methylthioninium.,increase,risk
Methylthioninium,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Venlafaxine.,increase,risk
Methylthioninium,Vilazodone,The risk or severity of serotonin syndrome can be increased when Vilazodone is combined with Methylthioninium.,increase,risk
Methylthioninium,Vortioxetine,The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Vortioxetine.,increase,risk
Methylthioninium,Yohimbine,The risk or severity of serotonin syndrome can be increased when Yohimbine is combined with Methylthioninium.,increase,risk
Methylthioninium,Zimelidine,The risk or severity of serotonin syndrome can be increased when Zimelidine is combined with Methylthioninium.,increase,risk
Methylthioninium,Ziprasidone,The risk or severity of serotonin syndrome can be increased when Ziprasidone is combined with Methylthioninium.,increase,risk
Methylthioninium,Zolmitriptan,The risk or severity of serotonin syndrome can be increased when Zolmitriptan is combined with Methylthioninium.,increase,risk
Methylthioninium,Zotepine,The risk or severity of serotonin syndrome can be increased when Methylthioninium is combined with Zotepine.,increase,risk
Methylthioninium,Zuclopenthixol,The risk or severity of serotonin syndrome can be increased when Zuclopenthixol is combined with Methylthioninium.,increase,risk
Tofacitinib,Galantamine,Galantamine may increase the bradycardic activities of Tofacitinib.,increase,no risk
Tofacitinib,Gemcitabine,Gemcitabine may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Gemtuzumab ozogamicin,Gemtuzumab ozogamicin may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Glatiramer,Glatiramer may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Glofitamab,The serum concentration of Tofacitinib can be increased when it is combined with Glofitamab.,increase,no risk
Tofacitinib,Glyburide,The metabolism of Tofacitinib can be decreased when combined with Glyburide.,decrease,no risk
Tofacitinib,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Tofacitinib.,increase,risk
Tofacitinib,Guanfacine,Guanfacine may increase the bradycardic activities of Tofacitinib.,increase,no risk
Tofacitinib,Guselkumab,Guselkumab may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tofacitinib.,decrease,no risk
Tofacitinib,Haloperidol,The metabolism of Tofacitinib can be decreased when combined with Haloperidol.,decrease,no risk
Tofacitinib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Tofacitinib.,increase,risk
Tofacitinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Tofacitinib.,decrease,no risk
Tofacitinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tofacitinib.,decrease,no risk
Tofacitinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Tofacitinib is combined with Human adenovirus e serotype 4 strain cl-68578 antigen.,increase,risk
Tofacitinib,Hydralazine,The metabolism of Tofacitinib can be decreased when combined with Hydralazine.,decrease,no risk
Tofacitinib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Tofacitinib.,increase,risk
Tofacitinib,Hydrocortisone,Hydrocortisone may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Hydrocortisone acetate,Hydrocortisone acetate may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Hydrocortisone succinate,Hydrocortisone succinate may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Tofacitinib.,increase,risk
Tofacitinib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Tofacitinib.,increase,risk
Tofacitinib,Hydroxyurea,Hydroxyurea may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tofacitinib.,decrease,no risk
Tofacitinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Tofacitinib.,decrease,no risk
Tofacitinib,Ketazolam,The metabolism of Tofacitinib can be decreased when combined with Ketazolam.,decrease,no risk
Tofacitinib,Ketoconazole,The metabolism of Tofacitinib can be decreased when combined with Ketoconazole.,decrease,no risk
Tofacitinib,Obinutuzumab,Obinutuzumab may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Octreotide,The metabolism of Tofacitinib can be decreased when combined with Octreotide.,decrease,no risk
Tofacitinib,Ofatumumab,Ofatumumab may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Olaparib,The metabolism of Tofacitinib can be decreased when combined with Olaparib.,decrease,no risk
Tofacitinib,Omaveloxolone,The serum concentration of Tofacitinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tofacitinib,Orphenadrine,The metabolism of Tofacitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Tofacitinib,Osilodrostat,The metabolism of Tofacitinib can be decreased when combined with Osilodrostat.,decrease,no risk
Tofacitinib,Oxaliplatin,Oxaliplatin may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Oxetacaine,The metabolism of Tofacitinib can be decreased when combined with Oxetacaine.,decrease,no risk
Tofacitinib,Oxprenolol,Oxprenolol may increase the bradycardic activities of Tofacitinib.,increase,no risk
Tofacitinib,Oxybutynin,The metabolism of Tofacitinib can be decreased when combined with Oxybutynin.,decrease,no risk
Tofacitinib,Oxymetholone,The metabolism of Tofacitinib can be decreased when combined with Oxymetholone.,decrease,no risk
Tofacitinib,Ozanimod,Ozanimod may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Quinidine,The metabolism of Tofacitinib can be decreased when combined with Quinidine.,decrease,no risk
Tofacitinib,Quinine,The metabolism of Tofacitinib can be decreased when combined with Quinine.,decrease,no risk
Tofacitinib,Quinupristin,The metabolism of Tofacitinib can be decreased when combined with Quinupristin.,decrease,no risk
Tofacitinib,Ublituximab,Ublituximab may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Upadacitinib,Upadacitinib may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Tofacitinib.,increase,risk
Tofacitinib,Vadadustat,The serum concentration of Tofacitinib can be increased when it is combined with Vadadustat.,increase,no risk
Tofacitinib,Valproic acid,The metabolism of Tofacitinib can be decreased when combined with Valproic acid.,decrease,no risk
Tofacitinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Tofacitinib is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Tofacitinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Tofacitinib.,decrease,no risk
Tofacitinib,Vedolizumab,Vedolizumab may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Venetoclax,The metabolism of Tofacitinib can be decreased when combined with Venetoclax.,decrease,no risk
Tofacitinib,Verapamil,The metabolism of Tofacitinib can be decreased when combined with Verapamil.,decrease,no risk
Tofacitinib,Vibrio cholerae CVD 103-HgR strain live antigen,The risk or severity of infection can be increased when Tofacitinib is combined with Vibrio cholerae CVD 103-HgR strain live antigen.,increase,risk
Tofacitinib,Vilanterol,Vilanterol may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Viloxazine,The metabolism of Tofacitinib can be decreased when combined with Viloxazine.,decrease,no risk
Tofacitinib,Vinblastine,The metabolism of Tofacitinib can be decreased when combined with Vinblastine.,decrease,no risk
Tofacitinib,Vincristine,Vincristine may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Vindesine,Vindesine may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Vinorelbine,Vinorelbine may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Voclosporin,Voclosporin may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Tofacitinib.,increase,risk
Tofacitinib,Voriconazole,The metabolism of Tofacitinib can be decreased when combined with Voriconazole.,decrease,no risk
Tofacitinib,Vorinostat,Vorinostat may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Tofacitinib.,increase,risk
Tofacitinib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Tofacitinib.,increase,risk
Tofacitinib,Yellow fever vaccine,The risk or severity of infection can be increased when Tofacitinib is combined with Yellow fever vaccine.,increase,risk
Tofacitinib,Zafirlukast,The metabolism of Tofacitinib can be decreased when combined with Zafirlukast.,decrease,no risk
Tofacitinib,Zidovudine,Zidovudine may increase the immunosuppressive activities of Tofacitinib.,increase,no risk
Tofacitinib,Zimelidine,The metabolism of Tofacitinib can be decreased when combined with Zimelidine.,decrease,no risk
Tofacitinib,Ziprasidone,The metabolism of Tofacitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Tofacitinib,Zonisamide,Zonisamide may increase the bradycardic activities of Tofacitinib.,increase,no risk
Emivirine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Emivirine.,decrease,no risk
Emivirine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Emivirine.,decrease,no risk
Emivirine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Emivirine.,decrease,no risk
Emivirine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Emivirine.,decrease,no risk
Emivirine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Emivirine.,decrease,no risk
Emivirine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Emivirine.,decrease,no risk
Emivirine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Emivirine.,decrease,no risk
Emivirine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Emivirine.,decrease,no risk
Nocodazole,Benzocaine,The risk or severity of methemoglobinemia can be increased when Nocodazole is combined with Benzocaine.,increase,risk
Nocodazole,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Nocodazole is combined with Benzyl alcohol.,increase,risk
Nocodazole,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Nocodazole is combined with Bupivacaine.,increase,risk
Nocodazole,Butacaine,The risk or severity of methemoglobinemia can be increased when Nocodazole is combined with Butacaine.,increase,risk
Nocodazole,Butamben,The risk or severity of methemoglobinemia can be increased when Nocodazole is combined with Butamben.,increase,risk
Nocodazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nocodazole is combined with Oxetacaine.,increase,risk
Nocodazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nocodazole is combined with Oxybuprocaine.,increase,risk
Sulthiame,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Sulthiame.,increase,risk
Sulthiame,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Sulthiame is combined with Gabapentin enacarbil.,increase,risk
Sulthiame,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Sulthiame.,increase,risk
Sulthiame,Gamolenic acid,The therapeutic efficacy of Sulthiame can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Sulthiame,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Sulthiame is combined with Ganaxolone.",increase,risk
Sulthiame,Ganciclovir,The therapeutic efficacy of Sulthiame can be decreased when used in combination with Ganciclovir.,decrease,no risk
Sulthiame,Gepirone,The risk or severity of CNS depression can be increased when Sulthiame is combined with Gepirone.,increase,risk
Sulthiame,Gestrinone,The metabolism of Gestrinone can be increased when combined with Sulthiame.,increase,no risk
Sulthiame,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulthiame.,increase,no risk
Sulthiame,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulthiame.,increase,no risk
Sulthiame,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Sulthiame.,increase,no risk
Sulthiame,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulthiame.,increase,no risk
Sulthiame,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Sulthiame.,increase,risk
Sulthiame,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Sulthiame.,increase,no risk
Sulthiame,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sulthiame.,increase,no risk
Sulthiame,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Sulthiame.,increase,risk
Sulthiame,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Sulthiame.,increase,risk
Sulthiame,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Sulthiame.,increase,risk
Sulthiame,Halofantrine,The therapeutic efficacy of Sulthiame can be decreased when used in combination with Halofantrine.,decrease,no risk
Sulthiame,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Sulthiame.,increase,risk
Sulthiame,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Sulthiame.,increase,risk
Sulthiame,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Sulthiame.,increase,risk
Sulthiame,Hydrocodone,Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Sulthiame,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Sulthiame.,increase,risk
Sulthiame,Hydroxychloroquine,The therapeutic efficacy of Sulthiame can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Sulthiame,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Sulthiame.,increase,no risk
Sulthiame,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Sulthiame.,increase,no risk
Sulthiame,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Sulthiame.,increase,risk
Sulthiame,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Sulthiame.,increase,risk
Sulthiame,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulthiame.,increase,risk
Sulthiame,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Sulthiame.,increase,risk
Sulthiame,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Sulthiame is combined with Oliceridine.",increase,risk
Sulthiame,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Sulthiame.,increase,risk
Sulthiame,Opium,The risk or severity of CNS depression can be increased when Sulthiame is combined with Opium.,increase,risk
Sulthiame,Orlistat,Orlistat can cause a decrease in the absorption of Sulthiame resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sulthiame,Orphenadrine,Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Sulthiame,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Sulthiame.,increase,risk
Sulthiame,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Sulthiame.,increase,risk
Sulthiame,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sulthiame is combined with Oxetacaine.,increase,risk
Sulthiame,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Sulthiame.,increase,risk
Sulthiame,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Sulthiame.,increase,risk
Sulthiame,Oxtriphylline,Sulthiame may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sulthiame,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sulthiame is combined with Oxybuprocaine.,increase,risk
Sulthiame,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Sulthiame.,increase,risk
Sulthiame,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Sulthiame.,increase,risk
Sulthiame,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Sulthiame.,increase,risk
Sulthiame,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Sulthiame.,increase,risk
Sulthiame,Quinidine,The therapeutic efficacy of Sulthiame can be decreased when used in combination with Quinidine.,decrease,no risk
Sulthiame,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Sulthiame.,increase,risk
Sulthiame,Quinupramine,The risk or severity of CNS depression can be increased when Sulthiame is combined with Quinupramine.,increase,risk
Sulthiame,Ulipristal,The metabolism of Ulipristal can be increased when combined with Sulthiame.,increase,no risk
Sulthiame,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Sulthiame.,increase,risk
Sulthiame,Valganciclovir,The therapeutic efficacy of Sulthiame can be decreased when used in combination with Valganciclovir.,decrease,no risk
Sulthiame,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Sulthiame.,increase,risk
Sulthiame,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Sulthiame.,increase,risk
Sulthiame,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Sulthiame.,increase,risk
Sulthiame,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Sulthiame.,increase,risk
Sulthiame,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Sulthiame.,increase,risk
Sulthiame,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulthiame.,increase,no risk
Sulthiame,Viloxazine,The risk or severity of CNS depression can be increased when Sulthiame is combined with Viloxazine.,increase,risk
Sulthiame,Vortioxetine,The risk or severity of CNS depression can be increased when Sulthiame is combined with Vortioxetine.,increase,risk
Sulthiame,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Sulthiame.,increase,risk
Sulthiame,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Sulthiame.,increase,risk
Sulthiame,Ziconotide,The risk or severity of CNS depression can be increased when Sulthiame is combined with Ziconotide.,increase,risk
Sulthiame,Zimelidine,The risk or severity of adverse effects can be increased when Sulthiame is combined with Zimelidine.,increase,risk
Sulthiame,Ziprasidone,The risk or severity of adverse effects can be increased when Sulthiame is combined with Ziprasidone.,increase,risk
Sulthiame,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Sulthiame.,increase,risk
Sulthiame,Zolpidem,Sulthiame may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Sulthiame,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Sulthiame.,increase,risk
Sulthiame,Zopiclone,The risk or severity of adverse effects can be increased when Sulthiame is combined with Zopiclone.,increase,risk
Sulthiame,Zotepine,The risk or severity of CNS depression can be increased when Sulthiame is combined with Zotepine.,increase,risk
Sulthiame,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Sulthiame.,increase,risk
Sulthiame,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Sulthiame.,increase,risk
Gosogliptin,Gatifloxacin,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Gosogliptin,Gefapixant,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Gefapixant.,increase,no risk
Gosogliptin,Gemifloxacin,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Gosogliptin,Gliclazide,Gosogliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Gosogliptin,Glimepiride,Gosogliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Gosogliptin,Glipizide,Gosogliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Gosogliptin,Gliquidone,Gosogliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Gosogliptin,Glyburide,Gosogliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Gosogliptin,Glymidine,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Glymidine.,increase,no risk
Gosogliptin,Goserelin,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Gosogliptin,Grepafloxacin,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Gosogliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Gosogliptin.,increase,risk
Gosogliptin,Haloperidol,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Haloperidol.,decrease,no risk
Gosogliptin,Histrelin,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Gosogliptin,Hydrochlorothiazide,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Gosogliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Gosogliptin.,increase,risk
Gosogliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Gosogliptin.,increase,risk
Gosogliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Gosogliptin.,increase,risk
Gosogliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Gosogliptin.,increase,risk
Gosogliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Gosogliptin.,increase,risk
Gosogliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Gosogliptin.,increase,risk
Gosogliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Gosogliptin.,increase,risk
Gosogliptin,Hydroflumethiazide,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Gosogliptin,Hydroxychloroquine,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Gosogliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Gosogliptin,Octreotide,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Gosogliptin,Ofloxacin,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Gosogliptin,Olanzapine,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Gosogliptin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Gosogliptin.,increase,no risk
Gosogliptin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Gosogliptin.,increase,no risk
Gosogliptin,Oxprenolol,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Gosogliptin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Gosogliptin.,increase,no risk
Gosogliptin,Quetiapine,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Gosogliptin,Quinapril,The risk or severity of angioedema can be increased when Gosogliptin is combined with Quinapril.,increase,risk
Gosogliptin,Quinethazone,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Gosogliptin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Gosogliptin.,increase,risk
Gosogliptin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Gosogliptin.,decrease,no risk
Gosogliptin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Gosogliptin.,increase,risk
Gosogliptin,Udenafil,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Udenafil.,increase,no risk
Gosogliptin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Gosogliptin.,increase,risk
Gosogliptin,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Gosogliptin.,increase,risk
Gosogliptin,Valdecoxib,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Valdecoxib.,increase,no risk
Gosogliptin,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Gosogliptin.,increase,risk
Gosogliptin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Gosogliptin.,increase,risk
Gosogliptin,Vemurafenib,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Vemurafenib.,increase,no risk
Gosogliptin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Gosogliptin.,increase,risk
Gosogliptin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Gosogliptin.,increase,risk
Gosogliptin,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Gosogliptin.,increase,risk
Gosogliptin,Vorinostat,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Vorinostat.,decrease,no risk
Gosogliptin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Gosogliptin.,increase,risk
Gosogliptin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Gosogliptin.,increase,risk
Gosogliptin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Gosogliptin.,increase,risk
Gosogliptin,Ziprasidone,The therapeutic efficacy of Gosogliptin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Gosogliptin,Zofenopril,The risk or severity of angioedema can be increased when Gosogliptin is combined with Zofenopril.,increase,risk
Gosogliptin,Zonisamide,The therapeutic efficacy of Gosogliptin can be increased when used in combination with Zonisamide.,increase,no risk
Piceatannol,Voriconazole,The serum concentration of Piceatannol can be increased when it is combined with Voriconazole.,increase,no risk
Puromycin,Gabapentin enacarbil,Puromycin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Puromycin,Gadobenic acid,Puromycin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Puromycin,Gadodiamide,Puromycin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Puromycin,Gadofosveset trisodium,Puromycin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Puromycin,Gadopentetic acid,Puromycin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Puromycin,Gadoteric acid,Puromycin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Puromycin,Gadoteridol,Puromycin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Puromycin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Puromycin.,increase,no risk
Puromycin,Ganciclovir,Puromycin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Puromycin,Gemcitabine,Puromycin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Puromycin,Gemfibrozil,Puromycin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Puromycin,Gentamicin,Puromycin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Puromycin,Gimeracil,Puromycin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Puromycin,Givosiran,The risk or severity of nephrotoxicity can be increased when Puromycin is combined with Givosiran.,increase,risk
Puromycin,Glipizide,Puromycin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Puromycin,Glycerol phenylbutyrate,Puromycin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Puromycin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Puromycin.,increase,risk
Puromycin,Golodirsen,Puromycin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Puromycin,Goserelin,Puromycin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Puromycin,Guanethidine,Puromycin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Puromycin,Guanfacine,Puromycin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Puromycin,Haloperidol,Puromycin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Puromycin,Heparin,The therapeutic efficacy of Puromycin can be decreased when used in combination with Heparin.,decrease,no risk
Puromycin,Hetacillin,The serum concentration of Puromycin can be decreased when it is combined with Hetacillin.,decrease,no risk
Puromycin,Hydralazine,Puromycin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Puromycin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Puromycin.,increase,risk
Puromycin,Hydromorphone,Puromycin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Puromycin,Hydroxocobalamin,Puromycin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Puromycin,Hydroxyethyl Starch,Puromycin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Puromycin,Kanamycin,Puromycin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Puromycin,Ketamine,Puromycin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Puromycin,Ketazolam,Puromycin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Puromycin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Puromycin.,increase,risk
Puromycin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Puromycin.,increase,risk
Puromycin,Octinoxate,Puromycin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Puromycin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Puromycin is combined with Olsalazine.,increase,risk
Puromycin,Opium,Puromycin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Puromycin,Oseltamivir,Puromycin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Puromycin,Ouabain,The risk or severity of adverse effects can be increased when Puromycin is combined with Ouabain.,increase,risk
Puromycin,Oxacillin,The serum concentration of Puromycin can be decreased when it is combined with Oxacillin.,decrease,no risk
Puromycin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Puromycin.,increase,risk
Puromycin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Puromycin.,increase,risk
Puromycin,Oxazepam,Puromycin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Puromycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Puromycin is combined with Oxetacaine.,increase,risk
Puromycin,Oxybenzone,Puromycin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Puromycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Puromycin is combined with Oxybuprocaine.,increase,risk
Puromycin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Puromycin.,increase,risk
Puromycin,Oxyquinoline,Puromycin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Puromycin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Puromycin.,increase,risk
Puromycin,Quetiapine,Puromycin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Puromycin,Quinidine,Puromycin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Puromycin,Quinine,The risk or severity of neuromuscular blockade can be increased when Quinine is combined with Puromycin.,increase,risk
Puromycin,Vaborbactam,Puromycin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Puromycin,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Puromycin.,increase,risk
Puromycin,Valbenazine,Puromycin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Puromycin,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Puromycin.,increase,risk
Puromycin,Valganciclovir,Puromycin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Puromycin,Vancomycin,Puromycin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Puromycin,Varenicline,The therapeutic efficacy of Varenicline can be decreased when used in combination with Puromycin.,decrease,no risk
Puromycin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Puromycin.,increase,no risk
Puromycin,Venlafaxine,Puromycin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Puromycin,Verapamil,Puromycin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Puromycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Puromycin.,decrease,no risk
Puromycin,Vilanterol,Puromycin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Puromycin,Viloxazine,Puromycin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Puromycin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Viomycin is combined with Puromycin.,increase,risk
Puromycin,Vortioxetine,Puromycin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Puromycin,Warfarin,Puromycin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Puromycin,Zaleplon,Puromycin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Puromycin,Zanamivir,Puromycin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Puromycin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Puromycin is combined with Zoledronic acid.,increase,risk
Puromycin,Zonisamide,Puromycin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Parecoxib,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Bemiparin.,increase,risk
Parecoxib,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Parecoxib is combined with Benazepril.",increase,risk
Parecoxib,Bendazac,The risk or severity of adverse effects can be increased when Parecoxib is combined with Bendazac.,increase,risk
Parecoxib,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Benorilate,The risk or severity of adverse effects can be increased when Parecoxib is combined with Benorilate.,increase,risk
Parecoxib,Benoxaprofen,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Parecoxib.,increase,risk
Parecoxib,Benserazide,Parecoxib may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Parecoxib,Benzatropine,Parecoxib may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Parecoxib,Benznidazole,Parecoxib may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Parecoxib,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Parecoxib.,increase,risk
Parecoxib,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Benzydamine,The risk or severity of adverse effects can be increased when Parecoxib is combined with Benzydamine.,increase,risk
Parecoxib,Bepotastine,Parecoxib may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Parecoxib,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Berotralstat,The metabolism of Parecoxib can be decreased when combined with Berotralstat.,decrease,no risk
Parecoxib,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Parecoxib.,increase,risk
Parecoxib,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Parecoxib.,increase,risk
Parecoxib,Betaxolol,Parecoxib may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Parecoxib,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Parecoxib.,increase,risk
Parecoxib,Betulinic Acid,The risk or severity of adverse effects can be increased when Parecoxib is combined with Betulinic Acid.,increase,risk
Parecoxib,Bexarotene,The metabolism of Parecoxib can be decreased when combined with Bexarotene.,decrease,no risk
Parecoxib,Bicisate,Parecoxib may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Parecoxib,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Bimekizumab,The metabolism of Parecoxib can be increased when combined with Bimekizumab.,increase,no risk
Parecoxib,Bismuth subgallate,Parecoxib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Parecoxib,Bisoprolol,Parecoxib may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Parecoxib,Bisoxatin,Parecoxib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Parecoxib,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Parecoxib is combined with Bivalirudin.,increase,risk
Parecoxib,Bleomycin,Parecoxib may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Parecoxib,Boceprevir,The metabolism of Parecoxib can be decreased when combined with Boceprevir.,decrease,no risk
Parecoxib,Bortezomib,The metabolism of Parecoxib can be decreased when combined with Bortezomib.,decrease,no risk
Parecoxib,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Brexpiprazole,The risk or severity of hypertension can be increased when Parecoxib is combined with Brexpiprazole.,increase,risk
Parecoxib,Brivaracetam,Parecoxib may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Parecoxib,Bromazepam,Parecoxib may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Parecoxib,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Parecoxib.,increase,risk
Parecoxib,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Parecoxib.,increase,risk
Parecoxib,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Parecoxib.,increase,risk
Parecoxib,Bufexamac,The risk or severity of adverse effects can be increased when Parecoxib is combined with Bufexamac.,increase,risk
Parecoxib,Bumadizone,The risk or severity of adverse effects can be increased when Parecoxib is combined with Bumadizone.,increase,risk
Parecoxib,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Parecoxib.,decrease,no risk
Parecoxib,Buprenorphine,The metabolism of Parecoxib can be decreased when combined with Buprenorphine.,decrease,no risk
Parecoxib,Bupropion,Parecoxib may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Parecoxib,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Parecoxib.,increase,risk
Parecoxib,Butabarbital,Parecoxib may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Parecoxib,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Parecoxib.,increase,risk
Ro 12-7310,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Ro 12-7310.,decrease,no risk
Ro 12-7310,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Ro 12-7310.,decrease,no risk
Ro 12-7310,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Ro 12-7310 is combined with Omadacycline.,increase,risk
Ro 12-7310,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Ro 12-7310 is combined with Oxytetracycline.,increase,risk
Ro 12-7310,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Ro 12-7310.,increase,no risk
Ro 12-7310,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Ro 12-7310.,increase,risk
Ellagic acid,Ofloxacin,The excretion of Ellagic acid can be decreased when combined with Ofloxacin.,decrease,no risk
Ellagic acid,Ouabain,The excretion of Ellagic acid can be decreased when combined with Ouabain.,decrease,no risk
Ellagic acid,Oxyphenbutazone,The excretion of Ellagic acid can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Ellagic acid,Oxytetracycline,The excretion of Ellagic acid can be decreased when combined with Oxytetracycline.,decrease,no risk
Ellagic acid,Quinidine,The excretion of Ellagic acid can be decreased when combined with Quinidine.,decrease,no risk
Ellagic acid,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Ellagic acid.,increase,no risk
Ellagic acid,Valproic acid,The excretion of Ellagic acid can be decreased when combined with Valproic acid.,decrease,no risk
Ellagic acid,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Ellagic acid.,decrease,no risk
Ellagic acid,Zidovudine,The excretion of Ellagic acid can be decreased when combined with Zidovudine.,decrease,no risk
(R)-warfarin,Bedaquiline,The risk or severity of bleeding can be increased when Bedaquiline is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Belinostat,The metabolism of (R)-warfarin can be increased when combined with Belinostat.,increase,no risk
(R)-warfarin,Belzutifan,The metabolism of Belzutifan can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Bemiparin,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Bemiparin.,increase,risk
(R)-warfarin,Bendamustine,The metabolism of (R)-warfarin can be decreased when combined with Bendamustine.,decrease,no risk
(R)-warfarin,Bendroflumethiazide,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
(R)-warfarin,Benorilate,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Benoxaprofen,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Benzocaine,The metabolism of (R)-warfarin can be decreased when combined with Benzocaine.,decrease,no risk
(R)-warfarin,Benzoic acid,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Benzoic acid.,increase,no risk
(R)-warfarin,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Benzthiazide,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Benzthiazide.,decrease,no risk
(R)-warfarin,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Benzyl alcohol,The metabolism of (R)-warfarin can be decreased when combined with Benzyl alcohol.,decrease,no risk
(R)-warfarin,Benzylpenicillin,Benzylpenicillin may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Benzylpenicilloyl polylysine,Benzylpenicilloyl polylysine may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with (R)-warfarin.,decrease,no risk
(R)-warfarin,Berotralstat,The metabolism of (R)-warfarin can be decreased when combined with Berotralstat.,decrease,no risk
(R)-warfarin,Betamethasone,Betamethasone may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Betamethasone phosphate,Betamethasone phosphate may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Betaxolol,The metabolism of (R)-warfarin can be decreased when combined with Betaxolol.,decrease,no risk
(R)-warfarin,Betrixaban,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Betrixaban.,increase,risk
(R)-warfarin,Bexarotene,The metabolism of (R)-warfarin can be increased when combined with Bexarotene.,increase,no risk
(R)-warfarin,Bezafibrate,The risk or severity of bleeding can be increased when Bezafibrate is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Bicalutamide,The serum concentration of (R)-warfarin can be increased when it is combined with Bicalutamide.,increase,no risk
(R)-warfarin,Bifonazole,The serum concentration of (R)-warfarin can be increased when it is combined with Bifonazole.,increase,no risk
(R)-warfarin,Bimekizumab,The metabolism of (R)-warfarin can be increased when combined with Bimekizumab.,increase,no risk
(R)-warfarin,Binimetinib,The metabolism of Binimetinib can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Bismuth subsalicylate,Bismuth subsalicylate may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Blinatumomab,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Blinatumomab.,increase,risk
(R)-warfarin,Boceprevir,The metabolism of (R)-warfarin can be decreased when combined with Boceprevir.,decrease,no risk
(R)-warfarin,Bortezomib,The metabolism of (R)-warfarin can be decreased when combined with Bortezomib.,decrease,no risk
(R)-warfarin,Bosentan,The metabolism of (R)-warfarin can be increased when combined with Bosentan.,increase,no risk
(R)-warfarin,Bosutinib,The serum concentration of (R)-warfarin can be increased when it is combined with Bosutinib.,increase,no risk
(R)-warfarin,Brentuximab vedotin,The serum concentration of (R)-warfarin can be increased when it is combined with Brentuximab vedotin.,increase,no risk
(R)-warfarin,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Brexpiprazole,The risk or severity of adverse effects can be increased when Brexpiprazole is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Brigatinib,The metabolism of (R)-warfarin can be increased when combined with Brigatinib.,increase,no risk
(R)-warfarin,Brivaracetam,The metabolism of (R)-warfarin can be decreased when combined with Brivaracetam.,decrease,no risk
(R)-warfarin,Bromazepam,The metabolism of (R)-warfarin can be decreased when combined with Bromazepam.,decrease,no risk
(R)-warfarin,Bromocriptine,The serum concentration of (R)-warfarin can be increased when it is combined with Bromocriptine.,increase,no risk
(R)-warfarin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Budesonide,Budesonide may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Buprenorphine,The serum concentration of (R)-warfarin can be increased when it is combined with Buprenorphine.,increase,no risk
(R)-warfarin,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Busulfan,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Busulfan.,increase,risk
(R)-warfarin,Butabarbital,The metabolism of (R)-warfarin can be increased when combined with Butabarbital.,increase,no risk
(R)-warfarin,Butalbital,The metabolism of (R)-warfarin can be increased when combined with Butalbital.,increase,no risk
(R)-warfarin,Butriptyline,The risk or severity of bleeding can be increased when Butriptyline is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Gatifloxacin,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Gatifloxacin.,increase,no risk
(R)-warfarin,Gefitinib,Gefitinib may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Gemcitabine,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Gemcitabine.,increase,no risk
(R)-warfarin,Gemfibrozil,The metabolism of (R)-warfarin can be decreased when combined with Gemfibrozil.,decrease,no risk
(R)-warfarin,Gemifloxacin,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Gemifloxacin.,increase,no risk
(R)-warfarin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Gemtuzumab ozogamicin.,increase,risk
(R)-warfarin,Gentamicin,The risk or severity of bleeding can be increased when Gentamicin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Givosiran,The serum concentration of (R)-warfarin can be increased when it is combined with Givosiran.,increase,no risk
(R)-warfarin,Glasdegib,The metabolism of Glasdegib can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Gliclazide,The metabolism of (R)-warfarin can be decreased when combined with Gliclazide.,decrease,no risk
(R)-warfarin,Glimepiride,Glimepiride may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Glipizide,Glipizide may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Gliquidone,Gliquidone may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Glofitamab,The serum concentration of (R)-warfarin can be increased when it is combined with Glofitamab.,increase,no risk
(R)-warfarin,Glucagon,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Glucagon.,increase,no risk
(R)-warfarin,Glucosamine,Glucosamine may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Glutethimide,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Glutethimide.,decrease,no risk
(R)-warfarin,Glyburide,The serum concentration of (R)-warfarin can be increased when it is combined with Glyburide.,increase,no risk
(R)-warfarin,Glycerol phenylbutyrate,The metabolism of (R)-warfarin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
(R)-warfarin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Golimumab,The metabolism of (R)-warfarin can be increased when combined with Golimumab.,increase,no risk
(R)-warfarin,Gramicidin D,The risk or severity of bleeding can be increased when Gramicidin D is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Grepafloxacin,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Grepafloxacin.,increase,no risk
(R)-warfarin,Griseofulvin,The metabolism of (R)-warfarin can be increased when combined with Griseofulvin.,increase,no risk
(R)-warfarin,Guanabenz,The metabolism of (R)-warfarin can be decreased when combined with Guanabenz.,decrease,no risk
(R)-warfarin,Halofantrine,The metabolism of (R)-warfarin can be decreased when combined with Halofantrine.,decrease,no risk
(R)-warfarin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with (R)-warfarin.,increase,no risk
(R)-warfarin,Haloprogin,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Haloprogin.,increase,no risk
(R)-warfarin,Halothane,The metabolism of (R)-warfarin can be decreased when combined with Halothane.,decrease,no risk
(R)-warfarin,Hemin,Hemin may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Hetacillin,Hetacillin may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Hexetidine,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Hexetidine.,increase,no risk
(R)-warfarin,Hydralazine,The serum concentration of (R)-warfarin can be increased when it is combined with Hydralazine.,increase,no risk
(R)-warfarin,Hydrochlorothiazide,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
(R)-warfarin,Hydrocortamate,The metabolism of (R)-warfarin can be increased when combined with Hydrocortamate.,increase,no risk
(R)-warfarin,Hydrocortisone,Hydrocortisone may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Hydrocortisone acetate,Hydrocortisone acetate may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Hydrocortisone succinate,Hydrocortisone succinate may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Hydroflumethiazide,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
(R)-warfarin,Hydromorphone,The metabolism of (R)-warfarin can be decreased when combined with Hydromorphone.,decrease,no risk
(R)-warfarin,Hydroxychloroquine,The metabolism of (R)-warfarin can be decreased when combined with Hydroxychloroquine.,decrease,no risk
(R)-warfarin,Hydroxyprogesterone caproate,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
(R)-warfarin,Hydroxyurea,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Hydroxyurea.,increase,risk
(R)-warfarin,Kanamycin,The risk or severity of bleeding can be increased when Kanamycin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Ketamine,The metabolism of (R)-warfarin can be increased when combined with Ketamine.,increase,no risk
(R)-warfarin,Ketazolam,The serum concentration of (R)-warfarin can be increased when it is combined with Ketazolam.,increase,no risk
(R)-warfarin,Ketoconazole,The metabolism of (R)-warfarin can be decreased when combined with Ketoconazole.,decrease,no risk
(R)-warfarin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Obeticholic acid,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Obeticholic acid.,decrease,no risk
(R)-warfarin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when (R)-warfarin is combined with Obinutuzumab.,increase,risk
(R)-warfarin,Octreotide,The serum concentration of (R)-warfarin can be increased when it is combined with Octreotide.,increase,no risk
(R)-warfarin,Ofloxacin,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Ofloxacin.,increase,no risk
(R)-warfarin,Olanzapine,The metabolism of (R)-warfarin can be decreased when combined with Olanzapine.,decrease,no risk
(R)-warfarin,Olaparib,The serum concentration of (R)-warfarin can be increased when it is combined with Olaparib.,increase,no risk
(R)-warfarin,Olive oil,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Olive oil.,decrease,no risk
(R)-warfarin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Olsalazine,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Olsalazine.,increase,risk
(R)-warfarin,Olutasidenib,The metabolism of (R)-warfarin can be increased when combined with Olutasidenib.,increase,no risk
(R)-warfarin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Omacetaxine mepesuccinate.,increase,risk
(R)-warfarin,Omadacycline,Omadacycline may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Omaveloxolone,The serum concentration of (R)-warfarin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
(R)-warfarin,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Omega-3-carboxylic acids,The therapeutic efficacy of (R)-warfarin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
(R)-warfarin,Omeprazole,The metabolism of (R)-warfarin can be decreased when combined with Omeprazole.,decrease,no risk
(R)-warfarin,Ondansetron,The metabolism of (R)-warfarin can be decreased when combined with Ondansetron.,decrease,no risk
(R)-warfarin,Oritavancin,The risk or severity of bleeding can be increased when Oritavancin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Orlistat,Orlistat may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Orphenadrine,The serum concentration of (R)-warfarin can be increased when it is combined with Orphenadrine.,increase,no risk
(R)-warfarin,Osilodrostat,The serum concentration of (R)-warfarin can be increased when it is combined with Osilodrostat.,increase,no risk
(R)-warfarin,Osimertinib,The serum concentration of (R)-warfarin can be decreased when it is combined with Osimertinib.,decrease,no risk
(R)-warfarin,Ospemifene,The metabolism of (R)-warfarin can be decreased when combined with Ospemifene.,decrease,no risk
(R)-warfarin,Oxacillin,Oxacillin may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Oxandrolone,Oxandrolone may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Oxcarbazepine,The metabolism of (R)-warfarin can be increased when combined with Oxcarbazepine.,increase,no risk
(R)-warfarin,Oxetacaine,The serum concentration of (R)-warfarin can be increased when it is combined with Oxetacaine.,increase,no risk
(R)-warfarin,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Oxtriphylline,The metabolism of (R)-warfarin can be decreased when combined with Oxtriphylline.,decrease,no risk
(R)-warfarin,Oxybutynin,The serum concentration of (R)-warfarin can be increased when it is combined with Oxybutynin.,increase,no risk
(R)-warfarin,Oxymetholone,The serum concentration of (R)-warfarin can be increased when it is combined with Oxymetholone.,increase,no risk
(R)-warfarin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Oxytetracycline,Oxytetracycline may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Ozanimod,The metabolism of Ozanimod can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Quinestrol,Quinestrol may decrease the anticoagulant activities of (R)-warfarin.,decrease,no risk
(R)-warfarin,Quinidine,The serum concentration of (R)-warfarin can be increased when it is combined with Quinidine.,increase,no risk
(R)-warfarin,Quinine,The serum concentration of (R)-warfarin can be increased when it is combined with Quinine.,increase,no risk
(R)-warfarin,Quinupramine,The risk or severity of bleeding can be increased when Quinupramine is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Quinupristin,The serum concentration of (R)-warfarin can be increased when it is combined with Quinupristin.,increase,no risk
(R)-warfarin,Ubidecarenone,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Ubidecarenone.,decrease,no risk
(R)-warfarin,Ulipristal,The therapeutic efficacy of (R)-warfarin can be decreased when used in combination with Ulipristal.,decrease,no risk
(R)-warfarin,Urokinase,Urokinase may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when (R)-warfarin is combined with Ursodeoxycholic acid.,increase,risk
(R)-warfarin,Vadadustat,The serum concentration of (R)-warfarin can be increased when it is combined with Vadadustat.,increase,no risk
(R)-warfarin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Valproic acid,The serum concentration of (R)-warfarin can be increased when it is combined with Valproic acid.,increase,no risk
(R)-warfarin,Valsartan,The metabolism of (R)-warfarin can be decreased when combined with Valsartan.,decrease,no risk
(R)-warfarin,Vamorolone,Vamorolone may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Vancomycin,The risk or severity of bleeding can be increased when Vancomycin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Vardenafil,The metabolism of (R)-warfarin can be decreased when combined with Vardenafil.,decrease,no risk
(R)-warfarin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Vemurafenib,The serum concentration of (R)-warfarin can be increased when it is combined with Vemurafenib.,increase,no risk
(R)-warfarin,Venetoclax,The serum concentration of (R)-warfarin can be increased when it is combined with Venetoclax.,increase,no risk
(R)-warfarin,Venlafaxine,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Venlafaxine.,increase,risk
(R)-warfarin,Verapamil,The serum concentration of (R)-warfarin can be increased when it is combined with Verapamil.,increase,no risk
(R)-warfarin,Vilazodone,The metabolism of (R)-warfarin can be decreased when combined with Vilazodone.,decrease,no risk
(R)-warfarin,Viloxazine,The metabolism of (R)-warfarin can be decreased when combined with Viloxazine.,decrease,no risk
(R)-warfarin,Vinblastine,The serum concentration of (R)-warfarin can be increased when it is combined with Vinblastine.,increase,no risk
(R)-warfarin,Vindesine,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Vindesine.,increase,risk
(R)-warfarin,Vinorelbine,The risk or severity of bleeding can be increased when (R)-warfarin is combined with Vinorelbine.,increase,risk
(R)-warfarin,Viomycin,The risk or severity of bleeding can be increased when Viomycin is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Vitamin E,Vitamin E may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with (R)-warfarin.,decrease,no risk
(R)-warfarin,Vonoprazan,The metabolism of (R)-warfarin can be decreased when combined with Vonoprazan.,decrease,no risk
(R)-warfarin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Voriconazole,Voriconazole may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Vorinostat,Vorinostat may increase the anticoagulant activities of (R)-warfarin.,increase,no risk
(R)-warfarin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Warfarin,The metabolism of (R)-warfarin can be increased when combined with Warfarin.,increase,no risk
(R)-warfarin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with (R)-warfarin.,increase,risk
(R)-warfarin,Zafirlukast,The serum concentration of (R)-warfarin can be increased when it is combined with Zafirlukast.,increase,no risk
(R)-warfarin,Zidovudine,The metabolism of (R)-warfarin can be decreased when combined with Zidovudine.,decrease,no risk
(R)-warfarin,Zileuton,The metabolism of (R)-warfarin can be decreased when combined with Zileuton.,decrease,no risk
(R)-warfarin,Zimelidine,The serum concentration of (R)-warfarin can be increased when it is combined with Zimelidine.,increase,no risk
(R)-warfarin,Ziprasidone,The serum concentration of (R)-warfarin can be increased when it is combined with Ziprasidone.,increase,no risk
(R)-warfarin,Zolmitriptan,The metabolism of (R)-warfarin can be decreased when combined with Zolmitriptan.,decrease,no risk
(R)-warfarin,Zolpidem,The metabolism of (R)-warfarin can be decreased when combined with Zolpidem.,decrease,no risk
(R)-warfarin,Zonisamide,The metabolism of (R)-warfarin can be decreased when combined with Zonisamide.,decrease,no risk
(R)-warfarin,Zopiclone,The metabolism of (R)-warfarin can be decreased when combined with Zopiclone.,decrease,no risk
(R)-warfarin,Zotepine,The metabolism of Zotepine can be decreased when combined with (R)-warfarin.,decrease,no risk
(R)-warfarin,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with (R)-warfarin.,increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Butorphanol,"The risk or severity of adverse effects can be increased when Butorphanol is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Butriptyline,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the serotonergic activities of Butriptyline.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Gabapentin,"The risk or severity of CNS depression can be increased when Gabapentin is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Gabapentin enacarbil,"The risk or severity of CNS depression can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Gabapentin enacarbil.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Gallamine triethiodide,"The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Ganaxolone.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Gepirone,"The risk or severity of serotonin syndrome can be increased when Gepirone is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Gliclazide,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Gliclazide.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Glimepiride,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Glimepiride.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Glipizide,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Glipizide.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Gliquidone,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Gliquidone.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Glutethimide,"The risk or severity of CNS depression can be increased when Glutethimide is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Glyburide,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Glyburide.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Glymidine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Glymidine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Granisetron,"The risk or severity of CNS depression can be increased when Granisetron is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Guanabenz,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Guanabenz.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Guanadrel,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Guanadrel.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Guanethidine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Guanethidine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Guanfacine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Guanfacine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Guanoxan,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Guanoxan.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Halazepam,"The risk or severity of CNS depression can be increased when Halazepam is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Haloperidol,"The risk or severity of CNS depression can be increased when Haloperidol is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Halothane,"The risk or severity of adverse effects can be increased when Halothane is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Heparin,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Heparin.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hexafluronium,"The risk or severity of CNS depression can be increased when Hexafluronium is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hydralazine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Hydralazine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hydrochlorothiazide,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Hydrochlorothiazide.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hydrocodone,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Hydrocodone.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hydroflumethiazide,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Hydroflumethiazide.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hydromorphone,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the serotonergic activities of Hydromorphone.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hydroxyzine,"Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Hyoscyamine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the anticholinergic activities of Hyoscyamine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Ketamine,"The risk or severity of CNS depression can be increased when Ketamine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Ketazolam,"The risk or severity of CNS depression can be increased when Ketazolam is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Obinutuzumab,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Obinutuzumab.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Olanzapine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Olanzapine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Oliceridine.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Olmesartan,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Olmesartan.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Olodaterol,"The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Olodaterol.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Ondansetron,"The risk or severity of CNS depression can be increased when Ondansetron is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Opicapone,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Opicapone.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Opium,"The risk or severity of adverse effects can be increased when Opium is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Orciprenaline,"The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Orciprenaline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Orphenadrine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxazepam,"The risk or severity of CNS depression can be increased when Oxazepam is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxcarbazepine,"The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxitriptan,"The risk or severity of CNS depression can be increased when Oxitriptan is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxprenolol,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Oxprenolol.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxybuprocaine,"The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxycodone,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the serotonergic and central nervous system depressant (CNS depressant) activities of Oxycodone.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxymetazoline,"The serum concentration of Oxymetazoline can be increased when it is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Oxymorphone,"The risk or severity of adverse effects can be increased when Oxymorphone is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Quazepam,"The risk or severity of CNS depression can be increased when Quazepam is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Quetiapine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Quetiapine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Quinapril,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Quinapril.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Quinine,"The risk or severity of CNS depression can be increased when Quinine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Quinupramine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the serotonergic activities of Quinupramine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Urethane,"The risk or severity of CNS depression can be increased when Urethane is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Urokinase,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Urokinase.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Valbenazine,"The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Valbenazine.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Valproate bismuth,"The risk or severity of serotonin syndrome can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Valproate bismuth.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Valproic acid,"The risk or severity of CNS depression can be increased when Valproic acid is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Valsartan,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Valsartan.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vecuronium,"The risk or severity of CNS depression can be increased when Vecuronium is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Venlafaxine,"The risk or severity of serotonin syndrome can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Venlafaxine.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Verapamil,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Verapamil.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vericiguat,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Vericiguat.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vigabatrin,"The risk or severity of CNS depression can be increased when Vigabatrin is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vilanterol,"The risk or severity of hypertension and cardiovascular complications can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Vilanterol.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vilazodone,"The metabolism of Vilazodone can be decreased when combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",decrease,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vildagliptin,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypoglycemic activities of Vildagliptin.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Viloxazine,"The risk or severity of hypertension can be increased when Viloxazine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vorapaxar,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Vorapaxar.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Vortioxetine,"The metabolism of Vortioxetine can be decreased when combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",decrease,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Warfarin,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Warfarin.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Ximelagatran,"The risk or severity of bleeding and hemorrhage can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Ximelagatran.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Xylometazoline,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypertensive activities of Xylometazoline.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Yohimbine,"The risk or severity of CNS depression can be increased when Yohimbine is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zaleplon,"The risk or severity of CNS depression can be increased when Zaleplon is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Ziconotide,"The risk or severity of CNS depression can be increased when Ziconotide is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zimelidine,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the serotonergic activities of Zimelidine.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Ziprasidone,"The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Ziprasidone.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zofenopril,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Zofenopril.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zolmitriptan,"The risk or severity of serotonin syndrome can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Zolmitriptan.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zolpidem,"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.",increase,no risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zonisamide,"The risk or severity of CNS depression can be increased when Zonisamide is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zopiclone,"The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Zopiclone.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zotepine,"The risk or severity of CNS depression can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Zotepine.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zuclopenthixol,"The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
"7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline",Zuranolone,"The risk or severity of CNS depression can be increased when Zuranolone is combined with 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline.",increase,risk
Delavirdine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Budesonide,The metabolism of Budesonide can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Bupropion,The metabolism of Delavirdine can be decreased when combined with Bupropion.,decrease,no risk
Delavirdine,Buspirone,The metabolism of Buspirone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Busulfan,The metabolism of Busulfan can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Galantamine,The metabolism of Galantamine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Givosiran,The serum concentration of Delavirdine can be increased when it is combined with Givosiran.,increase,no risk
Delavirdine,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Glipizide,The metabolism of Glipizide can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Glofitamab,The serum concentration of Delavirdine can be increased when it is combined with Glofitamab.,increase,no risk
Delavirdine,Glyburide,The metabolism of Glyburide can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Glycerol phenylbutyrate,The metabolism of Delavirdine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Delavirdine,Golimumab,The metabolism of Delavirdine can be increased when combined with Golimumab.,increase,no risk
Delavirdine,Granisetron,The metabolism of Granisetron can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Halothane,The metabolism of Halothane can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Delavirdine.,decrease,no risk
Delavirdine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Delavirdine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Ketamine,The metabolism of Ketamine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Olanzapine,Olanzapine can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Delavirdine,Olaparib,The metabolism of Olaparib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Omeprazole,Omeprazole can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Delavirdine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Opium,The metabolism of Opium can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Oritavancin,The metabolism of Delavirdine can be decreased when combined with Oritavancin.,decrease,no risk
Delavirdine,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Oxamniquine,The metabolism of Delavirdine can be decreased when combined with Oxamniquine.,decrease,no risk
Delavirdine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Quazepam,The metabolism of Quazepam can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Quinidine,The metabolism of Quinidine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Quinine,The metabolism of Quinine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Udenafil,The metabolism of Udenafil can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vadadustat,The serum concentration of Delavirdine can be increased when it is combined with Vadadustat.,increase,no risk
Delavirdine,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Valsartan,The metabolism of Valsartan can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Delavirdine.,decrease,no risk
Delavirdine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Verapamil,The metabolism of Verapamil can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Delavirdine.,decrease,no risk
Delavirdine,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Viloxazine,The metabolism of Delavirdine can be decreased when combined with Viloxazine.,decrease,no risk
Delavirdine,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vincristine,The metabolism of Vincristine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vindesine,The metabolism of Vindesine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Delavirdine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Delavirdine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Voriconazole,The serum concentration of Voriconazole can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Delavirdine.,increase,no risk
Delavirdine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Warfarin,The metabolism of Warfarin can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Delavirdine.,decrease,no risk
Delavirdine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zileuton,The metabolism of Zileuton can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zimelidine,The metabolism of Delavirdine can be decreased when combined with Zimelidine.,decrease,no risk
Delavirdine,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zotepine,The metabolism of Zotepine can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Delavirdine.,decrease,no risk
Delavirdine,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Delavirdine.,increase,no risk
Testosterone succinate,Urokinase,Testosterone succinate may increase the anticoagulant activities of Urokinase.,increase,no risk
Testosterone succinate,Vamorolone,The risk or severity of edema formation can be increased when Testosterone succinate is combined with Vamorolone.,increase,risk
Testosterone succinate,Vorapaxar,Testosterone succinate may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Testosterone succinate,Warfarin,Testosterone succinate may increase the anticoagulant activities of Warfarin.,increase,no risk
Testosterone succinate,Ximelagatran,Testosterone succinate may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Thiamphenicol,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Thiamphenicol.,decrease,no risk
Thiamphenicol,Benzocaine,The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Benzocaine.,increase,risk
Thiamphenicol,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Benzyl alcohol.,increase,risk
Thiamphenicol,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Bupivacaine.,increase,risk
Thiamphenicol,Butacaine,The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Butacaine.,increase,risk
Thiamphenicol,Butamben,The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Butamben.,increase,risk
Thiamphenicol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Oxetacaine.,increase,risk
Thiamphenicol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Thiamphenicol is combined with Oxybuprocaine.,increase,risk
Thiamphenicol,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Thiamphenicol.,decrease,no risk
Thiamphenicol,Warfarin,The risk or severity of bleeding can be increased when Thiamphenicol is combined with Warfarin.,increase,risk
TNP-470,Benzocaine,The risk or severity of methemoglobinemia can be increased when TNP-470 is combined with Benzocaine.,increase,risk
TNP-470,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when TNP-470 is combined with Benzyl alcohol.,increase,risk
TNP-470,Bupivacaine,The risk or severity of methemoglobinemia can be increased when TNP-470 is combined with Bupivacaine.,increase,risk
TNP-470,Butacaine,The risk or severity of methemoglobinemia can be increased when TNP-470 is combined with Butacaine.,increase,risk
TNP-470,Butamben,The risk or severity of methemoglobinemia can be increased when TNP-470 is combined with Butamben.,increase,risk
TNP-470,Oxetacaine,The risk or severity of methemoglobinemia can be increased when TNP-470 is combined with Oxetacaine.,increase,risk
TNP-470,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when TNP-470 is combined with Oxybuprocaine.,increase,risk
TNP-470,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when TNP-470 is combined with Zoledronic acid.,increase,risk
Crizotinib,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Bifonazole,The metabolism of Crizotinib can be decreased when combined with Bifonazole.,decrease,no risk
Crizotinib,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Crizotinib.,increase,risk
Crizotinib,Bimekizumab,The metabolism of Crizotinib can be increased when combined with Bimekizumab.,increase,no risk
Crizotinib,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Bisoprolol,Crizotinib may increase the bradycardic activities of Bisoprolol.,increase,no risk
Crizotinib,Boceprevir,The metabolism of Crizotinib can be decreased when combined with Boceprevir.,decrease,no risk
Crizotinib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Bosentan,The metabolism of Crizotinib can be increased when combined with Bosentan.,increase,no risk
Crizotinib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Bretylium,Crizotinib may increase the bradycardic activities of Bretylium.,increase,no risk
Crizotinib,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Crizotinib.,increase,risk
Crizotinib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Crizotinib.,increase,risk
Crizotinib,Budesonide,The metabolism of Crizotinib can be increased when combined with Budesonide.,increase,no risk
Crizotinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Crizotinib is combined with Bupivacaine.,increase,risk
Crizotinib,Buprenorphine,The metabolism of Crizotinib can be decreased when combined with Buprenorphine.,decrease,no risk
Crizotinib,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Crizotinib.,increase,risk
Crizotinib,Buspirone,The metabolism of Crizotinib can be decreased when combined with Buspirone.,decrease,no risk
Crizotinib,Busulfan,The metabolism of Busulfan can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Crizotinib is combined with Butacaine.,increase,risk
Crizotinib,Butalbital,The metabolism of Crizotinib can be increased when combined with Butalbital.,increase,no risk
Crizotinib,Butamben,The risk or severity of methemoglobinemia can be increased when Crizotinib is combined with Butamben.,increase,risk
Crizotinib,Butriptyline,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Butriptyline.,increase,risk
Crizotinib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Crizotinib.,increase,risk
Crizotinib,Galantamine,Crizotinib may increase the bradycardic activities of Galantamine.,increase,no risk
Crizotinib,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Crizotinib.,increase,risk
Crizotinib,Gefitinib,The metabolism of Crizotinib can be decreased when combined with Gefitinib.,decrease,no risk
Crizotinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Crizotinib.,increase,risk
Crizotinib,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Gilteritinib,The metabolism of Crizotinib can be decreased when combined with Gilteritinib.,decrease,no risk
Crizotinib,Ginkgo biloba,The metabolism of Crizotinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Crizotinib,Glasdegib,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Glasdegib.,increase,risk
Crizotinib,Glecaprevir,The serum concentration of Crizotinib can be increased when it is combined with Glecaprevir.,increase,no risk
Crizotinib,Glofitamab,The serum concentration of Crizotinib can be increased when it is combined with Glofitamab.,increase,no risk
Crizotinib,Glyburide,The metabolism of Crizotinib can be decreased when combined with Glyburide.,decrease,no risk
Crizotinib,Glycerol phenylbutyrate,The metabolism of Crizotinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Crizotinib,Golimumab,The metabolism of Crizotinib can be increased when combined with Golimumab.,increase,no risk
Crizotinib,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Crizotinib.,increase,risk
Crizotinib,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Crizotinib.,increase,risk
Crizotinib,Grapefruit,The serum concentration of Crizotinib can be increased when it is combined with Grapefruit.,increase,no risk
Crizotinib,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Grepafloxacin.,increase,risk
Crizotinib,Griseofulvin,The metabolism of Crizotinib can be increased when combined with Griseofulvin.,increase,no risk
Crizotinib,Guanfacine,Crizotinib may increase the bradycardic activities of Guanfacine.,increase,no risk
Crizotinib,Halofantrine,The metabolism of Crizotinib can be decreased when combined with Halofantrine.,decrease,no risk
Crizotinib,Haloperidol,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Haloperidol.,increase,risk
Crizotinib,Histamine,The serum concentration of Histamine can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Crizotinib.,increase,risk
Crizotinib,Hydralazine,The serum concentration of Crizotinib can be increased when it is combined with Hydralazine.,increase,no risk
Crizotinib,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Crizotinib.,increase,risk
Crizotinib,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Hydrocortamate,The metabolism of Crizotinib can be increased when combined with Hydrocortamate.,increase,no risk
Crizotinib,Hydrocortisone,The metabolism of Crizotinib can be increased when combined with Hydrocortisone.,increase,no risk
Crizotinib,Hydrocortisone acetate,The metabolism of Crizotinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Crizotinib,Hydrocortisone butyrate,The metabolism of Crizotinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Crizotinib,Hydrocortisone cypionate,The metabolism of Crizotinib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Crizotinib,Hydrocortisone phosphate,The metabolism of Crizotinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Crizotinib,Hydrocortisone succinate,The metabolism of Crizotinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Crizotinib,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Hydroxyprogesterone caproate,The metabolism of Crizotinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Crizotinib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Hydroxyzine.,increase,risk
Crizotinib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Crizotinib.,increase,risk
Crizotinib,Ketamine,The metabolism of Ketamine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Ketazolam,The serum concentration of Crizotinib can be increased when it is combined with Ketazolam.,increase,no risk
Crizotinib,Ketoconazole,The metabolism of Crizotinib can be decreased when combined with Ketoconazole.,decrease,no risk
Crizotinib,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Crizotinib.,increase,no risk
Crizotinib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Crizotinib.,increase,risk
Crizotinib,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Crizotinib.,increase,risk
Crizotinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Crizotinib.,increase,risk
Crizotinib,Olutasidenib,The metabolism of Crizotinib can be increased when combined with Olutasidenib.,increase,no risk
Crizotinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Ondansetron,The metabolism of Crizotinib can be decreased when combined with Ondansetron.,decrease,no risk
Crizotinib,Opium,The metabolism of Opium can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Oritavancin,The metabolism of Crizotinib can be increased when combined with Oritavancin.,increase,no risk
Crizotinib,Orphenadrine,The metabolism of Crizotinib can be decreased when combined with Orphenadrine.,decrease,no risk
Crizotinib,Osilodrostat,The metabolism of Crizotinib can be decreased when combined with Osilodrostat.,decrease,no risk
Crizotinib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Crizotinib.,increase,risk
Crizotinib,Oxatomide,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Oxatomide.,increase,risk
Crizotinib,Oxcarbazepine,The metabolism of Crizotinib can be increased when combined with Oxcarbazepine.,increase,no risk
Crizotinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Crizotinib is combined with Oxetacaine.,increase,risk
Crizotinib,Oxprenolol,Crizotinib may increase the bradycardic activities of Oxprenolol.,increase,no risk
Crizotinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Crizotinib is combined with Oxybuprocaine.,increase,risk
Crizotinib,Oxybutynin,The serum concentration of Crizotinib can be increased when it is combined with Oxybutynin.,increase,no risk
Crizotinib,Oxycodone,The metabolism of Crizotinib can be decreased when combined with Oxycodone.,decrease,no risk
Crizotinib,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Crizotinib.,increase,risk
Crizotinib,Quazepam,The metabolism of Quazepam can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Quetiapine,The metabolism of Crizotinib can be decreased when combined with Quetiapine.,decrease,no risk
Crizotinib,Quinidine,The metabolism of Quinidine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Quinine,The serum concentration of Crizotinib can be increased when it is combined with Quinine.,increase,no risk
Crizotinib,Quinupristin,The metabolism of Crizotinib can be decreased when combined with Quinupristin.,decrease,no risk
Crizotinib,Quizartinib,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Quizartinib.,increase,risk
Crizotinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Udenafil,The metabolism of Crizotinib can be decreased when combined with Udenafil.,decrease,no risk
Crizotinib,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Umbralisib,The serum concentration of Crizotinib can be increased when it is combined with Umbralisib.,increase,no risk
Crizotinib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Crizotinib.,increase,no risk
Crizotinib,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vadadustat,The serum concentration of Crizotinib can be increased when it is combined with Vadadustat.,increase,no risk
Crizotinib,Valbenazine,The metabolism of Crizotinib can be decreased when combined with Valbenazine.,decrease,no risk
Crizotinib,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Valproic acid,The serum concentration of Crizotinib can be increased when it is combined with Valproic acid.,increase,no risk
Crizotinib,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Varenicline,The excretion of Varenicline can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Velpatasvir,The serum concentration of Crizotinib can be increased when it is combined with Velpatasvir.,increase,no risk
Crizotinib,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Verapamil,Crizotinib may increase the bradycardic activities of Verapamil.,increase,no risk
Crizotinib,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Crizotinib.,increase,risk
Crizotinib,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Crizotinib.,increase,risk
Crizotinib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Viloxazine,The metabolism of Crizotinib can be decreased when combined with Viloxazine.,decrease,no risk
Crizotinib,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vitamin E,The metabolism of Crizotinib can be increased when combined with Vitamin E.,increase,no risk
Crizotinib,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Vonoprazan,The metabolism of Crizotinib can be decreased when combined with Vonoprazan.,decrease,no risk
Crizotinib,Vorapaxar,The serum concentration of Crizotinib can be increased when it is combined with Vorapaxar.,increase,no risk
Crizotinib,Voriconazole,The serum concentration of Crizotinib can be increased when it is combined with Voriconazole.,increase,no risk
Crizotinib,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Crizotinib.,increase,risk
Crizotinib,Vortioxetine,The metabolism of Crizotinib can be decreased when combined with Vortioxetine.,decrease,no risk
Crizotinib,Voxelotor,The serum concentration of Crizotinib can be increased when it is combined with Voxelotor.,increase,no risk
Crizotinib,Voxilaprevir,The serum concentration of Crizotinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Crizotinib,Warfarin,The metabolism of Warfarin can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Zafirlukast,The serum concentration of Crizotinib can be increased when it is combined with Zafirlukast.,increase,no risk
Crizotinib,Zaleplon,The metabolism of Crizotinib can be decreased when combined with Zaleplon.,decrease,no risk
Crizotinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Zileuton,The metabolism of Zileuton can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Zimelidine,The metabolism of Crizotinib can be decreased when combined with Zimelidine.,decrease,no risk
Crizotinib,Ziprasidone,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Ziprasidone.,increase,risk
Crizotinib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Zonisamide,Crizotinib may increase the bradycardic activities of Zonisamide.,increase,no risk
Crizotinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Zotepine,The metabolism of Zotepine can be decreased when combined with Crizotinib.,decrease,no risk
Crizotinib,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Zuclopenthixol.,increase,risk
Crizotinib,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Crizotinib.,decrease,no risk
"R,S-Warfarin alcohol",Glucosamine,"Glucosamine may increase the anticoagulant activities of R,S-Warfarin alcohol.",increase,no risk
"R,S-Warfarin alcohol",Glyburide,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Glyburide.",increase,no risk
"R,S-Warfarin alcohol",Glycerol phenylbutyrate,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Glycerol phenylbutyrate.",increase,no risk
"R,S-Warfarin alcohol",Griseofulvin,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Griseofulvin.",increase,no risk
"R,S-Warfarin alcohol",Haloperidol,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Haloperidol.",increase,no risk
"R,S-Warfarin alcohol",Hydralazine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Hydralazine.",increase,no risk
"R,S-Warfarin alcohol",Hydrocortamate,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Hydrocortamate.",increase,no risk
"R,S-Warfarin alcohol",Hydrocortisone,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Hydrocortisone.",increase,no risk
"R,S-Warfarin alcohol",Hydrocortisone acetate,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Hydrocortisone acetate.",increase,no risk
"R,S-Warfarin alcohol",Hydrocortisone butyrate,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Hydrocortisone butyrate.",increase,no risk
"R,S-Warfarin alcohol",Hydrocortisone succinate,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Hydrocortisone succinate.",increase,no risk
"R,S-Warfarin alcohol",Ketamine,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Ketamine.",increase,no risk
"R,S-Warfarin alcohol",Ketazolam,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Ketazolam.",increase,no risk
"R,S-Warfarin alcohol",Ketoconazole,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Ketoconazole.",increase,no risk
"R,S-Warfarin alcohol",Obeticholic acid,"The therapeutic efficacy of R,S-Warfarin alcohol can be decreased when used in combination with Obeticholic acid.",decrease,no risk
"R,S-Warfarin alcohol",Octreotide,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Octreotide.",increase,no risk
"R,S-Warfarin alcohol",Olaparib,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Olaparib.",increase,no risk
"R,S-Warfarin alcohol",Olsalazine,"The risk or severity of bleeding can be increased when R,S-Warfarin alcohol is combined with Olsalazine.",increase,risk
"R,S-Warfarin alcohol",Olutasidenib,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Olutasidenib.",increase,no risk
"R,S-Warfarin alcohol",Omaveloxolone,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Omaveloxolone.",increase,no risk
"R,S-Warfarin alcohol",Oritavancin,"The risk or severity of bleeding can be increased when Oritavancin is combined with R,S-Warfarin alcohol.",increase,risk
"R,S-Warfarin alcohol",Orlistat,"Orlistat may increase the anticoagulant activities of R,S-Warfarin alcohol.",increase,no risk
"R,S-Warfarin alcohol",Orphenadrine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Orphenadrine.",increase,no risk
"R,S-Warfarin alcohol",Osilodrostat,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Osilodrostat.",increase,no risk
"R,S-Warfarin alcohol",Oxcarbazepine,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Oxcarbazepine.",increase,no risk
"R,S-Warfarin alcohol",Oxetacaine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Oxetacaine.",increase,no risk
"R,S-Warfarin alcohol",Oxybutynin,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Oxybutynin.",increase,no risk
"R,S-Warfarin alcohol",Oxymetholone,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Oxymetholone.",increase,no risk
"R,S-Warfarin alcohol",Quinidine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Quinidine.",increase,no risk
"R,S-Warfarin alcohol",Quinine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Quinine.",increase,no risk
"R,S-Warfarin alcohol",Quinupramine,"The risk or severity of bleeding can be increased when Quinupramine is combined with R,S-Warfarin alcohol.",increase,risk
"R,S-Warfarin alcohol",Quinupristin,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Quinupristin.",increase,no risk
"R,S-Warfarin alcohol",Valproic acid,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Valproic acid.",increase,no risk
"R,S-Warfarin alcohol",Vemurafenib,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Vemurafenib.",increase,no risk
"R,S-Warfarin alcohol",Venetoclax,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Venetoclax.",increase,no risk
"R,S-Warfarin alcohol",Verapamil,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Verapamil.",increase,no risk
"R,S-Warfarin alcohol",Viloxazine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Viloxazine.",increase,no risk
"R,S-Warfarin alcohol",Vinblastine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Vinblastine.",increase,no risk
"R,S-Warfarin alcohol",Vitamin E,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Vitamin E.",increase,no risk
"R,S-Warfarin alcohol",Voriconazole,"Voriconazole may increase the anticoagulant activities of R,S-Warfarin alcohol.",increase,no risk
"R,S-Warfarin alcohol",Warfarin,"The metabolism of R,S-Warfarin alcohol can be increased when combined with Warfarin.",increase,no risk
"R,S-Warfarin alcohol",Zafirlukast,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Zafirlukast.",increase,no risk
"R,S-Warfarin alcohol",Zileuton,"The metabolism of R,S-Warfarin alcohol can be decreased when combined with Zileuton.",decrease,no risk
"R,S-Warfarin alcohol",Zimelidine,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Zimelidine.",increase,no risk
"R,S-Warfarin alcohol",Ziprasidone,"The serum concentration of R,S-Warfarin alcohol can be increased when it is combined with Ziprasidone.",increase,no risk
"S,R-Warfarin alcohol",Glucosamine,"Glucosamine may increase the anticoagulant activities of S,R-Warfarin alcohol.",increase,no risk
"S,R-Warfarin alcohol",Glyburide,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Glyburide.",increase,no risk
"S,R-Warfarin alcohol",Glycerol phenylbutyrate,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Glycerol phenylbutyrate.",increase,no risk
"S,R-Warfarin alcohol",Griseofulvin,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Griseofulvin.",increase,no risk
"S,R-Warfarin alcohol",Haloperidol,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Haloperidol.",increase,no risk
"S,R-Warfarin alcohol",Hydralazine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Hydralazine.",increase,no risk
"S,R-Warfarin alcohol",Hydrocortamate,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Hydrocortamate.",increase,no risk
"S,R-Warfarin alcohol",Hydrocortisone,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Hydrocortisone.",increase,no risk
"S,R-Warfarin alcohol",Hydrocortisone acetate,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Hydrocortisone acetate.",increase,no risk
"S,R-Warfarin alcohol",Hydrocortisone butyrate,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Hydrocortisone butyrate.",increase,no risk
"S,R-Warfarin alcohol",Hydrocortisone succinate,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Hydrocortisone succinate.",increase,no risk
"S,R-Warfarin alcohol",Ketamine,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Ketamine.",increase,no risk
"S,R-Warfarin alcohol",Ketazolam,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Ketazolam.",increase,no risk
"S,R-Warfarin alcohol",Ketoconazole,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Ketoconazole.",increase,no risk
"S,R-Warfarin alcohol",Obeticholic acid,"The therapeutic efficacy of S,R-Warfarin alcohol can be decreased when used in combination with Obeticholic acid.",decrease,no risk
"S,R-Warfarin alcohol",Octreotide,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Octreotide.",increase,no risk
"S,R-Warfarin alcohol",Olaparib,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Olaparib.",increase,no risk
"S,R-Warfarin alcohol",Olsalazine,"The risk or severity of bleeding can be increased when S,R-Warfarin alcohol is combined with Olsalazine.",increase,risk
"S,R-Warfarin alcohol",Olutasidenib,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Olutasidenib.",increase,no risk
"S,R-Warfarin alcohol",Omaveloxolone,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Omaveloxolone.",increase,no risk
"S,R-Warfarin alcohol",Oritavancin,"The risk or severity of bleeding can be increased when Oritavancin is combined with S,R-Warfarin alcohol.",increase,risk
"S,R-Warfarin alcohol",Orlistat,"Orlistat may increase the anticoagulant activities of S,R-Warfarin alcohol.",increase,no risk
"S,R-Warfarin alcohol",Orphenadrine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Orphenadrine.",increase,no risk
"S,R-Warfarin alcohol",Osilodrostat,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Osilodrostat.",increase,no risk
"S,R-Warfarin alcohol",Oxcarbazepine,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Oxcarbazepine.",increase,no risk
"S,R-Warfarin alcohol",Oxetacaine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Oxetacaine.",increase,no risk
"S,R-Warfarin alcohol",Oxybutynin,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Oxybutynin.",increase,no risk
"S,R-Warfarin alcohol",Oxymetholone,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Oxymetholone.",increase,no risk
"S,R-Warfarin alcohol",Quinidine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Quinidine.",increase,no risk
"S,R-Warfarin alcohol",Quinine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Quinine.",increase,no risk
"S,R-Warfarin alcohol",Quinupramine,"The risk or severity of bleeding can be increased when Quinupramine is combined with S,R-Warfarin alcohol.",increase,risk
"S,R-Warfarin alcohol",Quinupristin,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Quinupristin.",increase,no risk
"S,R-Warfarin alcohol",Valproic acid,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Valproic acid.",increase,no risk
"S,R-Warfarin alcohol",Vemurafenib,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Vemurafenib.",increase,no risk
"S,R-Warfarin alcohol",Venetoclax,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Venetoclax.",increase,no risk
"S,R-Warfarin alcohol",Verapamil,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Verapamil.",increase,no risk
"S,R-Warfarin alcohol",Viloxazine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Viloxazine.",increase,no risk
"S,R-Warfarin alcohol",Vinblastine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Vinblastine.",increase,no risk
"S,R-Warfarin alcohol",Vitamin E,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Vitamin E.",increase,no risk
"S,R-Warfarin alcohol",Voriconazole,"Voriconazole may increase the anticoagulant activities of S,R-Warfarin alcohol.",increase,no risk
"S,R-Warfarin alcohol",Warfarin,"The metabolism of S,R-Warfarin alcohol can be increased when combined with Warfarin.",increase,no risk
"S,R-Warfarin alcohol",Zafirlukast,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Zafirlukast.",increase,no risk
"S,R-Warfarin alcohol",Zileuton,"The metabolism of S,R-Warfarin alcohol can be decreased when combined with Zileuton.",decrease,no risk
"S,R-Warfarin alcohol",Zimelidine,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Zimelidine.",increase,no risk
"S,R-Warfarin alcohol",Ziprasidone,"The serum concentration of S,R-Warfarin alcohol can be increased when it is combined with Ziprasidone.",increase,no risk
Ethyl biscoumacetate,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Budesonide,Budesonide may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Buspirone,The risk or severity of adverse effects can be increased when Buspirone is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Busulfan,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Busulfan.,increase,risk
Ethyl biscoumacetate,Butabarbital,The metabolism of Ethyl biscoumacetate can be increased when combined with Butabarbital.,increase,no risk
Ethyl biscoumacetate,Butalbital,The metabolism of Ethyl biscoumacetate can be increased when combined with Butalbital.,increase,no risk
Ethyl biscoumacetate,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Gatifloxacin,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Gatifloxacin.,increase,no risk
Ethyl biscoumacetate,Gefitinib,Gefitinib may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Gemcitabine,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Gemcitabine.,increase,no risk
Ethyl biscoumacetate,Gemfibrozil,The risk or severity of bleeding can be increased when Gemfibrozil is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Gemifloxacin,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Gemifloxacin.,increase,no risk
Ethyl biscoumacetate,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Gemtuzumab ozogamicin.,increase,risk
Ethyl biscoumacetate,Gentamicin,The risk or severity of bleeding can be increased when Gentamicin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Gepirone,The risk or severity of adverse effects can be increased when Gepirone is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Glofitamab,The serum concentration of Ethyl biscoumacetate can be increased when it is combined with Glofitamab.,increase,no risk
Ethyl biscoumacetate,Glucagon,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Glucagon.,increase,no risk
Ethyl biscoumacetate,Glutethimide,The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Glutethimide.,decrease,no risk
Ethyl biscoumacetate,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Gramicidin D,The risk or severity of bleeding can be increased when Gramicidin D is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Granisetron,The risk or severity of adverse effects can be increased when Granisetron is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Grepafloxacin,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Grepafloxacin.,increase,no risk
Ethyl biscoumacetate,Griseofulvin,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Griseofulvin.,increase,no risk
Ethyl biscoumacetate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Haloprogin,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Haloprogin.,increase,no risk
Ethyl biscoumacetate,Hemin,Hemin may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Hetacillin,Hetacillin may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Hexetidine,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Hexetidine.,increase,no risk
Ethyl biscoumacetate,Hydrochlorothiazide,The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Ethyl biscoumacetate,Hydrocortisone,Hydrocortisone may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Hydrocortisone acetate,Hydrocortisone acetate may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Hydrocortisone cypionate,Hydrocortisone cypionate may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Hydrocortisone succinate,Hydrocortisone succinate may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Hydroflumethiazide,The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Ethyl biscoumacetate,Hydroxyprogesterone caproate,The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Ethyl biscoumacetate,Hydroxyurea,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Hydroxyurea.,increase,risk
Ethyl biscoumacetate,Kanamycin,The risk or severity of bleeding can be increased when Kanamycin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Ketoconazole,The metabolism of Ethyl biscoumacetate can be decreased when combined with Ketoconazole.,decrease,no risk
Ethyl biscoumacetate,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Ethyl biscoumacetate is combined with Obeticholic acid.,increase,risk
Ethyl biscoumacetate,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Ethyl biscoumacetate is combined with Obinutuzumab.,increase,risk
Ethyl biscoumacetate,Ofloxacin,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Ofloxacin.,increase,no risk
Ethyl biscoumacetate,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Olaparib,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Olaparib.,increase,risk
Ethyl biscoumacetate,Olive oil,The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Olive oil.,decrease,no risk
Ethyl biscoumacetate,Olsalazine,Olsalazine may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Omacetaxine mepesuccinate.,increase,risk
Ethyl biscoumacetate,Omadacycline,Omadacycline may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Omaveloxolone,The serum concentration of Ethyl biscoumacetate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ethyl biscoumacetate,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Omega-3-carboxylic acids,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Ethyl biscoumacetate,Ondansetron,The risk or severity of adverse effects can be increased when Ondansetron is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Oritavancin,The risk or severity of bleeding can be increased when Oritavancin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Oxacillin,Oxacillin may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Oxandrolone,Oxandrolone may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Oxitriptan,The risk or severity of adverse effects can be increased when Oxitriptan is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Oxymetholone,Oxymetholone may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Oxytetracycline,Oxytetracycline may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Quinestrol,Quinestrol may decrease the anticoagulant activities of Ethyl biscoumacetate.,decrease,no risk
Ethyl biscoumacetate,Quinidine,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Quinidine.,increase,no risk
Ethyl biscoumacetate,Quinine,The therapeutic efficacy of Ethyl biscoumacetate can be increased when used in combination with Quinine.,increase,no risk
Ethyl biscoumacetate,Quinupramine,The risk or severity of adverse effects can be increased when Quinupramine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Quinupristin,The risk or severity of bleeding can be increased when Quinupristin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Ubidecarenone,The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Ubidecarenone.,decrease,no risk
Ethyl biscoumacetate,Ulipristal,The therapeutic efficacy of Ethyl biscoumacetate can be decreased when used in combination with Ulipristal.,decrease,no risk
Ethyl biscoumacetate,Urokinase,Urokinase may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Ethyl biscoumacetate is combined with Ursodeoxycholic acid.,increase,risk
Ethyl biscoumacetate,Vadadustat,The serum concentration of Ethyl biscoumacetate can be increased when it is combined with Vadadustat.,increase,no risk
Ethyl biscoumacetate,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Vamorolone,Vamorolone may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Vancomycin,The risk or severity of bleeding can be increased when Vancomycin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Venetoclax,The metabolism of Ethyl biscoumacetate can be decreased when combined with Venetoclax.,decrease,no risk
Ethyl biscoumacetate,Venlafaxine,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Venlafaxine.,increase,risk
Ethyl biscoumacetate,Verapamil,The metabolism of Ethyl biscoumacetate can be decreased when combined with Verapamil.,decrease,no risk
Ethyl biscoumacetate,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Viloxazine,The metabolism of Ethyl biscoumacetate can be decreased when combined with Viloxazine.,decrease,no risk
Ethyl biscoumacetate,Vinblastine,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Vinblastine.,increase,risk
Ethyl biscoumacetate,Vindesine,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Vindesine.,increase,risk
Ethyl biscoumacetate,Vinorelbine,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Vinorelbine.,increase,risk
Ethyl biscoumacetate,Viomycin,The risk or severity of bleeding can be increased when Viomycin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Vitamin E,Vitamin E may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Ethyl biscoumacetate.,decrease,no risk
Ethyl biscoumacetate,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Voriconazole,The metabolism of Ethyl biscoumacetate can be decreased when combined with Voriconazole.,decrease,no risk
Ethyl biscoumacetate,Vorinostat,Vorinostat may increase the anticoagulant activities of Ethyl biscoumacetate.,increase,no risk
Ethyl biscoumacetate,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Yohimbine,The risk or severity of adverse effects can be increased when Yohimbine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Zidovudine,The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Zidovudine.,increase,risk
Ethyl biscoumacetate,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Ziprasidone,The metabolism of Ethyl biscoumacetate can be decreased when combined with Ziprasidone.,decrease,no risk
Ethyl biscoumacetate,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Ethyl biscoumacetate.,increase,risk
Ethyl biscoumacetate,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Ethyl biscoumacetate.,increase,risk
Azidocillin,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Azidocillin.,decrease,no risk
Azidocillin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Azidocillin.,increase,no risk
Azidocillin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Azidocillin.,decrease,no risk
Azidocillin,Warfarin,Azidocillin may increase the anticoagulant activities of Warfarin.,increase,no risk
Salicylamide,Bisoxatin,Salicylamide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Salicylamide,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Bivalirudin.,increase,risk
Salicylamide,Bleomycin,Salicylamide may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Salicylamide,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Brexpiprazole,The risk or severity of hypertension can be increased when Salicylamide is combined with Brexpiprazole.,increase,risk
Salicylamide,Brivaracetam,Salicylamide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Salicylamide,Bromazepam,Salicylamide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Salicylamide,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Salicylamide.,increase,risk
Salicylamide,Bromocriptine,The risk or severity of hypertension can be increased when Bromocriptine is combined with Salicylamide.,increase,risk
Salicylamide,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Salicylamide.,increase,risk
Salicylamide,Bufexamac,The risk or severity of adverse effects can be increased when Salicylamide is combined with Bufexamac.,increase,risk
Salicylamide,Bumadizone,The risk or severity of adverse effects can be increased when Salicylamide is combined with Bumadizone.,increase,risk
Salicylamide,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Bupropion,Salicylamide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Salicylamide,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Salicylamide.,increase,risk
Salicylamide,Butabarbital,Salicylamide may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Salicylamide,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Salicylamide.,increase,risk
Salicylamide,Gabapentin enacarbil,Salicylamide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Salicylamide,Gadobenic acid,Salicylamide may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Salicylamide,Gadodiamide,Salicylamide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Salicylamide,Gadofosveset trisodium,Salicylamide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Salicylamide,Gadopentetic acid,Salicylamide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Salicylamide,Gadoteric acid,Salicylamide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Salicylamide,Gadoteridol,Salicylamide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Salicylamide,Ganciclovir,Salicylamide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Salicylamide,Gatifloxacin,Salicylamide may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Salicylamide,Gemcitabine,Salicylamide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Salicylamide,Gemfibrozil,Salicylamide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Salicylamide,Gemifloxacin,Salicylamide may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Salicylamide,Gentamicin,Salicylamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Salicylamide,Gimeracil,Salicylamide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Salicylamide,Givosiran,The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Givosiran.,increase,risk
Salicylamide,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Salicylamide.,decrease,no risk
Salicylamide,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Salicylamide.,decrease,no risk
Salicylamide,Glipizide,The protein binding of Glipizide can be decreased when combined with Salicylamide.,decrease,no risk
Salicylamide,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Salicylamide.,decrease,no risk
Salicylamide,Glyburide,The protein binding of Glyburide can be decreased when combined with Salicylamide.,decrease,no risk
Salicylamide,Glycerol phenylbutyrate,Salicylamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Salicylamide,Glycol salicylate,The risk or severity of adverse effects can be increased when Salicylamide is combined with Glycol salicylate.,increase,risk
Salicylamide,Golodirsen,Salicylamide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Salicylamide,Goserelin,Salicylamide may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Salicylamide,Grepafloxacin,Salicylamide may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Salicylamide,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Salicylamide.,increase,no risk
Salicylamide,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Salicylamide.,increase,risk
Salicylamide,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Heparin.,increase,risk
Salicylamide,Hydralazine,Salicylamide may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Salicylamide,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Salicylamide.,increase,risk
Salicylamide,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Salicylamide.,increase,risk
Salicylamide,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Salicylamide.,increase,risk
Salicylamide,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Salicylamide.,increase,risk
Salicylamide,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Salicylamide.,increase,risk
Salicylamide,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Hydromorphone,Salicylamide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Salicylamide,Hydroxocobalamin,Salicylamide may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Salicylamide,Hydroxyethyl Starch,Salicylamide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Salicylamide,Kanamycin,Salicylamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Salicylamide,Ketamine,Salicylamide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Salicylamide,Ketazolam,Salicylamide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Salicylamide,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Salicylamide.,increase,risk
Salicylamide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Salicylamide.,increase,risk
Salicylamide,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Salicylamide.,increase,risk
Salicylamide,Octinoxate,Salicylamide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Salicylamide,Ofloxacin,Salicylamide may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Salicylamide,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Salicylamide.",increase,risk
Salicylamide,Olodaterol,The risk or severity of hypertension can be increased when Salicylamide is combined with Olodaterol.,increase,risk
Salicylamide,Olsalazine,The risk or severity of nephrotoxicity can be increased when Salicylamide is combined with Olsalazine.,increase,risk
Salicylamide,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Salicylamide is combined with Omacetaxine mepesuccinate.,increase,risk
Salicylamide,Opium,Salicylamide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Salicylamide,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Salicylamide.,increase,risk
Salicylamide,Oseltamivir,Salicylamide may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Salicylamide,Oxacillin,Salicylamide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Salicylamide,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Salicylamide.,increase,risk
Salicylamide,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Salicylamide.,increase,risk
Salicylamide,Oxazepam,Salicylamide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Salicylamide,Oxprenolol,Salicylamide may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Salicylamide,Oxybenzone,Salicylamide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Salicylamide,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Salicylamide.,increase,risk
Salicylamide,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Salicylamide.,increase,risk
Salicylamide,Oxyquinoline,Salicylamide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Salicylamide,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Salicylamide.,increase,risk
Salicylamide,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylamide is combined with Quinapril.",increase,risk
Salicylamide,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Quinidine,Salicylamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Salicylamide,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Salicylamide.,increase,risk
Salicylamide,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Salicylamide.,decrease,no risk
Salicylamide,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Urokinase.,increase,risk
Salicylamide,Vaborbactam,Salicylamide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Salicylamide,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Salicylamide.,increase,risk
Salicylamide,Valbenazine,Salicylamide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Salicylamide,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Salicylamide.,increase,risk
Salicylamide,Valganciclovir,Salicylamide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Salicylamide,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Salicylamide.,decrease,no risk
Salicylamide,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Salicylamide.",increase,risk
Salicylamide,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Salicylamide.,increase,risk
Salicylamide,Vancomycin,Salicylamide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Salicylamide,Varenicline,Salicylamide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Salicylamide,Venlafaxine,Salicylamide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Salicylamide,Verapamil,Salicylamide may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Salicylamide,Vilanterol,The risk or severity of hypertension can be increased when Salicylamide is combined with Vilanterol.,increase,risk
Salicylamide,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Salicylamide.,increase,risk
Salicylamide,Viloxazine,Salicylamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Salicylamide,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Vorapaxar.,increase,risk
Salicylamide,Voriconazole,The serum concentration of Salicylamide can be increased when it is combined with Voriconazole.,increase,no risk
Salicylamide,Vortioxetine,The risk or severity of hypertension can be increased when Salicylamide is combined with Vortioxetine.,increase,risk
Salicylamide,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Warfarin.,increase,risk
Salicylamide,Xamoterol,The risk or severity of hypertension can be increased when Salicylamide is combined with Xamoterol.,increase,risk
Salicylamide,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Salicylamide is combined with Ximelagatran.,increase,risk
Salicylamide,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Salicylamide.,increase,risk
Salicylamide,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Salicylamide.,increase,risk
Salicylamide,Zaleplon,Salicylamide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Salicylamide,Zanamivir,Salicylamide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Salicylamide,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Salicylamide.,increase,risk
Salicylamide,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Salicylamide.,increase,risk
Salicylamide,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Salicylamide.,increase,risk
Salicylamide,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Salicylamide is combined with Zofenopril.",increase,risk
Salicylamide,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Salicylamide is combined with Zoledronic acid.,increase,risk
Sulfamoxole,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfamoxole.,increase,no risk
Sulfamoxole,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfamoxole.,increase,no risk
Sulfamoxole,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Halothane,The metabolism of Halothane can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Ketamine,The metabolism of Ketamine can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfamoxole.,increase,risk
Sulfamoxole,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Sulfamoxole.,increase,no risk
Sulfamoxole,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Valsartan,The metabolism of Valsartan can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfamoxole.,increase,no risk
Sulfamoxole,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Warfarin,The metabolism of Warfarin can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Zileuton,The metabolism of Zileuton can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sulfamoxole.,decrease,no risk
Sulfamoxole,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sulfamoxole.,decrease,no risk
Antazoline,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Antazoline.,increase,risk
Antazoline,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Antazoline.,increase,risk
Antazoline,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Antazoline.,increase,risk
Antazoline,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Antazoline.,increase,risk
Antazoline,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Antazoline.,increase,risk
Antazoline,Gilteritinib,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Gilteritinib.,increase,risk
Antazoline,Glasdegib,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Glasdegib.,increase,risk
Antazoline,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Antazoline.,increase,risk
Antazoline,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Antazoline.,increase,risk
Antazoline,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Grepafloxacin.,increase,risk
Antazoline,Halofantrine,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Halofantrine.,increase,risk
Antazoline,Haloperidol,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Haloperidol.,increase,risk
Antazoline,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Antazoline.,increase,risk
Antazoline,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Antazoline.,decrease,no risk
Antazoline,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Antazoline.,decrease,no risk
Antazoline,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Antazoline.,decrease,no risk
Antazoline,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Antazoline.,increase,risk
Antazoline,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Antazoline.,increase,risk
Antazoline,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Hydroxyzine.,increase,risk
Antazoline,Hyoscyamine,Antazoline may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Antazoline,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Antazoline.,increase,risk
Antazoline,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Antazoline.,increase,risk
Antazoline,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Antazoline.,increase,risk
Antazoline,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Antazoline.,increase,risk
Antazoline,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Antazoline.,increase,risk
Antazoline,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Antazoline.,increase,risk
Antazoline,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Antazoline.,increase,risk
Antazoline,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Antazoline.,increase,risk
Antazoline,Oxatomide,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Oxatomide.,increase,risk
Antazoline,Oxymetazoline,The absorption of Antazoline can be decreased when combined with Oxymetazoline.,decrease,no risk
Antazoline,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Antazoline.,increase,risk
Antazoline,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Antazoline.,increase,risk
Antazoline,Quinidine,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Quinidine.,increase,risk
Antazoline,Quinine,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Quinine.,increase,risk
Antazoline,Quizartinib,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Quizartinib.,increase,risk
Antazoline,Valproic acid,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Valproic acid.,increase,risk
Antazoline,Vandetanib,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Vandetanib.,increase,risk
Antazoline,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Antazoline.,increase,risk
Antazoline,Vemurafenib,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Vemurafenib.,increase,risk
Antazoline,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Antazoline.,increase,risk
Antazoline,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Antazoline.,increase,risk
Antazoline,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Antazoline.,increase,risk
Antazoline,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Antazoline.,increase,risk
Antazoline,Ziprasidone,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Ziprasidone.,increase,risk
Antazoline,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Antazoline.,increase,risk
Antazoline,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Antazoline is combined with Zuclopenthixol.,increase,risk
Dimetindene,Galantamine,The therapeutic efficacy of Dimetindene can be decreased when used in combination with Galantamine.,decrease,no risk
Dimetindene,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Dimetindene.,increase,risk
Dimetindene,Ginkgo biloba,The therapeutic efficacy of Dimetindene can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Dimetindene,Glucagon,Dimetindene may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Dimetindene,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Dimetindene.,decrease,no risk
Dimetindene,Glycopyrronium,The risk or severity of adverse effects can be increased when Dimetindene is combined with Glycopyrronium.,increase,risk
Dimetindene,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Dimetindene.,increase,risk
Dimetindene,Guanfacine,The risk or severity of Tachycardia can be increased when Guanfacine is combined with Dimetindene.,increase,risk
Dimetindene,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Dimetindene.,increase,risk
Dimetindene,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Dimetindene.,increase,risk
Dimetindene,Homatropine,The risk or severity of adverse effects can be increased when Dimetindene is combined with Homatropine.,increase,risk
Dimetindene,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Dimetindene.,increase,risk
Dimetindene,Huperzine A,The therapeutic efficacy of Dimetindene can be decreased when used in combination with Huperzine A.,decrease,no risk
Dimetindene,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dimetindene.,decrease,no risk
Dimetindene,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Dimetindene.,decrease,no risk
Dimetindene,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Dimetindene.,decrease,no risk
Dimetindene,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Dimetindene.,increase,no risk
Dimetindene,Hydrocodone,The risk or severity of adverse effects can be increased when Dimetindene is combined with Hydrocodone.,increase,risk
Dimetindene,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Dimetindene.,increase,no risk
Dimetindene,Hydromorphone,The risk or severity of adverse effects can be increased when Dimetindene is combined with Hydromorphone.,increase,risk
Dimetindene,Hyoscyamine,Dimetindene may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Dimetindene,Ketamine,The therapeutic efficacy of Dimetindene can be decreased when used in combination with Ketamine.,decrease,no risk
Dimetindene,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Dimetindene.,increase,risk
Dimetindene,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Dimetindene is combined with Oliceridine.",increase,risk
Dimetindene,Olodaterol,The risk or severity of Tachycardia can be increased when Dimetindene is combined with Olodaterol.,increase,risk
Dimetindene,Opium,The risk or severity of adverse effects can be increased when Dimetindene is combined with Opium.,increase,risk
Dimetindene,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Dimetindene.,increase,risk
Dimetindene,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Dimetindene.,increase,risk
Dimetindene,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dimetindene.,increase,risk
Dimetindene,Oxycodone,The risk or severity of adverse effects can be increased when Dimetindene is combined with Oxycodone.,increase,risk
Dimetindene,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Dimetindene.,increase,risk
Dimetindene,Oxymorphone,The risk or severity of adverse effects can be increased when Dimetindene is combined with Oxymorphone.,increase,risk
Dimetindene,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Dimetindene.,increase,risk
Dimetindene,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Dimetindene.,decrease,no risk
Dimetindene,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Dimetindene.,increase,risk
Dimetindene,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Dimetindene.,increase,risk
Dimetindene,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Dimetindene.,increase,no risk
Dimetindene,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Dimetindene.,increase,risk
Dimetindene,Quinupramine,The risk or severity of adverse effects can be increased when Dimetindene is combined with Quinupramine.,increase,risk
Dimetindene,Umeclidinium,The risk or severity of adverse effects can be increased when Dimetindene is combined with Umeclidinium.,increase,risk
Dimetindene,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Dimetindene.,increase,risk
Dimetindene,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Dimetindene.,increase,risk
Dimetindene,Vilanterol,The risk or severity of Tachycardia can be increased when Dimetindene is combined with Vilanterol.,increase,risk
Dimetindene,Xamoterol,The risk or severity of Tachycardia can be increased when Dimetindene is combined with Xamoterol.,increase,risk
Dimetindene,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Dimetindene.,increase,risk
Dimetindene,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Dimetindene.,increase,risk
Isothipendyl,Benzphetamine,Benzphetamine may decrease the sedative activities of Isothipendyl.,decrease,no risk
Isothipendyl,Benzylpenicilloyl polylysine,Isothipendyl may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Isothipendyl,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Isothipendyl.,decrease,no risk
Isothipendyl,Hyoscyamine,Isothipendyl may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Tymazoline,Oxymetazoline,The absorption of Tymazoline can be decreased when combined with Oxymetazoline.,decrease,no risk
Nandrolone decanoate,Quinine,Nandrolone decanoate may increase the hypoglycemic activities of Quinine.,increase,no risk
Nandrolone decanoate,Vamorolone,The risk or severity of edema formation can be increased when Nandrolone decanoate is combined with Vamorolone.,increase,risk
Nandrolone decanoate,Vildagliptin,Nandrolone decanoate may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Nandrolone decanoate,Warfarin,Nandrolone decanoate may increase the anticoagulant activities of Warfarin.,increase,no risk
Nandrolone decanoate,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Nandrolone decanoate.,decrease,no risk
Metiamide,Benzphetamine,Benzphetamine may decrease the sedative activities of Metiamide.,decrease,no risk
Metiamide,Benzylpenicilloyl polylysine,Metiamide may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Metiamide,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Metiamide.,decrease,no risk
Metiamide,Bifonazole,Metiamide can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metiamide,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Metiamide.,decrease,no risk
Metiamide,Bosutinib,Metiamide can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metiamide,Budesonide,Metiamide can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metiamide,Gefitinib,Metiamide can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metiamide,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Metiamide.,decrease,no risk
Metiamide,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Metiamide.,decrease,no risk
Metiamide,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Metiamide.,decrease,no risk
Metiamide,Hyoscyamine,Metiamide may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Metiamide,Ketoconazole,Metiamide can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metiamide,Octreotide,Metiamide can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metiamide,Oteseconazole,Metiamide can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Metiamide,Voriconazole,Metiamide can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Benzphetamine,Benzphetamine may decrease the sedative activities of Roxatidine acetate.,decrease,no risk
Roxatidine acetate,Benzylpenicilloyl polylysine,Roxatidine acetate may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Roxatidine acetate,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Roxatidine acetate.,decrease,no risk
Roxatidine acetate,Bifonazole,Roxatidine acetate can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Roxatidine acetate.,decrease,no risk
Roxatidine acetate,Bosutinib,Roxatidine acetate can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Budesonide,Roxatidine acetate can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Gefitinib,Roxatidine acetate can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Roxatidine acetate.,decrease,no risk
Roxatidine acetate,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Roxatidine acetate.,decrease,no risk
Roxatidine acetate,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Roxatidine acetate.,decrease,no risk
Roxatidine acetate,Hyoscyamine,Roxatidine acetate may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Roxatidine acetate,Ketoconazole,Roxatidine acetate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Octreotide,Roxatidine acetate can cause a decrease in the absorption of Octreotide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Oteseconazole,Roxatidine acetate can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Roxatidine acetate,Voriconazole,Roxatidine acetate can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Bopindolol,Galantamine,Galantamine may increase the bradycardic activities of Bopindolol.,increase,no risk
Bopindolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Bopindolol.,increase,no risk
Bopindolol,Gefitinib,The metabolism of Bopindolol can be decreased when combined with Gefitinib.,decrease,no risk
Bopindolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Bopindolol.,increase,no risk
Bopindolol,Givosiran,The serum concentration of Bopindolol can be increased when it is combined with Givosiran.,increase,no risk
Bopindolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Bopindolol.,increase,no risk
Bopindolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Bopindolol.,increase,no risk
Bopindolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Bopindolol.,increase,no risk
Bopindolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Bopindolol.,increase,no risk
Bopindolol,Glucagon,The therapeutic efficacy of Bopindolol can be decreased when used in combination with Glucagon.,decrease,no risk
Bopindolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Bopindolol.,increase,no risk
Bopindolol,Glycerol phenylbutyrate,The metabolism of Bopindolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Bopindolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Bopindolol.,decrease,no risk
Bopindolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Bopindolol.,increase,no risk
Bopindolol,Golimumab,The metabolism of Bopindolol can be increased when combined with Golimumab.,increase,no risk
Bopindolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Bopindolol.,decrease,no risk
Bopindolol,Guanethidine,Guanethidine may increase the hypotensive activities of Bopindolol.,increase,no risk
Bopindolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bopindolol.,decrease,no risk
Bopindolol,Halofantrine,The metabolism of Bopindolol can be decreased when combined with Halofantrine.,decrease,no risk
Bopindolol,Haloperidol,The serum concentration of Bopindolol can be increased when it is combined with Haloperidol.,increase,no risk
Bopindolol,Halothane,Halothane may increase the cardiodepressant activities of Bopindolol.,increase,no risk
Bopindolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Bopindolol.,increase,risk
Bopindolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Bopindolol.,increase,no risk
Bopindolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Bopindolol.,increase,risk
Bopindolol,Huperzine A,Huperzine A may increase the bradycardic activities of Bopindolol.,increase,no risk
Bopindolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bopindolol.,decrease,risk
Bopindolol,Hydroxyzine,The metabolism of Bopindolol can be decreased when combined with Hydroxyzine.,decrease,no risk
Bopindolol,Ketamine,Ketamine may increase the bradycardic activities of Bopindolol.,increase,no risk
Bopindolol,Ketoconazole,The metabolism of Bopindolol can be decreased when combined with Ketoconazole.,decrease,no risk
Bopindolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Bopindolol.,decrease,no risk
Bopindolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Bopindolol.,decrease,no risk
Bopindolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Bopindolol.,increase,risk
Bopindolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Bopindolol.,increase,no risk
Bopindolol,Olanzapine,Bopindolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Bopindolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Bopindolol.,decrease,no risk
Bopindolol,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Bopindolol.,increase,risk
Bopindolol,Olodaterol,Bopindolol may decrease the bronchodilatory activities of Olodaterol.,decrease,no risk
Bopindolol,Ondansetron,The metabolism of Bopindolol can be decreased when combined with Ondansetron.,decrease,no risk
Bopindolol,Opium,The metabolism of Opium can be decreased when combined with Bopindolol.,decrease,no risk
Bopindolol,Orciprenaline,Bopindolol may decrease the bronchodilatory activities of Orciprenaline.,decrease,no risk
Bopindolol,Oritavancin,The metabolism of Bopindolol can be decreased when combined with Oritavancin.,decrease,no risk
Bopindolol,Orphenadrine,The metabolism of Bopindolol can be decreased when combined with Orphenadrine.,decrease,no risk
Bopindolol,Osilodrostat,The metabolism of Bopindolol can be decreased when combined with Osilodrostat.,decrease,no risk
Bopindolol,Ospemifene,The metabolism of Bopindolol can be decreased when combined with Ospemifene.,decrease,no risk
Bopindolol,Ouabain,Bopindolol may increase the bradycardic activities of Ouabain.,increase,no risk
Bopindolol,Oxamniquine,The metabolism of Bopindolol can be decreased when combined with Oxamniquine.,decrease,no risk
Bopindolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Bopindolol.,decrease,no risk
Bopindolol,Oxprenolol,The metabolism of Bopindolol can be decreased when combined with Oxprenolol.,decrease,no risk
Bopindolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Bopindolol is combined with Oxtriphylline.,increase,risk
Bopindolol,Oxybutynin,The metabolism of Bopindolol can be decreased when combined with Oxybutynin.,decrease,no risk
Bopindolol,Oxycodone,The metabolism of Bopindolol can be decreased when combined with Oxycodone.,decrease,no risk
Bopindolol,Oxymetazoline,The risk or severity of cardiovascular complications can be increased when Bopindolol is combined with Oxymetazoline.,increase,risk
Bopindolol,Oxymorphone,The metabolism of Bopindolol can be decreased when combined with Oxymorphone.,decrease,no risk
Bopindolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Bopindolol.,decrease,no risk
Bopindolol,Quetiapine,Bopindolol may increase the orthostatic hypotensive activities of Quetiapine.,increase,no risk
Bopindolol,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Bopindolol.,increase,risk
Bopindolol,Quinidine,The metabolism of Bopindolol can be decreased when combined with Quinidine.,decrease,no risk
Bopindolol,Quinine,The metabolism of Bopindolol can be decreased when combined with Quinine.,decrease,no risk
Bupranolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Bupranolol.,decrease,no risk
Bupranolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Bilastine,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Bilastine.,increase,risk
Bupranolol,Bimatoprost,Bimatoprost may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Bimekizumab,The metabolism of Bupranolol can be increased when combined with Bimekizumab.,increase,no risk
Bupranolol,Bioallethrin,Bupranolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Bupranolol,Biperiden,The metabolism of Bupranolol can be decreased when combined with Biperiden.,decrease,no risk
Bupranolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Bupranolol.,increase,risk
Bupranolol,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Bupranolol.,increase,risk
Bupranolol,Bosentan,Bosentan may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Bupranolol.,increase,risk
Bupranolol,Bretylium,Bretylium may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Brexpiprazole,Bupranolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Bupranolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Bupranolol.,increase,no risk
Bupranolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Bupranolol is combined with Bromotheophylline.,increase,risk
Bupranolol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Bupranolol.,increase,risk
Bupranolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Bupranolol.,increase,risk
Bupranolol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Bupranolol.,increase,risk
Bupranolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Bumetanide,Bumetanide may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Bupranolol.,increase,no risk
Bupranolol,Buprenorphine,The metabolism of Bupranolol can be decreased when combined with Buprenorphine.,decrease,no risk
Bupranolol,Bupropion,The metabolism of Bupranolol can be decreased when combined with Bupropion.,decrease,no risk
Bupranolol,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Bupranolol.,increase,risk
Bupranolol,Buspirone,Buspirone may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Butabarbital,The serum concentration of Bupranolol can be decreased when it is combined with Butabarbital.,decrease,no risk
Bupranolol,Butalbital,The serum concentration of Bupranolol can be decreased when it is combined with Butalbital.,decrease,no risk
Bupranolol,Butaperazine,The serum concentration of Bupranolol can be increased when it is combined with Butaperazine.,increase,no risk
Bupranolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Gadobenic acid.,increase,risk
Bupranolol,Galantamine,Galantamine may increase the bradycardic activities of Bupranolol.,increase,no risk
Bupranolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Bupranolol.,increase,no risk
Bupranolol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Bupranolol.,increase,risk
Bupranolol,Gefitinib,The metabolism of Bupranolol can be decreased when combined with Gefitinib.,decrease,no risk
Bupranolol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Gemifloxacin.,increase,risk
Bupranolol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Bupranolol.,increase,risk
Bupranolol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Gilteritinib.,increase,risk
Bupranolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Bupranolol.,increase,no risk
Bupranolol,Givosiran,The serum concentration of Bupranolol can be increased when it is combined with Givosiran.,increase,no risk
Bupranolol,Glasdegib,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Glasdegib.,increase,risk
Bupranolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Glucagon,The therapeutic efficacy of Bupranolol can be decreased when used in combination with Glucagon.,decrease,no risk
Bupranolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Glycerol phenylbutyrate,The metabolism of Bupranolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Bupranolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Golimumab,The metabolism of Bupranolol can be increased when combined with Golimumab.,increase,no risk
Bupranolol,Goserelin,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Goserelin.,increase,risk
Bupranolol,Granisetron,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Granisetron.,increase,risk
Bupranolol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Grepafloxacin.,increase,risk
Bupranolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Bupranolol.,decrease,no risk
Bupranolol,Guanadrel,Guanadrel may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Guanethidine,Guanethidine may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Bupranolol.,decrease,no risk
Bupranolol,Guanoxan,Bupranolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Bupranolol,Halofantrine,The metabolism of Bupranolol can be decreased when combined with Halofantrine.,decrease,no risk
Bupranolol,Haloperidol,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Haloperidol.,increase,risk
Bupranolol,Halothane,Halothane may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Bupranolol.,increase,risk
Bupranolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Bupranolol.,increase,no risk
Bupranolol,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Bupranolol.,increase,risk
Bupranolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Bupranolol.,increase,risk
Bupranolol,Huperzine A,Huperzine A may increase the bradycardic activities of Bupranolol.,increase,no risk
Bupranolol,Hydralazine,Hydralazine may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Hydrochlorothiazide,The therapeutic efficacy of Bupranolol can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Bupranolol,Hydroflumethiazide,The therapeutic efficacy of Bupranolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Bupranolol,Hydroxychloroquine,The risk or severity of QTc prolongation can be decreased when Hydroxychloroquine is combined with Bupranolol.,decrease,risk
Bupranolol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Hydroxyzine.,increase,risk
Bupranolol,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Ketamine,Ketamine may increase the bradycardic activities of Bupranolol.,increase,no risk
Bupranolol,Ketoconazole,The metabolism of Bupranolol can be decreased when combined with Ketoconazole.,decrease,no risk
Bupranolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Bupranolol.,increase,risk
Bupranolol,Obinutuzumab,Bupranolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Bupranolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Bupranolol.,increase,no risk
Bupranolol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ofloxacin.,increase,risk
Bupranolol,Olanzapine,Bupranolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Bupranolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Bupranolol.,decrease,no risk
Bupranolol,Olmesartan,Olmesartan may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Olodaterol,Bupranolol may decrease the bronchodilatory activities of Olodaterol.,decrease,no risk
Bupranolol,Ondansetron,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ondansetron.,increase,risk
Bupranolol,Opicapone,Opicapone may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Opium,The metabolism of Opium can be decreased when combined with Bupranolol.,decrease,no risk
Bupranolol,Orciprenaline,Bupranolol may decrease the bronchodilatory activities of Orciprenaline.,decrease,no risk
Bupranolol,Oritavancin,The metabolism of Bupranolol can be decreased when combined with Oritavancin.,decrease,no risk
Bupranolol,Orphenadrine,The metabolism of Bupranolol can be decreased when combined with Orphenadrine.,decrease,no risk
Bupranolol,Osilodrostat,The metabolism of Bupranolol can be decreased when combined with Osilodrostat.,decrease,no risk
Bupranolol,Ospemifene,The metabolism of Bupranolol can be decreased when combined with Ospemifene.,decrease,no risk
Bupranolol,Ouabain,Bupranolol may increase the bradycardic activities of Ouabain.,increase,no risk
Bupranolol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Bupranolol.,increase,risk
Bupranolol,Oxamniquine,The metabolism of Bupranolol can be decreased when combined with Oxamniquine.,decrease,no risk
Bupranolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Oxatomide,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Oxatomide.,increase,risk
Bupranolol,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Bupranolol is combined with Oxtriphylline.,increase,risk
Bupranolol,Oxybutynin,The metabolism of Bupranolol can be decreased when combined with Oxybutynin.,decrease,no risk
Bupranolol,Oxycodone,The metabolism of Bupranolol can be decreased when combined with Oxycodone.,decrease,no risk
Bupranolol,Oxymetazoline,The risk or severity of cardiovascular complications can be increased when Bupranolol is combined with Oxymetazoline.,increase,risk
Bupranolol,Oxymorphone,The metabolism of Bupranolol can be decreased when combined with Oxymorphone.,decrease,no risk
Bupranolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Bupranolol.,increase,risk
Bupranolol,Quetiapine,Quetiapine may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Quinapril,Quinapril may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Quinidine,Quinidine may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Quinine,The metabolism of Bupranolol can be decreased when combined with Quinine.,decrease,no risk
Bupranolol,Quinupramine,Quinupramine may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Quizartinib,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Quizartinib.,increase,risk
Bupranolol,Udenafil,Udenafil may increase the antihypertensive activities of Bupranolol.,increase,no risk
Bupranolol,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Bupranolol.,decrease,no risk
Bupranolol,Unoprostone,Unoprostone may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Urochloa mutica pollen,The risk of a hypersensitivity reaction to Urochloa mutica pollen is increased when it is combined with Bupranolol.,increase,risk
Bupranolol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Bupranolol.,decrease,no risk
Bupranolol,Valdecoxib,Valdecoxib may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Valproic acid,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Valproic acid.,increase,risk
Bupranolol,Valsartan,Valsartan may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Vandetanib,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Vandetanib.,increase,risk
Bupranolol,Vardenafil,Vardenafil may increase the antihypertensive activities of Bupranolol.,increase,no risk
Bupranolol,Varenicline,The risk or severity of adverse effects can be increased when Bupranolol is combined with Varenicline.,increase,risk
Bupranolol,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Bupranolol.,increase,risk
Bupranolol,Venlafaxine,The metabolism of Bupranolol can be decreased when combined with Venlafaxine.,decrease,no risk
Bupranolol,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Bupranolol.,increase,risk
Bupranolol,Vericiguat,Vericiguat may increase the hypotensive activities of Bupranolol.,increase,no risk
Bupranolol,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Bupranolol.,decrease,no risk
Bupranolol,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bupranolol.,decrease,no risk
Bupranolol,Vilazodone,The metabolism of Bupranolol can be decreased when combined with Vilazodone.,decrease,no risk
Bupranolol,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Bupranolol.,increase,no risk
Bupranolol,Viloxazine,The metabolism of Bupranolol can be decreased when combined with Viloxazine.,decrease,no risk
Bupranolol,Vinblastine,The metabolism of Bupranolol can be decreased when combined with Vinblastine.,decrease,no risk
Bupranolol,Vinorelbine,The metabolism of Bupranolol can be decreased when combined with Vinorelbine.,decrease,no risk
Bupranolol,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Bupranolol.,increase,risk
Bupranolol,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Bupranolol.,increase,risk
Bupranolol,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Bupranolol.,decrease,no risk
Bupranolol,Xylometazoline,Xylometazoline may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Yohimbine,Yohimbine may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Ziconotide,Ziconotide may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Zimelidine,The serum concentration of Bupranolol can be increased when it is combined with Zimelidine.,increase,no risk
Bupranolol,Ziprasidone,The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Ziprasidone.,increase,risk
Bupranolol,Zofenopril,Bupranolol may increase the hypotensive activities of Zofenopril.,increase,no risk
Bupranolol,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Bupranolol.,decrease,no risk
Bupranolol,Zolpidem,The metabolism of Bupranolol can be decreased when combined with Zolpidem.,decrease,no risk
Bupranolol,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Bupranolol.,increase,no risk
Bupranolol,Zuclopenthixol,Bupranolol may increase the orthostatic hypotensive activities of Zuclopenthixol.,increase,no risk
Cinitapride,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Cinitapride.,increase,risk
Cinitapride,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cinitapride is combined with Gabapentin enacarbil.,increase,risk
Cinitapride,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Cinitapride.,increase,risk
Cinitapride,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cinitapride is combined with Ganaxolone.",increase,risk
Cinitapride,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Cinitapride.,increase,risk
Cinitapride,Gilteritinib,The therapeutic efficacy of Cinitapride can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cinitapride,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Cinitapride.,increase,risk
Cinitapride,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Cinitapride.,increase,risk
Cinitapride,Guanabenz,Cinitapride may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Cinitapride,Guanadrel,Cinitapride may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Cinitapride,Guanethidine,Cinitapride may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Cinitapride,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Cinitapride.,increase,risk
Cinitapride,Guanoxan,Cinitapride may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Cinitapride,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Cinitapride.,increase,risk
Cinitapride,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Cinitapride.,increase,risk
Cinitapride,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Cinitapride.,increase,risk
Cinitapride,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Cinitapride.,increase,risk
Cinitapride,Hydralazine,Cinitapride may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Cinitapride,Hydrochlorothiazide,Cinitapride may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Cinitapride,Hydrocodone,Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cinitapride,Hydroflumethiazide,Cinitapride may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Cinitapride,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Cinitapride.,increase,risk
Cinitapride,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cinitapride.,increase,no risk
Cinitapride,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Cinitapride.,increase,risk
Cinitapride,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Cinitapride.,increase,risk
Cinitapride,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Cinitapride.,increase,risk
Cinitapride,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Cinitapride.,increase,risk
Cinitapride,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Cinitapride.,increase,risk
Cinitapride,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cinitapride is combined with Oliceridine.",increase,risk
Cinitapride,Olmesartan,Cinitapride may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Cinitapride,Olodaterol,The risk or severity of hypertension can be increased when Cinitapride is combined with Olodaterol.,increase,risk
Cinitapride,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Cinitapride.,increase,risk
Cinitapride,Opium,The risk or severity of CNS depression can be increased when Cinitapride is combined with Opium.,increase,risk
Cinitapride,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Cinitapride.,increase,risk
Cinitapride,Orphenadrine,Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cinitapride,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Cinitapride.,increase,risk
Cinitapride,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Cinitapride.,increase,risk
Cinitapride,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Cinitapride.,increase,risk
Cinitapride,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Cinitapride.,increase,risk
Cinitapride,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Cinitapride.,increase,risk
Cinitapride,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Cinitapride.,increase,risk
Cinitapride,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Cinitapride.,increase,risk
Cinitapride,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Cinitapride.,increase,risk
Cinitapride,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Cinitapride.,increase,risk
Cinitapride,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Cinitapride.,increase,risk
Cinitapride,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Cinitapride.,increase,risk
Cinitapride,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Cinitapride.,increase,risk
Cinitapride,Quinapril,Cinitapride may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Cinitapride,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Cinitapride.,increase,risk
Cinitapride,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Cinitapride.,increase,risk
Cinitapride,Quinupramine,The risk or severity of CNS depression can be increased when Cinitapride is combined with Quinupramine.,increase,risk
Cinitapride,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Cinitapride.,increase,risk
Cinitapride,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Cinitapride.,increase,risk
Cinitapride,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Cinitapride is combined with Valproate bismuth.,increase,risk
Cinitapride,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Cinitapride.,increase,risk
Cinitapride,Valsartan,Cinitapride may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Cinitapride,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Cinitapride.,increase,risk
Cinitapride,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Cinitapride is combined with Venlafaxine.,increase,risk
Cinitapride,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Cinitapride.,increase,risk
Cinitapride,Vilanterol,The risk or severity of hypertension can be increased when Cinitapride is combined with Vilanterol.,increase,risk
Cinitapride,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Cinitapride.,increase,risk
Cinitapride,Viloxazine,The risk or severity of CNS depression can be increased when Cinitapride is combined with Viloxazine.,increase,risk
Cinitapride,Vortioxetine,The risk or severity of CNS depression can be increased when Cinitapride is combined with Vortioxetine.,increase,risk
Cinitapride,Warfarin,The risk or severity of adverse effects can be increased when Cinitapride is combined with Warfarin.,increase,risk
Cinitapride,Xamoterol,The risk or severity of hypertension can be increased when Cinitapride is combined with Xamoterol.,increase,risk
Cinitapride,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Cinitapride.,increase,risk
Cinitapride,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Cinitapride.,increase,risk
Cinitapride,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Cinitapride.,increase,risk
Cinitapride,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Cinitapride.,increase,risk
Cinitapride,Zimelidine,The risk or severity of adverse effects can be increased when Cinitapride is combined with Zimelidine.,increase,risk
Cinitapride,Ziprasidone,The risk or severity of adverse effects can be increased when Cinitapride is combined with Ziprasidone.,increase,risk
Cinitapride,Zofenopril,Cinitapride may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Cinitapride,Zolmitriptan,The risk or severity of vasospastic reactions can be increased when Cinitapride is combined with Zolmitriptan.,increase,risk
Cinitapride,Zolpidem,Cinitapride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cinitapride,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Cinitapride.,increase,risk
Cinitapride,Zopiclone,The risk or severity of adverse effects can be increased when Cinitapride is combined with Zopiclone.,increase,risk
Cinitapride,Zotepine,The risk or severity of CNS depression can be increased when Cinitapride is combined with Zotepine.,increase,risk
Cinitapride,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Cinitapride.,increase,risk
Cinitapride,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cinitapride.,increase,risk
Tofisopam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Tofisopam.,increase,risk
Tofisopam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tofisopam is combined with Gabapentin enacarbil.,increase,risk
Tofisopam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tofisopam.,increase,risk
Tofisopam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tofisopam is combined with Ganaxolone.",increase,risk
Tofisopam,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Tofisopam.,increase,no risk
Tofisopam,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tofisopam.,increase,risk
Tofisopam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tofisopam.,increase,risk
Tofisopam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tofisopam.,increase,risk
Tofisopam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tofisopam.,increase,risk
Tofisopam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tofisopam.,increase,risk
Tofisopam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tofisopam.,increase,risk
Tofisopam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tofisopam.,increase,risk
Tofisopam,Hydrocodone,Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tofisopam,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tofisopam.,increase,risk
Tofisopam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tofisopam.,increase,no risk
Tofisopam,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Tofisopam.,increase,risk
Tofisopam,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Tofisopam.,increase,risk
Tofisopam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tofisopam.,increase,risk
Tofisopam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tofisopam is combined with Oliceridine.",increase,risk
Tofisopam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tofisopam.,increase,risk
Tofisopam,Opium,The risk or severity of CNS depression can be increased when Tofisopam is combined with Opium.,increase,risk
Tofisopam,Orphenadrine,Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tofisopam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tofisopam.,increase,risk
Tofisopam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Tofisopam.,increase,risk
Tofisopam,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Tofisopam.,increase,risk
Tofisopam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Tofisopam.,increase,risk
Tofisopam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Tofisopam.,increase,risk
Tofisopam,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tofisopam.,increase,risk
Tofisopam,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Tofisopam.,increase,risk
Tofisopam,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Tofisopam.,increase,risk
Tofisopam,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Tofisopam.,increase,risk
Tofisopam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Tofisopam.,increase,risk
Tofisopam,Quinupramine,The risk or severity of CNS depression can be increased when Tofisopam is combined with Quinupramine.,increase,risk
Tofisopam,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Tofisopam.,increase,risk
Tofisopam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Tofisopam.,increase,risk
Tofisopam,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Tofisopam.,decrease,no risk
Tofisopam,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Tofisopam.,increase,risk
Tofisopam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tofisopam.,increase,risk
Tofisopam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Tofisopam.,increase,risk
Tofisopam,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Tofisopam.,increase,risk
Tofisopam,Viloxazine,The risk or severity of CNS depression can be increased when Tofisopam is combined with Viloxazine.,increase,risk
Tofisopam,Vortioxetine,The risk or severity of CNS depression can be increased when Tofisopam is combined with Vortioxetine.,increase,risk
Tofisopam,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Tofisopam.,increase,no risk
Tofisopam,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Tofisopam.,increase,no risk
Tofisopam,Yohimbine,The therapeutic efficacy of Tofisopam can be increased when used in combination with Yohimbine.,increase,no risk
Tofisopam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Tofisopam.,increase,risk
Tofisopam,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Tofisopam.,increase,risk
Tofisopam,Zimelidine,The risk or severity of adverse effects can be increased when Tofisopam is combined with Zimelidine.,increase,risk
Tofisopam,Ziprasidone,The risk or severity of adverse effects can be increased when Tofisopam is combined with Ziprasidone.,increase,risk
Tofisopam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tofisopam.,increase,risk
Tofisopam,Zolpidem,Tofisopam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tofisopam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Tofisopam.,increase,risk
Tofisopam,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Tofisopam.,decrease,no risk
Tofisopam,Zotepine,The risk or severity of CNS depression can be increased when Tofisopam is combined with Zotepine.,increase,risk
Tofisopam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Tofisopam.,increase,risk
Tofisopam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tofisopam.,increase,risk
Nadroparin,Gemcitabine,The risk or severity of bleeding can be increased when Nadroparin is combined with Gemcitabine.,increase,risk
Nadroparin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Nadroparin is combined with Gemtuzumab ozogamicin.,increase,risk
Nadroparin,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Nadroparin.,decrease,no risk
Nadroparin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Nadroparin.,increase,risk
Nadroparin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Nadroparin.,increase,no risk
Nadroparin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Nadroparin.,increase,risk
Nadroparin,Hemin,Hemin may increase the anticoagulant activities of Nadroparin.,increase,no risk
Nadroparin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Nadroparin.,increase,risk
Nadroparin,Hydrochlorothiazide,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Nadroparin,Hydroflumethiazide,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Nadroparin,Hydroxyprogesterone caproate,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Nadroparin,Hydroxyurea,The risk or severity of bleeding can be increased when Nadroparin is combined with Hydroxyurea.,increase,risk
Nadroparin,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Nadroparin.,decrease,no risk
Nadroparin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Nadroparin.,increase,risk
Nadroparin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Nadroparin.,increase,risk
Nadroparin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Nadroparin.,increase,risk
Nadroparin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Nadroparin is combined with Obeticholic acid.,increase,risk
Nadroparin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Nadroparin is combined with Obinutuzumab.,increase,risk
Nadroparin,Olaparib,The risk or severity of bleeding can be increased when Nadroparin is combined with Olaparib.,increase,risk
Nadroparin,Olive oil,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Olive oil.,decrease,no risk
Nadroparin,Olmesartan,The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Olmesartan.,increase,risk
Nadroparin,Olsalazine,The risk or severity of bleeding can be increased when Nadroparin is combined with Olsalazine.,increase,risk
Nadroparin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Nadroparin is combined with Omacetaxine mepesuccinate.,increase,risk
Nadroparin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Nadroparin.,increase,no risk
Nadroparin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Nadroparin.,increase,risk
Nadroparin,Omega-3-carboxylic acids,The therapeutic efficacy of Nadroparin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Nadroparin,Oritavancin,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Oritavancin.,decrease,no risk
Nadroparin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Nadroparin.,increase,risk
Nadroparin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Nadroparin.,increase,risk
Nadroparin,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Nadroparin.,increase,risk
Nadroparin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Nadroparin.,increase,risk
Nadroparin,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Nadroparin.,increase,risk
Nadroparin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Nadroparin.,decrease,no risk
Nadroparin,Quinidine,The therapeutic efficacy of Nadroparin can be increased when used in combination with Quinidine.,increase,no risk
Nadroparin,Quinine,The therapeutic efficacy of Nadroparin can be increased when used in combination with Quinine.,increase,no risk
Nadroparin,Ulipristal,The therapeutic efficacy of Nadroparin can be decreased when used in combination with Ulipristal.,decrease,no risk
Nadroparin,Urokinase,Urokinase may increase the anticoagulant activities of Nadroparin.,increase,no risk
Nadroparin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Nadroparin is combined with Ursodeoxycholic acid.,increase,risk
Nadroparin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Nadroparin.,increase,risk
Nadroparin,Valsartan,The risk or severity of hyperkalemia can be increased when Nadroparin is combined with Valsartan.,increase,risk
Nadroparin,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Nadroparin.,decrease,no risk
Nadroparin,Venlafaxine,The risk or severity of bleeding can be increased when Nadroparin is combined with Venlafaxine.,increase,risk
Nadroparin,Vinblastine,The risk or severity of bleeding can be increased when Nadroparin is combined with Vinblastine.,increase,risk
Nadroparin,Vindesine,The risk or severity of bleeding can be increased when Nadroparin is combined with Vindesine.,increase,risk
Nadroparin,Vinorelbine,The risk or severity of bleeding can be increased when Nadroparin is combined with Vinorelbine.,increase,risk
Nadroparin,Vitamin E,Vitamin E may increase the anticoagulant activities of Nadroparin.,increase,no risk
Nadroparin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Nadroparin.,decrease,no risk
Nadroparin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Nadroparin.,increase,risk
Nadroparin,Vorinostat,The risk or severity of bleeding can be increased when Nadroparin is combined with Vorinostat.,increase,risk
Nadroparin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Nadroparin.,increase,risk
Nadroparin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Nadroparin.,increase,risk
Nadroparin,Zidovudine,The risk or severity of bleeding can be increased when Nadroparin is combined with Zidovudine.,increase,risk
Nadroparin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Nadroparin.,increase,risk
Nadroparin,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Nadroparin.,increase,risk
Nadroparin,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Nadroparin.,increase,risk
Triflusal,Gemcitabine,The risk or severity of bleeding can be increased when Triflusal is combined with Gemcitabine.,increase,risk
Triflusal,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Triflusal is combined with Gemtuzumab ozogamicin.,increase,risk
Triflusal,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Triflusal.,increase,risk
Triflusal,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Triflusal.,increase,no risk
Triflusal,Glucosamine,Glucosamine may increase the antiplatelet activities of Triflusal.,increase,no risk
Triflusal,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Triflusal.,increase,risk
Triflusal,Hemin,Hemin may increase the anticoagulant activities of Triflusal.,increase,no risk
Triflusal,Heparin,The risk or severity of bleeding can be increased when Triflusal is combined with Heparin.,increase,risk
Triflusal,Hydrochlorothiazide,The therapeutic efficacy of Triflusal can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Triflusal,Hydroflumethiazide,The therapeutic efficacy of Triflusal can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Triflusal,Hydroxyprogesterone caproate,The therapeutic efficacy of Triflusal can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Triflusal,Hydroxyurea,The risk or severity of bleeding can be increased when Triflusal is combined with Hydroxyurea.,increase,risk
Triflusal,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Triflusal.,increase,risk
Triflusal,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Triflusal.,increase,risk
Triflusal,Obeticholic acid,The risk or severity of adverse effects can be increased when Triflusal is combined with Obeticholic acid.,increase,risk
Triflusal,Obinutuzumab,The risk or severity of adverse effects can be increased when Triflusal is combined with Obinutuzumab.,increase,risk
Triflusal,Olaparib,The risk or severity of bleeding can be increased when Triflusal is combined with Olaparib.,increase,risk
Triflusal,Olive oil,The therapeutic efficacy of Triflusal can be decreased when used in combination with Olive oil.,decrease,no risk
Triflusal,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Triflusal.,increase,risk
Triflusal,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Triflusal is combined with Omacetaxine mepesuccinate.,increase,risk
Triflusal,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Triflusal.,increase,no risk
Triflusal,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Triflusal.,increase,risk
Triflusal,Omega-3-carboxylic acids,The therapeutic efficacy of Triflusal can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Triflusal,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Triflusal.,increase,risk
Triflusal,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Triflusal.,increase,risk
Triflusal,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Triflusal.,increase,risk
Triflusal,Quinestrol,Quinestrol may decrease the anticoagulant activities of Triflusal.,decrease,no risk
Triflusal,Quinidine,The therapeutic efficacy of Triflusal can be increased when used in combination with Quinidine.,increase,no risk
Triflusal,Quinine,The therapeutic efficacy of Triflusal can be increased when used in combination with Quinine.,increase,no risk
Triflusal,Ulipristal,The therapeutic efficacy of Triflusal can be decreased when used in combination with Ulipristal.,decrease,no risk
Triflusal,Urokinase,Urokinase may increase the anticoagulant activities of Triflusal.,increase,no risk
Triflusal,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Triflusal is combined with Ursodeoxycholic acid.,increase,risk
Triflusal,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Triflusal.,increase,risk
Triflusal,Venlafaxine,The risk or severity of bleeding can be increased when Triflusal is combined with Venlafaxine.,increase,risk
Triflusal,Vinblastine,The risk or severity of bleeding can be increased when Triflusal is combined with Vinblastine.,increase,risk
Triflusal,Vindesine,The risk or severity of bleeding can be increased when Triflusal is combined with Vindesine.,increase,risk
Triflusal,Vinorelbine,The risk or severity of bleeding can be increased when Triflusal is combined with Vinorelbine.,increase,risk
Triflusal,Vitamin E,Vitamin E may increase the antiplatelet activities of Triflusal.,increase,no risk
Triflusal,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Triflusal.,decrease,no risk
Triflusal,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Triflusal.,increase,risk
Triflusal,Vorinostat,The risk or severity of bleeding can be increased when Triflusal is combined with Vorinostat.,increase,risk
Triflusal,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Triflusal.,increase,risk
Triflusal,Warfarin,The risk or severity of bleeding can be increased when Triflusal is combined with Warfarin.,increase,risk
Triflusal,Ximelagatran,The risk or severity of bleeding can be increased when Triflusal is combined with Ximelagatran.,increase,risk
Triflusal,Zidovudine,The risk or severity of bleeding can be increased when Triflusal is combined with Zidovudine.,increase,risk
Triflusal,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Triflusal.,increase,risk
Lurasidone,Brexanolone,The risk or severity of CNS depression can be increased when Lurasidone is combined with Brexanolone.,increase,risk
Lurasidone,Brexpiprazole,Brexpiprazole may increase the hypotensive activities of Lurasidone.,increase,no risk
Lurasidone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Lurasidone.,increase,no risk
Lurasidone,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Lurasidone.,increase,risk
Lurasidone,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Lurasidone.,increase,risk
Lurasidone,Bromocriptine,Bromocriptine may increase the hypotensive activities of Lurasidone.,increase,no risk
Lurasidone,Bromperidol,The risk or severity of CNS depression can be increased when Lurasidone is combined with Bromperidol.,increase,risk
Lurasidone,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Lurasidone.,increase,risk
Lurasidone,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Lurasidone.,increase,risk
Lurasidone,Bumadizone,The risk or severity of hypertension can be increased when Lurasidone is combined with Bumadizone.,increase,risk
Lurasidone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Lurasidone.,increase,risk
Lurasidone,Buprenorphine,Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Lurasidone,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Lurasidone.,increase,risk
Lurasidone,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Lurasidone.,increase,risk
Lurasidone,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Lurasidone.,increase,risk
Lurasidone,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Lurasidone.,increase,risk
Lurasidone,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Lurasidone.,increase,risk
Lurasidone,Butaperazine,The risk or severity of CNS depression can be increased when Lurasidone is combined with Butaperazine.,increase,risk
Lurasidone,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Lurasidone.,increase,risk
Lurasidone,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Lurasidone.,increase,risk
Lurasidone,Butriptyline,The risk or severity of CNS depression can be increased when Lurasidone is combined with Butriptyline.,increase,risk
Lurasidone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Lurasidone.,increase,risk
Lurasidone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Lurasidone is combined with Gabapentin enacarbil.,increase,risk
Lurasidone,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Gadobenic acid.,increase,risk
Lurasidone,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lurasidone.,increase,risk
Lurasidone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Lurasidone.,increase,risk
Lurasidone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Lurasidone is combined with Ganaxolone.",increase,risk
Lurasidone,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lurasidone.,increase,risk
Lurasidone,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Gemifloxacin.,increase,risk
Lurasidone,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Lurasidone.,increase,risk
Lurasidone,Gilteritinib,The therapeutic efficacy of Lurasidone can be decreased when used in combination with Gilteritinib.,decrease,no risk
Lurasidone,Glasdegib,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Glasdegib.,increase,risk
Lurasidone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Glofitamab,The serum concentration of Lurasidone can be increased when it is combined with Glofitamab.,increase,no risk
Lurasidone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Lurasidone.,increase,risk
Lurasidone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Goserelin,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Goserelin.,increase,risk
Lurasidone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Lurasidone.,increase,risk
Lurasidone,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Grepafloxacin.,increase,risk
Lurasidone,Guanabenz,Lurasidone may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Lurasidone,Guanadrel,Lurasidone may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Lurasidone,Guanethidine,Lurasidone may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Lurasidone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Lurasidone.,increase,risk
Lurasidone,Guanoxan,Lurasidone may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Lurasidone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Lurasidone.,increase,risk
Lurasidone,Halofantrine,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Halofantrine.,increase,risk
Lurasidone,Haloperidol,The metabolism of Lurasidone can be decreased when combined with Haloperidol.,decrease,no risk
Lurasidone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Lurasidone.,increase,risk
Lurasidone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Lurasidone.,increase,risk
Lurasidone,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lurasidone.,increase,risk
Lurasidone,Hydralazine,Lurasidone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Lurasidone,Hydrochlorothiazide,Lurasidone may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Lurasidone,Hydrocodone,Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lurasidone,Hydroflumethiazide,Lurasidone may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Lurasidone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Lurasidone.,increase,risk
Lurasidone,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Lurasidone.,increase,risk
Lurasidone,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Hydroxyzine.,increase,risk
Lurasidone,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lurasidone.,increase,risk
Lurasidone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Lurasidone.,increase,risk
Lurasidone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Lurasidone.,increase,risk
Lurasidone,Ketoconazole,The metabolism of Lurasidone can be decreased when combined with Ketoconazole.,decrease,no risk
Lurasidone,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Lurasidone.,increase,risk
Lurasidone,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Lurasidone.,increase,risk
Lurasidone,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lurasidone.,increase,risk
Lurasidone,Ofloxacin,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Ofloxacin.,increase,risk
Lurasidone,Olanzapine,Olanzapine may increase the hypotensive activities of Lurasidone.,increase,no risk
Lurasidone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lurasidone is combined with Oliceridine.",increase,risk
Lurasidone,Olmesartan,Lurasidone may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Lurasidone,Olodaterol,The risk or severity of hypertension can be increased when Lurasidone is combined with Olodaterol.,increase,risk
Lurasidone,Olutasidenib,The therapeutic efficacy of Lurasidone can be decreased when used in combination with Olutasidenib.,decrease,no risk
Lurasidone,Omaveloxolone,The serum concentration of Lurasidone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lurasidone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Lurasidone.,increase,risk
Lurasidone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Opium,The risk or severity of CNS depression can be increased when Lurasidone is combined with Opium.,increase,risk
Lurasidone,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Lurasidone.,increase,risk
Lurasidone,Orphenadrine,Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Lurasidone,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Lurasidone.,increase,risk
Lurasidone,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Lurasidone.,increase,risk
Lurasidone,Oxatomide,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Oxatomide.,increase,risk
Lurasidone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Lurasidone.,increase,risk
Lurasidone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Lurasidone.,increase,risk
Lurasidone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Lurasidone.,increase,risk
Lurasidone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Lurasidone.,increase,risk
Lurasidone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Lurasidone.,increase,risk
Lurasidone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Lurasidone.,increase,risk
Lurasidone,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Lurasidone.,increase,risk
Lurasidone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Lurasidone.,increase,risk
Lurasidone,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Lurasidone.,increase,risk
Lurasidone,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lurasidone.,increase,risk
Lurasidone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Lurasidone.,increase,risk
Lurasidone,Quetiapine,Quetiapine may increase the hypotensive activities of Lurasidone.,increase,no risk
Lurasidone,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Quinapril,Lurasidone may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Lurasidone,Quinidine,Quinidine may increase the hypotensive activities of Lurasidone.,increase,no risk
Lurasidone,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Lurasidone.,decrease,no risk
Lurasidone,Quinupramine,The risk or severity of CNS depression can be increased when Lurasidone is combined with Quinupramine.,increase,risk
Lurasidone,Quizartinib,The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Quizartinib.,increase,risk
Ticagrelor,Quetiapine,The metabolism of Ticagrelor can be decreased when combined with Quetiapine.,decrease,no risk
Ticagrelor,Quinestrol,Quinestrol may decrease the anticoagulant activities of Ticagrelor.,decrease,no risk
Ticagrelor,Quinidine,The therapeutic efficacy of Ticagrelor can be increased when used in combination with Quinidine.,increase,no risk
Ticagrelor,Quinine,The therapeutic efficacy of Ticagrelor can be increased when used in combination with Quinine.,increase,no risk
Ticagrelor,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Udenafil,The metabolism of Ticagrelor can be decreased when combined with Udenafil.,decrease,no risk
Ticagrelor,Ulipristal,The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Ulipristal.,decrease,no risk
Ticagrelor,Umbralisib,The serum concentration of Ticagrelor can be increased when it is combined with Umbralisib.,increase,no risk
Ticagrelor,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Urokinase,Urokinase may increase the anticoagulant activities of Ticagrelor.,increase,no risk
Ticagrelor,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Ticagrelor is combined with Ursodeoxycholic acid.,increase,risk
Ticagrelor,Vadadustat,The serum concentration of Ticagrelor can be increased when it is combined with Vadadustat.,increase,no risk
Ticagrelor,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Ticagrelor.,increase,risk
Ticagrelor,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Valsartan,The metabolism of Valsartan can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Vemurafenib,The serum concentration of Ticagrelor can be increased when it is combined with Vemurafenib.,increase,no risk
Ticagrelor,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Venlafaxine,The risk or severity of bleeding can be increased when Ticagrelor is combined with Venlafaxine.,increase,risk
Ticagrelor,Verapamil,The metabolism of Ticagrelor can be decreased when combined with Verapamil.,decrease,no risk
Ticagrelor,Viloxazine,The metabolism of Ticagrelor can be decreased when combined with Viloxazine.,decrease,no risk
Ticagrelor,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Vincristine,The excretion of Vincristine can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Vindesine,The metabolism of Vindesine can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Vitamin E,Vitamin E may increase the antiplatelet activities of Ticagrelor.,increase,no risk
Ticagrelor,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Ticagrelor.,decrease,no risk
Ticagrelor,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ticagrelor.,increase,risk
Ticagrelor,Voriconazole,The metabolism of Ticagrelor can be decreased when combined with Voriconazole.,decrease,no risk
Ticagrelor,Vorinostat,The risk or severity of bleeding can be increased when Ticagrelor is combined with Vorinostat.,increase,risk
Ticagrelor,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Ticagrelor.,increase,risk
Ticagrelor,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ticagrelor.,increase,no risk
Ticagrelor,Ximelagatran,The risk or severity of bleeding can be increased when Ticagrelor is combined with Ximelagatran.,increase,risk
Ticagrelor,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Zaleplon,The metabolism of Ticagrelor can be decreased when combined with Zaleplon.,decrease,no risk
Ticagrelor,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Zidovudine,The risk or severity of bleeding can be increased when Ticagrelor is combined with Zidovudine.,increase,risk
Ticagrelor,Zileuton,The metabolism of Zileuton can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ticagrelor.,increase,risk
Ticagrelor,Ziprasidone,The metabolism of Ticagrelor can be decreased when combined with Ziprasidone.,decrease,no risk
Ticagrelor,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Zonisamide,The serum concentration of Ticagrelor can be increased when it is combined with Zonisamide.,increase,no risk
Ticagrelor,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ticagrelor.,decrease,no risk
Ticagrelor,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ticagrelor.,decrease,no risk
Tafluprost,Balsalazide,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Balsalazide.,decrease,no risk
Tafluprost,Benorilate,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Benorilate.,decrease,no risk
Tafluprost,Benoxaprofen,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Tafluprost,Benzydamine,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Benzydamine.,decrease,no risk
Tafluprost,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tafluprost.,decrease,no risk
Tafluprost,Bumadizone,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Bumadizone.,decrease,no risk
Tafluprost,Glycol salicylate,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Tafluprost,Ketoprofen,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Ketoprofen.,decrease,no risk
Tafluprost,Ketorolac,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Ketorolac.,decrease,no risk
Tafluprost,Oxaprozin,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Oxaprozin.,decrease,no risk
Tafluprost,Oxyphenbutazone,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Tafluprost,Valdecoxib,The therapeutic efficacy of Tafluprost can be decreased when used in combination with Valdecoxib.,decrease,no risk
Ioflupane I-123,Gabapentin enacarbil,Ioflupane I-123 may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gadodiamide,Gadodiamide may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gadoteric acid,Ioflupane I-123 may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gadoteridol,Gadoteridol may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Ganciclovir,Ganciclovir may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gemcitabine,Gemcitabine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gentamicin,Ioflupane I-123 may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Gimeracil,Ioflupane I-123 may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Givosiran,Givosiran may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Glipizide,Glipizide may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Glycerol phenylbutyrate,Ioflupane I-123 may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Golodirsen,Ioflupane I-123 may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Goserelin,Goserelin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Guanethidine,Guanethidine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Guanfacine,Guanfacine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Haloperidol,Haloperidol may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Hydralazine,Hydralazine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ioflupane I-123,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ioflupane I-123,Hydromorphone,Hydromorphone may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Hydroxyethyl Starch,Ioflupane I-123 may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Kanamycin,Ioflupane I-123 may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Ketamine,Ketamine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Ketazolam,Ketazolam may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Ketoprofen,Ketoprofen may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Ketorolac,Ketorolac may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Octinoxate,Ioflupane I-123 may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Olsalazine,Olsalazine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Opium,Ioflupane I-123 may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Oseltamivir,Oseltamivir may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Oxacillin,Oxacillin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Oxaprozin,Oxaprozin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Oxazepam,Oxazepam may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Oxybenzone,Oxybenzone may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Oxyquinoline,Ioflupane I-123 may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Quetiapine,Quetiapine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.,decrease,no risk
Ioflupane I-123,Quinethazone,Quinethazone may increase the excretion rate of Ioflupane I-123 which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ioflupane I-123,Quinidine,Ioflupane I-123 may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Deferiprone,Gabapentin enacarbil,Deferiprone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Deferiprone,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Gadodiamide,Gadodiamide may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Gadoteric acid,Deferiprone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Deferiprone,Gadoteridol,Gadoteridol may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Ganciclovir,Ganciclovir may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Gemcitabine,Gemcitabine may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Gentamicin,Deferiprone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Deferiprone,Gimeracil,Deferiprone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Deferiprone,Givosiran,Givosiran may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Glipizide,Glipizide may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Glycerol phenylbutyrate,Deferiprone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Deferiprone,Golodirsen,Deferiprone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Deferiprone,Goserelin,Goserelin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Guanethidine,Guanethidine may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Guanfacine,Guanfacine may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Haloperidol,Haloperidol may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Hydralazine,Hydralazine may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deferiprone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deferiprone,Hydromorphone,Hydromorphone may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Deferiprone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deferiprone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Hydroxyethyl Starch,Deferiprone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Deferiprone,Kanamycin,Deferiprone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Deferiprone,Ketamine,Ketamine may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Ketazolam,Ketazolam may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Ketoprofen,Ketoprofen may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Ketorolac,Ketorolac may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Octinoxate,Deferiprone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Deferiprone,Olsalazine,Olsalazine may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Opium,Deferiprone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Deferiprone,Oseltamivir,Oseltamivir may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Oxacillin,Oxacillin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Oxaprozin,Oxaprozin may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Oxazepam,Oxazepam may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Oxybenzone,Oxybenzone may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Deferiprone which could result in a higher serum level.,decrease,no risk
Deferiprone,Oxyquinoline,Deferiprone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Lomitapide,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Gilteritinib,The metabolism of Lomitapide can be decreased when combined with Gilteritinib.,decrease,no risk
Lomitapide,Ginkgo biloba,The metabolism of Lomitapide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Lomitapide,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Glecaprevir,The metabolism of Lomitapide can be decreased when combined with Glecaprevir.,decrease,no risk
Lomitapide,Glofitamab,The serum concentration of Lomitapide can be increased when it is combined with Glofitamab.,increase,no risk
Lomitapide,Glyburide,The metabolism of Lomitapide can be decreased when combined with Glyburide.,decrease,no risk
Lomitapide,Glycerol phenylbutyrate,The metabolism of Lomitapide can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Lomitapide,Golimumab,The metabolism of Lomitapide can be increased when combined with Golimumab.,increase,no risk
Lomitapide,Grapefruit,The serum concentration of Lomitapide can be increased when it is combined with Grapefruit.,increase,no risk
Lomitapide,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Griseofulvin,The metabolism of Lomitapide can be increased when combined with Griseofulvin.,increase,no risk
Lomitapide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Hydralazine,The serum concentration of Lomitapide can be increased when it is combined with Hydralazine.,increase,no risk
Lomitapide,Hydrocortamate,The metabolism of Lomitapide can be increased when combined with Hydrocortamate.,increase,no risk
Lomitapide,Hydrocortisone,The metabolism of Lomitapide can be increased when combined with Hydrocortisone.,increase,no risk
Lomitapide,Hydrocortisone acetate,The metabolism of Lomitapide can be increased when combined with Hydrocortisone acetate.,increase,no risk
Lomitapide,Hydrocortisone butyrate,The metabolism of Lomitapide can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Lomitapide,Hydrocortisone succinate,The metabolism of Lomitapide can be increased when combined with Hydrocortisone succinate.,increase,no risk
Lomitapide,Ketazolam,The serum concentration of Lomitapide can be increased when it is combined with Ketazolam.,increase,no risk
Lomitapide,Ketoconazole,The metabolism of Lomitapide can be decreased when combined with Ketoconazole.,decrease,no risk
Lomitapide,Octreotide,The serum concentration of Lomitapide can be increased when it is combined with Octreotide.,increase,no risk
Lomitapide,Olaparib,The metabolism of Lomitapide can be decreased when combined with Olaparib.,decrease,no risk
Lomitapide,Olutasidenib,The therapeutic efficacy of Lomitapide can be decreased when used in combination with Olutasidenib.,decrease,no risk
Lomitapide,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Omaveloxolone,The serum concentration of Lomitapide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lomitapide,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Oritavancin,The metabolism of Lomitapide can be increased when combined with Oritavancin.,increase,no risk
Lomitapide,Orphenadrine,The metabolism of Lomitapide can be decreased when combined with Orphenadrine.,decrease,no risk
Lomitapide,Osilodrostat,The metabolism of Lomitapide can be decreased when combined with Osilodrostat.,decrease,no risk
Lomitapide,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Oxcarbazepine,The metabolism of Lomitapide can be increased when combined with Oxcarbazepine.,increase,no risk
Lomitapide,Oxybutynin,The serum concentration of Lomitapide can be increased when it is combined with Oxybutynin.,increase,no risk
Lomitapide,Quinidine,The metabolism of Lomitapide can be decreased when combined with Quinidine.,decrease,no risk
Lomitapide,Quinine,The metabolism of Lomitapide can be increased when combined with Quinine.,increase,no risk
Lomitapide,Quinupristin,The metabolism of Lomitapide can be decreased when combined with Quinupristin.,decrease,no risk
Lomitapide,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Vadadustat,The serum concentration of Lomitapide can be increased when it is combined with Vadadustat.,increase,no risk
Lomitapide,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Lomitapide.,decrease,no risk
Lomitapide,Valproic acid,The serum concentration of Lomitapide can be increased when it is combined with Valproic acid.,increase,no risk
Lomitapide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Lomitapide.,decrease,no risk
Lomitapide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Lomitapide.,decrease,no risk
Lomitapide,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Verapamil,The metabolism of Lomitapide can be decreased when combined with Verapamil.,decrease,no risk
Lomitapide,Viloxazine,The metabolism of Lomitapide can be decreased when combined with Viloxazine.,decrease,no risk
Lomitapide,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Vincristine,The excretion of Vincristine can be decreased when combined with Lomitapide.,decrease,no risk
Lomitapide,Vindesine,The metabolism of Vindesine can be decreased when combined with Lomitapide.,decrease,no risk
Lomitapide,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Lomitapide.,decrease,no risk
Lomitapide,Vitamin E,The metabolism of Lomitapide can be increased when combined with Vitamin E.,increase,no risk
Lomitapide,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Vorapaxar,The metabolism of Lomitapide can be decreased when combined with Vorapaxar.,decrease,no risk
Lomitapide,Voriconazole,The metabolism of Lomitapide can be decreased when combined with Voriconazole.,decrease,no risk
Lomitapide,Voxelotor,The serum concentration of Lomitapide can be increased when it is combined with Voxelotor.,increase,no risk
Lomitapide,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Lomitapide.,increase,no risk
Lomitapide,Zafirlukast,The serum concentration of Lomitapide can be increased when it is combined with Zafirlukast.,increase,no risk
Lomitapide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lomitapide.,decrease,no risk
Lomitapide,Zimelidine,The metabolism of Lomitapide can be decreased when combined with Zimelidine.,decrease,no risk
Lomitapide,Ziprasidone,The metabolism of Lomitapide can be decreased when combined with Ziprasidone.,decrease,no risk
Lomitapide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Lomitapide.,decrease,no risk
Lomitapide,Zuclopenthixol,The metabolism of Lomitapide can be decreased when combined with Zuclopenthixol.,decrease,no risk
Vismodegib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Vismodegib.,increase,no risk
Vismodegib,Velpatasvir,Vismodegib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Vismodegib,Vemurafenib,Vismodegib may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Vismodegib,Venetoclax,Vismodegib may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Vismodegib,Vincristine,Vismodegib may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Vismodegib,Voxilaprevir,Vismodegib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Vismodegib,Zidovudine,Vismodegib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Dehydroascorbic acid,Benzphetamine,The serum concentration of Benzphetamine can be decreased when it is combined with Dehydroascorbic acid.,decrease,no risk
Dehydroascorbic acid,Bleomycin,The therapeutic efficacy of Bleomycin can be decreased when used in combination with Dehydroascorbic acid.,decrease,no risk
Dehydroascorbic acid,Bortezomib,The therapeutic efficacy of Bortezomib can be decreased when used in combination with Dehydroascorbic acid.,decrease,no risk
Dehydroascorbic acid,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Dehydroascorbic acid.,decrease,no risk
Dehydroascorbic acid,Quinestrol,The serum concentration of Dehydroascorbic acid can be decreased when it is combined with Quinestrol.,decrease,no risk
Taurochenodeoxycholic acid,Gestrinone,The therapeutic efficacy of Taurochenodeoxycholic acid can be decreased when used in combination with Gestrinone.,decrease,no risk
Taurochenodeoxycholic acid,Glofitamab,The serum concentration of Taurochenodeoxycholic acid can be increased when it is combined with Glofitamab.,increase,no risk
Taurochenodeoxycholic acid,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Taurochenodeoxycholic acid.,increase,no risk
Taurochenodeoxycholic acid,Heparin,The risk or severity of bleeding and bruising can be increased when Heparin is combined with Taurochenodeoxycholic acid.,increase,risk
Taurochenodeoxycholic acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Taurochenodeoxycholic acid,Kaolin,Kaolin can cause a decrease in the absorption of Taurochenodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Taurochenodeoxycholic acid,Ketoconazole,The metabolism of Taurochenodeoxycholic acid can be decreased when combined with Ketoconazole.,decrease,no risk
Taurochenodeoxycholic acid,Omaveloxolone,The serum concentration of Taurochenodeoxycholic acid can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Taurochenodeoxycholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurochenodeoxycholic acid.,increase,risk
Taurochenodeoxycholic acid,Vadadustat,The serum concentration of Taurochenodeoxycholic acid can be increased when it is combined with Vadadustat.,increase,no risk
Taurochenodeoxycholic acid,Venetoclax,The metabolism of Taurochenodeoxycholic acid can be decreased when combined with Venetoclax.,decrease,no risk
Taurochenodeoxycholic acid,Verapamil,The metabolism of Taurochenodeoxycholic acid can be decreased when combined with Verapamil.,decrease,no risk
Taurochenodeoxycholic acid,Viloxazine,The metabolism of Taurochenodeoxycholic acid can be decreased when combined with Viloxazine.,decrease,no risk
Taurochenodeoxycholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Taurochenodeoxycholic acid.,increase,risk
Taurochenodeoxycholic acid,Voriconazole,The metabolism of Taurochenodeoxycholic acid can be decreased when combined with Voriconazole.,decrease,no risk
Taurochenodeoxycholic acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Taurochenodeoxycholic acid.,increase,risk
Taurochenodeoxycholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Taurochenodeoxycholic acid.,increase,risk
Taurochenodeoxycholic acid,Zimelidine,The metabolism of Taurochenodeoxycholic acid can be decreased when combined with Zimelidine.,decrease,no risk
Taurochenodeoxycholic acid,Ziprasidone,The metabolism of Taurochenodeoxycholic acid can be decreased when combined with Ziprasidone.,decrease,no risk
Tauroursodeoxycholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Tauroursodeoxycholic acid.,increase,risk
Tauroursodeoxycholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Tauroursodeoxycholic acid.,increase,risk
Tauroursodeoxycholic acid,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Tauroursodeoxycholic acid.,increase,risk
Tauroursodeoxycholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Tauroursodeoxycholic acid.,increase,risk
Temocapril,Gemfibrozil,The excretion of Temocapril can be decreased when combined with Gemfibrozil.,decrease,no risk
Temocapril,Glecaprevir,The excretion of Temocapril can be decreased when combined with Glecaprevir.,decrease,no risk
Temocapril,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Temocapril.",increase,risk
Temocapril,Guanabenz,Guanabenz may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Guanadrel,Guanadrel may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Guanethidine,Guanethidine may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Guanfacine,Guanfacine may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Guanoxan,Temocapril may increase the hypotensive activities of Guanoxan.,increase,no risk
Temocapril,Halothane,Halothane may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Heparin,The risk or severity of hyperkalemia can be increased when Temocapril is combined with Heparin.,increase,risk
Temocapril,Holcus lanatus pollen,The risk or severity of adverse effects can be increased when Temocapril is combined with Holcus lanatus pollen.,increase,risk
Temocapril,Hydralazine,Hydralazine may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Hydrochlorothiazide,The therapeutic efficacy of Temocapril can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Temocapril,Hydroflumethiazide,The therapeutic efficacy of Temocapril can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Temocapril,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Temocapril.,increase,risk
Temocapril,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Temocapril.",increase,risk
Temocapril,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Temocapril.",increase,risk
Temocapril,Koeleria macrantha pollen,The risk or severity of adverse effects can be increased when Temocapril is combined with Koeleria macrantha pollen.,increase,risk
Temocapril,Obinutuzumab,Temocapril may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Temocapril,Olanzapine,Olanzapine may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Olmesartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Temocapril is combined with Olmesartan.",increase,risk
Temocapril,Olodaterol,Olodaterol may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Olsalazine,The risk or severity of renal failure can be increased when Olsalazine is combined with Temocapril.,increase,risk
Temocapril,Opicapone,Opicapone may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Ouabain,The excretion of Temocapril can be decreased when combined with Ouabain.,decrease,no risk
Temocapril,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Temocapril.",increase,risk
Temocapril,Oxprenolol,Oxprenolol may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Oxymetazoline,The therapeutic efficacy of Temocapril can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Temocapril,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Temocapril.",increase,risk
Temocapril,Quetiapine,Quetiapine may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Temocapril.,increase,risk
Temocapril,Quinethazone,The risk or severity of hypotension can be increased when Quinethazone is combined with Temocapril.,increase,risk
Temocapril,Quinidine,Quinidine may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Quinine,Quinine may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Quinupramine,Quinupramine may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Udenafil,Udenafil may increase the antihypertensive activities of Temocapril.,increase,no risk
Temocapril,Unoprostone,Unoprostone may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Urochloa mutica pollen,The risk or severity of adverse effects can be increased when Temocapril is combined with Urochloa mutica pollen.,increase,risk
Temocapril,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Temocapril.,increase,risk
Temocapril,Valdecoxib,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valdecoxib is combined with Temocapril.",increase,risk
Temocapril,Valsartan,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Temocapril is combined with Valsartan.",increase,risk
Temocapril,Vardenafil,Vardenafil may increase the antihypertensive activities of Temocapril.,increase,no risk
Temocapril,Velpatasvir,The excretion of Temocapril can be decreased when combined with Velpatasvir.,decrease,no risk
Temocapril,Venetoclax,The excretion of Temocapril can be decreased when combined with Venetoclax.,decrease,no risk
Temocapril,Verapamil,Verapamil may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Vericiguat,Vericiguat may increase the hypotensive activities of Temocapril.,increase,no risk
Temocapril,Vilanterol,Vilanterol may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Vilazodone,Vilazodone may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Temocapril.,increase,risk
Temocapril,Vinblastine,The excretion of Temocapril can be decreased when combined with Vinblastine.,decrease,no risk
Temocapril,Vincristine,The excretion of Temocapril can be decreased when combined with Vincristine.,decrease,no risk
Temocapril,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Voxilaprevir,The excretion of Temocapril can be decreased when combined with Voxilaprevir.,decrease,no risk
Temocapril,Xamoterol,Xamoterol may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Yohimbine,Yohimbine may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Temocapril.,increase,no risk
Temocapril,Zofenopril,The risk or severity of angioedema can be increased when Temocapril is combined with Zofenopril.,increase,risk
Temocapril,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Temocapril,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Temocapril.,increase,risk
Temocapril,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Temocapril.,decrease,no risk
Tetraethylammonium,Bethanechol,The risk or severity of hypotension can be increased when Tetraethylammonium is combined with Bethanechol.,increase,risk
Tetraethylammonium,Vasopressin,Tetraethylammonium may increase the hypertensive activities of Vasopressin.,increase,no risk
Agmatine,Galantamine,The therapeutic efficacy of Agmatine can be decreased when used in combination with Galantamine.,decrease,no risk
Agmatine,Gallamine triethiodide,Agmatine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Agmatine,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Agmatine.,increase,risk
Agmatine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Agmatine.,increase,risk
Agmatine,Ginkgo biloba,The therapeutic efficacy of Agmatine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Agmatine,Gliclazide,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Gliclazide.,increase,risk
Agmatine,Glimepiride,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Glimepiride.,increase,risk
Agmatine,Glipizide,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Glipizide.,increase,risk
Agmatine,Gliquidone,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Gliquidone.,increase,risk
Agmatine,Glofitamab,The serum concentration of Agmatine can be increased when it is combined with Glofitamab.,increase,no risk
Agmatine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Agmatine.,decrease,no risk
Agmatine,Glyburide,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Glyburide.,increase,risk
Agmatine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Agmatine.,decrease,no risk
Agmatine,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Agmatine.,increase,risk
Agmatine,Glymidine,The risk or severity of hypoglycemia can be increased when Agmatine is combined with Glymidine.,increase,risk
Agmatine,Grepafloxacin,The serum concentration of Agmatine can be increased when it is combined with Grepafloxacin.,increase,no risk
Agmatine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Agmatine.,increase,risk
Agmatine,Guanidine,The serum concentration of Agmatine can be increased when it is combined with Guanidine.,increase,no risk
Agmatine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Agmatine.,increase,no risk
Agmatine,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Agmatine.,increase,risk
Agmatine,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Agmatine.,increase,risk
Agmatine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Agmatine.,increase,risk
Agmatine,Histamine,The serum concentration of Agmatine can be increased when it is combined with Histamine.,increase,no risk
Serotonin,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Serotonin.,increase,risk
Serotonin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Serotonin is combined with Gabapentin enacarbil.,increase,risk
Serotonin,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Serotonin.,increase,risk
Serotonin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Serotonin is combined with Ganaxolone.",increase,risk
Serotonin,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Serotonin.,increase,risk
Serotonin,Gilteritinib,The therapeutic efficacy of Serotonin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Serotonin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Serotonin.,increase,risk
Serotonin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Serotonin.,increase,risk
Serotonin,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Serotonin.,increase,risk
Serotonin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Serotonin.,increase,risk
Serotonin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Serotonin.,increase,risk
Serotonin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Serotonin.,increase,risk
Serotonin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Serotonin.,increase,risk
Serotonin,Hydrocodone,Serotonin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Serotonin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Serotonin.,increase,risk
Serotonin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Serotonin.,increase,no risk
Serotonin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Serotonin.,increase,risk
Serotonin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Serotonin.,increase,risk
Serotonin,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Serotonin.,increase,risk
Serotonin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Serotonin is combined with Oliceridine.",increase,risk
Serotonin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Serotonin.,increase,risk
Serotonin,Opium,The risk or severity of CNS depression can be increased when Serotonin is combined with Opium.,increase,risk
Serotonin,Orphenadrine,Serotonin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Serotonin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Serotonin.,increase,risk
Serotonin,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Serotonin.,increase,risk
Serotonin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Serotonin.,increase,risk
Serotonin,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Serotonin.,increase,risk
Serotonin,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Serotonin.,increase,risk
Serotonin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Serotonin.,increase,risk
Serotonin,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Serotonin.,increase,risk
Serotonin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Serotonin.,increase,risk
Serotonin,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Serotonin.,increase,risk
Serotonin,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Serotonin.,increase,risk
Serotonin,Quinupramine,The risk or severity of CNS depression can be increased when Serotonin is combined with Quinupramine.,increase,risk
Serotonin,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Serotonin.,increase,risk
Serotonin,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Valproate bismuth.,increase,risk
Serotonin,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Serotonin.,increase,risk
Serotonin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Serotonin.,increase,risk
Serotonin,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Serotonin is combined with Venlafaxine.,increase,risk
Serotonin,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Serotonin.,increase,risk
Serotonin,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Serotonin.,increase,risk
Serotonin,Viloxazine,The risk or severity of CNS depression can be increased when Serotonin is combined with Viloxazine.,increase,risk
Serotonin,Vortioxetine,The risk or severity of CNS depression can be increased when Serotonin is combined with Vortioxetine.,increase,risk
Serotonin,Warfarin,The risk or severity of adverse effects can be increased when Serotonin is combined with Warfarin.,increase,risk
Serotonin,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Serotonin.,increase,risk
Serotonin,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Serotonin.,increase,risk
Serotonin,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Serotonin.,increase,risk
Serotonin,Zimelidine,The risk or severity of adverse effects can be increased when Serotonin is combined with Zimelidine.,increase,risk
Serotonin,Ziprasidone,The risk or severity of adverse effects can be increased when Serotonin is combined with Ziprasidone.,increase,risk
Serotonin,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Serotonin.,increase,risk
Serotonin,Zolpidem,Serotonin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Serotonin,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Serotonin.,increase,risk
Serotonin,Zopiclone,The risk or severity of adverse effects can be increased when Serotonin is combined with Zopiclone.,increase,risk
Serotonin,Zotepine,The risk or severity of CNS depression can be increased when Serotonin is combined with Zotepine.,increase,risk
Serotonin,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Serotonin.,increase,risk
Serotonin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Serotonin.,increase,risk
N-methylnicotinamide,Gabapentin enacarbil,N-methylnicotinamide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gadobenic acid,Gadobenic acid may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gadodiamide,Gadodiamide may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gadoteric acid,N-methylnicotinamide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gadoteridol,Gadoteridol may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Ganciclovir,The excretion of N-methylnicotinamide can be decreased when combined with Ganciclovir.,decrease,no risk
N-methylnicotinamide,Gemcitabine,Gemcitabine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gemfibrozil,Gemfibrozil may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gentamicin,N-methylnicotinamide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Gilteritinib,The excretion of N-methylnicotinamide can be decreased when combined with Gilteritinib.,decrease,no risk
N-methylnicotinamide,Gimeracil,N-methylnicotinamide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Givosiran,Givosiran may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Glasdegib,The excretion of N-methylnicotinamide can be decreased when combined with Glasdegib.,decrease,no risk
N-methylnicotinamide,Glipizide,Glipizide may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Glycerol phenylbutyrate,N-methylnicotinamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Golodirsen,N-methylnicotinamide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Goserelin,Goserelin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Guanethidine,Guanethidine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Guanfacine,Guanfacine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Guanidine,The excretion of N-methylnicotinamide can be decreased when combined with Guanidine.,decrease,no risk
N-methylnicotinamide,Haloperidol,Haloperidol may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Hydralazine,Hydralazine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of N-methylnicotinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
N-methylnicotinamide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of N-methylnicotinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
N-methylnicotinamide,Hydromorphone,Hydromorphone may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Hydroxyethyl Starch,N-methylnicotinamide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Kanamycin,N-methylnicotinamide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Ketamine,Ketamine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Ketazolam,Ketazolam may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Ketoprofen,Ketoprofen may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Ketorolac,Ketorolac may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Octinoxate,N-methylnicotinamide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Olsalazine,Olsalazine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Opium,N-methylnicotinamide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Oseltamivir,Oseltamivir may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Oxacillin,Oxacillin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Oxaprozin,Oxaprozin may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Oxazepam,Oxazepam may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Oxybenzone,Oxybenzone may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Oxyquinoline,N-methylnicotinamide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Quetiapine,Quetiapine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Quinethazone,Quinethazone may increase the excretion rate of N-methylnicotinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
N-methylnicotinamide,Quinidine,N-methylnicotinamide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Vaborbactam,N-methylnicotinamide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Valaciclovir,Valaciclovir may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Valbenazine,N-methylnicotinamide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Valdecoxib,Valdecoxib may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Valganciclovir,Valganciclovir may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Vancomycin,N-methylnicotinamide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Varenicline,Varenicline may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Venlafaxine,Venlafaxine may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Verapamil,Verapamil may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Vilanterol,N-methylnicotinamide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Viloxazine,N-methylnicotinamide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Vortioxetine,N-methylnicotinamide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Warfarin,N-methylnicotinamide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Zaleplon,Zaleplon may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Zanamivir,Zanamivir may decrease the excretion rate of N-methylnicotinamide which could result in a higher serum level.,decrease,no risk
N-methylnicotinamide,Zonisamide,Zonisamide may increase the excretion rate of N-methylnicotinamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tyramine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Tyramine.,increase,risk
Tyramine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Tyramine.,decrease,no risk
Tyramine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Tyramine.,increase,risk
Tyramine,Guanabenz,Tyramine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Tyramine,Guanadrel,Tyramine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Tyramine,Guanethidine,Tyramine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Tyramine,Guanfacine,Tyramine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Tyramine,Guanoxan,Tyramine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Tyramine,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Tyramine.,increase,risk
Tyramine,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Tyramine.,increase,risk
Tyramine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Tyramine.,increase,risk
Tyramine,Hydralazine,Tyramine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Tyramine,Hydrochlorothiazide,Tyramine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Tyramine,Hydroflumethiazide,Tyramine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Tyramine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Tyramine.,increase,risk
Tyramine,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Tyramine.,increase,risk
Tyramine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Tyramine.,increase,risk
Tyramine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Tyramine.,increase,risk
Tyramine,Olanzapine,The risk or severity of Tachycardia can be increased when Olanzapine is combined with Tyramine.,increase,risk
Tyramine,Olmesartan,Tyramine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Tyramine,Olodaterol,The risk or severity of hypertension can be increased when Tyramine is combined with Olodaterol.,increase,risk
Tyramine,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Tyramine.,increase,risk
Tyramine,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Tyramine.,increase,risk
Tyramine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Tyramine.,increase,risk
Tyramine,Oxprenolol,Tyramine may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Tyramine,Oxtriphylline,The risk or severity of adverse effects can be increased when Tyramine is combined with Oxtriphylline.,increase,risk
Tyramine,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Tyramine.,increase,risk
Tyramine,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Tyramine.,increase,risk
Tyramine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Tyramine.,increase,risk
Tyramine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Tyramine.,increase,risk
Tyramine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Tyramine.,increase,risk
Tyramine,Quetiapine,The risk or severity of hypertension can be increased when Quetiapine is combined with Tyramine.,increase,risk
Tyramine,Quinapril,Tyramine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Tyramine,Quinidine,The risk or severity of hypertension can be increased when Quinidine is combined with Tyramine.,increase,risk
Tyramine,Quinupramine,The risk or severity of hypertension can be increased when Tyramine is combined with Quinupramine.,increase,risk
Tyramine,Umeclidinium,The risk or severity of Tachycardia can be increased when Tyramine is combined with Umeclidinium.,increase,risk
Tyramine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Tyramine.,increase,risk
Tyramine,Valsartan,Tyramine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Tyramine,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Tyramine.,increase,risk
Tyramine,Vilanterol,The risk or severity of hypertension can be increased when Tyramine is combined with Vilanterol.,increase,risk
Tyramine,Vilazodone,The risk or severity of hypertension can be increased when Vilazodone is combined with Tyramine.,increase,risk
Tyramine,Vortioxetine,The risk or severity of hypertension can be increased when Tyramine is combined with Vortioxetine.,increase,risk
Tyramine,Xamoterol,The risk or severity of hypertension can be increased when Tyramine is combined with Xamoterol.,increase,risk
Tyramine,Xylometazoline,The risk or severity of hypertension can be increased when Xylometazoline is combined with Tyramine.,increase,risk
Tyramine,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Tyramine.,increase,risk
Tyramine,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Tyramine.,increase,risk
Tyramine,Zofenopril,Tyramine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Tyramine,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tyramine.,increase,risk
Tyramine,Zuclopenthixol,The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Tyramine.,increase,risk
Bamet-UD2,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Bamet-UD2.,increase,risk
Bamet-UD2,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Bamet-UD2.,increase,risk
Bamet-UD2,Warfarin,The risk or severity of bleeding and bruising can be increased when Warfarin is combined with Bamet-UD2.,increase,risk
Bamet-UD2,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Bamet-UD2.,increase,risk
cis-Diamminechlorocholylglycinateplatinum(II),Bentonite,The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Bentonite.,decrease,no risk
cis-Diamminechlorocholylglycinateplatinum(II),Bentoquatam,The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Bentoquatam.,decrease,no risk
cis-Diamminechlorocholylglycinateplatinum(II),Gestrinone,The therapeutic efficacy of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when used in combination with Gestrinone.,decrease,no risk
cis-Diamminechlorocholylglycinateplatinum(II),Hydrotalcite,The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Hydrotalcite.,decrease,no risk
cis-Diamminechlorocholylglycinateplatinum(II),Kaolin,The serum concentration of cis-Diamminechlorocholylglycinateplatinum(II) can be decreased when it is combined with Kaolin.,decrease,no risk
DPDPE,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with DPDPE.,increase,risk
DPDPE,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when DPDPE is combined with Gabapentin enacarbil.,increase,risk
DPDPE,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with DPDPE.,increase,risk
DPDPE,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when DPDPE is combined with Ganaxolone.",increase,risk
DPDPE,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with DPDPE.,increase,risk
DPDPE,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with DPDPE.,decrease,no risk
DPDPE,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with DPDPE.,increase,risk
DPDPE,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with DPDPE.,decrease,no risk
DPDPE,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with DPDPE.,increase,risk
DPDPE,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with DPDPE.,increase,risk
DPDPE,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with DPDPE.,increase,risk
DPDPE,Halazepam,The risk or severity of adverse effects can be increased when DPDPE is combined with Halazepam.,increase,risk
DPDPE,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with DPDPE.,increase,risk
DPDPE,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with DPDPE.,increase,risk
DPDPE,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with DPDPE.,increase,risk
DPDPE,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with DPDPE.,increase,risk
DPDPE,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with DPDPE.,increase,risk
DPDPE,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with DPDPE.,decrease,no risk
DPDPE,Hydrocodone,DPDPE may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
DPDPE,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with DPDPE.,decrease,no risk
DPDPE,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with DPDPE.,increase,risk
DPDPE,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of DPDPE.,increase,no risk
DPDPE,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with DPDPE.,increase,risk
DPDPE,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with DPDPE.,increase,risk
DPDPE,Ketazolam,The risk or severity of adverse effects can be increased when DPDPE is combined with Ketazolam.,increase,risk
DPDPE,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with DPDPE.,increase,risk
DPDPE,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when DPDPE is combined with Oliceridine.",increase,risk
DPDPE,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with DPDPE.,increase,risk
DPDPE,Opium,The risk or severity of adverse effects can be increased when DPDPE is combined with Opium.,increase,risk
DPDPE,Orphenadrine,DPDPE may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
DPDPE,Oxazepam,The risk or severity of adverse effects can be increased when DPDPE is combined with Oxazepam.,increase,risk
DPDPE,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with DPDPE.,increase,risk
DPDPE,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with DPDPE.,increase,risk
DPDPE,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with DPDPE.,increase,risk
DPDPE,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with DPDPE.,increase,risk
DPDPE,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with DPDPE.,increase,risk
DPDPE,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with DPDPE.,increase,risk
DPDPE,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with DPDPE.,increase,risk
DPDPE,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with DPDPE.,increase,risk
DPDPE,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with DPDPE.,decrease,no risk
DPDPE,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with DPDPE.,increase,risk
DPDPE,Quazepam,The risk or severity of adverse effects can be increased when DPDPE is combined with Quazepam.,increase,risk
DPDPE,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with DPDPE.,increase,risk
DPDPE,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with DPDPE.,decrease,no risk
DPDPE,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with DPDPE.,increase,risk
DPDPE,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with DPDPE.,increase,risk
DPDPE,Quinupramine,The risk or severity of CNS depression can be increased when DPDPE is combined with Quinupramine.,increase,risk
DPDPE,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with DPDPE.,increase,risk
DPDPE,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with DPDPE.,increase,risk
DPDPE,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when DPDPE is combined with Valproate bismuth.,increase,risk
DPDPE,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with DPDPE.,increase,risk
DPDPE,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with DPDPE.,increase,risk
DPDPE,Venlafaxine,The risk or severity of serotonin syndrome can be increased when DPDPE is combined with Venlafaxine.,increase,risk
DPDPE,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with DPDPE.,increase,risk
DPDPE,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with DPDPE.,increase,risk
DPDPE,Viloxazine,The risk or severity of CNS depression can be increased when DPDPE is combined with Viloxazine.,increase,risk
DPDPE,Vortioxetine,The risk or severity of CNS depression can be increased when DPDPE is combined with Vortioxetine.,increase,risk
DPDPE,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with DPDPE.,increase,risk
DPDPE,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with DPDPE.,increase,risk
DPDPE,Ziconotide,The risk or severity of adverse effects can be increased when DPDPE is combined with Ziconotide.,increase,risk
DPDPE,Zimelidine,The risk or severity of serotonin syndrome can be increased when DPDPE is combined with Zimelidine.,increase,risk
DPDPE,Ziprasidone,The risk or severity of adverse effects can be increased when DPDPE is combined with Ziprasidone.,increase,risk
DPDPE,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with DPDPE.,increase,risk
DPDPE,Zolpidem,DPDPE may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
DPDPE,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with DPDPE.,increase,risk
DPDPE,Zopiclone,The risk or severity of adverse effects can be increased when DPDPE is combined with Zopiclone.,increase,risk
DPDPE,Zotepine,The risk or severity of CNS depression can be increased when DPDPE is combined with Zotepine.,increase,risk
DPDPE,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with DPDPE.,increase,risk
DPDPE,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with DPDPE.,increase,risk
Cholecystokinin,Quinidine,The excretion of Cholecystokinin can be decreased when combined with Quinidine.,decrease,no risk
Cholecystokinin,Quinine,The excretion of Cholecystokinin can be decreased when combined with Quinine.,decrease,no risk
Cholecystokinin,Valsartan,The excretion of Cholecystokinin can be decreased when combined with Valsartan.,decrease,no risk
Cholecystokinin,Velpatasvir,The excretion of Cholecystokinin can be decreased when combined with Velpatasvir.,decrease,no risk
Cholecystokinin,Venetoclax,The excretion of Cholecystokinin can be decreased when combined with Venetoclax.,decrease,no risk
Cholecystokinin,Vinblastine,The excretion of Cholecystokinin can be decreased when combined with Vinblastine.,decrease,no risk
Cholecystokinin,Vincristine,The excretion of Cholecystokinin can be decreased when combined with Vincristine.,decrease,no risk
Cholecystokinin,Voxilaprevir,The excretion of Voxilaprevir can be decreased when combined with Cholecystokinin.,decrease,no risk
Fingolimod,Galantamine,Galantamine may increase the bradycardic activities of Fingolimod.,increase,no risk
Fingolimod,Gemcitabine,Gemcitabine may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Gemtuzumab ozogamicin,Gemtuzumab ozogamicin may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Glatiramer,Glatiramer may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Glycerin,The metabolism of Fingolimod can be increased when combined with Glycerin.,increase,no risk
Fingolimod,Golimumab,Golimumab may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Guanfacine,Guanfacine may increase the bradycardic activities of Fingolimod.,increase,no risk
Fingolimod,Guselkumab,Guselkumab may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Halothane,The metabolism of Fingolimod can be decreased when combined with Halothane.,decrease,no risk
Fingolimod,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Hydrocortisone,Hydrocortisone may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Hydrocortisone acetate,Hydrocortisone acetate may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Hydrocortisone butyrate,Hydrocortisone butyrate may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Hydrocortisone succinate,Hydrocortisone succinate may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Hydroxychloroquine,Hydroxychloroquine may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Hydroxyurea,Hydroxyurea may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Ketoconazole,The serum concentration of Fingolimod can be increased when it is combined with Ketoconazole.,increase,no risk
Fingolimod,Obinutuzumab,Obinutuzumab may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Fingolimod.,increase,no risk
Fingolimod,Ofatumumab,Ofatumumab may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Olaparib,Olaparib may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Orphenadrine,The metabolism of Fingolimod can be decreased when combined with Orphenadrine.,decrease,no risk
Fingolimod,Oxaliplatin,Oxaliplatin may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Oxprenolol,Oxprenolol may increase the bradycardic activities of Fingolimod.,increase,no risk
Fingolimod,Ozanimod,Ozanimod may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Quinidine,Fingolimod may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Fingolimod,Ublituximab,Ublituximab may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Upadacitinib,Upadacitinib may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Vayarin,The metabolism of Fingolimod can be decreased when combined with Vayarin.,decrease,no risk
Fingolimod,Vedolizumab,Vedolizumab may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Verapamil,The risk or severity of bradycardia can be increased when Verapamil is combined with Fingolimod.,increase,risk
Fingolimod,Vernakalant,Fingolimod may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Fingolimod,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Vilanterol,Vilanterol may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Vinblastine,Vinblastine may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Vincristine,Vincristine may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Vindesine,Vindesine may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Vinorelbine,Vinorelbine may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Voclosporin,Voclosporin may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Vorinostat,Vorinostat may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Fingolimod.,decrease,no risk
Fingolimod,Zidovudine,Zidovudine may increase the immunosuppressive activities of Fingolimod.,increase,no risk
Fingolimod,Zonisamide,Zonisamide may increase the bradycardic activities of Fingolimod.,increase,no risk
Fidaxomicin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Fidaxomicin.,decrease,no risk
Fidaxomicin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Benzocaine.,increase,risk
Fidaxomicin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Benzyl alcohol.,increase,risk
Fidaxomicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Bupivacaine.,increase,risk
Fidaxomicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Butacaine.,increase,risk
Fidaxomicin,Butamben,The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Butamben.,increase,risk
Fidaxomicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Oxetacaine.,increase,risk
Fidaxomicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fidaxomicin is combined with Oxybuprocaine.,increase,risk
Fidaxomicin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Fidaxomicin.,decrease,no risk
Fidaxomicin,Warfarin,The risk or severity of bleeding can be increased when Fidaxomicin is combined with Warfarin.,increase,risk
Belimumab,Galcanezumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Galcanezumab.,increase,risk
Belimumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Belimumab.,increase,risk
Belimumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Belimumab.,increase,risk
Belimumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Belimumab.,increase,risk
Belimumab,Glofitamab,The risk or severity of adverse effects can be increased when Belimumab is combined with Glofitamab.,increase,risk
Belimumab,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Belimumab.,increase,risk
Belimumab,Guselkumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Guselkumab.,increase,risk
Belimumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Belimumab.,decrease,no risk
Belimumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Belimumab.,decrease,no risk
Belimumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Belimumab.,increase,risk
Belimumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Belimumab.,decrease,no risk
Belimumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Belimumab.,increase,risk
Belimumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Belimumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Belimumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Belimumab.,increase,risk
Belimumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Belimumab is combined with Human Rho(D) immune globulin.,increase,risk
Belimumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Belimumab is combined with Human varicella-zoster immune globulin.,increase,risk
Belimumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Belimumab is combined with Hydrocortisone acetate.,increase,risk
Belimumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Belimumab is combined with Hydrocortisone butyrate.,increase,risk
Belimumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Belimumab is combined with Hydrocortisone succinate.,increase,risk
Belimumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Belimumab.,increase,risk
Belimumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Belimumab.,increase,risk
Belimumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Belimumab.,decrease,no risk
Belimumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Belimumab.,decrease,no risk
Belimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Belimumab.,increase,risk
Belimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Obinutuzumab.,increase,risk
Belimumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Belimumab.,increase,no risk
Belimumab,Odesivimab,The risk or severity of adverse effects can be increased when Belimumab is combined with Odesivimab.,increase,risk
Belimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Belimumab.,increase,risk
Belimumab,Olaparib,The risk or severity of adverse effects can be increased when Belimumab is combined with Olaparib.,increase,risk
Belimumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Belimumab.,increase,risk
Belimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Belimumab.,increase,risk
Belimumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Belimumab.,increase,risk
Belimumab,Ozanimod,The risk or severity of adverse effects can be increased when Belimumab is combined with Ozanimod.,increase,risk
Belimumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Belimumab.,increase,no risk
Belimumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Belimumab.,increase,risk
Belimumab,Upadacitinib,The risk or severity of adverse effects can be increased when Belimumab is combined with Upadacitinib.,increase,risk
Belimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Belimumab.,increase,risk
Belimumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Belimumab.,increase,risk
Belimumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Belimumab.,decrease,no risk
Belimumab,Vedolizumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Vedolizumab.,increase,risk
Belimumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Belimumab.,decrease,no risk
Belimumab,Vilanterol,The risk or severity of adverse effects can be increased when Belimumab is combined with Vilanterol.,increase,risk
Belimumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Belimumab.,increase,risk
Belimumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Belimumab.,increase,risk
Belimumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Belimumab.,increase,risk
Belimumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Belimumab.,increase,risk
Belimumab,Voclosporin,The risk or severity of adverse effects can be increased when Belimumab is combined with Voclosporin.,increase,risk
Belimumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Belimumab.,increase,risk
Belimumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Belimumab.,increase,risk
Belimumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Belimumab.,increase,risk
Linagliptin,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Linagliptin.,increase,no risk
Linagliptin,Bexarotene,The metabolism of Linagliptin can be increased when combined with Bexarotene.,increase,no risk
Linagliptin,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Bifonazole,The metabolism of Linagliptin can be decreased when combined with Bifonazole.,decrease,no risk
Linagliptin,Bimekizumab,The metabolism of Linagliptin can be increased when combined with Bimekizumab.,increase,no risk
Linagliptin,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Linagliptin.,increase,no risk
Linagliptin,Bisoprolol,The therapeutic efficacy of Linagliptin can be increased when used in combination with Bisoprolol.,increase,no risk
Linagliptin,Boceprevir,The metabolism of Linagliptin can be decreased when combined with Boceprevir.,decrease,no risk
Linagliptin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Bosentan,The metabolism of Linagliptin can be increased when combined with Bosentan.,increase,no risk
Linagliptin,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Linagliptin.,increase,risk
Linagliptin,Bumetanide,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Bumetanide.,decrease,no risk
Linagliptin,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Bupropion,The excretion of Linagliptin can be decreased when combined with Bupropion.,decrease,no risk
Linagliptin,Buserelin,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Buserelin.,decrease,no risk
Linagliptin,Buspirone,The metabolism of Buspirone can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Busulfan,The metabolism of Busulfan can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Butalbital,The metabolism of Linagliptin can be increased when combined with Butalbital.,increase,no risk
Linagliptin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Linagliptin.,decrease,no risk
Linagliptin,Galantamine,The metabolism of Galantamine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ganciclovir,The risk or severity of adverse effects can be increased when Linagliptin is combined with Ganciclovir.,increase,risk
Linagliptin,Gatifloxacin,The therapeutic efficacy of Linagliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Linagliptin,Gefapixant,The therapeutic efficacy of Linagliptin can be increased when used in combination with Gefapixant.,increase,no risk
Linagliptin,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Gemifloxacin,The therapeutic efficacy of Linagliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Linagliptin,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ginkgo biloba,The metabolism of Linagliptin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Linagliptin,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Gliclazide,Linagliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Linagliptin,Glimepiride,Linagliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Linagliptin,Glipizide,Linagliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Linagliptin,Gliquidone,Linagliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Linagliptin,Glofitamab,The serum concentration of Linagliptin can be increased when it is combined with Glofitamab.,increase,no risk
Linagliptin,Glyburide,Linagliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Linagliptin,Glycerol phenylbutyrate,The metabolism of Linagliptin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Linagliptin,Glymidine,The therapeutic efficacy of Linagliptin can be increased when used in combination with Glymidine.,increase,no risk
Linagliptin,Golimumab,The metabolism of Linagliptin can be increased when combined with Golimumab.,increase,no risk
Linagliptin,Goserelin,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Linagliptin,Granisetron,The metabolism of Granisetron can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Grapefruit,The metabolism of Linagliptin can be decreased when combined with Grapefruit.,decrease,no risk
Linagliptin,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Grepafloxacin,The therapeutic efficacy of Linagliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Linagliptin,Griseofulvin,The metabolism of Linagliptin can be increased when combined with Griseofulvin.,increase,no risk
Linagliptin,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Guanidine,The serum concentration of Linagliptin can be increased when it is combined with Guanidine.,increase,no risk
Linagliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Linagliptin.,increase,risk
Linagliptin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Histamine,The serum concentration of Linagliptin can be increased when it is combined with Histamine.,increase,no risk
Linagliptin,Histrelin,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Linagliptin,Hydralazine,The metabolism of Linagliptin can be decreased when combined with Hydralazine.,decrease,no risk
Linagliptin,Hydrochlorothiazide,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Linagliptin,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Hydrocortamate,The metabolism of Linagliptin can be increased when combined with Hydrocortamate.,increase,no risk
Linagliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Linagliptin.,increase,risk
Linagliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Linagliptin.,increase,risk
Linagliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Linagliptin.,increase,risk
Linagliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Linagliptin.,increase,risk
Linagliptin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Linagliptin.,increase,risk
Linagliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Linagliptin.,increase,risk
Linagliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Linagliptin.,increase,risk
Linagliptin,Hydroflumethiazide,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Linagliptin,Hydroxychloroquine,The therapeutic efficacy of Linagliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Linagliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Linagliptin,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ketamine,The metabolism of Ketamine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ketoconazole,The metabolism of Linagliptin can be decreased when combined with Ketoconazole.,decrease,no risk
Linagliptin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Linagliptin is combined with Ketotifen.,increase,risk
Linagliptin,Octreotide,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Linagliptin,Ofloxacin,The therapeutic efficacy of Linagliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Linagliptin,Olanzapine,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Linagliptin,Olaparib,The metabolism of Olaparib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Linagliptin.,increase,no risk
Linagliptin,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Opium,The metabolism of Opium can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Oritavancin,The metabolism of Linagliptin can be increased when combined with Oritavancin.,increase,no risk
Linagliptin,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Linagliptin.,increase,no risk
Linagliptin,Oxcarbazepine,The metabolism of Linagliptin can be increased when combined with Oxcarbazepine.,increase,no risk
Linagliptin,Oxprenolol,The therapeutic efficacy of Linagliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Linagliptin,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Linagliptin.,increase,no risk
Linagliptin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Quazepam,The metabolism of Quazepam can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Quetiapine,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Linagliptin,Quinapril,The risk or severity of angioedema can be increased when Linagliptin is combined with Quinapril.,increase,risk
Linagliptin,Quinethazone,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Linagliptin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Linagliptin.,increase,risk
Linagliptin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Linagliptin.,decrease,no risk
Linagliptin,Quinupristin,The metabolism of Linagliptin can be decreased when combined with Quinupristin.,decrease,no risk
Linagliptin,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Linagliptin.,increase,risk
Linagliptin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Udenafil,The metabolism of Udenafil can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Linagliptin.,increase,risk
Linagliptin,Umbralisib,The serum concentration of Linagliptin can be increased when it is combined with Umbralisib.,increase,no risk
Linagliptin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Linagliptin.,increase,risk
Linagliptin,Vadadustat,The serum concentration of Linagliptin can be increased when it is combined with Vadadustat.,increase,no risk
Linagliptin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Valproic acid,The metabolism of Linagliptin can be decreased when combined with Valproic acid.,decrease,no risk
Linagliptin,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Linagliptin.,increase,risk
Linagliptin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Linagliptin.,increase,risk
Linagliptin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Varenicline,The excretion of Varenicline can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vemurafenib,The serum concentration of Linagliptin can be increased when it is combined with Vemurafenib.,increase,no risk
Linagliptin,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Linagliptin.,increase,risk
Linagliptin,Verapamil,The metabolism of Linagliptin can be decreased when combined with Verapamil.,decrease,no risk
Linagliptin,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Linagliptin.,increase,risk
Linagliptin,Viloxazine,The metabolism of Linagliptin can be decreased when combined with Viloxazine.,decrease,no risk
Linagliptin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Vincristine,The excretion of Vincristine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vindesine,The metabolism of Vindesine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Voriconazole,The metabolism of Linagliptin can be decreased when combined with Voriconazole.,decrease,no risk
Linagliptin,Vorinostat,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Vorinostat.,decrease,no risk
Linagliptin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Linagliptin.,increase,no risk
Linagliptin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Linagliptin.,increase,risk
Linagliptin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zafirlukast,The metabolism of Linagliptin can be decreased when combined with Zafirlukast.,decrease,no risk
Linagliptin,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Linagliptin.,increase,risk
Linagliptin,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zileuton,The metabolism of Zileuton can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Linagliptin.,increase,risk
Linagliptin,Ziprasidone,The therapeutic efficacy of Linagliptin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Linagliptin,Zofenopril,The risk or severity of angioedema can be increased when Linagliptin is combined with Zofenopril.,increase,risk
Linagliptin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zotepine,The metabolism of Zotepine can be decreased when combined with Linagliptin.,decrease,no risk
Linagliptin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Linagliptin.,decrease,no risk
Perampanel,Bupivacaine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.,increase,no risk
Perampanel,Buprenorphine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Perampanel,Bupropion,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Bupropion.,increase,no risk
Perampanel,Buspirone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Buspirone.,increase,no risk
Perampanel,Busulfan,The metabolism of Busulfan can be increased when combined with Perampanel.,increase,no risk
Perampanel,Butabarbital,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Perampanel,Butacaine,The risk or severity of methemoglobinemia can be increased when Perampanel is combined with Butacaine.,increase,risk
Perampanel,Butalbital,The metabolism of Perampanel can be increased when combined with Butalbital.,increase,no risk
Perampanel,Butamben,The risk or severity of methemoglobinemia can be increased when Perampanel is combined with Butamben.,increase,risk
Perampanel,Butaperazine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Butaperazine.,increase,no risk
Perampanel,Butobarbital,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.,increase,no risk
Perampanel,Butorphanol,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.,increase,no risk
Perampanel,Butriptyline,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Butriptyline.,increase,no risk
Perampanel,Gabapentin,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Perampanel,Gabapentin enacarbil,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Perampanel,Gallamine triethiodide,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Gallamine triethiodide.,increase,no risk
Perampanel,Gamolenic acid,The therapeutic efficacy of Perampanel can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Perampanel,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Perampanel is combined with Ganaxolone.",increase,risk
Perampanel,Ganciclovir,The therapeutic efficacy of Perampanel can be decreased when used in combination with Ganciclovir.,decrease,no risk
Perampanel,Gatifloxacin,The metabolism of Perampanel can be decreased when combined with Gatifloxacin.,decrease,no risk
Perampanel,Gefitinib,The metabolism of Perampanel can be decreased when combined with Gefitinib.,decrease,no risk
Perampanel,Gemfibrozil,The metabolism of Perampanel can be decreased when combined with Gemfibrozil.,decrease,no risk
Perampanel,Gemifloxacin,The metabolism of Perampanel can be decreased when combined with Gemifloxacin.,decrease,no risk
Perampanel,Gepirone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Gepirone.,increase,no risk
Perampanel,Gestrinone,The metabolism of Gestrinone can be increased when combined with Perampanel.,increase,no risk
Perampanel,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Perampanel.,increase,no risk
Perampanel,Givosiran,The serum concentration of Perampanel can be increased when it is combined with Givosiran.,increase,no risk
Perampanel,Glofitamab,The serum concentration of Perampanel can be increased when it is combined with Glofitamab.,increase,no risk
Perampanel,Glutethimide,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Perampanel,Glyburide,The metabolism of Perampanel can be decreased when combined with Glyburide.,decrease,no risk
Perampanel,Glycerol phenylbutyrate,The metabolism of Perampanel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Perampanel,Golimumab,The metabolism of Perampanel can be increased when combined with Golimumab.,increase,no risk
Perampanel,Granisetron,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Perampanel,Grepafloxacin,The metabolism of Perampanel can be decreased when combined with Grepafloxacin.,decrease,no risk
Perampanel,Griseofulvin,The metabolism of Perampanel can be increased when combined with Griseofulvin.,increase,no risk
Perampanel,Guanabenz,The metabolism of Perampanel can be decreased when combined with Guanabenz.,decrease,no risk
Perampanel,Guanfacine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Perampanel,Halazepam,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Perampanel,Halofantrine,The therapeutic efficacy of Perampanel can be decreased when used in combination with Halofantrine.,decrease,no risk
Perampanel,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Perampanel.,increase,risk
Perampanel,Halothane,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Perampanel,Hexafluronium,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Perampanel,Hydrocodone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Perampanel,Hydrocortamate,The metabolism of Perampanel can be increased when combined with Hydrocortamate.,increase,no risk
Perampanel,Hydrocortisone,The metabolism of Perampanel can be increased when combined with Hydrocortisone.,increase,no risk
Perampanel,Hydrocortisone acetate,The metabolism of Perampanel can be increased when combined with Hydrocortisone acetate.,increase,no risk
Perampanel,Hydrocortisone butyrate,The metabolism of Perampanel can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Perampanel,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Hydrocortisone succinate,The metabolism of Perampanel can be increased when combined with Hydrocortisone succinate.,increase,no risk
Perampanel,Hydromorphone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Perampanel,Hydroxychloroquine,The therapeutic efficacy of Perampanel can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Perampanel,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Perampanel.,increase,no risk
Perampanel,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Perampanel.,increase,no risk
Perampanel,Ketamine,The metabolism of Perampanel can be increased when combined with Ketamine.,increase,no risk
Perampanel,Ketazolam,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,increase,no risk
Perampanel,Ketoconazole,The metabolism of Perampanel can be decreased when combined with Ketoconazole.,decrease,no risk
Perampanel,Obeticholic acid,The metabolism of Perampanel can be decreased when combined with Obeticholic acid.,decrease,no risk
Perampanel,Olanzapine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Perampanel,Olaparib,The metabolism of Olaparib can be increased when combined with Perampanel.,increase,no risk
Perampanel,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Perampanel is combined with Oliceridine.",increase,risk
Perampanel,Olutasidenib,The metabolism of Perampanel can be increased when combined with Olutasidenib.,increase,no risk
Perampanel,Omaveloxolone,The metabolism of Perampanel can be increased when combined with Omaveloxolone.,increase,no risk
Perampanel,Ondansetron,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Perampanel,Opium,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Perampanel,Oritavancin,The metabolism of Perampanel can be increased when combined with Oritavancin.,increase,no risk
Perampanel,Orlistat,Orlistat can cause a decrease in the absorption of Perampanel resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Perampanel,Orphenadrine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Perampanel,Osilodrostat,The metabolism of Perampanel can be decreased when combined with Osilodrostat.,decrease,no risk
Perampanel,Osimertinib,The serum concentration of Perampanel can be decreased when it is combined with Osimertinib.,decrease,no risk
Perampanel,Ospemifene,The metabolism of Perampanel can be decreased when combined with Ospemifene.,decrease,no risk
Perampanel,Oxazepam,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Perampanel,Oxcarbazepine,The metabolism of Perampanel can be increased when combined with Oxcarbazepine.,increase,no risk
Perampanel,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Perampanel is combined with Oxetacaine.,increase,risk
Perampanel,Oxitriptan,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Perampanel,Oxprenolol,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.,increase,no risk
Perampanel,Oxtriphylline,Perampanel may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Perampanel,Oxybuprocaine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Perampanel,Oxybutynin,The metabolism of Perampanel can be decreased when combined with Oxybutynin.,decrease,no risk
Perampanel,Oxycodone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Perampanel,Oxymorphone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Perampanel,Quazepam,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Quazepam.,increase,no risk
Perampanel,Quetiapine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Perampanel,Quinidine,The metabolism of Quinidine can be increased when combined with Perampanel.,increase,no risk
Perampanel,Quinine,The metabolism of Perampanel can be increased when combined with Quinine.,increase,no risk
Perampanel,Quinupramine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.,increase,no risk
Perampanel,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Udenafil,The metabolism of Perampanel can be decreased when combined with Udenafil.,decrease,no risk
Perampanel,Ulipristal,The metabolism of Ulipristal can be increased when combined with Perampanel.,increase,no risk
Perampanel,Urethane,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Perampanel,Vadadustat,The serum concentration of Perampanel can be decreased when it is combined with Vadadustat.,decrease,no risk
Perampanel,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Valganciclovir,The therapeutic efficacy of Perampanel can be decreased when used in combination with Valganciclovir.,decrease,no risk
Perampanel,Valproic acid,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.,increase,no risk
Perampanel,Vandetanib,The metabolism of Vandetanib can be increased when combined with Perampanel.,increase,no risk
Perampanel,Vardenafil,The metabolism of Perampanel can be decreased when combined with Vardenafil.,decrease,no risk
Perampanel,Vecuronium,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Perampanel,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Vemurafenib,The metabolism of Perampanel can be increased when combined with Vemurafenib.,increase,no risk
Perampanel,Venetoclax,The metabolism of Venetoclax can be increased when combined with Perampanel.,increase,no risk
Perampanel,Venlafaxine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Perampanel,Verapamil,The metabolism of Perampanel can be decreased when combined with Verapamil.,decrease,no risk
Perampanel,Vigabatrin,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,increase,no risk
Perampanel,Vilazodone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Perampanel,Viloxazine,The metabolism of Perampanel can be decreased when combined with Viloxazine.,decrease,no risk
Perampanel,Vinblastine,The metabolism of Perampanel can be increased when combined with Vinblastine.,increase,no risk
Perampanel,Vincristine,The metabolism of Vincristine can be increased when combined with Perampanel.,increase,no risk
Perampanel,Vindesine,The metabolism of Vindesine can be increased when combined with Perampanel.,increase,no risk
Perampanel,Vinflunine,The metabolism of Vinflunine can be increased when combined with Perampanel.,increase,no risk
Perampanel,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Perampanel.,increase,no risk
Perampanel,Vitamin E,The metabolism of Perampanel can be increased when combined with Vitamin E.,increase,no risk
Perampanel,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Perampanel.,increase,no risk
Perampanel,Voriconazole,The metabolism of Perampanel can be decreased when combined with Voriconazole.,decrease,no risk
Perampanel,Vortioxetine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Perampanel,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Perampanel.,decrease,no risk
Perampanel,Warfarin,The metabolism of Perampanel can be increased when combined with Warfarin.,increase,no risk
Perampanel,Yohimbine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Perampanel,Zaleplon,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Perampanel,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Perampanel.,increase,no risk
Perampanel,Ziconotide,The risk or severity of CNS depression can be increased when Perampanel is combined with Ziconotide.,increase,risk
Perampanel,Zileuton,The metabolism of Perampanel can be decreased when combined with Zileuton.,decrease,no risk
Perampanel,Zimelidine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Perampanel,Ziprasidone,The risk or severity of adverse effects can be increased when Perampanel is combined with Ziprasidone.,increase,risk
Perampanel,Zolmitriptan,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.,increase,no risk
Perampanel,Zolpidem,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Perampanel,Zonisamide,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Perampanel,Zopiclone,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Perampanel,Zotepine,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zotepine.,increase,no risk
Perampanel,Zuclopenthixol,Perampanel may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Perampanel,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Perampanel.,increase,risk
Gadoxetic acid,Valsartan,The excretion of Gadoxetic acid can be decreased when combined with Valsartan.,decrease,no risk
Gadoxetic acid,Velpatasvir,The excretion of Gadoxetic acid can be decreased when combined with Velpatasvir.,decrease,no risk
Gadoxetic acid,Venetoclax,The excretion of Gadoxetic acid can be decreased when combined with Venetoclax.,decrease,no risk
Gadoxetic acid,Vinblastine,The excretion of Gadoxetic acid can be decreased when combined with Vinblastine.,decrease,no risk
Gadoxetic acid,Vincristine,The excretion of Gadoxetic acid can be decreased when combined with Vincristine.,decrease,no risk
Gadoxetic acid,Voxilaprevir,The excretion of Gadoxetic acid can be decreased when combined with Voxilaprevir.,decrease,no risk
Aflibercept,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Aflibercept is combined with Zoledronic acid.,increase,risk
Asparaginase Erwinia chrysanthemi,Benzocaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Benzocaine.,increase,risk
Asparaginase Erwinia chrysanthemi,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Benzyl alcohol.,increase,risk
Asparaginase Erwinia chrysanthemi,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Bupivacaine.,increase,risk
Asparaginase Erwinia chrysanthemi,Butacaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Butacaine.,increase,risk
Asparaginase Erwinia chrysanthemi,Butamben,The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Butamben.,increase,risk
Asparaginase Erwinia chrysanthemi,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Asparaginase Erwinia chrysanthemi.,increase,no risk
Asparaginase Erwinia chrysanthemi,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Oxetacaine.,increase,risk
Asparaginase Erwinia chrysanthemi,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Asparaginase Erwinia chrysanthemi is combined with Oxybuprocaine.,increase,risk
Asparaginase Erwinia chrysanthemi,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Asparaginase Erwinia chrysanthemi.,decrease,no risk
Carfilzomib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Carfilzomib.,increase,no risk
Carfilzomib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Carfilzomib.,increase,risk
Carfilzomib,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Carfilzomib.,increase,no risk
Carfilzomib,Glasdegib,The serum concentration of Carfilzomib can be increased when it is combined with Glasdegib.,increase,no risk
Carfilzomib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Carfilzomib.,increase,risk
Carfilzomib,Glecaprevir,The serum concentration of Carfilzomib can be increased when it is combined with Glecaprevir.,increase,no risk
Carfilzomib,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Carfilzomib.,increase,risk
Carfilzomib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Carfilzomib.,increase,no risk
Carfilzomib,Guselkumab,The risk or severity of adverse effects can be increased when Carfilzomib is combined with Guselkumab.,increase,risk
Carfilzomib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Carfilzomib.,decrease,no risk
Carfilzomib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Carfilzomib.,increase,risk
Carfilzomib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Carfilzomib.,decrease,no risk
Carfilzomib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Carfilzomib.,decrease,no risk
Carfilzomib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Carfilzomib.,increase,risk
Carfilzomib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Carfilzomib.,increase,risk
Carfilzomib,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Carfilzomib is combined with Hydrocortisone acetate.,increase,risk
Carfilzomib,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Carfilzomib is combined with Hydrocortisone butyrate.,increase,risk
Carfilzomib,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Carfilzomib is combined with Hydrocortisone succinate.,increase,risk
Carfilzomib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Carfilzomib.,increase,risk
Carfilzomib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Carfilzomib.,increase,risk
Carfilzomib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Carfilzomib.,increase,risk
Carfilzomib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Carfilzomib.,decrease,no risk
Carfilzomib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Carfilzomib.,decrease,no risk
Carfilzomib,Ketoconazole,The serum concentration of Carfilzomib can be increased when it is combined with Ketoconazole.,increase,no risk
Carfilzomib,Obinutuzumab,The risk or severity of adverse effects can be increased when Carfilzomib is combined with Obinutuzumab.,increase,risk
Carfilzomib,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Carfilzomib.,increase,no risk
Carfilzomib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Carfilzomib.,increase,risk
Carfilzomib,Olaparib,The risk or severity of adverse effects can be increased when Carfilzomib is combined with Olaparib.,increase,risk
Carfilzomib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Carfilzomib.,increase,no risk
Carfilzomib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Carfilzomib.,increase,no risk
Carfilzomib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Carfilzomib.,increase,no risk
Carfilzomib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Carfilzomib.,increase,risk
Carfilzomib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Carfilzomib is combined with Oxetacaine.,increase,risk
Carfilzomib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Carfilzomib is combined with Oxybuprocaine.,increase,risk
Carfilzomib,Ozanimod,The risk or severity of adverse effects can be increased when Carfilzomib is combined with Ozanimod.,increase,risk
Carfilzomib,Quinidine,The serum concentration of Carfilzomib can be increased when it is combined with Quinidine.,increase,no risk
Carfilzomib,Quinine,The serum concentration of Carfilzomib can be increased when it is combined with Quinine.,increase,no risk
Carfilzomib,Quizartinib,The serum concentration of Carfilzomib can be increased when it is combined with Quizartinib.,increase,no risk
Peginesatide,Brivaracetam,Brivaracetam may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Bromazepam,Bromazepam may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peginesatide,Budesonide,Budesonide may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Bumadizone,Bumadizone may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Bumetanide,Bumetanide may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peginesatide,Bupropion,Bupropion may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Buserelin,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Buserelin.,increase,risk
Peginesatide,Buspirone,Buspirone may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Busulfan,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Busulfan.,increase,risk
Peginesatide,Butabarbital,Butabarbital may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gadodiamide,Gadodiamide may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gadoteric acid,Peginesatide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Peginesatide,Gadoteridol,Gadoteridol may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Ganciclovir,Ganciclovir may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gefitinib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Gefitinib.,increase,risk
Peginesatide,Gemcitabine,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Gemcitabine.,increase,risk
Peginesatide,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Gemtuzumab ozogamicin,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Gemtuzumab ozogamicin.,increase,risk
Peginesatide,Gentamicin,Peginesatide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Peginesatide,Gilteritinib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Gilteritinib.,increase,risk
Peginesatide,Gimeracil,Peginesatide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Peginesatide,Givosiran,Givosiran may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Glasdegib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Glasdegib.,increase,risk
Peginesatide,Glipizide,Glipizide may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Glycerol phenylbutyrate,Peginesatide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Peginesatide,Golodirsen,Peginesatide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Peginesatide,Goserelin,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Goserelin.,increase,risk
Peginesatide,Guanethidine,Guanethidine may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Guanfacine,Guanfacine may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Haloperidol,Haloperidol may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Hydralazine,Hydralazine may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peginesatide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peginesatide,Hydromorphone,Hydromorphone may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Hydroxyethyl Starch,Peginesatide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Peginesatide,Hydroxyprogesterone caproate,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Hydroxyprogesterone caproate.,increase,risk
Peginesatide,Hydroxyurea,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Hydroxyurea.,increase,risk
Peginesatide,Kanamycin,Peginesatide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Peginesatide,Ketamine,Ketamine may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Ketazolam,Ketazolam may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Ketoprofen,Ketoprofen may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Ketorolac,Ketorolac may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Obinutuzumab,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Obinutuzumab.,increase,risk
Peginesatide,Octinoxate,Peginesatide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Peginesatide,Octreotide,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Octreotide.,increase,risk
Peginesatide,Ofatumumab,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Ofatumumab.,increase,risk
Peginesatide,Olaparib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Olaparib.,increase,risk
Peginesatide,Olaratumab,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Olaratumab.,increase,risk
Peginesatide,Olsalazine,Olsalazine may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Olutasidenib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Olutasidenib.,increase,risk
Peginesatide,Omacetaxine mepesuccinate,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Omacetaxine mepesuccinate.,increase,risk
Peginesatide,Opium,Peginesatide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Peginesatide,Oseltamivir,Oseltamivir may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Osimertinib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Osimertinib.,increase,risk
Peginesatide,Oxacillin,Oxacillin may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Oxaliplatin,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Oxaliplatin.,increase,risk
Peginesatide,Oxaprozin,Oxaprozin may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Oxazepam,Oxazepam may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Oxybenzone,Oxybenzone may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Oxyquinoline,Peginesatide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Peginesatide,Quetiapine,Quetiapine may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Quinethazone,Quinethazone may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Peginesatide,Quinidine,Peginesatide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Peginesatide,Quizartinib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Quizartinib.,increase,risk
Peginesatide,Umbralisib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Umbralisib.,increase,risk
Peginesatide,Uracil mustard,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Uracil mustard.,increase,risk
Peginesatide,Urethane,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Urethane.,increase,risk
Peginesatide,Vaborbactam,Peginesatide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Peginesatide,Valaciclovir,Valaciclovir may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Valbenazine,Peginesatide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Peginesatide,Valdecoxib,Valdecoxib may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Valganciclovir,Valganciclovir may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Valproic acid,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Valproic acid.,increase,risk
Peginesatide,Valrubicin,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Valrubicin.,increase,risk
Peginesatide,Vancomycin,Peginesatide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Peginesatide,Vandetanib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vandetanib.,increase,risk
Peginesatide,Varenicline,Varenicline may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Vemurafenib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vemurafenib.,increase,risk
Peginesatide,Venetoclax,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Venetoclax.,increase,risk
Peginesatide,Venlafaxine,Venlafaxine may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Verapamil,Verapamil may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Vilanterol,Peginesatide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Peginesatide,Viloxazine,Peginesatide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Peginesatide,Vinblastine,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vinblastine.,increase,risk
Peginesatide,Vincristine,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vincristine.,increase,risk
Peginesatide,Vindesine,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vindesine.,increase,risk
Peginesatide,Vinflunine,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vinflunine.,increase,risk
Peginesatide,Vinorelbine,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vinorelbine.,increase,risk
Peginesatide,Vismodegib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vismodegib.,increase,risk
Peginesatide,Vorinostat,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Vorinostat.,increase,risk
Peginesatide,Vortioxetine,Peginesatide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Peginesatide,Warfarin,Peginesatide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Peginesatide,Zaleplon,Zaleplon may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Zanamivir,Zanamivir may decrease the excretion rate of Peginesatide which could result in a higher serum level.,decrease,no risk
Peginesatide,Zanubrutinib,The risk or severity of Thrombosis can be increased when Peginesatide is combined with Zanubrutinib.,increase,risk
Peginesatide,Zonisamide,Zonisamide may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Regorafenib,Galantamine,Galantamine may increase the bradycardic activities of Regorafenib.,increase,no risk
Regorafenib,Gefitinib,Regorafenib may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Regorafenib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Gilteritinib,The metabolism of Regorafenib can be decreased when combined with Gilteritinib.,decrease,no risk
Regorafenib,Ginkgo biloba,The metabolism of Regorafenib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Regorafenib,Glasdegib,The serum concentration of Regorafenib can be increased when it is combined with Glasdegib.,increase,no risk
Regorafenib,Glecaprevir,The serum concentration of Regorafenib can be increased when it is combined with Glecaprevir.,increase,no risk
Regorafenib,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Glipizide,The metabolism of Glipizide can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Glofitamab,The serum concentration of Regorafenib can be increased when it is combined with Glofitamab.,increase,no risk
Regorafenib,Glyburide,The metabolism of Regorafenib can be decreased when combined with Glyburide.,decrease,no risk
Regorafenib,Glycerol phenylbutyrate,The metabolism of Regorafenib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Regorafenib,Golimumab,The metabolism of Regorafenib can be increased when combined with Golimumab.,increase,no risk
Regorafenib,Grapefruit,The serum concentration of Regorafenib can be increased when it is combined with Grapefruit.,increase,no risk
Regorafenib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Griseofulvin,The metabolism of Regorafenib can be increased when combined with Griseofulvin.,increase,no risk
Regorafenib,Guanfacine,Guanfacine may increase the bradycardic activities of Regorafenib.,increase,no risk
Regorafenib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Halothane,The metabolism of Halothane can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Hydralazine,The serum concentration of Regorafenib can be increased when it is combined with Hydralazine.,increase,no risk
Regorafenib,Hydrocortamate,The metabolism of Regorafenib can be increased when combined with Hydrocortamate.,increase,no risk
Regorafenib,Hydrocortisone,The metabolism of Regorafenib can be increased when combined with Hydrocortisone.,increase,no risk
Regorafenib,Hydrocortisone acetate,The metabolism of Regorafenib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Regorafenib,Hydrocortisone butyrate,The metabolism of Regorafenib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Regorafenib,Hydrocortisone succinate,The metabolism of Regorafenib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Regorafenib,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Ketamine,The metabolism of Ketamine can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Ketazolam,The serum concentration of Regorafenib can be increased when it is combined with Ketazolam.,increase,no risk
Regorafenib,Ketoconazole,The metabolism of Regorafenib can be decreased when combined with Ketoconazole.,decrease,no risk
Regorafenib,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Regorafenib.,increase,no risk
Regorafenib,Olaparib,The metabolism of Regorafenib can be decreased when combined with Olaparib.,decrease,no risk
Regorafenib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Olutasidenib,The metabolism of Regorafenib can be increased when combined with Olutasidenib.,increase,no risk
Regorafenib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Omaveloxolone,The serum concentration of Regorafenib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Regorafenib,Ombitasvir,Regorafenib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Regorafenib,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Oritavancin,The metabolism of Regorafenib can be increased when combined with Oritavancin.,increase,no risk
Regorafenib,Orphenadrine,The metabolism of Regorafenib can be decreased when combined with Orphenadrine.,decrease,no risk
Regorafenib,Osilodrostat,The metabolism of Regorafenib can be decreased when combined with Osilodrostat.,decrease,no risk
Regorafenib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Oxaliplatin,Regorafenib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Regorafenib,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Oxcarbazepine,The metabolism of Regorafenib can be increased when combined with Oxcarbazepine.,increase,no risk
Regorafenib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Regorafenib is combined with Oxetacaine.,increase,risk
Regorafenib,Oxprenolol,Regorafenib may increase the bradycardic activities of Oxprenolol.,increase,no risk
Regorafenib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Regorafenib is combined with Oxybuprocaine.,increase,risk
Regorafenib,Oxybutynin,The serum concentration of Regorafenib can be increased when it is combined with Oxybutynin.,increase,no risk
Regorafenib,Ozanimod,Regorafenib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Regorafenib,Quinidine,The serum concentration of Regorafenib can be increased when it is combined with Quinidine.,increase,no risk
Regorafenib,Quinine,The serum concentration of Regorafenib can be increased when it is combined with Quinine.,increase,no risk
Regorafenib,Quinupristin,The metabolism of Regorafenib can be decreased when combined with Quinupristin.,decrease,no risk
Regorafenib,Quizartinib,The serum concentration of Regorafenib can be increased when it is combined with Quizartinib.,increase,no risk
Regorafenib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Umbralisib,The serum concentration of Regorafenib can be increased when it is combined with Umbralisib.,increase,no risk
Regorafenib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Vadadustat,The serum concentration of Regorafenib can be increased when it is combined with Vadadustat.,increase,no risk
Regorafenib,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Regorafenib.,decrease,no risk
Regorafenib,Valproic acid,The serum concentration of Regorafenib can be increased when it is combined with Valproic acid.,increase,no risk
Regorafenib,Valsartan,The metabolism of Valsartan can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Vandetanib,The serum concentration of Regorafenib can be increased when it is combined with Vandetanib.,increase,no risk
Regorafenib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Velpatasvir,The serum concentration of Regorafenib can be increased when it is combined with Velpatasvir.,increase,no risk
Regorafenib,Vemurafenib,The serum concentration of Regorafenib can be increased when it is combined with Vemurafenib.,increase,no risk
Regorafenib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Verapamil,The serum concentration of Regorafenib can be increased when it is combined with Verapamil.,increase,no risk
Regorafenib,Vericiguat,The metabolism of Vericiguat can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Viloxazine,The metabolism of Regorafenib can be decreased when combined with Viloxazine.,decrease,no risk
Regorafenib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Vincristine,The excretion of Vincristine can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Vitamin E,The metabolism of Regorafenib can be increased when combined with Vitamin E.,increase,no risk
Regorafenib,Voclosporin,The serum concentration of Regorafenib can be increased when it is combined with Voclosporin.,increase,no risk
Regorafenib,Vorapaxar,The serum concentration of Regorafenib can be increased when it is combined with Vorapaxar.,increase,no risk
Regorafenib,Voriconazole,The serum concentration of Regorafenib can be increased when it is combined with Voriconazole.,increase,no risk
Regorafenib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Voxelotor,The serum concentration of Regorafenib can be increased when it is combined with Voxelotor.,increase,no risk
Regorafenib,Voxilaprevir,The serum concentration of Regorafenib can be increased when it is combined with Voxilaprevir.,increase,no risk
Regorafenib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Regorafenib.,increase,no risk
Regorafenib,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Zafirlukast,The serum concentration of Regorafenib can be increased when it is combined with Zafirlukast.,increase,no risk
Regorafenib,Zidovudine,Regorafenib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Regorafenib,Zileuton,The metabolism of Zileuton can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Zimelidine,The metabolism of Regorafenib can be decreased when combined with Zimelidine.,decrease,no risk
Regorafenib,Ziprasidone,The metabolism of Regorafenib can be decreased when combined with Ziprasidone.,decrease,no risk
Regorafenib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Zonisamide,The serum concentration of Regorafenib can be increased when it is combined with Zonisamide.,increase,no risk
Regorafenib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Regorafenib.,decrease,no risk
Regorafenib,Zuclopenthixol,The metabolism of Regorafenib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Aclidinium,Buspirone,Buspirone may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Aclidinium.,increase,risk
Aclidinium,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Aclidinium.,increase,risk
Aclidinium,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Aclidinium.,increase,risk
Aclidinium,Butorphanol,The risk or severity of adverse effects can be increased when Aclidinium is combined with Butorphanol.,increase,risk
Aclidinium,Butriptyline,The risk or severity of adverse effects can be increased when Aclidinium is combined with Butriptyline.,increase,risk
Aclidinium,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Aclidinium.,increase,risk
Aclidinium,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gadodiamide,Gadodiamide may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gadoteric acid,Aclidinium may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Aclidinium,Gadoteridol,Gadoteridol may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Galantamine,Galantamine may increase the neuromuscular blocking activities of Aclidinium.,increase,no risk
Aclidinium,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Aclidinium.,increase,risk
Aclidinium,Ganciclovir,Ganciclovir may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gemcitabine,Gemcitabine may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Gentamicin,Aclidinium may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Aclidinium,Gimeracil,Aclidinium may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Aclidinium,Ginkgo biloba,Ginkgo biloba may increase the neuromuscular blocking activities of Aclidinium.,increase,no risk
Aclidinium,Givosiran,Givosiran may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Glipizide,Glipizide may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Glucagon,Aclidinium may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Aclidinium,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Aclidinium.,decrease,no risk
Aclidinium,Glycerol phenylbutyrate,Aclidinium may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Aclidinium,Glycopyrronium,The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Aclidinium.,increase,risk
Aclidinium,Golodirsen,Aclidinium may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Aclidinium,Goserelin,Goserelin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Aclidinium.,increase,risk
Aclidinium,Guanethidine,Guanethidine may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Guanfacine,Guanfacine may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Haloperidol,Haloperidol may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Hexafluronium,Hexafluronium may increase the neuromuscular blocking activities of Aclidinium.,increase,no risk
Aclidinium,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Aclidinium.,increase,risk
Aclidinium,Homatropine,The risk or severity of adverse effects can be increased when Aclidinium is combined with Homatropine.,increase,risk
Aclidinium,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Aclidinium.,increase,risk
Aclidinium,Huperzine A,Huperzine A may increase the neuromuscular blocking activities of Aclidinium.,increase,no risk
Aclidinium,Hydralazine,Hydralazine may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aclidinium,Hydrocodone,The risk or severity of adverse effects can be increased when Aclidinium is combined with Hydrocodone.,increase,risk
Aclidinium,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aclidinium,Hydromorphone,The risk or severity of adverse effects can be increased when Aclidinium is combined with Hydromorphone.,increase,risk
Aclidinium,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Hydroxyethyl Starch,Aclidinium may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Aclidinium,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Aclidinium.,increase,risk
Aclidinium,Kanamycin,Aclidinium may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Aclidinium,Ketamine,Ketamine may increase the neuromuscular blocking activities of Aclidinium.,increase,no risk
Aclidinium,Ketazolam,Ketazolam may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Ketoprofen,Ketoprofen may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Ketorolac,Ketorolac may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Octinoxate,Aclidinium may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Aclidinium,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Aclidinium.,increase,risk
Aclidinium,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Aclidinium is combined with Oliceridine.",increase,risk
Aclidinium,Olodaterol,The risk or severity of Tachycardia can be increased when Aclidinium is combined with Olodaterol.,increase,risk
Aclidinium,Olsalazine,Olsalazine may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Opium,The risk or severity of adverse effects can be increased when Aclidinium is combined with Opium.,increase,risk
Aclidinium,Orciprenaline,The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Aclidinium.,increase,risk
Aclidinium,Orphenadrine,The risk or severity of adverse effects can be increased when Orphenadrine is combined with Aclidinium.,increase,risk
Aclidinium,Oseltamivir,Oseltamivir may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Oxacillin,Oxacillin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Oxaprozin,Oxaprozin may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Oxazepam,Oxazepam may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Oxybenzone,Oxybenzone may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Oxybuprocaine,The serum concentration of Aclidinium can be increased when it is combined with Oxybuprocaine.,increase,no risk
Aclidinium,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Aclidinium.,increase,risk
Aclidinium,Oxycodone,The risk or severity of adverse effects can be increased when Aclidinium is combined with Oxycodone.,increase,risk
Aclidinium,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxymetazoline is combined with Aclidinium.,increase,risk
Aclidinium,Oxymorphone,The risk or severity of adverse effects can be increased when Aclidinium is combined with Oxymorphone.,increase,risk
Aclidinium,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Aclidinium.,increase,risk
Aclidinium,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Aclidinium.,decrease,no risk
Aclidinium,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Aclidinium.,increase,risk
Aclidinium,Oxyquinoline,Aclidinium may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Aclidinium,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Aclidinium.,increase,risk
Aclidinium,Quinethazone,Quinethazone may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aclidinium,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Aclidinium.,increase,risk
Aclidinium,Quinupramine,The risk or severity of adverse effects can be increased when Aclidinium is combined with Quinupramine.,increase,risk
Aclidinium,Umeclidinium,The risk or severity of adverse effects can be increased when Umeclidinium is combined with Aclidinium.,increase,risk
Aclidinium,Vaborbactam,Aclidinium may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Aclidinium,Valaciclovir,Valaciclovir may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Valbenazine,Aclidinium may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Aclidinium,Valdecoxib,Valdecoxib may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Valganciclovir,Valganciclovir may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Vancomycin,Aclidinium may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Aclidinium,Varenicline,Varenicline may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Vecuronium,The risk or severity of adverse effects can be increased when Vecuronium is combined with Aclidinium.,increase,risk
Aclidinium,Venlafaxine,Venlafaxine may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Verapamil,Verapamil may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Vilanterol,Aclidinium may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Aclidinium,Viloxazine,Aclidinium may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Aclidinium,Vortioxetine,Aclidinium may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Aclidinium,Warfarin,Aclidinium may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Aclidinium,Xamoterol,The risk or severity of Tachycardia can be increased when Aclidinium is combined with Xamoterol.,increase,risk
Aclidinium,Xylometazoline,The risk or severity of Tachycardia can be increased when Xylometazoline is combined with Aclidinium.,increase,risk
Aclidinium,Zaleplon,Zaleplon may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Zanamivir,Zanamivir may decrease the excretion rate of Aclidinium which could result in a higher serum level.,decrease,no risk
Aclidinium,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Aclidinium.,increase,risk
Aclidinium,Zonisamide,Zonisamide may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Teduglutide,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gadodiamide,Gadodiamide may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gadoteric acid,Teduglutide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Teduglutide,Gadoteridol,Gadoteridol may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Ganciclovir,Ganciclovir may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gemcitabine,Gemcitabine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Gentamicin,Teduglutide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Teduglutide,Gimeracil,Teduglutide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Teduglutide,Givosiran,Givosiran may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Glipizide,Glipizide may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Glycerol phenylbutyrate,Teduglutide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Teduglutide,Golodirsen,Teduglutide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Teduglutide,Goserelin,Goserelin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Guanethidine,Guanethidine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Guanfacine,Guanfacine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Halazepam,The serum concentration of Halazepam can be increased when it is combined with Teduglutide.,increase,no risk
Teduglutide,Haloperidol,Haloperidol may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Hydralazine,Hydralazine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Teduglutide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Teduglutide,Hydromorphone,Hydromorphone may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Hydroxyethyl Starch,Teduglutide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Teduglutide,Kanamycin,Teduglutide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Teduglutide,Ketamine,Ketamine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Ketazolam,The serum concentration of Ketazolam can be increased when it is combined with Teduglutide.,increase,no risk
Teduglutide,Ketoprofen,Ketoprofen may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Ketorolac,Ketorolac may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Octinoxate,Teduglutide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Teduglutide,Olsalazine,Olsalazine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Opium,Teduglutide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Teduglutide,Oseltamivir,Oseltamivir may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Oxacillin,Oxacillin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Oxaprozin,Oxaprozin may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Oxazepam,The serum concentration of Oxazepam can be increased when it is combined with Teduglutide.,increase,no risk
Teduglutide,Oxybenzone,Oxybenzone may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Oxyquinoline,Teduglutide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Teduglutide,Quazepam,The serum concentration of Quazepam can be increased when it is combined with Teduglutide.,increase,no risk
Teduglutide,Quetiapine,Quetiapine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Quinethazone,Quinethazone may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Teduglutide,Quinidine,Teduglutide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Teduglutide,Vaborbactam,Teduglutide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Teduglutide,Valaciclovir,Valaciclovir may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Valbenazine,Teduglutide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Teduglutide,Valdecoxib,Valdecoxib may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Valganciclovir,Valganciclovir may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Vancomycin,Teduglutide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Teduglutide,Varenicline,Varenicline may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Venlafaxine,Venlafaxine may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Verapamil,Verapamil may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Vilanterol,Teduglutide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Teduglutide,Viloxazine,Teduglutide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Teduglutide,Vortioxetine,Teduglutide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Teduglutide,Warfarin,Teduglutide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Teduglutide,Zaleplon,Zaleplon may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Zanamivir,Zanamivir may decrease the excretion rate of Teduglutide which could result in a higher serum level.,decrease,no risk
Teduglutide,Zonisamide,Zonisamide may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bedaquiline,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Bedaquiline.,increase,risk
Bedaquiline,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Bedaquiline.,increase,risk
Bedaquiline,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Bedaquiline.,increase,risk
Bedaquiline,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Bedaquiline.,increase,risk
Bedaquiline,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Bedaquiline.,increase,risk
Bedaquiline,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Bedaquiline.,increase,risk
Bedaquiline,Glasdegib,The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Glasdegib.,increase,risk
Bedaquiline,Glofitamab,The serum concentration of Bedaquiline can be increased when it is combined with Glofitamab.,increase,no risk
Bedaquiline,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Bedaquiline.,increase,risk
Bedaquiline,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Bedaquiline.,increase,risk
Bedaquiline,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Bedaquiline.,increase,risk
Bedaquiline,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Bedaquiline.,increase,risk
Bedaquiline,Haloperidol,The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Haloperidol.,increase,risk
Bedaquiline,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Bedaquiline.,increase,risk
Bedaquiline,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Bedaquiline.,increase,risk
Bedaquiline,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Bedaquiline.,increase,risk
Bedaquiline,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Hydroxyzine.,increase,risk
Bedaquiline,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Bedaquiline.,increase,risk
Bedaquiline,Ketoconazole,The metabolism of Bedaquiline can be decreased when combined with Ketoconazole.,decrease,no risk
Bedaquiline,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Bedaquiline.,increase,risk
Bedaquiline,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Bedaquiline.,increase,risk
Bedaquiline,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Bedaquiline.,increase,risk
Bedaquiline,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Bedaquiline.,increase,risk
Bedaquiline,Omaveloxolone,The serum concentration of Bedaquiline can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Bedaquiline,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Bedaquiline.,increase,risk
Bedaquiline,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Bedaquiline.,increase,risk
Bedaquiline,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Bedaquiline.,increase,risk
Bedaquiline,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Bedaquiline.,increase,risk
Bedaquiline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Oxetacaine.,increase,risk
Bedaquiline,Oxprenolol,The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Bedaquiline.,increase,risk
Bedaquiline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Bedaquiline is combined with Oxybuprocaine.,increase,risk
Bedaquiline,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Bedaquiline.,increase,risk
Bedaquiline,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Bedaquiline.,increase,risk
Bedaquiline,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Bedaquiline.,increase,risk
Bedaquiline,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Bedaquiline.,increase,risk
Bedaquiline,Quizartinib,The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Quizartinib.,increase,risk
Bedaquiline,Vadadustat,The serum concentration of Bedaquiline can be increased when it is combined with Vadadustat.,increase,no risk
Bedaquiline,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Bedaquiline.,increase,risk
Bedaquiline,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Bedaquiline.,increase,risk
Bedaquiline,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Bedaquiline.,increase,risk
Bedaquiline,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Bedaquiline.,increase,risk
Bedaquiline,Venetoclax,The metabolism of Bedaquiline can be decreased when combined with Venetoclax.,decrease,no risk
Bedaquiline,Verapamil,The metabolism of Bedaquiline can be decreased when combined with Verapamil.,decrease,no risk
Bedaquiline,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Bedaquiline.,increase,risk
Bedaquiline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Bedaquiline.,decrease,no risk
Bedaquiline,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Bedaquiline.,increase,risk
Bedaquiline,Viloxazine,The metabolism of Bedaquiline can be decreased when combined with Viloxazine.,decrease,no risk
Bedaquiline,Voriconazole,The metabolism of Bedaquiline can be decreased when combined with Voriconazole.,decrease,no risk
Bedaquiline,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Bedaquiline.,increase,risk
Bedaquiline,Warfarin,The risk or severity of bleeding can be increased when Bedaquiline is combined with Warfarin.,increase,risk
Bedaquiline,Zimelidine,The metabolism of Bedaquiline can be decreased when combined with Zimelidine.,decrease,no risk
Bedaquiline,Ziprasidone,The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Ziprasidone.,increase,risk
Bedaquiline,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Bedaquiline.,increase,risk
Bedaquiline,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Bedaquiline.,increase,risk
Certolizumab pegol,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Certolizumab pegol.,decrease,no risk
Certolizumab pegol,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Bacitracin,Bacitracin may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Baclofen,Baclofen may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Balsalazide,Balsalazide may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Bamlanivimab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Bamlanivimab.,increase,risk
Certolizumab pegol,Baricitinib,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Baricitinib.,increase,risk
Certolizumab pegol,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Belantamab mafodotin,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Belantamab mafodotin.,increase,risk
Certolizumab pegol,Belatacept,The risk or severity of adverse effects can be increased when Belatacept is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Belimumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Belumosudil,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Belumosudil.,increase,risk
Certolizumab pegol,Belzutifan,The metabolism of Belzutifan can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bendamustine,The metabolism of Bendamustine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Certolizumab pegol,Benorilate,Benorilate may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Benralizumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Benralizumab.,increase,risk
Certolizumab pegol,Benserazide,Certolizumab pegol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Benzatropine,The metabolism of Benzatropine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Benznidazole,Certolizumab pegol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Benzocaine,The metabolism of Benzocaine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Benzthiazide,Benzthiazide may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Certolizumab pegol,Benzydamine,Benzydamine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bepotastine,Bepotastine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Bepridil,The metabolism of Bepridil can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Besilesomab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Besilesomab.,increase,risk
Certolizumab pegol,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Betaxolol,The metabolism of Betaxolol can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Bexarotene,The metabolism of Bexarotene can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bezlotoxumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Bezlotoxumab.,increase,risk
Certolizumab pegol,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bicisate,Certolizumab pegol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Bimekizumab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Bimekizumab.,increase,risk
Certolizumab pegol,Binimetinib,The metabolism of Binimetinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bismuth subgallate,Certolizumab pegol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Bisoprolol,Bisoprolol may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Bisoxatin,Certolizumab pegol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Certolizumab pegol,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Certolizumab pegol.,increase,risk
Certolizumab pegol,Blinatumomab,The risk or severity of adverse effects can be increased when Certolizumab pegol is combined with Blinatumomab.,increase,risk
Certolizumab pegol,Boceprevir,The metabolism of Boceprevir can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Certolizumab pegol.",decrease,no risk
Certolizumab pegol,Bortezomib,The metabolism of Bortezomib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bosentan,The metabolism of Bosentan can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Bosutinib,The metabolism of Bosutinib can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Certolizumab pegol.,increase,no risk
Certolizumab pegol,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Certolizumab pegol.,increase,no risk
